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ABSTRACT 
This thesis argues that health policy practices on access to medication in 
Cameroon have been shaped by global health partnerships (GHPs), with the 
result that the capacity of the s t a t ~ ~ has been undermined and the national health 
system fragmented, with no resultant reduction in the incidence and burden of 
malaria and HIV I AIDS. GHPs have played an increasing part in relation to 
access to medication in a number of developing countries in Africa, defined in 
terms of potential and actual access to pharmaceuticals and healthcare services. 
GHPs are supposed to provide a better policy response to the practical problem 
of access to medication by combining the expertise of UN agencies, the 
pharmaceutical industry, international civil society organizations, national 
government and local groups to formulate and implement country-specific 
policies. Ostensibly, they are able to bridge the gap between medical 
technology and the public health needs of poor societies. Neither of these 
claims can be substantiated. 
Theoretical approaches to models, embodied knowledge and social 
constructionism are used to provide a conceptual framework to study the role 
of GHPs on access to medication. GHPs are conceptualised as 'models' that 
occupy the intermediate position between theory and policy practices, within 
which are found three major narratives, based on public health, economistic 
and human rights approaches to the issue of access to medication. These 
narratives became embodied within GHPs, and arc analysed to show how they 
shape different elements of policy practices. The operation of GHPs within a 
i 
'transcalar network', this 'social space' in which global-national-Iocallinkages 
arc formed and interactions take place is also examined. 
Global and national (country-specific) perspectives on the emergence of the 
GHP as a facilitator of access to medication are identified, and the role of 
GHPs in determining national health policy and local delivery practices for 
achieving access to medication for the poor and most vulnerable popUlation is 
investigated. Two programmes in Cameroon are used as case studies: 1) 
National Malaria Programme created on Roll Back Malaria partnership 
guidelines and 2) National HIV/AIDS Programme created on Accelerating 
Access Initiative and Equitable Access Initiative guidelines respectively. 
The empirical evidence from this thesis supports a critical evaluation. GHPs 
emphasise specific medical intervention programmes, and are effective only in 
this narrow technical sense. Even though their efforts have not reduced the 
incidence and burden of malaria and HIV I AIDS, they have legitimised the 
direct intervention of international agencies, private corporations and civil 
society organizations at the local level. The GHPs' pursuit of 'quick results' 
has fragmented the national health system and undermined the role of the state. 
This thesis suggests that the key to reducing disease burden and improving 
public health is a strengthened national health system, one that the current GHP 
model does not offer. Developed to address the supposed failure of African 
states to ensure access to medication, GHPs have further marginalised the role 
of the Cameroon state, thereby reducing its capacity to protect and advance the 
health of its citizens. 
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CHAPTER 1: INTRODUCTION 
1.1 Background 
This is a Science and Technology Studies (STS) thesis about embodied 
knowledge. The case study is the role of global health partnerships (GHPs) on 
access to medication for malaria and HIV / AIDS in Cameroon. In particular, the 
thesis investigates how the embodiment of public health, economistic and 
human rights ideas in GHPs shape policy practices on access to medication in 
African countries and Cameroon, in particular. OHPs have been created to 
provide 'universal access I to medication for the poor in developing countries 
(Huse and Walt, 2000a; Buse and Harmer, 2007; Caines et aI., 2004; Carlson, 
2004). As such, they arc meant to provide, directly or indirectly, a better public 
health policy and better national health system to respond to previous policies 
and systems failures to deal with the rising pandemic of diseases in these 
countries. To achieve these objectives GHPs combine the expertise of global 
UN agencies, the pharmaceutical industry, international civil society 
organizations (CSOs), national governments and local groups in a public-
private partnerships (PPPs) to formulate and implement country-specific 
policies. The often conflicting and competing public health, economistic and 
human rights ideas from these stakeholders, expressed in international 
meetings and conventions as narratives (Ngoasong, 2009) obviously shape 
policy practices. 
This thesis argues that the global and country-specific claims on the capacity of 
OUPs to achieve 'universal' access to medication can be substantiated. 
10 
However, the GHP model is inadequate as a justification for policies aimed at 
correcting the persistent institutional and public challenges facing African 
countries. Such claims are grounded in the prior assumption that medical 
technology, whatever the science behind it, can be adapted in a socially useful 
way to simultaneously increase the commercial interest of the pharmaceutical 
industry and address the healthcare needs of the world's poorest peoples 
(Doyle 2004; Chataway and Smith, 2006; Grace, 2006). This thesis is able to 
demonstrate that the claims for a GHP model, one that can be implemented on 
a country-specific context, lacks credibility in relation to the overemphasis on 
the medical model (which assumes a causal relationship between medical 
technology and health) and the complex dynamics associated with the 
deployment of specific GHP programmes (strategic interests and actions of 
GHP partners, the complexities around the type of diseases being targeted and 
country-specific challenges). This does not undermine the urgent need for the 
global activism put forward by GHPs to combat disease pandemics in 
developing countries. 
'The poor in developing countries are disproportionately affected by 
global diseases like HIV/AIDS, tuberculosis and pneumonia, as well as 
tropical diseases such as malaria, sleeping sickness or river blindness. 
Around 80% of the poor/rich health disparity - measured in avoidable 
health or disability adjusted life years - probably still arises from 
infectious diseases, as it did in 1990. If interventions exist to prevent or 
treat some of these diseases which account for the rich-poor differences 
in health status, these products are not reaching those who need them. 
While neither the public nor the private sector alone can eliminate health 
inequities, focused partnerships involving both sectors have the potential 
to contribute to their reduction.' I 
I Global Forum for Health Research created the Initiative on Public-Private Partnerships for 
Health (IPPPH) in 2000 (defunct end of2004), as a database for global policy responses to 
disease pandemics (http://www.globalforumhealth.org!enlAboutlResearch-initiativesllPPPH) 
(Accessed: 12/10108). 
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Initiated by UN-based agencies, GHPs have been formed to deal with the 
above challenges. Accordingly, medical technology has been suggested by 
high profile personalities and institutions from all over the world as a panacea. 
Notable examples abound on malaria and HIV/AIDS, the two diseases studied 
in this thesis. A joint study by the WHO, LSHTM and Harvard University 
claims that wider use of insecticide-treated mosquito nets (ITNs) could reduce 
malaria infection in Africa by half (UN, 2000a). Similarly, the potential for 
Anti-retroviral therapies (ART) to provide life-sustaining support as a way of 
containing the incidence (and consequently the burden) of the H I V / A I I ~ S S
pandemic in hardest hit regions of the world is well documented (Joseph, 2003; 
UNAIDS/WHO, 2002a). Influential personalities within these institutions do 
not only use this scientific knowledge about the potential for medical 
technology to act as a means of improving the livelihoods and life chances of 
the poor, but also to push for a globally backed strategy (such as those pursued 
by GHPs) in realising it2• They even mobilise world renowned celebrities to 
help promote and popularise global strategies on access to medication.3 
In principle, the above claims appear compelling in the context of disease-
endemic and poverty-ridden African countries. Despite several decades of 
international health policy interventions, Africa remains the hardest hit region 
when talking about the incidence and burden of both communicable and non-
communicable diseases. For example by 2000, Africa accounted for about 80% 
2 Dellamy, C. (1999) 'Public, private and civil society' Statement of UNICEF Executive 
Director to the Harvard International Development Conference on Sharing Responsibility: 
public private and civil society, Cambridge, MA, 16 April; Drundtland, G.H. (2000) Towards a 
strategic agenda for the WHO secretariat: Statement by the Director General to the Executive 
Doard (I OSth session, WHO: ED 1 0512. 
3 E.g. 'Celebrities lend their voices to children's fight against malaria' WHO New Releases 
22/0412004 <http://www.who. int/mediacentre/news/releasesl2004/pr27 len/index.html> 
(Accessed: 01/06/09). 
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of 300-500 million world-wide cases of malaria detectcd annually (WHO, 
2000; Fcachem et aI., 2002:5) and by 2004, 90% of an estimated one million 
world-wide malaria deaths (mostly children younger than 5 years were reported 
in Africa (SheUy, 2004: 319)4. Similarly, HIV/AIDS has hit hardest in Africa 
with about 29.4 million people living with the disease by 2002 
(UNAIDS/WHO, 2002a:6). These examples illustrate the fact that access to 
medication is undoubtedly one of the greatest development challenges in 
Africa. Governments continue to struggle to implement a national health 
system needed to adequately deliver pharmaceutical and healthcare delivery 
while public health measures are challenged by traditional medicine, self-help 
treatments, alternative healings and the inability of the poor households to pay 
the costs of treatment (Essomba, Bryant & Bodart, 1993; WHO, 2002). 
Increased awareness of these health crises has led· to the development of 
innovative measures by a number of agencies to facilitate access to medication, 
and has brought some of the key actors together. Clearly, this new kind of 
approach put forward by GHPs is evidence of failures of previous policy 
efforts, but also when other factors such as the rising disease pandemics, prices 
of patent protected drugs, poverty and the challenges posed by globalization 
(Dodgson, Lee, & Drager, 2002; Piachaud, 2005) come into play. The severe 
lack of reliable access to medication for the 'poorest people' (WHO, 2005: 48), 
demonstrates the failure of African governments to build proper health systems 
capable of ensuring pharmaceutical and healthcare delivery on a sustainable 
4 For progress in the global fight against malaria see WHOIUNICEF (2005a) World Malaria 
Report <http://www.rollbackmalaria.orglwmr2005IhtmVintroduction.htm> (Accessed: 
21101107). 
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basis.' Thus, to achieve 'universal access' to medication in Africa many factors 
need to be considered by GIIPs. Most notable are the nature of the health 
problem (which is related to public health), the resource constraints (which are 
rooted in economics) and the very nature of OHPs at global, national and local 
levels (which is related to institutional refonns). 
Malaria and HIV / AIDS are typical disease areas to illustrate the nature of the 
above challenges. Having survived over 4000 years of human history,6 malaria 
continues to be described as a disease of poverty caused by high annual 
entomological inoculation rates (EIR), tropical location of countries, 
population growth and movements, poor housing conditions, drug resistance 
and insufficient capacity of the health care system to deliver anti-malarial 
interventions (Gallup and Sachs, 2001; Feachem et aI, 2002). While it was 
successfully eradicated in Europe and North Africa by the 1960s, it continues 
to take the lives of 700,000 African children annually and costing the continent 
$3·12 billions each year (UN, 2000a): 'Malaria is taking costly bites out of 
Africa ... It is feasting on the health and development of African children and 
draining the life out of African economies.,7 
As a sexually transmitted disease, HIV / AIDS, despite being a more recent case, 
also poses daunting societal and resource constraints. First detected in 1981, 
IIIV/AIDS quickly became a global pandemic with statistics showing up to 10 
S Statistical evidence from various editions of the Human Development Reports is often cited 
by proponents of OUPs to demonstrate the lack of access to medication in Africa. 
6 More history on malaria: <http://www.cdc.gov/malarialhistory/index.htm> (Accessed: 
IS/01l07) 
7 Former WHO Executive Director Dr. David Navarro speaking during the launching ofthe 
Africa summit to Ro1\ Dack Malaria in Ahuja, Nigeria (UN, 2000a). 
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million people infected in 1990 (UNAIDS, 2000) and 38 million by the end of 
2003 (UNAIDS, 2004: 190). By 2002, the total number of deaths caused by 
HIV/AIDS had exceeded 20 million with Africa being the hardest hit region 
(UNAIDS, 2002: 5). Highly active ARTs that went into circulation in 1996 
promised life-sustaining support for people infected by the disease. With 
US$8-10 average per capita spending on health for least developed countries 
(Dodd and Cassels, 2006:383) way below $10.000-15.000 for ART treatment 
in 1996 (Joseph, 2003:428), African countries struggled to contain the rising 
incidence and associated socio-economic burden of HI VIA IDS. 
Apart from the above public health and economic challenges, the debate 
around the spread of HIV I AIDS in the face of high treatment costs in the late 
1990s put the recognition of human rights as an essential element of public 
healtl1 policy on the global agenda, a concept that was only made implicit 
previously (Mann, 1999). The advocacy efforts of influential personalities such 
as former WHO Director Jonathan Mann (Fee and Parry, 2008), the rise of 
international civil society activism in response to economic globalization in the 
pharmaceutical industry and political activism by African leaders (Hill, 2006: 
156-157)8 made it even more urgent that a new kind of global approach to 
policy practices was needed to deal with the HIV / AIDS pandemic. 
From the above perspectives, proponents claim that GHPs can help developing 
countries such as those in Africa to improve access to diagnosis and treatment 
and to develop better scientific and institutional mechanisms for the detection 
• ACP-UP (2000) 'Treatment for all ... NowP Global Manifesto, Durban, South Africa 
<http://www.actupny.orglreportsldurban-access.html> (Accessed: 21/09/08). 
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and management of epidemics such as HIV / AIDS and malaria. They recognise 
that 'treatment is technically feasible in every part of the world,9 as long as 
there is political will and 'sustainability of drug financing' (WHO, 2002a: 9). 
Apart from mobilising political will and funding, GHPs are also needed to 
create a national health system capable of distributing medicines and care 
facilities as well as delivering general healthcare services (Holms, 2001) 
irrespective of the abilities of governments and households to pay. to The PPP 
approach, haven worked in previous international campaigns such as the 
Mectizan Donation Programme, is being adopted by GHPs to address other 
disease areas (Etya'ale, 1998; Peters and Philips, 2004). 
Despite the optimism about the role of GHPs as a panacea to the problem of 
access to medication in developing countries, technical studies commissioned 
by UN agencies and their affiliated academic institutions point to many 
controversial issues: the co-option of the values of African partners by UN 
agencies; overemphasis on reconciling the interest of UN-based agencies and 
private corporations; neglect of interfaces between institutions and structures of 
national vis-A-vis global health governance and the potential for GHPs to 
fragment or overwhelm Africa's national health systems. ll These issues point 
our attention to the need to clarify some of these global controversies by 
exploring the practical ways in which medical technologies (such as deployed 
9 Statement by Dr Peter Piot, Executive Director, Joint United Nations Programme on AIDS 
during the International AIDS Conference in Barcelona, July 2002 (WHO, 2002:9) 
10 WHOIUNICEF (2003) Africa Malaria Report; WHO, Geneva; WHO (2002) 'Scaling up the 
response to infectious diseases: A way out of poverty' Ch 3:42-60, Geneva, Switzerland. 
<http://www. who.intlinfectious-disease-reportl2002/pdfversionlCh2HealthServices.pdf.> 
(Accessed: 211 I 0/07) 
II Details ofa combination of the issues raised here can be found in the following GHP studies: 
Frost and Reich 1998, Kickbusch & Quick 1998, Holm 200 I, Buse 2004a, Caines and Lush 
2004, Nishter 2004, Richter 2004a, 2004b, Piachaud 2005. 
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by GHPs) can be linked to the specific needs of the poor in developing 
countries through a country-specific empirical study. 
GHP evaluations focus on statistical data that attempt to prove that global 
targets are met in the context of disease-endemic countries. More recently 
precise claims about 'localising' GHPs by applying programmes to meet 
country-specific needs are beginning to emerge. It marks a potential departure 
from the dominant terms of the debate, which initially revolved around global 
statistics, global policy documents in various regions of the world. Most GHPs 
are increasingly claiming to target global policies to the treatment of diseases 
in African country-context (WEF, 2005; Martens, 2007) and funding of R&D 
for Africa's diseases (Grace 2006). Yet, there remain some unanswered 
questions about the feasibility of GHPs solving the medical and healthcare 
needs of the poor in African countries, beyond the narrow objective of access 
to medicines, especially integrating GHP programmes as part of the national 
health systems (Carlson, 2004; Caines and Lush, 2004; Caines et aI., 2004). 
Apart from the issues above, Buse and Walt (2000b) had already identified two 
major challenges to be addressed for GHPs to claim country-specific 
achievements. First, it is not clear if GHPs have in fact succeeded in targeting 
resources at health problems and opportunities to strengthen existing 
infrastructures (such as the national health system). Second, the extent to which 
GHPs involve the national government (such as the Ministry of Health 
officials) in creating and implementing programmes and activities remains 
debatable. These claims, often reported in policy documents and technical 
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reports of GHPs (or individual GHP partners), need to be investigate through 
theoretically-informed country-specific empirical studies. 
What we see from the discussion above is a problem of health development in 
the context of globalization, the interplay of GHPs and established bodies of 
thoughts (for example public health, economics and human rights) in both 
understanding and shaping institutions and local practices on access to 
medication. In many ways, each of these bodies of thoughts is relevant for 
achieving access to medication. In public health, ideas shape efforts to define 
the causes of diseases and their remedies as well as the process of developing 
preventive health policy (Tesh, 1988). In economics, ideas are powerful 
political weapons used by decision makers to shape the direction of the 
economy (Blyth, 2002) with implications for public health. Furthermore, it is 
no longer surprising to hear about the unavoidable significance of human rights 
ideas in the conceptualisation of health policy and practice (Mann et a1., 1999). 
Nevertheless what appears to be crucial in the case of GHPs is the interplay of 
ideas (or forms of knowledge) from public health, economics and human rights 
in relating to access to medication (e.g. N goasong, 2009). This is where the 
notion of embodied knowledge found in SIS (MacKinzie, 2006) becomes 
useful for understanding the role of GHPs on access to medication. An STS 
approach involves analysing the link between technology and policy by side-
stepping into established bodies of thoughts to uncover the scientific and 
technical expertise and the non-technical communications that are contributing 
to the production of context-sensitive knowledge (Gibbons, 2000: 162). 
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The technology, in this case of GHPs is the medically-based interventions and 
the dominance of the medical modcl promoted by the main global partners. 
The policy is the PPP approach that exists at global, national and local levels 
for ensuring that this technology is able to facilitate access to medication. In 
this case, GHPs breach the gap between technology and the public health needs 
of society. The concept of 'access to medication' used by GHPs appears 
therefore to represent the combination of the simultaneous pursuit of collective 
activism (or global citizenship) and good medical technology/science. If GHPs 
can achieve access to medication for the poorest segment of the global society, 
then proponents would have a powerful case for the implementation of this 
'global model' in all countries of the world. 
1.2 Objectives and Research Questions 
The above optimism, questions and controversies reveal that the relationship 
between GHPs and access to medication is an interesting one. They all point to 
country-specific needs in relation to access to medication, the broader political 
economy of healthcare and the respective roles played by global (multilateral 
and bilateral organizations, MNCs, !NGOs) and local (government, public and 
private sectors, civil society) actors in shaping the prospects of GHPs to 
facilitate access to medication in specific African countries. One question that 
begs to be explored in this debate is: what exactly is 'access to medication' and 
how best can GHPs deliver it in the context of the poor in Africa? In other 
words, how does the emergence of GHPs relate to the meanings ascribed to, 
and the country-specific barriers to 'access to medication'? Answering the 
above questions provide the basis for assessing the case for GHPs solving the 
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country-specific policy and institutional challenges relating to access to 
medication in African countries. 
The aim of this thesis is therefore to investigate the role of GHPs in 
determining policy and local practices on access to medication in Cameroon. 
The validity of claims that by providing access to medication for the poor 
implies GHP can deal with disease pandemic in African countries is 
interrogated through a set of inter-related investigations. First the underlying 
assumptions about the role of GHPs in Africa are analysed, which includes the 
global, national and local perspective on the emergence of GHPs as a new kind 
of model on access to medication. Second, the interplay of different 
constructions of 'access to medication' by the wide range of actors involved in 
GHPs is explored to bctter understand how the GHP model relates to the nature 
of the health problem. Both investigations are pursued within the analytical 
framework of models and the notion of embodied knowledge. Two case studies 
on GHPs for malaria and HIV/AIDS treatment and control in Cameroon 
respectively provide the setting for these investigations, leading to a 
comparative insight (one country with multiple disease areas in which GHPs 
are actively involved). The findings, in conjunction with the data from the case 
studies, provide the basis for an appropriate and well-informed consideration of 
thc feasibility of GHPs solving the pharmaceutical and healthcare needs of the 
poor in African countries. 
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The specific research questions for this thesis are based on previous research 
on the conceptualization of 'OllP' and 'access to medication' and the 
relationship between the two terms. Although PPP appears to be the core term 
(Buse and Walt, 2000a: 550), Buse and Harmer (2007) propose the term OHPs 
to signify the shift away from geopolitical or historical relations towards more 
selective partner-recipient commitments, longer time horizons, responsiveness 
to recipient priorities and equality. This definition is relevant in this research 
because it best captures the involvement of non-state actors (NO Os, 
foundations, community groups), private industry, multilateral and bilateral 
agencies, and governments. OHPs can be categorised under three broad 
headings: policy-oriented organizations (Caines et aI., 2004), institutionalised 
forms of organization (Buse and Harmer, 2007) and organizational ventures 
(Kaul, 2006). 
Ngoasong (2009) identifies three narrative strategies used to relate to access to 
medication: public health (WHOIUNICEF), economistic (WTOIIMF/Worid 
Bank) and human rights (UNDHR) narratives respectively. The formation of 
OHPs is an attempt to pursue a global strategy on access to medication by 
integrating these narratives. Accordingly, the nature of demand and supply 
sides of access to medication (problem-oriented, patient-oriented, demand-
oriented) and the necessary levels of commitment expected at global, national 
and local levels need to be understood in the context of these narratives, as well 
as the multi-stakeholder nature of OHPs. This involves investigating how the 
narrative strategies of GHPs partners are aligned and integrated with those of 
national governments and local communities as well as the opportunities for 
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continued dialogue to coordinate the efforts of global, national and local actors 
in providing access to medication for the poor. 
The specific research questions that this thesis will answer are: 
1. How best can the role of GHPs in facilitating access to medication be 
understood? 
2. How does the global perspective on the emergence of GHPs relate to 
the history of the political economy of health development in 
Cameroon? 
3. What effects do global-national-local linkages have on the effectiveness 
of GHP programmes? 
4. What are the challenges of all the above for the future role of GHPs? 
Access to medication is defined in this thesis in terms of potential access (the 
presence of health care) and realized access (the actual use of health services) 
(Andersen, 1995). Potential access include the availability and accessibility of 
healthcare taken into account the infrastructure needed to reduce the rural-
urban differential and the time to reach a health facility for the poorest persons. 
Realised access is related to quality and acceptability of public health measures 
(preventive and curative) in relation to traditional medicine, self-help 
treatments, alternative healings and the costs of treatment (Essomba et aI., 
WHO, 2002; 2005). 
Despite the working definition of access above, it is ultimately the ways in 
which various GHP partners' conceptualised 'access' (whether potential or 
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actual) that determincs the ways in which GHPs grapple to meets their target 
objectives. In order to investigate these questions the next section presents a 
brief description and justification of the theoretical and methodological 
framework and the choice of Cameroon as the setting for empirical case study 
analysis. The structure of the constituent chapters is then presented, giving 
brief overviews of their contents. 
1.3 Framework and Methodology 
The discussion on the emergence, conceptualisations and typologies of GHPs 
reveals different manifestations of public health, economics and human rights 
narratives by key actors and institutions whose existence directly or indirectly 
implicate the creation of GHP models. Buse and Walt (2000a: 551) illustrates 
this in terms of ideological shifts informed by changes in economic philosophy 
and socio-political orthodoxy in UN-based agencies. This suggests that each 
narrative represents a form of knowledge; each emerged from previous 
theoretical models and later expressed in international meetings for 
incorporated into GHP programmes. The notion of transcalar networks is used 
to conceptualise the 'social spaces' through which global, national and local 
interactions take place in a GHP context12• The three narratives play important 
roles both in the construction of access to medication in GHPs and the 
constitution of transcalar networks (global-national-local linkages) through 
which different GHP partners contribute to policy making and implementation. 
12 The notion oftranscalar network for policy transfer and implementation is developed further 
in Chapter 2 as a better conceptualisation of interactions between global, national and local 
GHP partners. It is preferred to transnational networks used to study international health policy 
transfers (e.g. Reich 1995, Walt et at. 2004) as it better reflects the contemporary era of 
globalization (Castells 2000, Compagnon 2008) 
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This thesis therefore builds on the theoretical literature on models and the 
notion of embodied knowledge to provide a conceptual framework on which 
these claims can be examined in more detail. Specifically, the framework 
illustrates the basis on which the three narratives on access to medication are 
embodied in GHPs, and how the emergent GHP model in tum shapes policy 
practices on access to medication. The study of GHPs as models is relevant in 
two ways. Firstly, it highlights where to look for answers to questions on GHPs 
that are not captured by the development studies literature. This is achieved by 
unpacking the systematic forms of knowledge (MacKenzie, 2006) deployed in 
(medical) technology and with their social infrastructure (Callon, 1991). 
Secondly, it reveals the extent to which the models link theory and practice, 
and the opportunities they offer to introduce new practice elements in the 
models to better reflect practice settings (Cartwright, 1983; Morgan and 
Morrison, 1999). Accordingly, the thesis conceptualises GHPs as 'models' that 
occupy the intermediate position between theory and policy practices and 
analyses how the public health, economistic and human rights narratives 
embodied within the GHP model shape different elements of policy practices 
on access to medication. 
The analytical tool is social constructivism, a social science perspective that 
can be used for understanding global institutions (Boas and McNeil, 2004), but 
which so far has received limited attention in the case of GHPs. Within this 
approach narrative policy analysis (NP A) has been selected as the method of 
empirical analysis. NPA relies on 'the explanatory power of story' (Kaplan, 
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1986), 'drama' and 'historical narratives' in understanding 'big decisions' 
(Krieger, 1986; Doron, 1986; Roe, 1989; Feldman et aI., 2004). Accordingly, it 
allows us to conduct a content and context analysis of the 'range of complex 
characteristics and distinctive narratives' surrounding the contexts within 
which GHPs grapple with meeting targets for successful healthcare delivery in 
Africa (Ngoasong, 2009:950). This involves a systematic reading and analysis 
of secondary literature (policy documents, technical reports, books, and journal 
and magazine articles) and qualitative interviews with representatives of 
selected global, national and local partners of two GHP programmes in 
Cameroon: 
I. The National Malaria Programme created after Cameroon endorsed 
the WHOIUNICEF-led Roll Back Malaria partnership (RBM). The 
RBM puts forward a public health narrative that 'aims to help African 
families create a mosquito-free zone in the home,13 by creating a tri-
sectoral network (global, regional and local levels) to strengthen 
national health systems to reduce malaria mortality by half by 2010 
(WHO 2000a; WHOIUNICEF, 2005). The functional focus of the RBM 
is advocacy coordination (Buse, 2004a:227). It seeks to hannonise or 
bring strategic c o n s i s t e ~ c y y to the approaches of various actors to single 
diseases, as well as to raise the profile of the disease on the health 
policy agenda (Buse and Walt, 2000b:702). 
II. The National IIIV/AIDS Programme created after Cameroon 
endorsed two GHPs: 1) Accelerating Access Initiative (AAI) launched 
13 RBM Campaign Manager Dr. Awash Teklehaimanot (UN, 2000a) 
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in May 2000 by five UN agencies and five pharmaceutical companies l4 
to facilitate access to patent-protected lIlV I AIDS medication through 
discounted pricing (UNAIDS/WHO, 2002); 2.) Equitable Access 
Initiative (EAI), a human rights model promoted by Medecin Sans 
Frontiere (MSF) to facilitate access to generic treatment in poor 
countries through generic competition (MSF, 2002). The functional 
focus of the AAI is to broker price discounts for patent-protected drugs 
through negotiations between developing country governments and 
pharmaceutical companies (Buse 2004a:227) while the EAI performs 
the same function, but with generic manufacturers. 
In terms of potential access, both RBM and AAI attempt to empower 
governments to emphasise health system strengthening through political 
commitment and capacity development (Caines et a1. 2004, Carlson 2004, Buse 
and Harmer 2007:261). The choice of Cameroon is very instructive. Apart 
from its rich colonial, political economy and cultural-ethnic diversity (Kofele-
Kale, 1986; DeLancey and Mokeba, 1990; 2000), Cameroon has always been 
one of the first African countries to endorse international/global initiatives and 
therefore presents a rich historical context in which the emergence and impacts 
of GHPs in Africa can be understood. The choice of GHPs from two disease 
areas is also very significant, malaria with a long history of failed eradication 
campaigns on the one hand and HIV/AIDS (with a shorter history) as one of 
the most popularised global pandemic. The two case studies from Cameroon 
14 (WHO, UNICEF, UNPF, World Bank, UNA IDS) and (Boehringer Ingelheim; Bristol Myers 
Squibb; F. Hoffman-LaRoche; G1axoSmithKline; Merck and Co., Inc; Pfizer); Abbott and 
GiJeadjoined the initiative two year later). 
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therefore allows for a nuanced analysis of the country-specific role of OlIPs in 
shaping polices on access to medication. 
1.4 Organization of Thesis Chapters 
The second chapter develops in detail the conceptual framework that will be 
used to study OHPs in this thesis. It begins with a more detailed overview of 
the reasons why OHPs have proved to be controversial despite their popularity, 
why the needs of the poor initially seem cogent with regards to the situation of 
Africa's poor and the importance of the way access to medication is 
constructed in the study of OHPs. It then justifies the use of theoretical 
literature on models by reviewing its interpretations and ramifications in the 
philosophy of science, management science and social sciences. The notion of 
embodied knowledge is justified as a suitable theoretical framework for the 
study of models. This approach has already been used to analyse the 
relationship between models and policy practices in socio-technical systems 
(Calion, 1991; King and Kraemer, 1992) and global financial markets 
(MacKenzie, 2006). However, a review of theoretical approaches to the study 
of global institutions reveals that, it has not been applied in a social policy 
arena, such as those in which OHPs operate. A social constructivist approach 
(Boas and McNeil, 2004), notably NPA (Ngoasong, 2009) is shown to be 
consistent with the theoretical literature on models and provides a useful 
framework for analysing the transcalar networks through which OHPs shape 
policy practices on access to medication. 
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The third chaptcr explains the social constructionist qualitative case study 
mcthodology to the study of GHP programmes. The critical assessment of the 
links between the range of complex characteristics and distinctive narratives 
constitutive of GHP programmes begins with a re-examination of the agenda of 
researching transcalar networks. It then follows Kaplan (1986), Krieger (1986), 
Roe (1989), Feldman et ai., (2004) and Ngoasong (2009) to develop a 
methodology for the identification and study of the relevant contextual features 
in the policy processes and structures enacted by GHPs in Cameroon. This 
methodology is developed to study the implicit and explicit forces, which 
constitute transcalar networks (global-national-local linkages) constituting 
GHP programmes. 
Chapter four presents the link between public health, economistic and human 
rights narratives on access to medication including the key actors and 
institutions who initiated them. In particular, the chapter presents the global 
perspective on the emergence of GHPs. It begins by investigating the 
theoretical origin of development models from which each of the public health, 
economistic, and human rights narratives emerged from the early 1900s and 
how they came to play important roles in GHPs from the late 1990s. It then 
describes how each of these narratives are embodied in RBM, AAI and EAI 
(three GHP models studied in this thesis). 
Chapter five presents the historical and contextual background of the case 
studies by exploring the emergence of GHP programmes in Cameroon. It aims 
to extrapolate the main history of state building, the most important actors and 
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institutions and the context in which GHP models come to play an important 
role on access to medication. What emerges is that GHP programmes represent 
the embodiment of competing development models that were previously 
implemented in Cameroon during the colonial and post-colonial periods. The 
historical context presents for analysis of how donor-recipient commitments 
(North-South divide) and the centrality of the state (pre-GHP era) have been 
replaced by public-private partnerships that tend to bypass the state to better 
serve the local communities (GHP era). This blurring of the boundaries of 
North-South relationships is crucial in detennining the role of specific GHP 
programmes on access to medication. 
Chapter Six presents the first case study findings and analysis on the National 
Malaria Programme in Cameroon. It applies the theoretical framework 
developed in chapter two to answer the research questions. Following the same 
approach, Chapter Seven presents the second case study findings and analysis 
on the National HIV/AIDS Programme in Cameroon. Finally, conclusions, 
policy implications and the theoretical contributions of this research are 
presented in Chapter Eight. 
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CHAPTER 2: UNDERSTANDING THE 
DEVELOPING ROLE OF GLOBAL HEALTH 
PARTNERSHIPS: A REVIEW OF THE KEY 
LITERATURE 
2.1 Introduction 
The objective of this chapter is to develop a conceptual framework for studying 
the role of GHPs in determining policy practices on access to medication. The 
chapter argues that the theoretical literature on models and the notion of 
embodied knowledge found in STS can be combined with social 
constructionist international relations theory when studying GHPs. 
Accordingly, the theoretical framework developed conceptualises GHPs as 
models that occupy the intermediate position between theory and policy 
practices. To develop such a theoretical framework the chapter reviews four 
key sets of literature each of which make a contribution to the generation of an 
effective conceptualisation and analysis of the role of GHPs on access to 
medication. 
The first section reviews the literature on the definitions and meanings of 
GHPs and access to medication. It identifies the key actors in global health and 
their respective narrative strategies in relating to access to medication. The 
reason why the notion of GHPs has proved to be controversial despite being 
highly popular with UN agencies is evident from the fact that the definitions 
and typologies of GHPs do not explicitly define access to medication (and 
30 
consequently the best policy measures to achieve it). However, a review of the 
historical context in which GHPs emerge in Africa suggests that access to 
medication is a historical construct that enables GHPs (through UN agencies) 
to introduce policy issues on a global and national level. The historical contexts 
describes GHPs as an attempt to integrate three previously conflicting 
constructs (or narratives) on access to medication - public health, human rights 
and economistic. More importantly, it reveals why the needs of the poor 
initially seem cogent with regards to the situation of Africa's poor and the 
importance of the way access to medication is constructed in the study of 
GHPs. 
The second section reviews the literature on the relationship between theory, 
models and policy practices from science, social science and SIS perspectives 
respectively. It argues that the notion of embodied knowledge is useful for 
explaining the sociology of knowledge embedded in GHPs. While this 
approach has mostly been applied to socio-technical systems, recent 
applications in more social policy settings suggests that it can successfully be 
applied to a global health policy domain such as the study of GHPs and access 
to medication. A case is therefore made for GHPs to be conceptualised as 
models that mediate between theory and practice as a way of understanding 
their emergence and their role in shaping policy practices. 
The third set of literature focuses on the theoretical approaches to the study of 
global institutions (Boas and McNeil, 2004), with emphasis on those relevant 
for the study of GHPs. The analysis suggests that a social constructivist 
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approach, which so far has received very limited attention in the study of 
GHPs, is more suitable than liberal/neo-liberal perspectives (which to date 
dominate the literature and interpretations), realist and neo-Gramscian theories 
in international development. In view of this social constructivist perspective, 
the notion of transcalar network is introduced as a way of conceptualising the 
'social space' through which global, national and local interactions take place 
within a GHP context while narrative policy analysis (NPA) is presented as the 
method of analysing these interactions. An STS perspective on the role of 
models in policy practices is consistent with a constructivist approach (the 
social construction of technology) and provides a useful framework for 
investigating the role of GHP models in access to medication. 
The fourth section explains further the choice of transcalar networks and NP A 
for conceptualising and analysing GHPs as models. Firstly, theoretical 
concepts from policy transfer (Dolowitz and Marsh 2000), multi-level 
governance (Marks 1993, Marsh 1998), and the 'politics of scale' (Brenner 
2001) are used to conceptualise the policy transfer process in GHPs as taking 
place within transcalar networks (global-national-local linkages). Unlike 
rational planning approaches proposed by liberal interventionists (Dodgson et 
aI., 2002), GHPs rely on negotiating and integrating competing narratives, 
advocacy and sometimes activism in formulating global policies (Ngoasong, 
2009) that are transferred to developing countries. NP A then becomes useful 
for uncovering the key policy agendas that often remain hidden (mostly 
implicit) in global and national policy documents and technical reports. 
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Finally, the theoretical framework for studying the role of GHPs on access to 
medication is presented. Conceptualising GHPs as models that mediate 
between theory and practice enables us to better understand the ways in which 
GHPs are able to develop a global language and a single global strategy that is 
supposed to be used to shape national health policy and local delivery practices 
on access to medication in poor countries. The competing and conflicting 
narratives on access to medication and the strategic objectives of GHPs 
partners represent manifestations of forms of knowledge within GHPs leading 
to the creation of GHP models. These manifestations in tum explain why there 
are specific GHPs for specific diseases areas, why certain GHP 'models' are 
favoured in specific countries and contexts, the factors perceived to have 
driven African countries to embrace GHPs and the impact of GHP on access to 
medication. 
2.2 GHPs and Access to Medication - Definition of Key 
Terms 
Since the late 1990s, GHPs have being formed to provide a global collective 
response to the problem of access to medication in developing countries. 
Understanding what GHPs are is useful in understanding how they are 
modelled and how they are expected to shape policies on access to medication 
to achieve their target objectives. This section presents the different ways in 
which GHPs have been defined and their relationship to the meaning of access 
to medication in the context of African countries. 
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2.2.1 Definition and typologies of GHPs 
Most studies on GHPs have focused on defining what a GHP means, 
discussing how they can be conceptualised and examining their impact on 
access to medication. In the presence of confusion over a generic definition of 
the term GHP, Utting and Zammit (2006, iv) over-state the case with their 
claim that the term GHP has become an 'infinitely elastic concept'. Typical of 
the various definitions is the use of terms such as partnership, public-private, 
global and trans-national or cross-border. 
Partnership appears to be the core term. Pearson (1969) used partnership to 
signify the relationship between donors (e.g. WHO, World Bank) and recipient 
countries (poor and disease-endemic countries), based on reciprocal rights and 
obligations and the establishment of clear objectives that are beneficial to both 
parties. Later conceptualisations focus on broader 'development' partnerships 
(World Bank 1998) that stress the need to include the ethical principles of 
'beneficence, non-maleficence, autonomy and equity' (WHO 1999:4). This 
perspective calls for the need for partnerships to lead to public health gains, 
improve health and healthcare, respect the autonomy of all stakeholders and 
distribute benefits to those who need them most. 
In a study of post-1990 partnerships, Buse and Walt (2000a: 550) propose the 
term global pUblic-private partnerships (GPPPs) for health development. It 
refers to 'a collaborative relationship which transcends national boundaries and 
brings together at least three parties, among them a corporation (and/or 
industry association) and an intergovernmental organization, so as to achieve a 
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shared health-creating goal on the basis of a mutually agreed division of 
labour.' 
From the above definition, Buse and Harmer (2007) propose the term global 
health partnerships (GHPs) to signify the shift away from geopolitical or 
historical relations towards more selective partner-recipient commitments, 
longer time horizons, responsiveness to recipient priorities and equality. This 
definition is relevant in this research because it best captures the involvement 
of non-state actors (NGDs, foundations, community groups), private industry, 
multilateral and bilateral agencies, and governments. Consistent with the above 
definitions of GHPs, there are three broad categories or typologies of GHPs: 
policy-oriented organizations (Caines et aI., 2004), institutionalised forms of 
organization (Buse and Harmer, 2007) and organizational ventures (Kaul, 
2006). 
GHPs as policy-oriellted orgallizatiolls 
Caines et ai., (2004) provide a comprehensive study on GHPs as policy-
oriented organizations that pursue a combination of four objectives. 1) 'product 
discovery and development of new diagnostics, drugs and vaccines'; 2) 
'support improved service access, may provide discounted or donated drugs, 
and give technical assistance'; 3) 'raise the profile of the disease and advocate 
for increased international and/or national response, and resource mobilization' 
and 4) 'provides funds for specific disease programs'. This descriptive, policy-
oriented conceptualisation illustrates that GHPs can be categorised within more 
than one typology. Buse and Harmer (2007: 260) note that approximately 80-
100 GHPs created in the last two decades fit into this policy-oriented typology. 
3S 
They argue that better criteria for evaluating GHPs should focus on broad 
composition and the presence of actors from all sectors in board-level decision-
making processes, an approach they use to reduce the number of GHPs to 23. 
GIIPs as illstitlltiollal relatiolls 
According to Buse and Harmer (2007), GHPs are institutional forms of 
organization through which private actors participate in the strategic level 
decision-making in the public's interest. They identify three sub categories of 
GHPs: 1) Elite Committee models where relative equality of partners ensures 
negotiations lead to consensus (citing the Accelerating Access Initiative as a 
typical example); 2) NGO Model emphasises delegation and resource transfer 
(such as the work of international NGOs and community organizations); 3) 
Quasi-public authority model is one where a hybrid organization with both 
public and private characteristics is created by public sector institutions (citing 
both the AAI and the RBM as having these attributes). The notion of 'hybrid' 
is useful in this categorization because it reveals the multi-stakeholder 
character of GHPs as captured in the definition of GHPs by Buse and Harmer 
above. 
GIIPs as orgallizatiollal vellture 
Kaul (2006) proposes a comprehensive typology that can be used to classify 
GHPs as organizational ventures, that is, a purposeful or industrious 
undertaking that requires readiness and boldness. In this typology he 
distinguishes between domestic and global PPPs, showing the latter to be more 
effective for leveraging resources for infrastructure developments such as 
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'construction and operation of airports, hospitals, roads' in relation to the 
largely state-centric models of the World War II era (Kaul, 2006:219). Through 
a study of 100 GPPPs, he presents 'three venture classes and seven functional 
types' of partnerships (business ventures, double-bottom line ventures and 
social ventures), designed to provide a working analytical model through 
which partnerships can be examined and conceptualised (p. 223). Within this 
typology the social venture class and two functional types (Type 5 and Type 6) 
are particularly applicable to GHPs since they capture issues that are related to 
the policy-oriented typologies of Caines et aI., (2004) and Buse and Harmer 
(2007) discussed above. The social venture class refers to global partnerships 
(such as GHPs) that are 'oriented toward public service' (p. 235). 
From the definitions and typologies above, the definition of GHPs as 
'relatively institutionalised initiatives, established to address global health 
problems, in which public and for-profit private sector organisations have a 
voice in collective decision making' (Buse and Harmer 2007:259) appears 
suitable for capturing the global context of the types of chalJenges they are 
created to face. GHPs can be product-based (e.g. drug donation programmes), 
product development-based (such as vaccine development) or issue/systems 
based (harmonise approaches of different actors) (Buse and Walt, 2000b). All 
the studies reviewed above make reference to the following specific functions 
of GHPs in relation to access to medication: 
• Access 10 pharmaceutical products for the poor: GHPs provide 
pharmaceutical corporations with the enhanced corporate legitimacy of 
UN-based agencies to penetrate commercially unattractive health 
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markets; and funding for phannaceutical innovations (leading to the 
availability of drugs, supplies, training services and disease 
management). The development of vaccines by IA VI (Chatawaya and 
Smith, 2006) and drug donation programmes and bulk purchase of 
ARTs by AAI are much cited examples). 
• Access to a strengthened national health system: GHPs can better 
integrate programmes and activities into the national health system to 
'improve effectiveness and ensure impact and sustainability' (Bruce 
and Hanner, 2007). RBM is a much cited example (WHOIUNICEF 
2003; WHO 2006) 
• Advocacy for political commitment and resource mobilization: GHPs 
promote priority programmes and empower governments to put more 
emphasis on health system strengthening through capacity development 
(Caines et al., 2004; Carlson et aI, 2004; Buse and Hanner 2007: 261). 
• GHPs are 'issue-specific' and designed for quick results: This 
objective of GHPs relates to the challenges involved in attempts to 
align global policies to implementing countries' priorities, systems and 
procedures and to align with development aid (Carlson, et al., 2004; 
Buse and Harmer, 2007). 
Most of the above studies reveal that for GHPs to be effective, the interests of 
global, national and local stakeholders with both shared and competing 
interests must be taken into consideration when designing global policies. All 
the studies reviewed call for country-specific studies to test and assess the 
above claims. Despite the comprehensive analysis of the history of health 
partnerships studied and the impact ofGHPs, neither of them defines ' a c c ~ s s s to 
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medication' nor discusses explicitly where thc emphasis on access should be 
placed. The next section explains the meaning of access to medication in the 
context of the emergence of OHPs in Africa. 
2.2.2 What is Access to Medication in the context of GHPs? 
This section describes the historical context in which OHPs emerge in Africa 
and identifes key actors and their respective narrative stratcgies on access to 
medication. IS This is seen as a first step towards identifying the origin of the 
different forms of knowledge through which OHPs shape health policies and 
local delivery practices. In this respect, Ngoasong (2009) conceptualises 
'access to medication' as a construct that has been used in the policy literature. 
This can be seen in the traditional contrast between potential (the presence of 
healthcare measured as availability and accessibility) and actual or realised (the 
actual use of health services as measured III quality and 
acceptability/affordable) access to medication (Andersen, 1995). 
As a historical construct, access to medication has been defined implicitly in 
the policy literature on Africa using narratives and counter-narratives. Table 1 
below, reveals the main actors and their narrative strategies around access to 
medication in different historical periods in Africa's colonial and post-colonial 
history. 
IS This section is adapted from my recent article: Ngoasong, M.Z. (2009) The Emergence of 
Global Health Partnerships as Facilitators of Access to Medication in Africa: a narrative policy 
analysis. Social Science & Medicine 68(5): 949-956. The article uses NPA to analyse the 
historical context in which different narratives on access to medication emerged leading to the 
creation of specific GHPs, with RDM and AAI as case studies. 
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Table 1. The historical context of access to medication in Africa 
Conventional <1950 1950-70s 1970s - >1990s 
time line 1990s 
Scope of Colonial National vs. National vs. National vs. 
Policy International International Global 
Development Colonialism Government Government Governance 
llolicy (Dictatorship) (Planning) (Privatisation & (Global Health 
Regulation) Partnershi£& 
Policy Maker Colonial The States and States & State & 
Master Colonial International Non-State Actors 
Masters Organizations 
Health Policy Curative & Curative & Medical & Non- Access to 
Goal Preventive Preventive medical medication 
interventions 
Source: Adapted/rom Ngoasong (2009) 
Unlike the fonner colonial masters and transnational/multinational 
corporations with a long historical presence, the role of international 
organizations became more influential from the 1970s when national health 
policy goals in Africa were largely influenced by the WHO and UNICEF, 
while development policy was the domain of the IMF and the World Bank. 
Other UN agencies (WTO, UNAIDS and Global Fund) and stakeholders such 
as international CSOs and foundations emerged in the 1990s. These 
stakeholders agree on the goal of access to medication: 'every human being 
should have access to treatment irrespective of ability to pay' (Ngoasong, 
2009:950). However, they differ on how this should be achieved. Those 
differences are systemic, and point to three emerging narratives on access to 
medication - public health, human rights and economistic narratives 
respectively. 
The public health narrative is rooted in the 1978 WHOIUNICEF-led Primary 
Health Care (PHC) model that emphasises medical (curative) and non-medical 
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(preventive) dctenninants of health. The cconomistic narrative is rootcd in the 
WTO·led TRIPS Agrcements (affordability and accessibility of patent· 
protect cd medicines) and the IMF/World Bank·led nco·libcral market modcls 
(privatisation and liberalization of public utilities including hcalthcare) 
promoted in many developing countries. Finally, the human rights narratives 
are rooted on the Universal Declaration of Human Rights (UNDHR), latcr 
taken up by CSOs to challenge the economistic narrative. The article argues 
that the fonnation of GHPs is an attempt to integrate these narratives and 
stakeholders to address the following challenges: 
Government and market failures to provide public goods to the poorest 
and most vulnerable people ... Widespread bureaucracy, infighting and 
inefficiencies among multi· lateral and bilateral agencies and the need to 
foster collaboration with the private industry ... An 'unavoidable 
necessity' in harnessing the resources to address global health issues and 
the challenges posed by globalization. (pp: 952) 
The discussion contrasting economistic, public health and human rights 
narratives on access to medication is especially significant because it suggests 
that full access to medication in the moral sense (potential and actual) has 
never existed in practice in Africa. The article illustrates this argument using 
two case studies on RBM and AAI. It emphasises that the need for an enabling 
environment for GHP programmes, the importance of 'potential' rather than 
'actual access' to medication, and the problem of privileging the prices of 
drugs over the quality of care are three issues that make the emergence of 
GHPs as controversial and worth exploring further. All of these issues need to 
be taken into consideration to better understand the effectiveness of GHPs in 
achieving access to medication. 
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On the basis of the above categorization of GHPs and the historical context in 
which they emerged in Africa, it can be seen that the relationship between 
GHPs and access to medication is a complex one. There is confusion over the 
nature of demand and supply sides of access to medication (is it problem-
oriented, patient-oriented or demand-oriented?) and their relationships; the 
necessary levels of commitment expected at community, country and global 
levels; and the strong position of pharmaceutical companies vis-a-vis civil 
society activism. What does emerge is that a mix of colonial, post-colonial, 
international and global health agenda created in the context of western 
ideologies were forced onto African countries. For example, it has been 
suggested that the strategic interest of UN and other bilateral agencies override 
those of developing country governments during GHP-related consultations 
(Holm, 2001; Caines and Lush, 2004; Nishtar, 2004). There are also claims that 
the monopoly of power of pharmaceutical companies puts national 
governments in a disadvantaged position when negotiating drug prices and 
supply arrangements (Buse 2004a). A study of the narrative strategies of GHP 
partners, such as those studied in this thesis, needs to be understood in these 
contexts - how they potentially influence global-national-local interactions in 
formulating and implementing policies. 
Nevertheless, the narrative strategies of GHP partners in relating to access to 
medication direct our attention to the need to explore, theoretically and 
empirically, the role of GHPs as facilitators of access to medication in this 
thesis. This involves investigating the setting in which important dialogues, 
negotiations and learning among public, private and civil society organizations 
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at all levels take place, as well as the opportunities for continuing dialogue, 
collaboration and negotiation to coordinate the efforts of global, national and 
local actors in providing access to medication for the poor. This will include an 
exploration of how the narrative strategies of GHPs partners are aligned and 
integrated with those of national governments and local communities, and the 
impact this has on ultimately determining the potential of GHPs to achieve 
country-specific objectives. It is this notion of alignment and integration of 
economistic, public health and human rights narratives that provide the basis 
for conceptualising and studying GHPs as models that mediate between theory 
and policy practices. To establish the conceptual framework, the next section 
reviews the literature on the interplay of theory, models and policy practices as 
relevant to the context of GHPs. 
2.3 Theory, Models and Practice 
At first glance, neither GHPs nor access to medication are in the realm of 
theory. Access to medication is a specific problem, requiring an effective 
remedial practice. GHPs have emerged as a way of dealing with both the 
presenting problem and organisational and stakeholder challenges to develop 
and implement such a practice. As such, GHPs offer a new an interesting 
model of mixed-stakeholder intervention, a model that is devised to be 
practical both in terms of its intent and the context within which it operates. 
However, the GHP model is animated by more than practical considerations.' 
This model is also informed by theoretical traditions, the range of which 
reflects the nature and history of the various stakeholders contributing to the 
GHP approach. Accordingly, it is necessary to discuss the nature of a model, in 
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order to understand the impact of differing theoretical perspectives on the GHP 
model and the interplay between theory and practice. Finally, to understand 
this model is a prerequisite to developing the most appropriate way of 
analysing it. 
2.3.1 Traditional Conceptualisation of Models 
Within philosophy, science or the social sciences there is no generally agreed 
theoretical and practical definition of a 'model' (Fetzer, 1999; Johnson-Laird 
and Byrne, 1999; Morgan and Morrison, 1999; Morton and Suarez, 2001). 
However, by understanding the general notion of what a model is it becomes 
easier to examine the theoretical foundations under which models are 
developed as well as the relationship between models and policy practices. 
Although no one perspective captures a generalised use of 'model', what 
matters here is the intent to do so in the context of the interdisciplinary 
approach to this research. 
Studies on models are usually traced to the 1960s. During this period, the 
process of rebuilding theory, theory change and scientific discovery motivated 
scholars within the philosophy of science to study models and model use 
(Hesse, 1966; Bailer-Jones 1999:31; 2003). The earliest writers conceptualised 
models as analogies and metaphors that shaped scientific reasoning. For 
example, Hesse (1966) used analogies to demonstrate that models play a 
creative role in science. Models, to her, are analogies on which a new theory is 
conceived from a pre-existing theory. However, she claims that although the 
properties that characterise the model are analogies of a pre-existing structure, 
the new theory is not identical with those of the model (Hesse 1966:8). In this 
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case, models shape developments in theory while analogies distinguish 
between new and old theories. 
Other studies on models emphasise 'manipulability' and 'workability' by 
creating typologies of models to account for the variety of models in science. 
Much cited are Black's (1962:220) scale models, which, he claims, help us to 
reproduce selected features of 'original' three-dimensional models in physics. 
Achinstein's (1968) representational model is another example. He argues that 
'Instead of investigating an object directly, the engineer may construct a 
representation of it, which can be studied more readily" (1968:209). In these 
cases a model is defined as a representation of reality in ways that embody 
theoretical principles. 
More recently, scholarly work on models identifies two commonalities among 
the studies on models in the 19960s: the emphasis on the sciences (such as 
mathematics, physics, chemistry and computer sciences); and the treatment of 
models as either abstract or physical entities. As abstract entities, models are 
direct or indirect representations of the thoughts and ideas of people (Suppe 
1977; Giere, 1999). This means that once a theory is formulated, it.is used to 
develop a model, such that the model in tum becomes an interpretation (based 
on empirical analysis) within which the theory can be considered to be true or 
false (Giere, 1999; 2004). As physical entities, models are real world objects 
that have an imperfect isomorphic relation to another object (Suppe, 1977). 
These studies explain how models are predominantly used in practice, for 
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example, as instruments of instruction and as platforms for further empirical 
investigation. 
The objective of this research is not to define or prove the relationship between 
theory, model and practice, but to investigate how models are developed and 
how they affect practice. Van Fraassen (1980:64) claims that although early 
scholars on models (including those cited above) were originally motivated by 
considerations of the role of models in practice, they ended up 
overemphasising different aspects of the development of models of science. In 
terms of practice, Cartwright (1983) investigates the relationship between the 
theoretical principles of physics and the phenomenological laws that they tried 
to capture (amid the messiness and complexity of data): 'the route from the 
theory to reality is from theory to model, and then from model to the 
phenomenological law' (p. 4). The development of models, he argues, is a 
pragmatic activity involving adjustments that are based on the objective to be 
achieved rather than the literal suitability of such adjustments. 
Morgan and Morrison (1999) draw on the ideas of earlier works (Cartwright, 
1983; Nagel, 1961; Hesse, 1966) to conceptualise models as mediators. They 
claim that this scientific conceptualisation of models does not aim to 
distinguish between a model and a theory, but provides the foundation on 
which the role of models in practice (or world as they put it) can enable such a 
distinction (Morgan and Morrison, 1999:12). They stress the epistemic 
importance of building and manipulating models as a way of mediating 
between theory and practice in two ways. On the one hand, a model can be 
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autonomous from theory and practice where it is the product of attempting to 
integrate both. On the other hand, a model can be an instrument whose 
representative nature provides the tools with which the relationship between 
theory and practice can be better understood. 
Figure 1. The relationship between theory, model and practice 
Theory ~ ~.. - - - . ~ ~ Model ~ ~.. --.. ~ ~ Practice 
The above literature review provides three interesting insights about models 
and their roles in practice. Firstly, models link theory and practice by 
occupying a middle space between them (see Figure 1. above). Secondly, a 
model may offer the opportunity to manipulate or introduce new elements to 
better explain why and how the elements are connected to different theoretical 
and practical settings, as well as illustrate the circumstances under which they 
may be considered as autonomous. Thirdly, a two-way causation may exist in 
cases where models take their representative cues from both theory and 
practice in similar ways although there may be an overlap in the practicality of 
the direction of causation. 
2.3.2 The place of models within disciplinary traditions 
The use of 'disciplinary traditions' to review studies on models in this section 
is justified on the basis of the preference for an interdisciplinary SIS approach 
to this 'thesis. As mentioned in the introduction, this approach allows us to side 
step into other disciplines to understand not only knowledge production but the 
interplay of different forms of knowledge. In this context, there is distinction 
between the place of models in science and social science disciplinary 
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traditions in which the latter is shown to be more attractive for analysing 
GHPs. Within the social science disciplines (for example STS, development 
studies, international relations, sociology, globalization policies) reference is 
made to key aspects of some social science approaches on the basis of a 
critique of positivism. The framework developed in this chapter therefore side-
steps into these disciplines to capture the complex social realities necessary for 
understanding GHPs in a non-positivist way. This explains why the analysis 
draws on some apects of an STS approach and some aspects of the discipline of 
international relations (namely, its social constructivist variant). 
The role of models in policy practices (policy formulation and implementation) 
was already a subject of intense debate in the 1960s, the same period when the 
study of models became popular. However, the object of study was not the 
relationship between theory, model and practice that was emphasised by 
scholars in the philosophy and practice of science reviewed above. Scholars in 
management sciences emphasised the extent to which models can be trusted in 
decision-making (the practice domain). A much cited proponent is Herbert 
Simon's bounded rationality approach to the study of models in management 
sciences. Simon and colleagues developed and studied computer models of 
decision-making, which they claim provide the 'correct answer' that decision 
makers need to achieve policy objectives (Simon, 1960:40-43; 1991; Newell 
and Simon, 1963; 1972). Counter arguments emerged from the 1970s in 
science (Greenberger et aI., 1976; Brewer and Shubik, 1979) and manageme'nt 
science (Radnor, et aI., 1970; Fromm, et aI, 1975; Schultz and Sleven, 1975; 
House and McLeod, 1977), questioning why some models lead to more 
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successful policy outcomes than others (if Simon's claims wcre realistic). 
These opponents point to implementation issues as the principal challenge. 
Dantzig (1979: I 0) identifies the complexity involved in the implementation of 
models (as against the material foundation of models) as the answer to the 
question of why some models perfonn better than others. He claims that as 
'politicians and the public demand simple answers to complex issues, the 
search goes on to find ways of expressing policies in simple terms', and 
concludes that models do not provide for this dynamic flexibility. Exploring 
this complexity, he defines a model as 'a black box ... it is possible, however, 
to observe the various inputs into it or outputs from it' (p.II). He distinguishes 
between three types of models: 1) a model of ignorance (one whose inner 
workings are a mystery or not known); 2) a linear model (one whose inner 
workings are exogenous or assumed to be known), and 3} a model of 
alternative processes (one whose inner workings is known and can be 
adjusted). 
Studies such as those of Dantzig (1979) provide a basis for questioning the 
rationalist assumption of science and management sciences on the role of 
models. King and Kraemer (1992) take on this argument by claiming that the 
problem of why some models perform better than others lies in the overlapping 
treatment of models (whether implicitly or explicitly) as either science or non-
science. They distinguish between scientific models (such as Geographic 
Information Systems) and social science models (such as macro-econometric 
simulations) in tenns of their acceptability in a policy process. They argue that 
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the policy relevance of scientific models as 'the truth' that is 'always right' 
(p.IO) has been moot, as the word 'science' has become something of a 
euphemism when considered from a social science perspective. Thus the 
findings of social science are dismissed on the basis that its 'modelling' is 
unscientific. However, this judgement betrays not only an uncritically positivist 
perspective, but appears uninformed about all other approaches to the 
generation of social scientific knowledge. 
This points out attention to the general preference for a methodology that is 
social constructivist in other to be able to investigate and account for allegedly 
'correct' or 'scientific' beliefs in the same way as 'incorrect' or 'unscientific' 
beliefs. Studies in the 'Sociology of Knowledge' become very relevant in this 
context. In a review of realities and relationships within social constructionism 
in relation to pioneering works by Barry Barnes (1974) and David Bloor 
(1976), Gergen (1995:43) presents the case for a social constructionist 
perspective as follows: 
, ... virtually all scientific accounts are determined by social interests -
political, economic, professional, and so on. In effect to remove the 
social from the scientific would leave nothing left over to count as 
knowledge' 
The above comparisons between scientific and social science models are very 
relevant in the context of the social construction of technology in STS, the 
approach in which models are studied in this research. STS scholars have 
recently began to treat technologies as models; however, rather than treat it as a 
'black box I model, the social shaping approaches within STS study view 
technology as an 'engine of enquiry' (MacKinzie, 2006). Technology shapes 
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human perception of the world; it does not completely replace human abilities 
(Mackenzie and Wajcman, 1987; 1999). In addition, those developing new 
technologies in tum impose their own human limitations upon society (Latour, 
1999). Thus, as models, technology mediates theory (creators of technology) 
and practice (effects on society). 
The above interaction between technology and society takes place in what STS 
scholars call socio-technical systems. MacKinzie (2006) defines socio-
technical systems involving hybrid networks of social institutions as models 
that embody different forms of knowledge. He argues that the best way to 
understand the nature and functions of models created by such a network is to 
unpack the forms of knowledge, examine how they are embodied in models 
and how the models in tum shape policy practices. For example, the choices 
made by designers and users of technology (not the technology) determine 
whether access to that technology can be achieved (Dutton, 1992). Once access 
to technology becomes feasible, a broad range of processes in which people 
and institutions constantly interact shapes the impacts of that technology on 
society (Danzinger and Andersen, 2002). Thus, a model cannot simply be an 
'answer machine' that provides policy makers with the 'truth' about a given 
situation (King and Kraemer, 1992:7), as scientific and management literature 
predicted. It is instead the multitude of interactions among actors who develop 
and/or implement models that determines the ultimate outcomes tied to models. 
It is this notion of embodied knowledge that suggests an STS perspective on 
the social studies of models can successfully be applied to the study of GHPs. 
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Although STS approaches have mainly been used to analyse things that are 
technical, the argument made here is that they can also be used in a social and 
public policy arena such as GHPs. Within GHPs people and institutions 
constantly interact in a hybrid network in the same way as they do within 
socio·technical systems. GHPs also consist of hybrid networks involving 
multiple interactions among those actors who create GHP models and those 
who use the models to formulate and implement policies on access to 
medication. Furthermore, hybrid networks such as GHPs have been 
characterised as 'social technologies' (models) that serve as brokers and 
integrators (model as mediators) between creators (theory) and users (policy 
practices) of medical technology (Chataway, et at, 2007). The next section 
explores the role of models in shaping policy practices. 
2.2.3 The role of models on policy making and 
implementation 
This section reviews empirical studies on the relationship between theory, 
models and policy practices, especially those with a global dimension. It 
explains why and how a specific model might be selected for implementation 
in a given policy context. 
Dantzig (1979) investigates the role of models in determining global energy 
policies that were being implemented in the US. He classifies global models 
under models of 'alternative processes' because of their use of a mixture of 
approaches and great variety of detail. He argues that one of the key reasons 
why global models became popular in the late 1970s stems from not only 'their 
prophecies of worldwide shortages of food and energy' (p.6) but their ability to 
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address these challenges. In such contexts, 'various groups who may be 
opposed to change because they feel that their vital interests will suffer' (p.IO) 
had to cooperate for the common good. Here, model developers such as 
Danzig, apart from their academic pursuit, are very aware of the need to 
develop consistent programs of action that are advantageous to society. He 
suggests that the role of models can be studied by examining how policy 
makers (directly or indirectly) use the model to determine what changes are 
necessary or to reach a consensus on what actions should be carried out and 
how. Here, a process of consensual decision-making links a model to policy 
practices. 
King and Kraemer (1992) carried out a comparative study on the role of 
models in policy making, focusing on the use of similar econometric models of 
Geographic Information Systems by the German and American governments. 
They studied the nature of the models, their implementation and the way the 
models are actually used in the policy process. They found that models are 
'effective weapons in ideological, partisan, and bureaucratic warfare over 
fundamental issues of public policy' (p.S). The extent of using a model 
depends on the effectiveness of the model in 'the political battles over what 
kinds of economic and domestic policy should be followed' (p.S). Models, to 
them, serve as a key focus of negotiation and are 'boundary objects' that bring 
people from different social domains together. From this context a study of 
models needs to consider the issues on Table 2 below. 
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Table 2. The role of models in shaping policy practices 
Model as political weapon The use of model in policy practices 
To clarify issues in a debate To decide which variables are included vs. excluded, 
or to define common ground exogenous vs. endogenous, weighted vs. unweighted 
as the basis ora political discourse 
To enforce a discipline of Enables partners to adhere to technical realities 
analysis and discourse needed to be addressed to formulate a better policy 
Powerful form of advice on To identify positive/negative aspects of policy (or 
what to do and not to do make decisions) likely to achieve acceptable 
outcomes 
Source: Review of King and Kraemer (1992) 
As already mentioned, although studies on .models have focused on socio-
technical systems (such as those above), recent studies are beginning to extend 
it to the social policy arena. Pianta and Rimm-Kaufman (2006) investigate the 
role of models on policy practices by comparing inputs and outputs (as well as 
their linkages) of models of early childhood development. They argue that, 
despite apparent inadequacies, a wide range of (national) policy and practice 
(local implementation) initiatives draw on models in fundamental ways. At the 
national level, the model is reflected in one of the more contentious and 
legislative decisions related to accountability in early childhood development. 
At the local levels, the model is reflected in the many discussions between 
parents and teachers. They distinguish between models that focus on and 
regulate around 'outputs' and those that focus on 'inputs' and suggest that a 
successful model is one that attends to the diverse sets of inputs needed to 
inform policy and the ways in which those inputs are linked together at any 
given time. 
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Thus, the impact of a model depends on the extent to which the model 
emphasises the organization of assets within an objective, how this 
organization emerges, and how it operates to support policy effectiveness over 
time. They caution that the success of a model depends on the current state of 
knowledge (not the context in which the model was formulated) since the 
complexity of the models often pose challenges to implementation. 
In all of the above accounts of the selection and use of models, forms of 
knowledge and specific data - whether technical or social - have been crucial. 
It is this dependence that makes the notion of embodied knowledge that is 
relevant for the study of the role of models. Using the above notion, 
MacKenzie (2006) claims that the study of models is a potential contribution 
because it enables the researcher to treat both technical and non-technical 
objects (such as markets) in the same way as physical technologies. To 
substantiate this claim, he unpacks the 'black box' of financial markets by 
exploring how financial models created from economic theories of markets 
shape the practices and outcomes in the global stock exchange markets. He 
discusses how the publication of landmark research papers on options theory in 
finance (the models) in 1973 coincided with the creation of the Chicago Board 
Options Exchange (for the practice of those models) as a reflected of an 
ongoing transformation in the study of finance (theory and models) and the 
corresponding influence on markets. In this case four variables are critical in 
investigating the relationship between models and practice: ideas (theories 
behind models), tools (major research universities), access to technology (such 
as computers) and data (which became increasingly abundant in the stock 
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exchange markets). Understanding the relationship among these variables 
involves exploring the ways in which they arc embedded in cultures, politics 
and networks of personal interconnections, what MacKenzie (2006) refers to as 
unpacking 'the systematic forms of knowledge' deployed in technology (in his 
case financial markets). 
The above discussions on the theoretical literature on models and the notion of 
embodied knowledge suggests that models can be located and studied where 
developments in theory paralleled or preceded developments in policy 
practices (or the other ~ a y y round) (MacKenzie, 2006) and the opportunities 
that the models provide for the inclusion of additional elements in the future to 
better reflect practice settings (Cartwright, 1983; Morgan and Morrison, 1999). 
Such an approach to the study of models in a social policy setting is, for 
example, relevant in the field of development studies, where it is important for 
understanding the role of global institutions (such as GHPs) in shaping policy 
practices. It enables us to understand the alignment of the technical and the 
social, as well as human and non-human interests through several options (e.g. 
CalIon, 1991). The study of the emergence of GHPs by Ngoasong (2009) 
mentioned earlier suggested that the interplay of different narratives (as forms 
of knowledge) and institutions in different periods of Africa's history provides 
an explanation of the emergence of GHPs from the late 1990s. In order to 
develop a framework for conceptualising and studying GHPs as models, the 
next scction explores theoretical approaches to the study of GHPs to better 
understand the basis on which they can be conceptualised and studied as 
models. 
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2.3 Approaches to the Study of GHPs and Access to 
Medication 
2.3.1 Liberal and neo-Iiberal approaches to the study of GHPs 
Most studies on global partnerships that use the typologies discussed above are 
based on liberal and neo-liberal theories in development studies and in 
international relations. Within the broad literature, the emphasis has been on 
the functional and operational demand for partnerships such as GHPs as 
governance solutions in an era of globalization. From a functional demand 
perspective, the advantages of globalization arguably outweigh the 
disadvantages across African countries, but create governance gaps at global 
and national levels (Reinicke and Deng 2000; Zacher, 1999). At the national 
level, governance gaps are specified in tenns of capacity to provide public 
goods such as heaIthcare. Various editions of the Human Development Reports 
(pointing to the lack of reliable access to medicines for the poorest people), 
WHOIUNICEF (on weak health systems) and IMF/World Bank reports (poor 
development indicators) are cited as evidence of governance failures (e.g. 
WHO, 2005: 48). In this context, GHPs have been created to fill governance 
gaps by leveraging the resources and interests of different sectors at global and 
national levels (Reinicke and Deng, 2000), offering cost effective opportunities 
for coalition building (Grant and Keohane, 2005; Slaughter 2004) and breaking 
complex issues into smaller, more manageable sub-components on which 
actors are more likely to agree upon (Reinicke and Deng, 2000). 
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There is a general assumption that governance gaps exist in state-centred 
systems in developing countries, gaps that can only be resolved through the 
hybrid network on which OHPs are structured. Liberal interventionists argue 
that the inability of countries such as those in Africa to implement effective 
health governance solutions and the growing capacity or pressure from trans-
national public and private organizations force them to share responsibility for 
health care with global institutions (Mathews, 1987). In this context, state and 
non-state actors voluntarily agree to undertake specific functions in health 
governance (Dodgson, et al., 2002) and so 'share risks, responsibilities, 
resources, competencies and benefits' (Nelson 2002: 47). 
In globalization studies on the role of global institutions (such as OHPs), 
transcalar coalitions (global-national-local linkages) are used to legitimise the 
intervention of an array of non-state actors in a given country's internal affairs 
in order to facilitate access to medication: 'when a local environmental NOD, 
forest indigenous dwellers, international NODs and the World Bank join 
efforts, using both sticks and carrots, an African country's government cannot 
convincingly claim that it fell victim to an imperialist plot!' (Compagnon, 
2008: 15). In the case of OHPs, there is so much talk of 'scaling up' access to 
medication in terms of space (from the local to a larger scale), time (short-term 
vs. longer-term) and 'sustainability' through 'mainstreaming' (to incorporate 
the specific country context) in 'weak states' in Africa, while terms such as 
'inter-governmental', 'multi-actor' and 'public-private' are used in explaining 
global governance and country operational mechanisms (Dodgson et aI., 2002; 
Caines et aI, 2004; Buse and Harmer, 2007; Carlson, 2004). 
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Other studies on GHPs have used liberal and neo-liberal approaches to study 
the emergence and impact of civil society organizations and other non-state 
actors in influencing (through advocacy efforts) national government and 
bilateral and multilateral agencies to take specific actions to facilitate access to 
medication. One powerful method of influence is advocacy. Abbott and Snidal 
(2006) argue that non-state actors have the power to influence agenda setting, 
negotiation or other forms of rule-making, implementation, monitoring and 
evaluation as well as enforce procedures. Abbott (2007) sees this approach as a 
reinvention of liberalism as a positive theory that seeks to explain' major 
outcomes in international politics. He claims that positive liberalism directs 
analysts to focus on particular actors, causal factors, and political arenas. In 
this case, the major actors in world politics are not states, but individuals (such 
as civil society organizations, interest groups and other non-state actors) 
assumed to be either rational (or egoistic) or motivated by values and norms, to 
pursue their interests in domestic politics. Neo-liberals such as Moravcsik 
(1997) see liberalism in this context as a "bottom up" theory in which the 
preferences and policies of governments are being influenced by societal 
actors. According to Abbott (2007:3), 'by opening the "black box" of the state, 
liberalism renders areas ruled out by other international relations approaches 
integral to the study of international relations'. 
Traditional liberal theories such as the liberal-internationalist approaches are 
highly normative. They overemphasise the role of the state and place the 
analytical weight on the nature and application of the state political economy 
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policy. Neo·libcrals and positivists alike presuppose that states are the key 
actors in international relations even though they discuss the increasing 
importance of non·state actors and intergovernmental organizations. Most 
empirical studies that use these approaches limit the activities of non-state 
actors to domestic politics without emphasising their influence on multilateral 
and bilateral agencies and multinational corporations through public activism 
at international conferences and other forums (Abbott, 2007). As demonstrated 
in the next section, these approaches also fail to capture the full controversies 
surrounding the role of GHPs on access to medication, such as the importance 
of the historical contexts as well as the competing and conflicting narratives on 
access to medication explained earlier. 
2.3.2 Social constructivism and the study of GHPs 
Boas and McNeill (2004) review the shortcomings of development studies in 
relation to global institutions and suggest the creation of an alternate analytical 
framework from realist theory, the neo-Gramscian school of thought or social 
constructivism. Both realist and neo-Gramscian approaches are not suitable for 
the study of GHPs, as defined in the introduction chapter of this thesis, because 
both represent weak analytical frameworks for conceptualising global 
institutions. For example, realists over·rely on state sovereignty and argue that 
the emphasis must still be placed on the state because it is the state that has 
power, and must ratify international organizations (Abbott, 2007). Neo-
Gramscian theory is unable to explain change mechanisms by over-
emphasising the political element of development. Although it does politicise 
the processes of power relations, by arguing that ideas and theories of 
development arc 'always for someone and for some purpose' (Cox, 1995:31; 
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Cox and Sinclair, 1996}, it docs not offer a convincing account of how agency 
can bring about structural or process ural change. On the other hand, 
constructivism, an approach drawn from social theory, has emerged as an 
attractive alternative to realist, liberal and neo-Marxist theories for analysing 
GHPs. It highlights the specific source(s} where causes and effects can be 
located (Boas and McNeill, 2004) and is better able to develop explanations of 
the actions of both states and at non-states actors in international development 
(Hopf, 1998; 2002; Wendt, 1992; 1999). 
Studies on GHPs would benefit from an effective alternative framework to the 
dominant liberal and neo-liberal theories. Most GHPs claim to target global 
policies on the treatment of diseases in a country-context and on funding of 
R&D for developing country diseases. Yet as pointed out in chapter one, the 
literature on the impact of GHPs points to many unanswered questions: 
whether the values of the weaker partners (such as those in Africa) are co-
opted by the more powerful ones (UN agencies and their affiliated private 
partners and international); is reconciling the interest of UN-based agencies 
and private corporations overemphasised; why is scant attention paid to 
interfaces between institutions and structures of national vis-a-vis global health 
governance; is the capacity and fragmentation of national health systems 
overwhelmed (Hancock, 1998; Bellamy, 1999; Holm, 2001; Caines and Lush, 
2004; Nishtar, 2004; Buse, 2004a). In such cases, they may contribute to a 
fonn of developing country dependency on UN-based agencies and their 
internationally affiliated partners (Richter, 2004a; 2004b), rather than serving 
the needs of the poor. 
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Where the nature of the above challenges and complexities has been 
documented, it is suggested that alternative governance strategies should be 
explored. Even liberal interventionists such as Dodgson et al., (2002), despite 
over-emphasising the role of the state, directs attention to the urgency of re-
examining global health to uncover the implicit (often taken-for-granted) 
conceptual challenges in the face of incongruous global public-private 
relationships. In addition, the observation that collaborations in GHPs lead to 
national health 'systems change' necessitates the establishment of parameters 
for theoretical and practical terms in relation to country-context and 
sustainability (Lewis, 2005: 131). 
Social constructivist approaches related to GHPs avoid the problems of realist 
state-centrism and the lack of a focus on the role of agency in social processes 
implicit in neo-Gramscianism by using a range of methods to examine 
decision-making and power relations. The focus of most GHPs focus on a 
narrowly defined role (Buse 2004a) implies that their role in a liberal 
interventionist context would vary from one GHP to another (or one country to 
another) and with varying implications for access to medication. This also 
depends on the conceptualisation of the determinants of access to medication 
by partners to GHPs, an issue that is hardly made explicit in most of the 
conceptualisations of GHP. Constructivist approaches attempt to address these 
issues using methods such as framing (Odell and Sell, 2003; Sell, 2004; Sell 
and Prakash, 2004) and NPA (Feldman et al., 2004; McBeth et al., 2007; 
Ngoasong, 2009). Framing and narrative analyses enables specific issues to be 
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considered as crucial rather than other issues of equal importance when 
formulating and implementing policies. They arc therefore relevant analytical 
tools for understanding how GHPs shape policy practices. 
For example, Sell and Prakash (2004) illustrate how a shift in framing from 
concerns about patent protections for specialists pharmaceutical innovations to 
one of a global challenge to reduce mortality is critical in understanding the 
sudden importance of Paragraph 6 of the TRIPS agreement. Kanner (2004) 
elaborates on the importance of framing by showing how one actor in a 
bargaining situation can alter the frame for a second actor and thus successfully 
alter the frame (and outcome) for future negotiations. This is similar to the 
types of negotiations that take place within GHPs, espacially between 
participating pharmaceutical companies and developing country governments 
on drug procurement and supply arrangements. In this case, Ngoasong (2009) 
proposes NP A as a relevant analytical framework. He shows how the formation 
of GHPs was an attempt to define access to medication globally by integrating 
public health, economistic and human rights narratives on access to medication 
each of which is capable of altering the way global actors frame issues within 
GHPs in response to other actors. 
Thus, it can be shown that these competing and conflicting narratives have the 
potential to shape the types of policies formulated by GHPs, policies that are 
meant to be transferred to developing countries to shape national health policy 
and local delivery practices on access to medication. The next section builds on 
the social constructivst perspective further by conceptualising the 'social 
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spaces' through which GHP policies are formulated, transferred and 
implemented what can be termed transcalar networks. 
2.3.3 Transcalar network for policy transfer and 
implementation 
So far we have portrayed the GHP model as new because it is different from 
previous international models of health interventions. The discussions 
presented earlier on the nature of GHPs suggest that global health policy has 
effectively replaced international health policy. While international health 
policy agendas in the 1980s and 90s had clear organizational homes, such as 
WHO and UNICEF (Reich, 1995; Walt, 2001), global health policy agendas do 
not necessarily have organizational homes as most GHPs are not. accountable 
to any institutional authority (Buse 2004a; Buse and Harmer, 2007). This calls 
for the need to reconceptualise the nature of the network through which GHP 
policies are transferred (from global to national) and how they are implemented 
(from national to local). In this thesis, the term transcalar networks will be 
used to conceptualise the 'social space' in which policies are transferred and 
implemented in a GHP context. This conceptualisation is further justified 
below using concepts from policy transfer, multi-level governance, and the 
notion of the 'politics of scale' found in globalization studies. 
There is a general concurrence that policy transfer takes plays through informal 
networks of public and private actors who have distinctive but interdependent 
interests, and who are striving to solve similar problems (Marsh 1998). In this 
context, policy transfer has been defined as 'the process by which knowledge 
about policies, administrative arrangements, institutions and ideas in one 
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political system is used in the development of policies, arrangements, 
institutions and ideas in another political system' (Dolowitz and Marsh 
2000:5). Multi-level governance, 'a system of continuous negotiation among 
nested governments at several territorial tiers' (Marks 1993:392), reveals how 
this transfer process has transformed the role of the state towards new 
strategies of co-ordination in the face of accountability challenges and the 
increased participation of non-state actors (Bache and Flinders 2004: 197). This 
transformation further supports the argument that a social constructivist 
approach is preferred to the liberal interventionist perspective when analysing 
GHPs. Policy networks enable actors to 'play the boundary' of national and 
international, public and private, formal and informal, market and bureaucracy, 
state and non-state, legal and illegal in shaping policy practices (Stone 
2003:43, Sikkink 2005:152). 
Apart from the above boundary problem, Bache and Taylor (2003:283) refer to 
country-specific challenges and partners' strategic interests as 'policy 
resistance strategies' that may hinder the effectiveness of policy transfer and 
implementation - the same factors described by Ngoasong (2009) as crucial for 
understanding GHPs in Africa. The notion of 'the politics of scale' (Brenner 
1999,2001) then becomes useful to expose areas where policy transfer clashes 
with policy resistance strategies. Unlike traditional transnational policy 
networks built around government ministries (e.g. Reich 1995, McCormick 
2001, Walt et al. 2004), we now have GHP programmes in which the state 
(through various ministries) no longer has this centralised bureaucratic 
authority (Dodgson et al. 2002, Abbott 2007). National GHP programmes have 
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been created in which representatives of public health (WHO, UNICEF, and 
ministries of health), donor agencies (Global Fund, World Bank and private 
foundations) and CSOs at global, national and local levels sit around the same 
table to formulate and implement country-led health policies. 
The term 'transcalar network' is used to describe this new type of global-
national-local linkage. The existence of networks indicates levels of 
institutionalised authority (McCormick 2001) and their transcalar character 
reveals the existence of social spaces through which global, national and local 
actors interact (Brenner 1999, 2001). In several writings, Castells (1996, 1997, 
1998, 2000) demonstrates that globalization has transformed the 'social space' 
found in traditional network studies from a 'space of spaces' to a 'space of 
flows'. Castells (1996: 412) defined the space of flows as 'the material 
organization of time-sharing social practices that work through flows (e.g 
global-national-local linkages). By flows I understand purposeful, repetitive, 
programmable sequences of exchange and interaction between physically 
disjointed positions held by social actors in the economic, political, and 
symbolic structures of society' . 
This transformation is evident in the GHP context. For example, while GHPs 
recognise the autonomy of the State, the failures of 'weak states' in Africa 
(Dodgson et at 2002) suggest that GHPs use CSOs and donors to by-pass the 
bureaucratic structures of the State to produce 'quick results' (Caines et at 
2004, Buse and Harmer 2007). This transcalar c h a r a ~ t e r i s t i c c of contemporary 
global institutions has been shown, in the case of forest exploitation, to 
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constrain national politicians' capacity for corrupt practices while ensuring 
policies are implemented effectively (Compagnon 2008). The fact that key 
GHP partners (e.g. World Bank) put good governance as major conditions for 
funding, as well as channel funds directly to non-state actors (CREDES 2004, 
World Bank, 2007) suggest that the role of GHPs also needs to be understood 
in terms of whether they have such underlying objective. If local none-state 
actors are also deeply penetrated by neo-patrimonial tendencies (Compagnon 
2008), they may become another form of local policy resistance. 
The notion oftranscalar network enables us to better describe the 'social space' 
in which public health, economistic and human rights narratives (and the 
associated actors) are negotiated, as well as the nature of global-national-local 
linkages in a GHP context. Understanding the ways in which public health, 
economistic and human rights narratives (and the associated actors) are 
connected and the consequent effect on the types of specific GHPs deployed to 
formulate policies on access to medication for a given developing country is 
the basis for a more incisive approach to studying the role of GHPs on access 
to medication. Thus, conceptualising GHPs as models that occupy the 
intermediate position between theory and policy practices and using NPA as a 
method of analysing the ways in which GHPs perform this integrating role 
becomes a potentially fruitful theoretical framework for understanding the role 
of GHPs as facilitators of access to medication. The next section provides a 
more detailed justification of NPA as suitable analytical framework for 
studying the embodiment of knowledge GHP programmes on access to 
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medication (and consequently, the role of knowledge in shaping policy 
practices). 
2.3.4 Narrative policy analysis as a framework for analysing 
the role of GHPs 
As discussed earlier, one of the key characteristics of GHPs is that they are 
policy-oriented institutions. They formulate global policies that are meant to be 
applied on a country-specific basis. This points our attention to the ways in 
which policy makers in a GHP context formulate policies at the global level, 
how they transfer policies to the national level and how they are translated into 
specific programmes at the local levels. Policy makers can approach this 
difficult task in a number of ways. One method is policy analysis, described 
positively as 'the choice of the best policy among a set of alternatives with the 
aid of reason and evidence' (MacRae, 1980:74). However, Quade (1975) had 
already argued that most immediate social goals are usually the result of 
opportunities offered by newly discovered or perceived choices rather than a 
source. This undermines the possibility of such a rational or linear policy 
transfer process suggested by MacRae. NP A, the application of narratives that 
takes social values and historical contexts into consideration, has emerged as 
an effective way of dealing with these problems. 
Thomas Kaplan (1986) provides a useful starting point for discussing the 
!elevance of the NP A approach. He argues against writers who emphasize a 
priori criteria for policy analysis, emphasising that rational planning (the 
o 
approach suggested by most liberal interventionists theorists mentioned earlier) 
can only take place when one establishes clear criteria at the very outset. As an 
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alternative, Kaplan proposes infonnal narratives or 'the explanatory power of 
stories' (p.768) as an equally rational approach. Along a similar line, Krieger 
(1986) advocates the explanatory power of dramatic or historical narratives in 
understanding 'big decisions I as choices that arc seen as discontinuous, abrupt, 
and unique. According to Doron (1986), neither Kaplan nor Krieger reject the 
rational and scientific aim of policy analysis; they simply used NP A as a means 
of clarifying policy issues in especially complex situations. 
From the above context, later studies that employ NP A emphasize semiotic and 
rhetorical issues for interpreting policy narrative strategies (e.g. Roe 1989; 
Feldman et aI., 2004; McBeth et aI., 2007). These features of NP A have also 
been applied in STS. For example, actor network theory approaches apply 
versions of NPA which focused on following the views (or narratives) of 
specific actors across complex socio-technical actor networks over time 
(Bowden, 1995). Through 'snowball effects' (Bijker, 1995:270), the relevant 
system and actors are identified, and by 'following the actors' (Latour and 
Woolgar, 1986), the ways in which their narrative strategies become embodied 
within models thereby shaping policy practices can be better understood. 
In the presence of policy questions with controversial law-like explanations, 
NP A is useful to describe change over time and to uncover the hidden 
assumptions that are implicit in policy documents (Kaplan, 1986). NPA uses 
narratives such as characters, contents, plots, colourful language, and 
metaphors (McBeth et aI., 2007) to explain the occurrence of and the linkages 
between events in an attempt to select and justify desirable courses of action 
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(Zilber, 2007). As Ngoasong (2009:950) demonstrates, 'it is this capacity' to 
address a range of complex characteristics and distinctive narratives that 
suggest the NP A can successfully be applied to the issue of access to 
medication'. NPA is suitable for distinguishing between public health, 
economistic and human rights narratives within specific GHP programmes as 
well as the ways in which they are meant to shape different elements of the 
GHP model. Thus, NPA has already shown itself capable of being applied in 
the domains of STS, policy studies, international relations and development 
studies including the GHP contexts. It therefore provides a relevant 
methodological tool for analysing the role of the GHP model on access to 
medication. The next section presents the theoretical framework for this thesis. 
2.4 A Conceptual Framework to Study GHPs as Models 
This chapter has demonstrated that the theoretical literature on models and the 
notion of embodied knowledge as applied within some STS research, when 
combined with social constructionist international relations, provides a suitable 
framework for analysing the role of GHPs on access to medication. In 
particular, the first contribution of this chapter is that a constructivist 
perspective on the relationship between theory, model and policy practices 
forms an interesting area of investigation that can be applied to the case of 
GHPs. A parallel argument is that socio-technical systems are hybrids of social 
institutions that embody different forms of knowledge. This can be applied to 
the case of a global social policy system in which GHPs operate. This 
combination of approaches and methods is best suited to achieving the goal of 
this thesis - an investigation into the role of GHPs in determining policy and 
local practices on access to medication. 
70 
Figure 2 How a GHP model mediates between theory and policy prnctices 
Theory 
(Models have theoretical origins) 
t 
Global Health Partnership 
(How a GHP Model is created) 
. /\ Global Health Programmes 
Global Health ~ o h c y y (How models work in practice 
(Models shape different OIl ~ ~ at national/local levels) 
elements o/policy) 
As presented on Figure 2 below, this thesis therefore conceptualises a GHP as a 
model, operating in the space between theory and practice, and affected by 
both. The theories behind the public health, economistic and human rights 
narratives provide the basis on which GHP partners' interests and ideologies 
are built and consequently the basis on which GHP policies are negotiated and 
adopted for transfer to practice settings by stakeholders with very different 
interests. 
The second contribution of the chapter is the realisation that NP A is an 
appropriate analytical tool, given the STS perspective on the role of models, 
the social constructionists approach in international relations on policy analysis 
and the transcalar networks within which GHP programmes operate. It is useful 
for exploring how public health (WHOIUNICEF), economistic 
(WTOIIMF/World Bank) and human rights (UN/International CSOs) 
narratives on access to medication emerged at a global level, how they became 
embodied within specific GHPs and how they shape national health policies 
and local practices on access to medication. This is relevant in the case of 
GHPs because the policy framework is not simply imposed through any 
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international legal instruments or rational planning framework. Like most 
global institutions, the policy framework is 'constructed through social 
interactions that include both formal negotiations and informal deliberation' 
(Compagnon,2008:15). The notion oftranscalar network enables us to capture 
the global-national-local linkages that characterise such social interactions, and 
therefore the role of actors and their narratives' in shaping policy practices. 
Each OHP model has different frameworks and capacities to shape different 
aspects of policy formulation and implementation at national and local levels. 
The domination of liberal and neo-liberal theories in the study of OHPs could 
imply that they play a leading role in determining the nature of OHPs. 
However, these theories have significant limitations when considering the 
impact of OHP programmes. There is need to evaluate the nature of specific 
OHPs in terms of how they are aligned and integrated with country-specific 
contexts to better appreciate their potential to promote country-specific access 
to medication. The theoretical framework developed in this research provides 
an attractive alternative way of achieving this. Extending the notion of 
embodied knowledge into governance, international relations and development 
studies for analysing OHPs is very instructive. It is somewhat surprising that it 
has not been done previously. OHPs put forward a moral claim for 'universal 
access' to medication to protect the interest of the poor. The key challenge in 
unpacking the OHP model is therefore to understand how the competing and 
conflicting narratives of access to medication are negotiated at global and 
national levels and how the combination of these are translated into specific 
programmes and activities at the local level. This is what makes the 
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'knowledge approach' relevant in this thesis, particularly the possibility it 
creates to adopt concepts from globalization and development studies into an 
interdisciplinary framework to understand the role of GHPs on access to 
medication. 
The above framework is applied to the global (Chapter Four) and national 
(Chapter Five) perspectives on the emergence of GHPs as facilitators of access 
to medication. It is then applied to two empirical case studies on the role of two 
GHP programmes on access to medication in Cameroon in Chapter Six and 
Chapter Seven respectively. Before going into these chapters, the next chapter 
presents the research methodology used in this thesis. 
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CHAPTER 3: RESEARCH DESIGN AND METHODS 
3.1 Introduction 
This chapter explains the methodology used to study the role of GHP models in 
shaping policy practices on access to medication. Sivennan (2001) 
demonstrates that when conducting empirical research there must be a set of 
explanatory concepts (Theory), a testable proposition (Hypothesis), a general 
approach to studying research topics (Methodology) and a specific research 
technique (Method). This thesis uses a similar guideline. The purpose, 
according to the introduction, is to understand how GHPs grapple with meeting 
targets for successful healthcare delivery in Cameroon, with specific reference 
to access to medication. The theoretical approach combines STS and social 
constructionist IR, in a NP A research technique. This involves studying and 
analysing the multitude of interactions between theory, models and policy 
practices and the ways in which such interactions produce intended and 
unintended outcomes. 
The traditional philosophical views see models as detennining and containing 
social structures (Nagel, 1961; Hesse, 1966; Cartwright, 1983) or as socially 
constructed (Morrison and Morgan (1999). Still others (King and Kramer, 
1992) have interpreted the development and deployment of models as subject 
to the changes by users as well as a constraint on users' choices and actions. 
More recent views (MacKenzie, 2006) go on to give historical texture to the 
descriptive accounts of the cross-contextual interaction among creators and 
users of models in the structures and processes of globalization. This thesis 
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follows MacKinzie (2006) in studying the interplay of theory, models and 
policy practices and Ngoasong (2009) in applying interpretive NPA research 
methodology (Kaplan, 1986; Feldman et at, 2004) to study the role of GHPs as 
facilitators of access to medication in Cameroon. 
Using the above discussion as a point of departure, this chapter begins by re-
examining the agenda of researching transcalar networks using NP A 
methodology, including a justification of the unit and levels of analysis. It then 
describes the methods and techniques used in conducting the empirical 
research. Finally, the limitations of the study are presented followed by a brief 
chapter conclusion. 
3.2 Re-examining the Agenda of Researching Transcalar 
Networks 
GHPs attempt to link global and national actors and coordination mechanisms 
to address country-specific barriers to access to medication. As such the global-
national-local linkages within which such multi-actor or multi-stakeholder 
interactions take. play is similar to those of what is termed in globalization 
studies as transcalar coalitions operating within a nation state (Compagnon, 
2008). In this liberal interventionist construction, the object of study is the 
nation state. Transnational actors build coalitions of state and non-state actors 
around government ministries thereby constraining the capacity of the state 
authorities to practice rent-seeking behaviour and corruption. In this thesis a 
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more socially constructed conceptualization that replaces the term coalition 
with network is used. 
As pointed out in chapter two, due to the hybrid and interwoven character of 
the network of actors within GHP settings, the nation state of Cameroon 
represents a limiting analytical category to understand the nature of the links 
between the various actors involved in the deployment of GHP programmes. 
Therefore, understanding the institutional interactions requires us to move 
beyond state-centrism as the main object of investigation and to analyse its 
networking with a set of comingled interests (Brenner 1999) interacting within 
the global-national-local space, defined as transcalar networks. Each GHP 
model is animated by several transcalar networks of PPPs at global, national 
and local levels. The object of analysis is therefore the GHP model while the 
unit of analysis is transcalar networks. 
The frequent absence of discussions on policy and development issues in the 
STS literature is worthy of mention. Jasanoff (1999) suggested a way of 
integrating STS and public policy studies together to conduct empirical 
research, explain findings and make policy proposals. In her case, a 
combination of the SCOT theory (Social Construction of Technology) and 
policy studies was used to offer fresh potential for answering questions about 
development. This suggests that any theory's applicability must first be tested 
through case studies and it is always possible that inconsistencies and 
contradictions will be exposed. This chapter provides the methodological 
framework from which the theoretical framework developed in chapter two can 
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be shown to contribute to the study of GHPs by offering new insights for 
answering questions about globalization and development. 
The object of analysis, the GHP model, is consistent with the objectives and 
research questions of this thesis (Yin 1994). The data collected enables us to 
capture aspects of the network properties and its governance. In this scnsc, 
individual GHP partners are not the object of study since they represent 
separate institutions. Such institutions do not always predict, perceive or 
determine individual or network level interactions (Coleman 1990; Powell and 
DiMaggio 1991). It is the hybrid nature of the network (Oliver and Ebers, 
1998) within which the GHP model operates and the transcalar characteristics 
(Companogn, 2008) that determine such interactions and therefore form the 
focus of analysis in GHP settings. In a comprehensive review of theoretical and 
empirical studies relating to the nature of networks, Oliver and Ebers (1998) 
argue that networks can be clustered around four themes: contingent decision-
making (nodes. in a network), social network relations (social linking), inter-
organizational power/control (nodes and the links) and inter-organizational 
governance structures (nodes and the links). 
The scope of this thesis does not allow us to attempt to situate GHPs within 
any of the above clusters. As mentioned in chapter two, in the contemporary 
era of globalization, Castells (2000) describes a network as a 'space of flows'. 
Hargittai and Centeno (2001: 1550) describe the daunting challenge in trying to 
quantify global-national-local linkages in contemporary global networks as 
follows: 
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'Under the previous system of international contact different parts of the 
world might be connected to relatively few others. Now the number of 
paths between different people and locations has exploded. This implies 
that changes in the form and frequency of flows between two points may 
have reverberations in unexpected paths far removed from them. Whereas 
previously we might have spoken of a world on which a variety of lines 
were drawn we now need to think of the globe as enmeshed in a web.' 
The above quotation justifies the qualitative approach used to study networks 
in this thesis, one that does not measure the links and nodes among global, 
national and local actors in GHPs. The aim is simply to study how forms of 
knowledge (or narratives) are embodied in GHP models and how the interplay 
of the knowledge and the actors involve shape global, national and local 
practices. This approach suggests that the infrastructures within which GHP 
programmes operate are formed by boundaries and institutions contra-posed to 
the historical rules and structures of agency that once defined such space. For 
instance, the interplay of different fonns of knowledge within GHPs affect the 
ways in which power is mobilised, which in tum influences the emergent 
structures of coordination and control of such knowledge. The emergent nature 
of specific GHP programmes obviously exhibit considerable variation, while 
the structures of transcalar networks supported by the GHP model become the 
scene of new conflicts over their governance. 
At one level of interest there are the interactions taken place in networks of 
multinational agencies in the UN, international development agencies (western 
nations), international CSOs and private multinational corporations and their 
roles, functions and responsibilities (GHPs at a global level). At another level 
is the relationship between this western-dominated global network and the 
local implementing GHP agencies, the rules and methods governing such 
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interactions and their relevance for carrying out the proposed reronns, plans 
and general initiatives (GHPs at country level). Finally, there is the relationship 
between the local implementing agencies, the local implementing bodies and 
specific global partners which arc local in character and generally part of either 
the government of the country of interest or a global GHP partner (transcalar 
networks). 
There are parallels, opposites, compliments and competing narratives on access 
to medication within and between all these scales. Governing the various 
aspects of policy transfer and implementation in such circumstances is 
obviously challenging, especially, reconciling between commercial and 
developmental objectives. However, the governance of such networks is not 
the subject of study in this dissertation. The focus here is to identify the public 
health, economistic and human rights narratives on access to medication that 
operate across these scales, how they become embodied in specific GHP 
programmes and their role in shaping different elements of global and national 
health policies as well as local delivery practices on access to medication. This 
is of interest here because; little is understood about the creation, interaction 
and maintenance of the web-like structures of actors and narratives that 
animate the GHP model and how such a model grapples with the challenges for 
achieving specific targets relating to access to medication. 
In this context a state-centric system of decision-making is different from that 
put forward by GHPs in terms of PPPs (National Programme Committees). 
Similarly, the network of actors, relations and resources at various levels of 
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interactions is hard to quantify. These forces are in many ways defining the 
contexts qualitatively, through an indication of willingness and readiness to 
participate, submitting policy proposals, showcasing best practice and forming 
strategic alliances within the global and national structures that define the 
organization of political, economic, demographic and cultural activities in 
Cameroon. Therefore, by examining such structures, the nature of the GHP 
model can be better understood. It also becomes possible to make an 
assessment about the network of forces and events that give texture to the 
descriptive accounts in specific GHP and related programme documents. This 
will be achieved by looking for patterns in the roles that various elements 
comprising the networks, but preceding the intended outcomes of the overall 
initiative display and analysing how they are connected to and dependent upon 
other contexts and the broader national and global dynamics. 
Finally, this thesis has not studied in greater detail the role of specific actors 
and inter-organizational interaction within GHPs. Covering the details of what 
specific actors are doing and how they link to every other actors through a 
qualitative approach is not realistic given the time and resources devoted to this 
thesis, and the number of global, national and local organizations that make up 
each GHP programme. As described later, the focus of analysis at the local 
level emphasized two provinces in the country each of which represents 
contrasting political, economic and socio-cultural characteristics of Cameroon 
as a whole. However, every attempt was made to capture inter-organizational 
interaction in areas where such interactions enable us to understand to the role 
of the GHP model in shaping specific areas of policy formulation and 
implementation. 
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3.3. Research Strategy 
3.3.1 Justification of qualitative research method 
As mentioned earlier, narrative policy analysis, the analytical framework 
adopted to study GHPs as model, is consistent with actor-network theory 
approach popular among STS practitioners, which focused on following the 
views of specific actors across socio-technical networks over time. In the field 
of SIS, Bowden (1995:64-64) provides a dual meaning of method: 'various 
strategies for data collection and analysis' and 'the method of explanation for 
data that have been collected'. While the latter refers to general and 
prescriptive rules, he stresses that the former refers to traditional disciplinary 
approaches that are already dominantly used in SIS (participant observation, 
ethno-methodological research, analysis of historical documents, and textual 
analysis). In particular, Bowden argues that because of the multidisciplinary 
and interdisciplinary nature of topics being investigated each 'researcher uses 
the methods and techniques of his or her particular academic discipline to study 
some aspect of science or technology' (Bowden, 1995 :67). It is on the basis of 
this second meaning of research method that suggest NPA is a relevant method 
of analysis in this thesis since the theoretical framework developed in chapter 
two is interdisciplinary. 
Following Murphy and Dingwall's (2003) argument that the empirical methods 
should he chosen on the basis that they are appropriate for the nature of the 
investigation, this research employs a qualitative approach. This allows for a 
more interpretive analysis of social knowledge and encompasses a range of 
philosophical underpinnings (Kvale, 1996). A qualitative approach enabled this 
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research to explain and understand in detail the complexities surrounding the 
creation of GHP models for specific diseases and their deployment to facilitate 
access to medication for the poor in Cameroon. The in-built flexibility present 
in the qualitative approach permitted the constant refining of the research, 
leading to context and content analyses. 
In a social (public) policy context such as those in which GHPs operate, 
qualitative research is known to adopt a wide range of research methods 
(Silverman, 2001). Silverman points to the historical, political and contextual 
characteristics involve in the transformation of issues into researchable 
problems. On the basis of the historical and contextual nature of diseases (such 
a malaria with a long history of failed eradication efforts and HIV / AIDS which 
is more recent) and the history of health interventions (colonial, international 
and global eras) it was decided that this research should primarily use more 
than one case study. It was also decided that both documentary and interview 
data would be collected and analysed. 
This thesis seeks to investigate the GHP model as it is deployed in an African 
country, specifically the prospects of facilitating access to medication for the 
poor. It was decided at an early stage that case studies would be used to 
compare GHPs in one country, one in which GHPs are meant to strengthen the 
national health system as a whole and another one where GHPs are meant to 
achieve a narrow objective within the national health system. Case studies have 
been variously criticised for their lack of generalisability (Hamel, Dufour & 
Fortin, 1993; Yin, 1994), however they are still employed as a crucial method 
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in social scientific studies (Stake, 1994). Analysing the historical emergence of 
GHPs at global and local levels through case studies is particularly important 
because of 'the contribution of the historical method in dealing with the 'dead' 
past - that is, when no relevant persons are alive to report, even retrospectively, 
what occurred and when an investigator must rely on primary documents, 
secondary documents, and cultural and physical artifacts as the main sources of 
evidence (Yin, 2003:7). Historical analysis is important for understanding the 
structural framework on which contemporary events are based. This thesis 
therefore emphasises in-depth historical assessments of the role of the GHP 
model in relation to previous models of health interventions and health policy 
reforms. 
Two case studies are therefore used in this research to enable us to make 
comparable (and not necessarily generalisable) claims on the role GHPs in 
shaping policy practices on access to medication. The use of case studies is to 
aid empirical analysis and the two case studies were chosen in order to 
investigate empirical claims on GHPs achieving their target objectives in the 
context of disease-endemic countries and also to obtain comparative outcomes 
for the research. The National malaria and HIV/AIDS programmes' in 
Cameroon were the final selection case studies, as they provide a comparison 
of GHPs with different strategic objectives (the malaria programme focusing 
on health system strengthening and the HIV I AIDS programme focusing on 
drug procurement and local distribution) in a single country (Cameroon). 
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When chosen the specific country and case studies for this research, both 
practical and theoretical considerations were taken into account. Practically it 
was imperative that it was feasible to collect data from the given country. The 
issues of language, political stability and safety were important factors. It was 
decided that Cameroon provides an interesting case study as it presents in a 
nutshell the political economy trajectory of Africa as elaborated in chapter five. 
English and French are the official languages and being a Cameroonian, this 
allowed me to personally conduct interviews and analyse interviews and 
documentary data from a wide range of local, national and international 
organizations without the need for a translator. It was also important that the 
case study country is stable politically, so that fieldwork could be carried out. 
In addition, Cameroon has always endorsed international health initiatives and 
many GHPs are already very active in the country. This allows for a more in-
depth analysis of the deployment and implementation of GHP programmes in 
an African country context. 
Practically, it was feasible for fieldwork to be carried out in Cameroon. In 
Cameroon, many different local languages co-exist but English and French are 
the official languages and all actors interviewed were fluent in either English 
and/or French. Despite a few cases of instability that are easily contained by 
the government, Cameroon has a history of political stability and arguably 
enjoys a stable democracy. The issue of safety was not-particularly important 
with regards to Cameroon, as it is not known to be one of the highest crime 
rates in Africa. However, when conducting fieldwork in Cameroon measures 
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were taken to ensure my personal safety (e.g. interviewing during the day time, 
taking trusted transport to interview locations). 
In principle the choice of case study should add something new to existing 
literature. Despite a long history of eradication, treatment and control 
campaigns, malaria is still one of the common causes of deaths in Cameroon. 
The HIV/AIDS, a more recent pandemic, has attracted substantial funding and 
mobilization; however, incidence and burden of the disease continues to rise. 
More so, for both disease areas, little theoretically backed empirically research 
has been done on GHPs in Cameroon beyond case studies to inform policy 
documents, compile technical reports or evaluation of specific programme by 
various GHP partners. This research therefore adds new knowledge to the 
scattered and arguably limited empirical literature on this subject area in 
Cameroon. Although there is a vast amount literature on GHPs in African 
countries, by using the 'knowledge approach' to unpack the network of actors 
and institutions involved in GHP programmes in Cameroon, this thesis offers 
new insights on GHP issues in both Cameroon and other African countries and 
can therefore contribute to existing knowledge. 
3.3.2 Interviews 
While there is no standard approach for qualitative research, interviews were 
used as the primary means of data collection in this research, complemented by 
documentary analysis. According to Silverman (2001:18) an interview study 
'highlights the advantages of qualitative research in offering the apparently 
'deeper' picture than the variable-based correlations of quantitative studies.' 
Apart from allowing an exploration of the variables in a much more 
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exploratory fashion, interviews provide a means of generating data for this 
research that could not be obtained only from documents or web based 
searches. In this context, Murphy and Dingwall (2003:93) state that qualitative 
interviews: 'Allows researchers to explore the ways in which informants 
themselves define the experience and practice that are the focus of the research 
.... They open up the possibility of challenging the researcher's preconceptions 
about what is important or significant.' 
In line with the above perspectives, semi-structured interview were adopted 
throughout this research.' Semi-structured interviews provide a level of 
flexibility that allows interviewees to discuss GHPs and focus on themes of 
particular importance to them, without hindrance from the interviewer. The aim 
was to create an environment conducive for a purposeful conversation 
(Burgess, 1984) where interviewees were able to freely express their views. It 
was also decided that with the consent of interviewees, interviews would be 
recorded so that transcripts could remain as faithful to what interviewees said 
as possible. As the recorder is quite inconspicuous, this allows for a more 
conversational style interview as opposed to an interrogation that closely 
follows a script. 
In cases where consent was not given, detailed notes would be taken both 
during and after the interviews. It was recognised that this method did have its 
limitations, as one could become distracted with note taking and not devote full 
attention to the interviewees and their responses. Also it is not possible to 
record all the information given during the interview via this method and the 
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possibility of omitting important details is increased. However, in the absence 
of consent, this was the method deemed most suitable for recording interview 
data. 
Many writers point the limitations of using interview data for academic 
inquiry: 'The limitations of such data are related to the fact that such accounts 
were consciously and deliberately produced for the purpose' (Prior, 2001 :573). 
The accounts given during interviews can represent what interviewees think 
they should say as opposed to what actually happened. This does not present a 
major problem for this research as it was always kept in mind that the 
interviews represented a reflection of interviewees' perspectives on the role of 
GHPs in access to medication and it was these perspectives that were of 
interest. This is why interviews were essential for this research. They 
represented narratives that are not directly observed by the researcher (the 
interviewer), and therefore there was a potential gap between what was said 
and the actual situation. In order to overcome this, the documentary and 
observational data collected were used as complementary sources. 
A log book was kept detailing the day's events, including target dates or 
schedules of interviews and other planned meetings, the interview location, 
behaviour of interviewee(s), references to be consulted in specific locations 
during the fieldwork, notes taken during infonnal interviews and interactions, 
general thoughts on the interview as well as all observations made during the 
fieldwork. This enabled me to reflect on the whole interview process and not 
carry over any thoughts or feelings on previous interviews. It also enabled me 
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to collect relevant data from certain employees (such as research and 
administrative assistants, information and documentation officers) working in 
the organizations or institutions that I visited. Such data are obviously useful as 
a way of corroborating those from interviews and technical reports. 
3.3.3 Sampling, Approach and Access 
This thesis is about the embodiment of knowledge (expressed as narratives) in 
GHP models and how this shapes global, national and local policy practices. At 
such it was important to select relevant actors from each of these levels for 
interview. Two classic STS methods of data collection were employed, 
namely, 'snowball effects' (Bijker, 1995) and 'following the actors' (Latour 
and Woolgar, 1986). According to the former, researchers are supposed to 'roll 
a snowball' to identify and engage a preliminary set of relevant social groups, 
ask them to identify relevant groups and in this w ~ y y eventually build up a 
group of informants. In terms of the latter, the researcher is expected to 'follow 
the actors' to listen to what they say, observe what they do and recreate a 
picture of the construction process. During the fieldwork for this research, a 
manageable number of snowballs were rolled and a sufficient number of actors 
were selected for interview. However, the plan to follow the actors and observe 
what they did was not possible due to the limited time and resources available 
for the entire fieldwork. In addition, GHPs do not hold meetings frequently, 
implying that the objective was to contact selected participant on a mutually 
accepted time for an interview. 
The notion that GHP models shape health policies and local delivery practices 
guided the researcher as to which groups represent the key with regards to 
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GHPs and therefore where to 'roll a snowball'. These were the initiators of 
GHP models (senior board members of specific GHPs and their affiliated 
international partners), national policy makers (Ministry of Public Health) and 
local policy implementers (provincial and district centrcs and parallel 
initiatives). This leads to a wider selection of stakeholders including local 
public, private and civil society groups. Practically these key actors were 
identified mainly from GHP literature through web·based searches and 
informal contacts established in Cameroon. 
Feasibility studies for this research were carried out between February and 
April 2007 through informal telephone contacts. As this research was not fully 
funded, it was decided that only one fieldwork trip would be carried out, that 
is, to conduct interviews for the empirical research. It was therefore more 
convenient to conduct feasibility studies through telephone interviews. This did 
not pose any problem as the researcher is a Cameroonian born and bread in 
Cameroon and was therefore knowledgeable enough on who to contact at an 
initial stage. The feasibility study was useful to assess what was happening on 
the ground with regards to access to medication in Cameroon, as there was 
little written on this subject in Cameroon through web·based sources. 
At the level of Cameroon, it was decided that the research will focus on two 
provinces, namely, the Centre Province and the North West Province 
respectively. The Centre Province is located in the French·speaking region of 
Cameroon. Apart from hosting Yaounde, the capital of Cameroon, all the 
country offices of GHP programmes, international private and civil society 
89 
GHP partners and UN agencies are located in the Centre Province. The 
province is also arguably the most developed in the country in terms of 
infrastructural development and high levels of economic activity. It hosts the 
country's single University Teaching Hospital, one of two Central Hospitals in 
the country and well developed private, religious and civil society run hospitals 
and pharmacies. On the other hand, the North West Provinces is located in the 
English-speaking region of Cameroon. With its capital city of Bamenda, it is 
arguably the least developed in the country. The main economic activity for a 
large majority of the population is subsistence agriculture. Traditional culture 
dominates political and social organizations. Unlike the centre province, its 
most advanced health unit is the Provincial Hospital with public, private, 
religious and civil society health units and pharmacies scattered all over the 
provinces. These contrasting provinces were selected because they provide the 
broad view of GHP processes in terms of the much talked about concentration 
of programmes in cities and urban areas and the need for decentralization to 
better serve the needs of the poor in rural villages. 
After a series of informal discussions with specific persons in these two 
regions, two persons, one from the Centre and North West Provinces 
respectively, were selected to act as informants for this research. They were 
selected primarily because of their local knowledge about key actors and 
organizations taking part in GHP-related activities and personal affiliations 
with the researcher. The informant for the Centre Province is a senior medical 
practitioner at the Yaounde Central Hospital while the informant for the North 
West Province is senior medical practitioner at the Bamenda Provincial 
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Hospital. Both persons graduated in the University Teaching Hospital in 
Yaounde and have over five years experience working on issues related to 
malaria and HIV/AIDS in these respective regions. It was interesting to realise 
that they did not only know the national policy makers, medical practitioners, 
public and civil society representatives of the two GHP programmes studied in 
this research; most of them were either former workplace colleagues or former 
school mates. These informants are also trusted to be able to voluntarily help 
the researcher to avoid the lengthy process of requesting permission to conduct 
interviews. 
Through the informants, snowballing was used to access interviewees. In the 
Cameroonian cultural context it is acceptable to go directly to any given 
address and ask to speak to a representative of an organization. However, in 
case where the researcher is not very affiliated with the organizations or 
persons to be interviewed, or where due to technical difficulties in contacting 
prospective interviewees at the local levels (for example poor communication 
networks) it is useful to make use of a local contact persons to assist in getting 
to interviewees as soon as possible. This proved a successful method during the 
fieldwork for this thesis. The two informants were very useful in collecting 
phone numbers, email addresses and other contact details of potential 
interviewees that are otherwise not accessible in programme files and 
documents (and therefore hard to access through a formal process). Due to 
political reasons, certain government officials (such as those in the government 
ministries and ministerial departments) are sometimes less interested in 
granting interviews even with formal consent. These local informants also play 
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a key role in connecting me to specific persons within such departments who 
are then able to pass over my request to the person that I have selected for an 
interview. 
At the global level, interviewees included specific persons within UN agencies, 
western development agencies, pharmaceutical companies, international CSOs 
and foundations who represent these organizations in the GHPs studied (RBM, 
AAI and EAI). At the national level, interviewees were selected from within 
the Ministry of Public Health and National Malaria and HIV/AIDS Programme 
Secretariat respectively. At the local level, interviewees were sought from 
Provinical and District Delegations for Public Health, Provincial and District 
Units of the malaria and HIV I AIDS programmes. At each levels, the selection 
was done to reflect the pUblic-private nature of GHP programmes (public, 
private and civil society groups were included in the selection). 
Thus through the formal and informal processes above, all the organizations 
contacted willingly gave me the details of relevant people to speak to and the 
snowballing technique was of importance in this respect. There was a huge 
secondary literature on GHPs in Cameroon (mostly presented as technical 
reports and programme evaluations) in the secretariat of specific GHP 
programme offices as well as local initiatives affiliated with GHP programmes. 
Although the year 2000 was the year of GHPs, there was little capacity for its 
research and regulation. Internet searches to identify key groups presented a 
problem in Cameroon. 
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A feasibility study to identify the interviewees at the global level was not 
necessary as it was possible to ascertain that GHPs were a highly debated issue 
in African countries as can be seen from a reading of GHP literature available 
online (accessed through university libraries in the UK). However, some 
INOOs and foundations either do not have websites (or have websites that are 
hardly updated) and their details were not readily available in published 
documents. The infonnants were quite useful in directing me where to go (in 
cases where they cannot travel to get the relevant contacts) to access the 
persons or organizations sought. This was especially very useful when 
arranging interviews in urban and rural areas of the selected provinces. 
Potential interviewees were initially approached with a letter which was faxed, 
emailed (if an email address was available) or presented directly (through the 
two infonnants), giving details on my research and why I would like to speak 
to them. The email approach worked best for those persons who work in 
international organizations or at the national level of GHPs. In case of no 
replies, contact was sought through the telephone. This strategy had a far 
greater success rate as once I spoke to either the individuals or organizations 
personally; I was assured that they would be willing to speak to me. It was 
rather difficult to arrange exact interview dates and times whilst in the UK for 
the research, due to the 'laid-back' approach to timetabling and scheduling 
prevalent in Cameroonian culture. 16 Although I was a little anxious about 
access and the availability of interviewees prior to my research trip, this proved 
not to be a problem as access was never denied and, due to the flexibility of 
16 When I contacted the organization I was reassured that it was not necessary to arrange a 
meeting and that I could tum up and speak to them at any time. 
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interviewees' timetables, availability was not a problem. Again in many cases, 
the two informants had established how flexible certain interviewees would be 
with respect to timetables during the period of the research. 
The groups at the global level were identified mainly through web·based 
searches. This proved a useful method for the fieldwork, as websites were 
regularly available and fully updated. In order to engage with some 
pharmaceutical companies I contacted prominent persons known to promote 
corporate social responsibility {where the right person to interview could not be 
identified in GHP documents and other sources} and was able to arrange 
interviews with the relevant persons through them. In these cases interviewees 
were mainly approached via emails with a reference to the person through 
whom contact has been sought. In all other cases, interviewees were mainly 
approached via emails and the majority of interviews were arranged this way 
including specific date, time and location {telephone interviews}. 
Access was more of an issue at the global level than at the national and local 
levels. GHPs and access to medication is a highly controversial issue in many 
developing countries and this had ramifications for this research. Some 
organizations were concerned as to the agenda of this research although all the 
organizations noted that the Information Sheet and Consent Form clearly 
explained the funding of the research as well as the underlying motivation 
behind it. However, while the organizations were assured that this research was 
purely academic and without any ulterior motives, the interviewees recruited 
expressed concerns as to the wider implications of their responses. At the 
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national and local levels all participants were willing to participate even if an 
authorisation to carryout fieldwork in Cameroon issued by the Department of 
Research at the MoH was not presented. 
There were some unsuccessful attempts at obtaining interviews from some 
international private organizations. In the case of one pharmaceutical company, 
two persons who had been recommended as most suitable for an interview 
never accepted to participate. One of them had left the position since six 
months and opted as not being in a position to participate. The other person 
said 'Unfortunately, I am not in a position to answer to your interview due to 
the nature of my job'. For a similar reason, a sample of the themes and possible 
interview questions were sent to three pharmaceutical companies before they 
accepted to participate. It appears, on the basis of the interviews, their concerns 
centred around the possibility of releasing internal information on bilateral 
negotiations they have with each developing country on drug prices/quality and 
supply arrangements that are independent of the OHPs to which they belong. 
There was an unsuccessful attempt at obtaining interviews from the French 
Cooperation, considered as one of the most important global partners 
(especially in terms of funding and governance guidelines). Both its offices in 
France and Cameroon were approached for an interview. However, they were 
unable to arrange a suitable date and time for an interview and were not able to 
contribute to this research through this method. However, there are several 
interviews given by the French Cooperation in Cameroon in their website that 
were suitable for the purpose of this research. All other international 
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organizations that were approached happily accepted to participate in the 
interview. 
3.3.4 Interview Process 
The main fieldwork for this research was carried out in December 2007 in 
Cameroon and between January and February 2008 in the UK (telephone 
interviews). Thus approximately three months in total was spent conducting 
fieldwork. Before setting out to Cameroon an interview s c h e ~ u l e e was prepared, 
detailing questions to be asked. A number of draft and amendments were made 
before the final interview schedules were reached. There were three types of 
interview schedules, one devoted to analysing the nature of the national health 
system (pharmaceutical and healthcare delivery) in general and two devoted to 
the national malaria and IIIV I AIDS programmes respectively (see Appendix). 
The interview schedule on the national health system was devoted to the 
historical context of the national health system and the emergence of GHPs in 
Cameroon. It was specifically targeted at those interviewees who do not have 
any direct responsibility in national GHP programmes. This included the 
Division of Healthcare Organization and Health Technology within the MoH, 
Provincial and District Delegations of Public Health and selected public, 
private and civil society health and pharmacy units. The questions were 
designed around the following themes: 
• Description of the structure of the national health system 
• The process of pharmaceutical and health care delivery 
• Barriers to access to medication (potential vs. actual access) 
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• Awareness of the impact of GHP programmes (overlapping 
programmes) 
The interview schedules for the national malaria and HIV / AIDS programmes 
were similar to each other, the only difference being specific issues related to 
disease areas. In addition, during the course of interviews references were 
made to the questions on the interview schedule designed for non-GHP 
partners (described above). In general, the interviews were designed in relation 
to the following broad themes: 
• Barriers to access to medication and the creation of national GHP 
programmes 
• The nature of GHP programmes vis-a-vis country-specific context 
• The role of each partner vis-a-vis other partners (policy making and 
implementation) 
• Impact or outcome of GHP programmes, challenges and future 
prospects 
The interview schedules were variable at the global, national and local levels to 
reflect the different status of GHP across these scales. For example, questions 
about bilateral negotiations between developing country governments and 
individual pharmaceutical companies were not deemed to be relevant for 
interviewees at provincial units whose tasks are limited to coordinating 
programmes and activities within the province. The interview schedule was 
used as more of guidance than a rigid framework and attention was paid to the 
interviewees' responses. In addition, interview questions were tailored to each 
individual's response. Indeed, in some interviews it was not necessary to ask 
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the majority of the questions in the interview schedule, as the interviewees 
covered most of the topics without prompting. 
Twenty-six interviews were conducted throughout the fieldwork. They varied 
in length from approximately fourteen minutes to fifty-six minutes. Seven of 
the interviews were conducted by telephone (most with global partners) while 
the rest were face-to-face interviews. As explored later in the case studies, 
some of the interviewees spoke as representative of more than one GHP 
partner. For example, the national disease committees consist of 
representatives at global, national and local level. Therefore some interviewees, 
in addition to being members of the national committee, also hold positions of 
responsibility in specific GHP programme or activity at global, national or 
local level. In this case it was ascertained that a total of thirty-four interviews 
were conducted for this research. The interviews took place in a range of 
locations including governmental offices, university laboratories, cafes, 
interviewees' home and telephone. Much care was taken to ensure that 
telephone interviews took place at locations that were tailored to suit the 
interviewees. Brief notes were taken during and after the interviews 
(highlighting key points) and more detailed field notes were taken after the 
interviews, which typically included observational notes. These were noted in 
the log book 
3.3.5 Ethics and Consent 
Although the interviews for this research did not require ethical approval 
through an ethics committee, the issues of ethics and consent were of great 
importance. The ethical guidelines of both the University of Nottingham and 
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the national ethical framework for conducting research in Cameroon 
respectively were used throughout this research. Nottingham University's six 
key principles on ethical guidelines l7 are as follows: 
I. That the ethical basis and design of research projects are ethically sound 
and have received the approval of the relevant ethics committee(s) and all 
relevant statutory regulatory authorities before they commence. 
II. The safety of all involved in the research process, ensuring that the 
research is carried out in accordance with health and safety policies and 
legislative requirements; 
III. Ensuring that research is conducted in a suitable working environment 
with appropriate equipment and facilities; 
IV. The probity of the financial management of all research projects, and for 
seeking to provide the optimum value for the public or private funders 
who have invested in them including effective project management to 
agreed project plans and appropriate quality standards, as well as the 
timely delivery of any scheduled tangible outcomes; 
V. Management of research data in accordance with the Data Protection Act 
1998 and any other legal provisions, conditions and guidelines that may 
apply to the handling of personal infonnation; 
VI. Undertaking professional development appropriate to the research 
The national ethical framework for conducting fieldwork in Cameroon requires 
a set of documents to be submitted, to the Research Ethics Officer of the 
17 The University's Research Ethics Review Checklist 
(http://www.nottingham.ac.uklrso/JocaVresearch-strategy-andpol icy/code _ ot conduct.pdf) is 
complied by the Institute for Science and Society Code of Research 
Conduct:<https:llwww.nottingham.ac.uklsharedlshared iss/documentsllSS _Research_Code _ of 
_ ConductV3 _ DctOS.pdf.> (Last accessed: 10/02/09) -
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relevant Ministry to which the research is most related. After receiving the 
documents, a clearance is issued in the form of an authorization to conduct 
research in Cameroon. In the case of this research, this involved submitting the 
following documents for approval by the Ethics Officer in the Ministry of 
Public Health prior to the start of fieldwork: 
I. An undertaken from the head of the department or institute in which the 
research is being carried out declaring the status of the institution, 
modalities for dissemination and valorisation of results and that ethical 
clearances have been approved by the institution. 
II. Personal undertaken by the principal investigator in respect of 
fieldwork research in Cameroon declaring full costs of fieldwork, 
sources of funding, relevant external ethical guidelines and modalities 
for dissimilating findings prior to the start of fieldwork. 
III. Presentation by principal investigators a CV (that he/she is qualified to 
undertake the research), research proposal, information sheet and 
consent form. 
The above ethics framework emphasises the use of judgement, discretion, 
accountability and integrity and these principles were followed throughout the 
research. Prior to the interview, the objective of this research were made 
explicit to the interviewees, in that this thesis seeks to investigate impact of 
GHPs on access to medication in Cameroon. They were informed that the 
findings of this research would be available in the public domain in the form of 
an academic thesis and possibly in scientific journals. They were also assured 
that any comments made would be suitably anonymised in order to protect 
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their confidentiality and that all data would be destroyed once the thesis had 
been competed (this was done in line with the University of Nottingham's 
research ethics framework). 
All interviews gave their written (face-to-face interviews) and verbal 
(telephone interviews) consent for their interviews to be used in this way. 
Although the above ethics guidelines state that consent is typically given in 
written form it was judged not to be practically suitable for telephone 
interviews as well as that verbal consent was able to fulfil the primary 
objective of 'conducting research openly and without deception,.18 Consent for 
the interviews to be recorded was also asked prior to the interview. All the 
interviewees accepted. Once the interview was over, interviewees were given 
my contact details and asked to contact me if they have any further queries 
regarding this research. The confidentiality of interviewees was ensured by 
treating quotes and comments as anonymous. 
3.3.6 Documents 
During the interviews, some of the interviewees provided me with 
documentary data, usually in the form of annual reports, technical reports, 
programme evaluations, organizational literature, and government documents 
and, in some cases, academic literature (usually written by the interviewee or a 
member of the organization). For example, during the interview at the 
secretariat of the National Malaria Programme, the Provincial Delegation for 
Public Health (for both Centre and North West Provinces) I was granted access 
IS ESRC Research Ethics Framework :24 
<http://www.esrcsocietytoday.ac.uklESRCInfoCentrelImageslESRC_Re_Ethics_Frame_tcm6-
11291.pdf.> (Accessed: 10/02/09) 
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to the documentation department. The relevant information officers in each of 
these offices were available to show me around and have informal chats with 
me on any questions or issues that I raised. These informal discussions (noted 
in my logbook) provided valuable data that enabled me to corroborate 
interview data and get more insights about specific issues on GHP 
programmes. These documents lie between observational data and individual 
data and can provide evidence as to how people or organizations would like to 
project themselves and their experiences (Murphy and Dingwall, 2003). These 
documents were used as complementary sources and often aided understanding 
of the interviews. However, these documents were not formally analysed. 
3.4 Analysis of Data 
This section will detail the process used to analyse data in this thesis. How one 
regards the status of an interview data is important in how one analyses it. One 
of the difficulties of describing this process is that it was very much an ongoing 
process that was present, both formally and informally, throughout the writing 
of the thesis and had no precise beginning or end. However, this section will 
detail the formal methods used to analyse data. 
Interviews can be analysed as 'straightforward reports on another reality or 
whether they merely report upon, or express their own structures' (Silverman, 
2001: 111). This thesis regarded the accounts given by interviewees as their 
own personal reflections on the role GHPs on access to medication as opposed 
to an objective depiction of GHPs. The interpretation of the data took this into 
account as well as the social context of the interviews, including the behaviour 
of the interviewee (noted in field notes), as this impacted the data gathered. 
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As already mentioned the analytical method used in this thesis is NPA. It 
focuses on rhetorical issues as applied to content analysis of texts, or a close 
reading of interview transcripts (Silverman 2003) to understand the stories (or 
narratives) people tell with very detailed quotation from texts and interviews 
(e.g. Roe, 1989; McBeth et aI., 2007). For this reason, the interviews were 
transformed into data through transcription. The interviews were transcribed 
verbatim (although those conducted in French were translated into English) and 
although key notes of context (e.g. when someone left or entered the room) 
were also detailed, minute linguistic details such as false starts were not 
documented as it was deemed that the impact of these on the research analysis 
was minimal. 
It was therefore decided that the use of computer assisted qualitative data 
analysis (CAQDAS) was not suitable for this research. Some authors have 
stated the limitations of CAQDAS as stifling qualitative creativity, limiting 
interpretations, distorting and weakening data (Becker, 1993; Kelle, 1995; 
Richards and Richards, 1998; Roberts and Wilson, 2002). It was also decided 
that computer software package (such as NVivo) were irrelevant as they have 
not previously been used for NP A related studies. In addition, it was also 
thought that the use of such software could potentially limit the reflexivity of 
analysis and therefore not allow for an in-depth review and detailed quotation 
of the interview data. Therefore a manual approach to data analysis was 
adopted. 
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The first step of data analysis involved reading the transcribed interviews and 
field note, without any note taking or writing on the scripts. This was in order 
to familiarise myself with the actual scripts. After this first stage of 
familiarisation interview scripts and field notes were read again, noting 
prevalent and interesting themes that would be used as the basis for the second 
stage of data analysis. 
A second stage of analysis was inspired by coding practises. Bryman 
(2001 :392) describes coding as a process of 'reviewing transcripts and/or field 
notes and given labels (names) to component parts that seem to be of potential 
theoretical significance and/or that appear to the particularly salient within the 
social worlds being studied'. At this stage scripts were read several times so 
that labels could be ascribed to emergent themes within the data. Practically, 
this was done by assigning themes to a particular colour and manually 
highlighting relevant parts of the data that corresponded to particular themes 
with the assigned colour. For example, red equalled governance issues, yellow 
equalled transcalar network issues and blue equalled discussions on access to 
medication. By this time most of the script was highlighted and, indeed, I was 
so familiar with the scripts that I committed to memory large sections. 
The next stage of data analysis involved constructing a skeletal thematic 
structure. This structure was based on the themes of the data analysis but also, 
related to the research questions and theoretical framework that shaped the 
thesis. In line with Coffee and Atkinson (1996:30) this involved expanding and 
teasing out data in order to formulate more levels of interpretation. 
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The broad themes that emerged from the data were: 
• the formal and informal mechanisms through different narrative 
strategies on access to medication were negotiated when formulating 
and implementing policies 
• the interpretation of policies and practices on global, national and local 
levels 
• the types of cooperation existing among and between actors that lead to 
the formulation of policies and the design of programmes and activities 
at local levels 
• the role of key institutions in coordinating and directing different levels 
of policy formulation and implementation 
Documents were also analyzed in order to understand how the current status of 
GHP programmes relates to the historical and contextual characteristic of the 
emergence and role of GHPs in facilitating access to medication. This was also 
relevant because many of these documents were used to create the interviews 
especially in terms of the hierarchy of global, national and local processes. 
The above themes provided the basis and structure of the subsequent data 
chapters. Each theme relates to a particular research question that the thesis 
sought to answer. The theoretical framework adopted in this thesis was also 
used to analyse the data. The construction of access to medication and the role 
of actors in fonnulating and implementing policies guided the classification of 
the themes that had emerged from the field work. These two perspectives 
proved to be extremely useful analytical tools as they anchored the data 
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theoretically and this enabled deeper more complex levels of interpretation 
which would not have otherwise occurred. 
3.5 Critical Reflections 
So far in this chapter I have detailed the methods used to conduct this thesis 
and the rational behind them. In this section I shall discuss some of the 
unanticipated and somewhat unexpected elements of the research process. I 
shall also outline some of the limitations of this research and propose ways in 
which this research could be improved. 
3.5.1 The Role of Identity 
It has been shown that, 'conscious subjectivity' of researchers has replaced the 
'value-free objectivity' of traditional research and that this does not only 
increase honesty, but also helps to break down the power relationship between 
researcher and researched (Cotterill and Letherby, 1993:72). 
One of the main findings, particularly from the national level was how much 
my identity impacted the research. The first thing I realised when doing 
research in Cameroon was the impact of the colonial legacy, which seems to 
infiltrate all aspects of Cameroonian society. Although it did not exert a 
significant effect on my project it shaped how interviewees viewed me as a 
Cameroonian on the one hand, and as someone coming from the UK (where 
my research study is based) on the other. It was quite amusing to see people 
wanting to speak in English simply because I was an English-speaking 
Cameroonian coming from Britain for research. In particular, when I arrived 
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for one interview at the MoH, the secretary was quick to politely refer me to 
another office (instead of her boss) saying 'that is where English-speaking 
persons are located'. In another office located in the English-speaking region, a 
French-speaking director, on entering his office, immediately apologised for 
his insufficient English proficiency and requested to have the interview in 
French to enable more detailed discussions. In a few cases, an interviewee 
would start to speak in English and suddenly switches to French (and vice 
versa) while in others it was mutually decided that I ask my questions in 
English for the interviewee to respond in French. 
The concept of a 'native' was quite useful to most of the national and local 
interviewees. Some interviewees spoke in the vernacular when welcoming me 
to their offices and many were very happy when I did understand what they 
were saying. It was quite an interesting experience because it made me very 
aware of my cultural background and how this can shape the way in which 
people, in particular interviewees respond to me. It also facilitated the whole 
interview processes as many interviewees even invited me for refreshments 
after the interview (or at a later convenient time). 
According to Arendell (1997:343) 'conscious subjectivity' takes into account 
issues as identity, race and cultural background. Researchers bring to the 
research process cultural, social and historical 'baggage' which effects the 
interaction between researchers and researched'. Although Arcndell focused on 
the impact on a woman interviewing a man (in which case my research 
displays the opposite) awareness of these issues can enrich the research 
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process, as it enables reflexivity on the part of the researcher. It is obvious that 
my identity did impact my research findings in ways that allowed me to subject 
the research itself to investigation and also my role within it. Such an 
additional self-reflexivity adds another level of analysis that would not be 
possible if issues such as identity were not taken into account. 
The role of my identity and the part it played in how the interviewees 
responded to me could be seen to present a form of bias in my research, which 
could challenge the reliability of the findings. However, it is recognised in all 
social scientific research it is not possible to exactly replicate social settings, 
even with the same person/people conducting the research (LeCompte and 
Goetz, 1982). This phenomenon is not unique to my research and does not pose 
a challenge to the findings as this does not affect the validity of the research as 
there is a direct link between my observations and the analysis of the data. 
3.5.2 Limitations of Study 
On reflection more public, private and civil society organizations could have 
been included in this research. Although many local partners were contacted 
(especially representatives from patient groups) they were only interviewed 
informally to compliment the data collected from documents and formal 
interviews. It would be more representative to include more of these local 
partners as they would have given a deeper insight to GHPs from their local 
perspective and perhaps add new levels of complexity on the role of GHP in 
Cameroon (for example, the extent to which policy issues agreed at the global 
and national level are translated into programmes and activities at the local 
levels). 
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One of the main areas of improvement was the lack of inclusion of the local 
civil society partners in this research. The people included in the research 
where identified as key stakeholders, but arguments could be made for the 
inclusion of local people. However, ordinary people who would belare affected 
by GHP policy discuss and make sense of GHP would have been an interesting 
topic to investigate. Although this would have broadened the research focus, it 
would have provided useful insights as to the how these people make sense of 
GHP issues since GHPs are meant to address the needs of the poor. In addition 
a systematic study of the role of supporting ministries and the public, private 
(for-profit) and religious health units in GHP processes was also not given 
serious consideration. At the end of the fieldwork, it became obvious that the 
multiple providers of healthcare in Cameroon play a crucial role and have a 
significant impact in detennining the chances of success of the GHPs. This is 
because, many of these non-state partners run parallel HIV / AIDS and malaria 
initiatives independently of national GHP programme committees. 
As pointed out in chapter two, existing studies on GHPs have usually taken 
institutional structures as given, rather than in a process of change. In this 
thesis, the role of the nation-state is related to its surrounding global and local 
dynamics as a way of developing new categories and analytical strategies for 
the study of what happens within the borders of a nation and the construction 
of its social, economic and industrial space. Such an approach does not only 
reveal the challenges facing global, national and local partners within GHP 
programmes, but provides the possibility for proposals to incorporate their 
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competing interests. In such a multi-range or multi-level analysis of policy 
choices, Sahay and Walsham (1997) illustrate that the use of metaphors (e.g. 
narrative strategies) can influence specific choices over time. Similarly, Lind 
(1991) point to the potential for new types of risks arising because differences 
in the context of global, 'national and local development policy. 
Accordingly, the object of analysis in this thesis is not a single organization or 
inter-organization relations, but the multiple interactions, dependencies and 
interdependencies of UN agencies, government ministries, development 
agencies and other local (public, private and civil society) organizations 
involved in the process of policy making and implementation. Ultimately, the 
study is not restricted solely to the national country setting, but also to events 
outside the direct control of Cameroon and in relation to events happening in 
the surrounding region and the global context as well. This places the case 
studies of GHPs for HIV/AIDS and malaria in Cameroon in a position of 
special interest with respect to similar initiatives in other African countries. 
3.6 Conclusions 
This thesis aims to investigate the impact of GHPs on access to medication in 
Cameroon. This chapter has outlined the rationale behind the research design 
and methods used to carry out the investigation. It agues that the key challenge 
in unpacking the GHP model is to understand how the competing and 
conflicting narratives of access to medication are negotiated at global and 
national levels and how the combination of these are translated into specific 
programmes and activities at the local level. This is what makes the NP A a 
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suitable method for analyzing the OllP model in Cameroon. Documentary 
analysis, case studies and semi-structured interviews have been used in this 
study in order to conduct a social scientific project that analysis how OHPs 
grapple with the issue of access to medication in Cameroon. Ethics and consent 
have been considered and how these were managed was discussed. Finally this 
chapter critically reflects upon the research process as a whole and the 
limitations and unexpected findings of this research have been detailed. 
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CHAPTER 4: A GLOBAL PERSPECTIVE THE 
EMERGENCE OF GHPS 
4.1 Introduction 
The main objective of this chapter is to present the global perspective on the 
emergence of GHPs as a new kind of global model for securing access to 
medication in developing countries. As mentioned earlier, the emergence of 
GHPs reflects the challenges facing medicine and healthcare in developing a 
global language and a global strategy that can help to improve the health of the 
poorest people in the world. As such, GHPs attempt to achieve access to 
medication by integrating previously competing and conflicting narrative 
strategies on where the emphasis on access to medication should be placed, 
namely, public health (WHO and UNICEF), economistic (WTO, IMF and 
World Bank) and human rights (UN and International Civil Society 
Organizations) respectively. This chapter identifies and explains the role of 
theory in shaping these narratives and consequently how the narratives became 
embodied in GHP models on access to medication for malaria and HIV/AIDS. 
It therefore sheds new light on how GHPs are modelled to formulate global 
policies that are meant to be implemented on a country-by-country basis. 
The key argument here is that each GHP represent the embodiment of elements 
(forms of knowledge) from previous public health, economic and human rights 
models into a GHP 'models' on access to medication. To substantiate this 
argument, this chapter applies the theoretical framework developed in this 
thesis, especially, to conceptualise GHPs as models that mediate between 
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theory and practice as a better way of understanding their role on access to 
medication. In this case, models (Morrison and Morgan, 1999; King and 
Kraemer, 1992:7) can be located and studied where developments in theory 
paralleled or preceded developments in policy practices related to the models 
(MacKenzie, 2006). The focus of most GHPs on a narrowly defined role (Buse 
2004a) suggests that modelling their role as liberal/neo-liberal interventionists 
have done (Dodgson et aI., 2002) may not fit country-specific context. In 
addition, the conceptualisation of the determinants/narrative of access to 
medication by partners to GHPs is hardly made explicit in most study of GHPs. 
NP A (Kaplan, 1986) therefore becomes a useful analytical framework for 
making explicit certain issues that are only implicit in GHP policy documents, 
technical reports and the wider development studies literature on access to 
medication (N goasong, 2009). 
Thus, to better understand how GHPs are modelled, this chapter conceptualises 
them as the embodiment of parallel development models previously promoted 
by Western nations and UN agencies respectively in developing countries. This 
implies that although GHPs are of a practical nature, they are implicitly theory 
informed and this is how they should be studied. Economistic and public health 
models created in Europe and North America first found their way into 
developing countries through colonial routes. Later on modified versions of the 
models were endorsed at international meetings convened by UN agencies and 
deployed to developing countries for implcmention. From the late 1990s, GHPs 
began to integrate elements of these models into a global model on access to 
medication. 
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After exploring the role of theories in shaping the three narratives (forms of 
knowledge) embodied in GHP models, the potential role of GHP models in 
shaping local practices (national GHP programmes) are discussed. The next 
section of this chapter presents the public health narrative on access to 
medication. It is rooted in behavioural and change models that became 
embodied in variants of the Primary Health Care (PHC) model promoted by the 
WHO and UNICEF. Next the economistic narrative, rooted in theories of 
technological change and economic growth that dominate liberal and neo-
liberal market models promoted by IMF, World Bank and WTO is presented. 
This is followed by a discussion of the rise of a human rights narrative on 
access to medication. Though rooted in human rights theories, this narrative 
was implicit in both economic and public health models but later taken up 
more seriously by UN agencies due to rising incidence and burden of diseases 
such as HIV / AIDS and malaria and activism by international CSOs. 
After exploring the role of theories in shaping the three narratives (forms of 
knowledge) above, the ways in which they are embodied in GHP models as 
well as the potential role of GHP models in shaping local practices (national 
GHP programmes) are discussed using three case studies: WHO/UNICEF-Ied 
RBM with a public health emphasis, UNAIDS-Ied AAI with an economistic 
emphasis and the MSF·led EAI with a human rights emphasis. Finally the 
overlapping nature of the three models in relation to country-specific 
implementation challenges is discussed. 
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4.2 The Public Health Narrative of Access to Medication 
This section provides a description of how theoretical models of public health, 
developed decades ago, contributed to the emergence of a public health 
narrative on access to medication in GHPs. The field of public health does not 
have its own traditional theories. Theories were often adapted from the social 
and behavioural sciences and applied to epidemiology and the biological 
sciences (Kreuter and Skinner, 2000) to inform public health policies. Thus the 
terms theoretical concepts, theoretical models or frameworks are often used 
interchangeably to r e f ~ r r to theories of public health. This also allows theorists 
to continue to use new social science research to refine, adapt and integrate 
existing theories (Caplan 1993; Rawson 1992). As discussed below, although 
global health policy is generic or of a practical nature, they are implicitly 
theory-informed. 
4.2.1 The relationship between public health models and 
policy practices 
The period 1910-1950 is often described as the 'golden age' of scientific, 
techno-medicine in public health. Following the Flexner Report (1910) 19, the 
medical profession was institutionalised in universities and research institutes 
across the US and Europe in relation to changing socio-economic conditions. A 
growing middle class demand for health care supported a substantial growth in 
medical centres offering individually focused fee-for-service specialist 
medicine, what became known as the medical model (Turner, 1995). By 1950, 
significant developments in micro-biology had heralded a 'New Public Health' 
19 Flexner, A. (1910) 'Medical Education in the United States and Canada' Bulletin Number 
Four (fhe Flexner Report). New York: The Carnegie Foundation for the Advancement of 
Teaching. 
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as practitioners appeared to fully embrace the medical model rather the 
environment or 'social' model (Draper, 1991). However, as discussed below, 
1950 proved to be a turning point, largely due to the popularity of social theory 
(psychology and behavioural sciences) in introducing a focus on lifestyles and 
health behaviour into public health settings. 
Armstrong (1988) explains the above shift in terms of the institutionalization of 
the medical profession and the changing clinical practice that undermines more 
traditional oppositions between health and illness. This is very much reflected 
in the numerous theoretical models developed within public health from 1950s. 
There are 'explanatory theories' (Table 3) on the causes of public health 
problems and 'change theories' (Table 4) on the development of public health 
intervention/evaluation programmes. The former emphasise individual and 
interpersonal levels (cognitive-behaviour theories) and while the latter focus on 
the community or society as a whole (frameworks for implementing multi-
dimensional approaches to promote healthy behaviours) respectively. The 
development of these models was largely dependent on the health settings and 
the professional background of those who developed them. 
Explanatory theoretical models explore behaviour caused by intra- and 
interpersonal factors, including attitudes, beliefs, motivation, historical context, 
past experience, and skills (Table 3). The context of health care during the 
early 1950s encouraged an emphasis on disease prevention rather than 
treatment. The theoretical models were also characterised by some degree of 
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mathematisation, risk analysis and cartographic representations to give a 
material foundation to the models. 
Table 3. Key individual and interpersonal theoretical public health models 
Model Originators Theory Purpose of model 
Health Belief Rosenstock, Kegel, Behavioural Predicts preventive 
Modell Hochbaum (1950s) Science/Psychology health behaviour in USA 
Stages of Change Prochaska J.O & Behavioural Science Explain smokers' 
Modell DiClemente C.C. decision to give up 
(1970s) smoking habits 
Planned Fishbein & Ajzen Social Psychology Behavioural intention as 
Behaviour; (1970sl1980s) a determinant of 
Reasoned Action] behaviour 
Precaution Weinstein (1980s). Social Psychology Explain path from health 
Adoption Process awareness to health 
Model" action 
• 1 
" 
• J . Source. Rosenstock (1974); Prochaska & DIClemente (1983), Flshbem & 
Ajzen (1975); "Weinstein (1988) 
Change theoretical models (Table 4), were largely motivated by social 
networks, social support and systems theory. Saul Alinsky and Jan Rothman 
were very influential. They challenged the structural/individuallevel models in 
the face of' the war on poverty in the sixties • in the USA and Europe, a process 
that led to concepts such as community organization, community participation 
and community development to be widely applied national and international 
from the 1960s (Tones and Tilford, 2001:398). Midgley et aI., (1986:20) 
illustrate the role of these community activisits as follows: 'Instead of seeking 
to help deprived communities to improve their social and environmental 
circumstances, the new community work activists urged that people take direct 
political action to demand changes and improvements.' The writings and 
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campaigns of community activists provided the basis for the development of 
tools and methods for evaluating community-level health promotion efforts 
(Fettennan et ai., 1996; Fawcett et ai., 2000). 
Table 4. Key community (change) models of public health 
Model Originators Theory Purpose of model 
(Background) 
Community Saul Alinsky Social activism To mobilize and organize 
Action1 (1940s-1970s) grass roots campaigners in 
Chicago 
Community Jack Rothman Social and community How a community function, 
Organizingl (1960s-1970s) planning; social action change and mobilize 
community members 
1 ~ ~Source: A/msley (1946, 1971); Rothman (1968, 2001) 
The structural/individual models (Table 3), having emerged from publicly 
funded university project and programmes, were more important in policy 
making than the community models (Table 4). They helped policy makers to 
interpret field conditions and guided their decisions about intervention 
strategies. Once intervention strategies were decided the theories behind the 
models again played an important role in fonnulating models of 
implementation. Much cited examples include social marketing programmes 
that voluntary behaviour change (Alcalay and Bell, 2000) for health benefit 
(such as condom users or cigarette smokers) (Andreason, 1995). Similarly, 
PRECEDE-PROCEED enable researchers to identify and implement outcome-
based intervention strategies in public health (Green and Kreuter, 1999). 
At the international level, health policy practices did not necessarily follow the 
theory-infonned rational planning process described above. Policy making 
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often took place during international conferences and meetings and involvcd 
negotiations among conflicting and competing narratives offered by diverse 
stakeholders with an interest in the policy process (Ngoasong, 2009). The 
acceptance of a model depended on a combination of negotiated interrelated 
factors which determined the specific policy proposal that might be adopted. 
This was sometimes done without any consideration to country or context-
specificities. This further justifies the argument in this research, that the best 
way to study global models is by studying how different elements of theoretical 
models come to playa role in the formulation of a model. 
4.2.2 From international health to global health - How models 
shaped a public health narrative on access to medication 
The debate around the best model to adopt internationally since the 1950s 
focuses on whether substantial improvements in the health of a community are 
dependent on medical (access to medicines) or non-medical (access to 
healthcare but also food, sanitation and other socio-economic needs) 
intervention (McKeown, 1979; McKinlay and McKinlay, 1977). The WHO 
was created in 1945 as a specialised agency in charge of international health 
policy formulation and implementation. It defines health as 'a state of complete 
physical, mental and social well-being and not merely the absence of disease or 
infirmity' .20 The role of the models described above in the policy practices of 
the WHO first became explicit in the 1978 Alma Ata Declaration, the first of 
20 Preamble to the Constitution of the World Health Organization as adopted by the 
International Health Conference, New York, 19·22 June, 1946; signed on 22 July 1946 by the 
representatives of61 States (Official Records of the World Health Organization, no. 2, p. 100) 
effective on 7 April 1948. 
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its kind to be fully embraced by developed and developing countries (WHO, 
1978). 
The Lalonde Field Model of 1974 was very influential in committing WHO 
member countries to the principles of the Primary Health Care (PHC) model 
adopted at Alma Ata. The report was presented by Marc LaLonde, a former 
Canadian Minister of Health. It used behaviouraUexplanatory theory-based 
evidence to put forward the claim that improvements within the environment (a 
structuralist approach) and in behaviour (a lifestyle approach) should be the 
main objective of public health (preventive measures). According to Hanckock 
(1985:10): 
'(The Lalonde Field Model was) the first modern government document 
in the western world to acknowledge that our emphasis upon a 
biomedical health care system is wrong, and that we need to look beyond 
the traditional health care (sick care) system if we wish to improve the 
health of the public. The Lalonde report was followed by similar reports 
in Britain, Sweden, USA & elsewhere'. 
In the Alma Ata Declaration, PHC was defined as 'essential health care based 
on a practical, scientifically sound and socially acceptable method, made 
universally acceptable to individuals and their families in the community 
through their full participation and at a cost country and community can afford 
at each stage of development in the spirit of self reliance and detennination' .21 
Apart from embracing the provisions of the LaLonde model, the PHC also 
incorporated a commitment to community participation and inter-sectoral 
action, a commitment which has been explicitly emphasised in subsequent 
reorientations of the PHC system (Table 5). In particular, the Jakarta 
21 WHO (1978) Primary Health Care: Report on the International Conference on Primary 
Health Care, Alma Ata, 6·12 September. Geneva: WHOIUNICEF 
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Declaration states 'participation is essential to sustain efforts. People have to 
be at the centre of health promotion action and decision-making processes for 
them to be effective,22. 
Table 5. Importance of community models at WIIO/UNICEF-Ied meetings 
Dale Theme of meeting Narratives 011 participation 
1978 Alma-Ata Declaration: The Participatory approach adopted as core of 
Primary Health Care the Primary Health Care system 
1987 Bamako Initiative: Re- Community participation in co-financing 
orientation of Primary and co-management of drug supplies 
Healthcare in Africa 
1986 Ottawa Charter for Health Empowerment and Equity in health policy 
Promotion practices at global, national & local levels 
1988 Adelaide Recommendation on Equity in all areas of health policy making 
Health Public Policy and implementation 
1991 Sundsvall Statement: Community empowerment and community 
Supportive Environment for participation in democratic health 
Health promotion 
1997 Jakarta Declaration Participation is essential to sustain efforts 
2000 Bridging the Equity Gap Improved interactions between all players 
(Mexico Conference) in bridging the equity gap in health 
programmes 
2005 Bangkok Charter for Health Key focus on communities and civil society 
Promotion as a requirement for good corporate practice. 
Source: Author's processing of WHO/UNICEF-led meetings 
At first glance, it is not clear why the community model became so important 
at the international stage given that, unlike the behavioural models, they were 
less institutionalised and received limited· public funding. MacDougall 
(2007:955) claims that: 'internal political and economic forces are as important 
22 
<http://www.who.intlhealthpromotionlconferences/previous/jakartaldeclarationlenlindexl.htm I 
> (Accessed: 21/04/09) 
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as international trends in determining healthcare policy initiatives'. He offers 
the following as part of the explanation for this trend: 
'In the 1970s all the English-speaking developed nations were facing 
deficits as curative costs rose. Adopting health promotion policies 
permitted them to shift responsibility back to local governments and 
individuals while limiting their expenditures. Health and community 
activists, however, used this concept to broaden their focus to include the 
social, economic and political determinants of health and thus reinvented 
public health discourse and practice for the 21 st century. ' 
Unsurprisingly, therefore, the PHC model implicitly offered a new vision of 
health promotion that aims to combine both individual and community level 
approaches. It also addresses the structural determinants of health. This is what 
made it so attractive - it combined everything, including the socia-economic 
determinants of health. Health promotion is what held everything together 
(Tones and Tilford, 2001). 
Participation is defined not in terms of a single community-level model, but in 
terms of achieving a level playing field between both approaches and taking 
into account conflicting interest of partners in developed and developing 
countries. Future models of public health such as P ATCH23 that emerged from 
the international meetings on Table 5 above combined both approaches (see for 
example Haglund et al., 1996). This meant that, although countries endorsed 
the PHC model and its subsequent variants, in reality, national health systems 
consisted of discrete disease control programmes and activities that were 
hierarchically organised (Gish, 1992) based on specific or a combination of 
individual, interpersonal and community models described above (Beaglehole 
and Bonita, 1997: 124). These models had long been exported to developing 
23 For details on PATCH (Planned Approach to Community Health) see Kreuter (1992) 
122 
countries through colonial routes even before the PIIC was launched. A former 
WHO Director General noted as follows: 
'Repeatedly ... I was forced to keep a prudent silence when high·level 
officials from a given government would tell me with pride that they had 
a specific "office" or a "national program" for primary care, or that they 
had primary care activities only in the most peripheral health centres' 24 
Thus, the public health narrative on access to medication, as put forward by the 
PHC system, focused on balancing preventive and curative measures through 
community compliance (what the medical experts say) and community 
participation (communities provide funding and help with preventive activities 
such as hygiene and sanitation programmes). The strategy for implementation 
was to be determined by member countries. 
The discussion above reveals how traditional theoretical models found their 
way into the public health arena of countries all over the world and ultimately 
became objects of 'international' enquiry. Starting with Alma Ata, the WHO 
(and UNICEF) began to give certain models more legitimacy over others, 
serving as a major export route for models around the world through 
international policies endorsed by member countries. Subsequently, the Ottawa 
Charter argued that 'health promotion can only make sense as a 'global' 
phenomenon,.2s Since then, health policies promoted by international 
organizations have come under increasing scrutiny in terms of their 
applicability in different countries of the world. Whitelaw, McKeown & 
Williams (1997:480) define 'global models of health promotion' as 
24 Tejada de Rivero, D.A. (2003)' Alma-Ata Revisited: Perspectives in Health Magazine' The 
Magazine of the Pan American Health Organization 8(2): 
<http://www.paho.org/EnglishlddlpinlNumber17article14.htm> Accessed: 25101/2008 .. 
2S WHO (1986) The Ottawa Charter for Health P r o m o t i o n ~ ~Health Promotion, 1(4): i-v. 
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'perspectives which focus on simple additions of different health promotion 
activities, approaches, agents and/or levels of intervention to facilitate health 
promotion.' They distinguish between models that focus on the 'determinants 
of health' (conceptual relevance of traditional public health models) and those 
that emphasise 'health promotion practice' (range of interventions envisaged 
by creators of models). They argue that both types of models present a 
'holistic' view of 'wholeness' of health, one that encompass the entirety of 
either health determination or health promotion action. 
Such a holistic global view is captured in the WHO report on Macroeconomics 
and Health (WHO, 2001). It provides a framework for defining the extent of 
consensus in the global health community about the values and approaches that 
should underpin efforts to improve the health of all people. It also reveals the 
WHO's conflicting position on public health, that is, a strong emphasis on 
public health as an instrument of broader economic development, rather than 
the individual and community orientation at the core of the PHC model. Thus, 
to understand the role of the public health narrative in policy practices, the next 
section examines the case of malaria in historical perspective. 
4.2.3 Illustrating the public health narrative - the case of 
malaria eradication campaigns 
Malaria is a mosquito-borne disease that has survived human history. It is 
currently endemic in 130 countries and as explained in the introduction is one 
of the major causes of death in Africa and Asia, espacially infants and pregnant 
mothers. It is described as a disease of poverty caused by high annual 
entomological inoculation rates (EIR), tropical location of countries, 
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population growth and movements, poor housing conditions, drug resistance 
and poor health care (Gallup and Sachs, 2001). As discussed in this section, 
these factors cut across the public health models discusscd abovc. 
The shift from a strict reliance on the 'medical model' to those emphasising 
preventive activities (promoting rural to urban migration, improved housing, 
indoor spraying insecticides and draining of swampland) led to malaria being 
eradicated from most of Europe and North America by the early 1950s (Farley, 
2004; de Zulueta, 1994). Based on the eradication 'success stories', an 
emphasis on disease prevention formed the basis for the first ever WHO-led 
Malaria Eradication Programme (1954-1965) implemented in the developing 
world (Najera, 2001; Mabaso et aI., 2004; Rosenberg 2004). The programme's 
model was built around a' strategy that included draining swamps, 
infrastructure development and socio-economic changes. While projects 
proved successful in some African countries (Mabaso et aI., 2004), others were 
largely ineffective and left in the hands of governments (Greenwood and 
Mutabingwa, 2002). 
In 1992, the WHO attributed the country-specific programmes that failed to 
growing drug resistance, economic shocks that reduced governments' health 
spending, insufficient and sustained donor funding, and lack of community 
participation (Sachs and Malaney, 2002; WHO 1993), factors which reflect the 
combination of elements from both individual and community level models. It 
then launched a Global Strategy for Malaria Control (GSMC) in response to 
these challenges (WHO 1993). The GSMC provided Special Funds for 
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Accelerated Implementation of Malaria Control in African countries focusing 
on the use of insecticide and anti-malarial drugs. However, from the early 
1990s, empirical evidence began to emerge stating that adherence to treatment, 
country-specificities (the need to focus on behavioural models) rather than the 
use of insecticide and the generosity of donors (El Geddal, 1985; de Zulueta, 
1994) were the major causes of failures (Najera et al., 1998). 
The above contrasting evidence coincided with the resurgence of malaria in 
many developing countries in late 1980s and became the focus of intense 
international debate about where the emphasis on malaria treatment and control 
should be placed. The debate was spearheaded by numerous international 
initiatives launched in the late 1990s, such as 1997 Multilateral Initiative on 
Malaria (MIM),26 1997 Medicines for Malaria Venture (MMV)27 and Harvard 
Malaria Initiative (1997)28 and the Wellcome trust report (1999).29 These 
efforts culminated in the Roll Back Malaria Partnership in 199830 a global 
model for access to medication for malaria. As will be discussed later, the 
public health narrative was challenged by the economistic and human rights 
narrative and ultimately broadened the nature of the RBM model from being 
limited to a public health only debate. 
26 There are two reports explaining the role ofMIM: 'Final Report: International Conference 
on Malaria in Africa: Challenges and Opportunities for Cooperation' (1997) and 'Progress on 
Priority: Support a Malaria Conference in Africa' (1999) 
h ~ : / / w w w . m i m a l a r i a . o r g l e n g / h i s t o r y a n d e v o l u t i o n . a s p p (Accessed: 06/08/07) 
27 See MMV website: http://www.mmv.orglrubrique.php3?idJubrique=11 (Accessed: 
06/08/07) 
28 See IIMI website: http://www.hsph.harvard.edulresearchlhmilabout-hmil (Accessed: 
06/08/07). 
29 The full report is available at: http://www.wellcome.ac.uklpublications (Accessed: 
06/08/07). 
30 See RBM website: http://www.rollbackmalaria.orglrbmmandate.html (Accessed: 06/08/07). 
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In the late 1990s, the public health model increasingly clashed with an 
econoministic (the WTO-Ied TRIPS Agreement, the IMF/World Bank market 
policies) and human rights (civil society activism) models. Before exploring 
the nature of this clash as reflected in GHP models, the next two sections 
examine the emergence of the economistic and human rights narratives 
respecti vel y. 
4.3 Economistic Narrative on Access to Medication 
The economistic narrative on access to medication was put forward by the 
WTO under the banner of the TRIPS Agreement, itself rooted in developments 
in economic theory. An economistic narrative defines access to medication in 
terms of the interrelationships among patent protection, drug prices, poverty, 
economic growth and pharmaceutical R&D. Liberal and neo-liberal economic 
theories provided the IMF and the World Bank with models of free markets 
that were promoted in many developing countries. 
As discussed in this section, by advocating patent protection, TRIPS came into 
conflict with free market principles (privatization and liberalization) and 
consequently became the subject of intet:J,se international enquiry (from GAA T 
to the WTO). This is because the introduction of TRIPS was a new kind of 
protectionist regime in international trade, one that did not exist before on such 
a global scale. TRIPS internationalised a certain type of neo-liberal regime of 
public health within international trade agreements. Thus, multilateral agencies 
translated theoretical models into international trade agreements; and so 
onwards into GHPs. This section explores this process. It discusses the theories 
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of technology and economic growth behind this market-oriented strategy and 
explores their contribution to the formulation of GHP models of access to 
medication. 
4.3.1 Theories of Technology and Economic Growth 
Traditional economic theory postulates a linear relationship between 
technology and society (economic growth). The Solow (1956) and Swan 
(1956) theories of economic growth were the most influential since the two 
World Wars. Both theorists argue that the rate of technological change 
exclusively determines the long-run growth rate of the economy, and 
ultimately the wellbeing of society. Technological change in tum is 
'exogenous', that is, a 'black box' or 'deus ex machine' that operates outside 
the realm of economics. In this case, a government's economic policy cannot 
alter long run economic growth, as this depends on progress in the sciences and 
engineering. After three decades of dominance, mainstream economists 
conceded that such a linear relationship no longer makes sense. 
In the early 1980s, Roomer (1986; 1990) and Lucas (1988) extended the 
traditional growth models above focusing on interaction rather than causation 
between economics and technology (technological change as 'endogenous'), 
what became known as New Growth Theory. Here, technological progress is a 
form of capital accumulation. Unlike physical and human knowledge embodied 
in machines and people respectively, new growth theories argue that 
technological knowledge is embodied in savings (future R&D expenditures). 
This makes economic growth a private activity since an economy can become 
rich in the same way as individuals (given a rationality assumption). 
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Government's economic policy action is therefore needed to stimulate R&D 
through incentives to save. This argument, as explained later, formed the basis 
for public and private investments in pharmaceutical R&D. 
More recently, Schumpeterian economists have extended the endogenous 
growth models by exploring explicitly who gains from technological progress, 
who loses, how the gains and losses depend on social arrangements, and how 
such arrangements affect society's willingness and ability to create and cope 
with technological change (e.g. Aghion and Howitt 1998, Porter, 1990). In 
terms of the notion of embodied knowledge, the framework for this research, it 
is the multitude of interactions among actors involved with inputs, 
technological processes and outputs that ultimately determines the relationship 
between technology and economic growth (or societal wellbeing). 
This above view of economic theories obviously sheds new light on a number 
of important policy issues that theory affects, and ultimately justifies the link 
between theory, models and policy practices. The liberal and neo-liberal 
economic arguments above are invoked in empirical studies to advice on the 
policies and views of governments on the international stage. They arc also 
used to develop studies that inform corporate strategy of multinational firms as 
well as providing them with the tools to influence international trade 
negotiations. Their effects are illustrated below in the areas of competition in 
the pharmaceutical industry, trade agreements and ultimately the inclusion of 
an economistic narrative on access to medication in GHP models. 
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4.3.2 Free markets and intellectual property rights protection 
The free market doctrine put forward by the liberal and neo-liberal economic 
theories above largely inform the debate on the protection of Intellectual 
Property Rights (IPRs). Despite substantial increase in international trade, 
investment and migration since the 1960s, the laws of countries continue to 
differ, thereby creating tension in international economic relations. The TRIPS 
Agreement, one of the outcomes of the Uruguay Round (1986-94) of 
international trade talks is arguably the first major international attempt at 
resolving this tension31 • GATT set out to establish an international legal 
framework with similar IPRs around the world. Traditionally, three diverse 
conceptualisations of IPRs and their protection were put forward: natural rights 
(moral rights to one's own mental creation), public rights (the non-rivalry 
nature of inventions) and utilitarian rights (non-excludability in the absence of 
legal protection). Various individuals and institutions translated these in terms 
of economic/commercial, political or human rights. The TRIPS treats IPRs as 
economic or commercial rights (Article 7 of TRIPS).32 Neo-liberal economic 
theory played a crucial role in this treatment. 
The TRIPS agreement was a challenge to the liberal market models of the 
1950s that saw technological progress 'through discovery and invention that is 
purported to be separate from the natural workings of the economy' 
31 'UNDERSTANDING THE WTO: BASICS - The GATT years: from Havana to Marrakesh', 
WTO website: <http://www.wto.orglenglishlthewto_e/whatis_e/tite/fact4_e.htm> (Accessed: 
13/02/09) 
32 WTO Factsheet: 'Philosophy: TRIPS attempts to strike a balance' TRIPS and 
Pharmaceutical Patents 
<http://www.wto.orglenglishltratop_eITRIPS_e/factsheetJlharrn01_e.htm> (Accessed: 
17/07/08) 
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(Fagerberg, 2000:302) as the only source of economic growth. Events leading 
to the TRIPS agreements (the GA TI agreement and successive Uruguay 
Rounds of international trade talks from the 1970s to 1994) paralleled the shift 
from the traditional exogenous to endogenous (new) growth theories described 
earlier. The conceptualization of technology as an inherent part of economic 
structures was taken up by international trade economists who studied how 
trade, foreign investment and IPRs are related to the process of development 
(e.g. Bhagwati, 1987; Helpman and Krugman, 1985; Helpman, 1993). In a 
detailed study of the key literature, Bhagwati (1987:551-2) argues that 
mainstream economic 'theory of trade and welfare provides the underpinnings 
for the general principles that underlie GA TI' . The general consensus 
argument here is that, if technology is endogenous, then the 
economic/commercial interests of phannaceutical inventions and innovation 
should be patent-protected, thereby justifying the TRIPS agreement. 
The political influence of economic theories is also implicit in its evolution 
(Fagerberg, 2000), as well as consistent with technological and institutional 
change. For example, the most important argument supporting TRIPS is the 
well-known R&D model in growth theories of the 1980s. According to the 
W I ~ , , through IPR protection, 'inventors and creators ... can expect to earn 
some future benefits from their creativity. This encourages new inventions, 
such as new drugs,' whose development costs can sometimes be extremely 
high, so private rights also bring social benefits' .33 
33 WTO Factsheet: 'Philosophy: TRIPS attempts to strike a balance' TRIPS and 
Pharmaceutical Patents 
<http://www.wto.org/english/tratop_e!TRIPS_e/factsheeCpharmOl_e.htm> (Accessed: 
17/07/08) 
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Even the advent of economic liberalization that dominated trade and 
investments from the 1990s did not stop the WTO and its affiliated partners 
from continually defending patent-protection by capitalising on theory-
informed evidence in negotiating the way forward. Both multilateral and 
bilateral development agencies in western countries depend on the academic 
literature on the relationship between trade and development by teams of 
economists to inform their policy on the international state (Globkom, 2002; 
Nordstrom, 2000). Thus, Maskus' (2000) justification of patent protection in 
the face of globalization and economic liberalization is widely cited by the 
WTO and the United Nations (UN). Consequently, it can be argued that 
economic growth theory played a substantive and substantial role in the 
formulation of patent protection laws. 
4.3.3 A medicine market monopoly as an instrument of 
corporate influence 
Economic theories provide pharmaceutical companies with the tools to 
establish a medicine market monopoly. Pharmaceutical corporations in tum use 
this monopoly power to influence the decisions of their national governments 
and ultimately those of multilateral organizations (such as WTO). For example, 
in a study of the monopoly market for HIV / AIDS drugs, Schulz (2002) 
demonstrates how pharmaceutical companies employ economic calculations to 
establish a monopoly power. They then use this power to progressively 
withhold medicines in order to maximise their profits. According to him, this 
process creates an 'economic death row', a point at which, because of the 
monopoly people cannot afford medicines and will eventually die. In addition, 
the people willing to buy the withheld quantity cannot do so because of high 
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prices. In the case of HIV I AIDS medicines, while developed countries such as 
Norway (fewer incidence of HI VIA IDS and huge government funding support) 
may never reach the economic death row, African countries such as South 
Africa (millions of HIV I AIDS cases with limited government funding support) 
were within it by 1999 (Hill, 2006:156·157). 
Thus, from the 1990s when the patented commodity became ARTs for 
HIV I AIDS treatment, customers who could not access the medicines died 
much faster with widespread consequences. Poor countries found themselves in 
a difficult trade-off situation due to the monopoly power of pharmaceutical 
firms (Maskus, 2000: 161). The free market policies promoted by the IMF and 
World Bank meant that they had to give up most forms of trade protection and 
become exposed to the monopoly pharmaceutical companies. The negative 
effect of economic globalization is that it reduces aggregate economic welfare 
through rising prices that both individuals and governments could not afford. 
Although developing countries like India, Brazil and South Africa exposed the 
limits of IPR protraction by resisting international IPR regimes in the 1990s, 
most IPRs were owned by firms in developed countries. After successfully 
creating a medicine market monopoly, western pharmaceutical companies use 
their corporate influence at international trade talks to push developing 
countries to respect international agreements (such as TRIPS). Although the 
talks are usually negotiated by national governments in relation to domestic 
and international interests, corporate interests have been shown in several 
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instances to dominate. In a documentary series, 'War By Other Means', Woods 
(2007) describes the influence of corporations in international trade talks: 
'Politicians have very limited technical capacity ... private markets and 
multinational corporations understand the real dynamics of the global 
market. ... They help politicians to define their country's interests .... But 
they have their own interests as well. . .. So they become the most 
powerful players' . 
Partly because of the above reasons, Woods explains, the outcome of trade 
talks 'depends on rules decided in tough negotiations behind closed doors'. 
Dearborf (2004:5) has also demonstrated that while economic theory is 
reassuring about the effects of the profit motive when it drives behaviour in 
the marketplace; there is no trust in its effects in the political arena. In the 
case of the TRIPS Agreement, he states: 'A group of very large corporations 
especially in the pharmaceutical industry were, as I understand it, the 
initiators of the push for TRIPs in these negotiations, and they played an 
active role in moving the negotiations along'. According to him, 
pharmaceutical companies initially aimed to defend their IPRs by preventing 
countries like India from importing unlicensed generic drugs western 
countries. Once this was achieved, they 'pushed to have the international 
trading system override the decision that many developing countries had 
made, that the 'short-term' health of their p o p u l a ~ i o n s s was more important 
than the profits of the big drug companies' (p.5). 
Although it was generally acceptable that a patent system creates 
monopolistic markets, global projections based on neo-liberal economic 
models were used to tout western pharmaceutical innovations as the panacea 
to health problems of the 21st century. Pharmaceutical companies made this 
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explicit on thcir websites, claiming to hold the key to access to medicines in 
least developed countries. For example, GlaxoSmithKline (2002) stated as 
follows: 
'We support intellectual property protection because it stimulates and 
fundamentally underpins the continued research and development of new 
and better medicines, including those for diseases prevalent in the 
developing world.' 
Publishing statements such as the above became the obvious choice for the 
pharmaceutical industry in the western world. From the late 1990s, the 
industry had come under serious international scrutiny by developing 
countries and international esos. Trullen and Stevenson (2006) analyse the 
historical narrative of events in seven western pharmaceutical companies in 
relation to several 'years of accusations of being socially irresponsible in 
dealing with the HIV/AIDS virus in Africa' (p.178). Their analyses reveal 
that pharmaceutical companies 'respond in strategic ways to institutional 
pressure that stems from social scandals' (p.178). Specifically, 
pharmaceutical companies began to claim that corporate social responsibility 
(CSR) trumps corporate strategy (CS). By the end of 1999, many 
pharmaceutical companies changed their mission statements from one based 
on CS (advertising and other marketing strategies to increase sales vis-a-vis 
pharmaceutical R&D) to one focused on CSR (discounted drug pricing and 
philanthropic drug donation programmes). 
Unsurprising, therefore, most global programmes on drug donation and 
discounted drug pricing are typically initiated by pharmaceutical companies 
(Buse and Walt 2000a:700). The 1997 court case bctwcen the South African 
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government and 39 western pharmaceutical companies is a classic example 
(Hill, 2006:156·157). The South African government authorised the 
importation of generic drugs for HIV I AIDS in defiance of TRIPS. The 
government, supported by interest groups, NGOs, celebrities and other 
developing countries put forward the argument that medicine for HIV I AIDS 
ought to be treated as human rights. On the other hand, pharmaceutical 
companies focused on the economic narratives and the fact that South Africa 
defied the TRIPS Agreement. As a result of the human rights narrative, the 
outcome of the case went in favour of the South African government. 
This South African case, among others, ushered in a wave of negotiations 
among UN agencies, western development agencies, pharmaceutical 
companies, civil society groups and developing country governments in an 
attempt to achieve 'universal' access to medication through discounted drug 
pricing. These negotiations formed the basis for certain GHP 'models' on 
access to medication emphasising the economistic, rather than public health 
and human rights approaches. This is explored later in this chapter in the case 
of the AAI initiative launched by UN agencies and western pharmaceutical 
companies to provide discounted patent-protected drugs in developing 
countries. The next section explores the human rights narrative to access to 
medication. 
4.4 The Human Rights Narrative on Access to Medication 
The human rights narrative on access to medication does not have a strong 
connection to theories of economic growth and international trade, as does the 
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economic narrative discussed above. The concept of human rights does not also 
have a strong theoretical connection to the behavioural and change models of 
public health discussed earlier in this chapter. Rather, the human rights to 
health reflect a broader, societal approach to the complex problem of well-
being. Since being crystallized in the Universal Declaration of Human Rights 
in 1948, human rights concepts, meaning, content and process only became 
widely understood by health care professionals and academics from the 1990s 
as an essential framework for promoting and protecting health. In Human 
Rights and Health Jonathan Mann and co-authors (Mann et ai., (1999: 7) claim 
that one cannot explicitly establish a relationship between human rights 
theories and the introduction of human rights principles and concepts in health 
policy discussions: 
'Health and rights have rarely been linked in an explicitly manner. With 
few exceptions, notably involving access to healthcare, discussions about 
health has not included human rights considerations. Similarly except 
when obvious damage to health is the primary manifestation of a human 
rights abuse, such as with torture, health perspectives have been generally 
absent from human rights discourse. Explanations for the dearth of 
communication between the fields of health and human rights include 
different philosophical perspectives, vocabularies, professional 
recruitment and training, societal roles, and method of work' 
Nevertheless, there must be a big theoretical literature on the rise of human 
rights that can be linked to public health (e.g. Toebes, 1999). However, the 
scope of this chapter does not allow for exploring such literature. Thus, instead 
of discussing human rights theories as in the previous sections, the focus here 
is on the evolution of different forms of knowledge (expressed in the forms 
described in the above quotation) through which human rights ideas come to 
play a significant role in shaping GHP models. Human rights ideas emerged 
from two successive and sometimes interwoven movements: 1) The implicit 
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adoption of human rights principles by international organizations (e.g. WHO 
and UNICEF) in public health agendas that are subsequently ratified as law by 
national governments; 2.) The rise of civil society activism (groups of 
individuals and NGOs) using human rights language and concepts to influence 
national and global policy, as well as inspire and energise their own health 
related activities. These two movements are discussed below. 
4.4.1 The emergence of the concept of health as human rights 
The concept of health as human rights was formally developed in the aftermath 
of World War II and crystallized in the Universal Declaration of Human Rights 
in April 1948. The WHO, created in the same year, was charged with its 
implementation. The declaration explicitly defines the right to health as the 
right to the 'enjoyment of the highest attainable standard of health.' Although 
considered as the first international legal document, the human rights 
requirement only appears in the WHO's preamble (Nielsen, 2001:14). It was 
adopted as a result of Brazil's concerns that medicine ought to be treated as 
'one of the pillars of peace' (Toebes, 1999:15). This is evidence of how an 
event with no direct links to theories played an important role in introducing 
human rights concepts in health policy debates. Health as human rights was 
given a similarly less explicit role in determining policy practices in the PHC 
model adopted at Alma Ata. 
Although health as human rights was given a similarly less explicit role in 
determining policy practices in the PHC model adopted at Alma Ata, certain 
events in the 1980s illustrate the emergence of a human rights narrative 
internationally. The debate on access to medicines became global in the early 
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1980s with the rapid growth of unregulated international trade in medicine 
(WHO, 2004). Using this pretext the WHO put forward a narrative on access to 
essential medicines from the mid 1980s that was considered by international 
NGOs as promoting the rise of liberalism at the international level (the 
economistie narrative). Individual countries began to establish their own drug 
regulatory regime in the face of accusations from esos (such as Health Action 
International and Medeeins Sans Frontieres) that the big pharmaceutical 
companies were (indirectly) dumping medicines in developing countries 
through the WHO (Redfield, 2008). Developing countries such as Bangladesh 
even attempted to establish their own White List of Essential Medicines 
claiming to be defending the rights of their citizens, a move that attracted 
threats of law suits (from pharmaceutical companies) and sanctions (e.g. from 
the United States) (Loue, 2006). 
The evidence above further illustrates that elements of human rights already 
existed in national programmes to facilitate access to medication for several 
decades, though with little connection to human rights theorists. Much of the 
role of human rights depended on the advocacy of CSOs. However, the advent 
of the HIV / AIDS pandemic in the 1990s, the statistics on the incidence and 
burden of the HIV / AIDS, the fact that it has no cure, and the emergence of 
expensive life-sustaining drugs that were well beyond the reach of least 
developed countries, questions were being asked whether and to what extent 
access to medication is guaranteed by public health, international trade 
agreements and human rights treaties. Within the UN agencies, much of the 
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role of human rights depended on the advocacy of key persons who supported 
the human rights perspective. 
In this context, Fee and Parry (2008:1) provide detailed illustrations on how 
Jonathan Mann 'developed his theory of human rights and health' thereby 
promoting the human rights narrative on access to medication within the UN. 
First as a public health epidemiologist, Mann perceptively demonstrated that 
the HIV/AIDS epidemic is the first global epidemic and therefore touches the 
core of the Universal Declaration of Human Rights (the ethics of public health 
to provide the conditions under which humans can flourish). Subsequently, as 
the first director of the WHO's Global Programme on AIDS, Mann pushed for 
a human rights approach as a necessary response to the fact that the social 
determinants of health (essential components of variants of the PHC model in 
1990s) had become too economistic. Accordingly to Fee and Parry (2008) 
Mann's vision for a human rights model emphasises all the social factors 
(social marginalization, demographic, socioeconomic and racial inequality) 
that influence health and well-being, as articulated in the original PHC model 
of 1978. 
In addition to the advocacy campaigns of world renown UN authorities such as 
Jonathan Mann, the devastating burden and incidence of the HIV/AIDS in the 
late 1990s also led international CSOs, research and academic institutions, as 
well as UN agencies Gust as the WHO was doing in the early 1990s through 
Mann) concede that the TRIPS Agreement touches on human rights standards 
that guarantee the accessibility of medication by enabling pharmaceutical 
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companies to demand higher prices - and thus hamper access to medication. 
This debate is summarised below. 
4.4.2 Access to medication as human rights 
The evidence from the economistic narrative of access to medication provided 
enormous data and evidence that were later used to crystallise a human rights 
narrative as an opposing strategy to the economistic narrative. The TRIPS 
agreement is assumed to stimulate both economic growth and R&D aimed at 
illnesses in poor and vulnerable populations (Maskus, 2000). However, as early 
as 1996, there were international calls for a change in the legal framework of 
TRIPS to accommodate human resources and infrastructure development in 
poor countries (UNCTAD, 1996: 23-26), a call which relates to Mann's human 
rights concerns. Similarly, many scholars published evidence contradicting the 
TRIPS argumene4• Yet the WTO and its affiliated partners were reluctant to 
change the rules until the emergence of HIV I AIDS and subsequent 
international advocacy. 
Multilateral organizations, led by UNAIDS (2000a: 11), initially described 
HIV/AIDS as 'only a health problem' and identified inadequate healthcare 
infrastructure, scepticism within the global health community, and the costs of 
chronic therapy as major barriers to access (UNAIDS, 2002). Similarly, 
pharmaceutical companies defended both their pricing policies and the patent 
system stating that social, political, and infrastructural barriers, not drug prices, 
impede access (as demonstrated, for example, in the case of South Africa 
mentioned earlier). Advocates from both UN agencies, private industry and 
34 For a review of the major arguments see Sakakibara and Branstetter (2001) 
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CSO expressed admiration for breakthroughs in pharmaceutical innovation and 
the supporting role of the pharmaceutical industry in public health 
interventions: the development of drugs that can treat both HIV I AIDS and 
other opportunistic infections that kill people with HIV/AIDS (MSF, 2003; 
WHO, 2002a: 8). Another shared theme was the difficulty of living up to the 
rising pandemic of HIV I AIDS and its devastating consequences at all levels, an 
awareness which led to the global recognition unanimously acknowledged that 
'treatment is technically feasible in every part of the world' (WHO, 2002a: 9). 
Nevertheless, the general outcry that least developed countries would not be 
able to cope with the rising number of HI VIA IDS cases, high cost of treatment 
and given the devastating nature of the disease, the right to health was taken up 
in numerous economic, public health and legal instruments. The most 
significantly legal document to take up the right to health was the International 
Covenant on Economic, Social and Cultural Rights (ICESCRis established 
long before TRIPS. It protects access to medicines as an integral part of the 
right to health (contained in article 12) under international law. Access to 
medication is currently defined as the 'right to the highest attainable standard 
of physical and mental health' (General Comment No. 14, ICESCR, 2000, 
para. 6). It has four determinants: (a.) the availability of the medication in 
sufficient quantity, (b.) the accessibility of the treatment to everybody, (c.) the 
35 In 1985 the ICESCR as set up as a committee (ElRES/1985117 of28 May 1985) to help the 
Commission of Economic, Social and Cultural Rights in motoring and implementation. 
Specific issues related to access to medication are documented in two legal documents: 
Substantive Issues Arising in the Implementation of the International Covenant on Economic. 
Social and Cultural Rights: Follow-up to the day of general discussion on article 15.1 (c). 
(26/1112001) and Human Rights and Intellectual Property: Star'ement by the Committee on 
Economic. Social and Cultural Rights. Doc.E/C.12/2001l15 (14/1212001). 
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acceptability of the treatment with respect to the culture and ethics of the 
individual and (d.) an appropriate quality of the medication. 
The GC No. 14 para.12 includes only 'essential drugs I within the scope of the 
right. The WHO endorses this and maintains a regularly updated list of 
essential drugs that all countries should use (WHO, 2003). However, member 
states are not bound to the list, as the WHO state that: 'exactly which 
medicines are regarded as essential remains a national responsibility,36. This 
list also attempts to put an end to the long running debate about access to 
essential medicines promoted by WHO in the mid 1980s (e.g Bangladesh 
White List of Essential Medicines and drug dumping in the Third World 
mentioned earlier). 
Being the hardest hit region of the world, African leaders also came out 
strongly on the role of human rights. In the Ouagadougou Commitment of May 
2000, African leaders unanimously declared that while 'health constitutes a 
right and a foundation for socio-economic development'; the HIV/AIDS 
epidemic is a major 'public health, development and security problem for 
Africa.,37 Such a collective political activism and the relaxation of the TRIPS 
Agreement translated into the WHO's drug lists provide African countries the 
possibilities to legitimately procure drugs from both patent-protected and 
generic manufacturers in the fight against diseases such as lIIV I AIDS. This is 
an example of how the economistic, public health and human rights narratives 
36 'Essential Medicines': http://www. who.intltopics/essential_medicineslenl (Accessed: 
30/06/09) 
37 ACP-UP (2000) 'Treatment for all ... Now!' Global Manifesto, Durban, South Africa 
<http://www.actupny.orglreports/durban-access.html> (Accessed: 21/09/08). 
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and the actors who initiated them increasingly became interwoven and 
integrated into a global political activism to ensure access to medication for the 
poorest people in the world. 
4.4.3 The role of civil society activism in the popularity of the 
human rights narrative 
As already discussed in the case of Health Action International and the 
Bangladesh drug list, international CSO and activist groups have played a 
significant role in promoting the human rights narrative on access to 
medication. This section illustrates further, the global perspective on the role of 
CSO movements in the debate on access to medication. CSOs and activist 
groups can rightly be credited for putting a human rights narrative into the 
economistie agenda of the WTO and the public health agenda of the WHO. 
Some notable CSOs include Treatment Action Campaign, Oxfam International, 
Health GAP, CPTcch, Health Action International, Act UP and MSF. The 
human rights narrative is built around the argument that if pharmaceutical 
companies cannot reduce prices to the level that the poorest person in the world 
can afford, copying patented medicines should be legitimate to save the life of 
the poor. In relation to the emergence of GHPs, CSOs use statistics from 
pharmaceutical companies, WTO and the World Bank to question the 
arguments that the TRIPS agreement stimulates drug R&D thereby providing 
medicines to the poor. 
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One of the most notable is MSF (2002)38. MSF uses statistics from 
phannaceutical companies, \VTO and the World Dank to question the 
arguments that the TRIPS agreement stimulates drug R&D. It established a 
series of findings that contradicted the main economistic arguments, namely, 
global development costs of new drugs ($30-$160 million) arc far less than 
global R&D expenditure ($70-$90 billion); the big phannaceutical companies 
spend more on marketing, administration and executive salaries than on R&D; 
most essential drugs marketed by private companies were originally discovcrcd 
with public funding (including six AIDS drugs); the phannaceutical industry is 
one of the most profitable in the world; and developing countries make up a 
small part of drug industry revenue (Africa accounts for about I % of global 
drug market) (MSF, 2002). 
The WHO, having initially favoured patent protection, also concluded that 
IPRs offer little incentive for R&D on developing country diseases, because of 
insignificant markets (WHO, 2001 :77). The Commission on Intellectual 
Property Rights (CIPR) stated that they 'do not think that the globalisation of 
IPR protection will make a significant contribution ... to the treatment of 
diseases that particularly affect developing countries' (CIPR, 2002: 39). TIle 
UN, the World Bank and MSF jointly claim that phamlaceutical companies 
have little interest in poor countries because it they arc not profitable enough 
even in the case of neglected diseases (MSF, 2003:5). 
31 Notable examples of international esos nnd their campaign slogans include: Access 10 
Essential Medicines Campaign (Medecins Sans Frontieres); Cut the Cost Campaign (Oxfam 
International), Oxfam Briefing Paper IS, 2002; Oxfam (2002) Generic Competition, Price nnd 
Access to Medicines, Oxfam Briefing Paper No. 26, Oxfam, Oxford; lIea/lh Care and 
Intellectual Properly Campaign (CPTech) and Trealment Action Campaign (T AC), Act UP. 
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cso activism also led to a relaxation of the TRIPS Agreement as seen in the 
inclusion of the CSOs mentioned above in the Doha Round of trade talks 
launched from 2001. The talks have now shifted the emphasis to more 
consideration of the interest of the poor in developing countries. The Doha 
declaration (WTO, 2001: Para.4) on public health states as follow: 
'We affirm that the Agreement can and should be interpreted and 
implemented in a manner supportive of WTO members' right to protect 
public health and, in particular, to promote access to medicines for all .... 
In this connection, we reaffirm the right of WTO members to use, to the 
full, the provisions in the TRIPS Agreement, which provide flexibility for 
this purpose' 
Two measures seem relevant in the HIV I AIDS case, namely parallel imports 
and compulsory licensing. Paragraph 5(b) of the Doha declaration specifies 
that each member has 'the freedom to determine the grounds upon which such 
licences are granted'. The same paragraph clearly identifies 'public health 
crises, including those relating to HIV I AIDS, tuberculosis, malaria and other 
epidemics, can represent a national emergency or other circumstances of 
extreme urgency' (WTO, 2001). Parallel imports are relevant if a drug 
manufacturer provides drugs at a lower price. However, international NGOs 
have continually challenged the TRIPS agreement. For example, a joint 
statement by MSF and Oxfam criticise the WTO's agreement on patent-
protected m e d i c i n ~ ~ as follows: 
'The burdensome system being put in place does nothing to ensure that 
generic production will happen in the future. Rather, developing countries 
will have little alternative to the high prices and long-term monopolies of 
brand-name pharmaceutical companies. ,39 
39 MSF and Ox/am say WTO drugs deal is 'flawed' In European Public Health Alliance, 
Available Online: <http://www.epha.org/a/623> (Accessed: 13/05/09) 
'-
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This meant that the implementation of TRIPS would no longer restrain the 
supply of generic copies of patented pharmaceuticals. Although the human 
rights narrative serves to challenge the economistic narrative, attempts at 
arriving at a point of agreement has always proved impossible. Numerous 
international meetings have brought opposing parties together. The outcome is 
that different global models are being promoted, emphasising a combination of 
different aspects of the three narratives discussed above. The above distinctive 
human rights narrative formed the basis for the creation of the Equitable 
Access Initiative (EAI). a GHP launched by MSF at the end of 2000 (MSF 
2002, 2002a, 2003). The next section explores two types of GHP models - the 
first focuses on strengthening the health system in developing countries 
(RBM), and the other focuses on access to pharmaceuticals (AAI and EAI). 
4.5 GHPs for Health System Functioning - Roll Back 
Malaria Partnerships 
The WHO, World Bank, UNICEF and their partner organizations launched the 
RBM in November 1998 to half global malaria deaths by 2010 and again by 
2015.40 As a global PPP the RBM combines the expertise of pharmaceutical 
companies (such as MMV, MIM, and Novartis), the field experience of the 
public sector (WHO, UNICEF and national governments and civil society 
organizations), donor support from UN agencies (such as the World Bank and 
the Global Fund) and private foundations (such as Bill and Melinda Gates 
Foundation). The global RBM network now includes malaria-endemic 
countries and about 90 bilateral, non-governmental and private sector 
40 See the website of Roll Back Malaria: httpllwww.rollbackmalaria.org/ 
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organizations seen as 'core' partners due to their active involvement in adding 
expertise, infrastructure and funds into the partnership. 
As mentioned earlier, the RDM promotes a global response to previously failed 
attempts at malaria eradication. The historical narrative leading the launching 
of the RBM reveals the interplay of economistic, pub.1ic health and human 
rights narratives on access to medication. Consultations on strategies to reduce 
the rising incidence and burden of malaria intensified between 1990 and 2000 
spearheaded by several regional and international initiatives to address specific 
issues relating to the treatment of malaria (MIM, MMV, HMI). The main focus 
of these consultations was on the extent to which the public health models (a 
combination of medical and preventive strategies) promoted by the WHO was 
responsible for suppressing short-term malaria cases and achieving long-term 
control over malaria epidemics. The public health model (as defined by the 
PIIC) included measures to reduce infected vector populations feeding on 
humans through house spraying with residual insecticides, antimalarial drug 
treatment and surveillance (Nabarro and Tayler 1998). 
Unsurprisingly, the global context of RBM when it was launched in 1998 is a 
tri-sectoral network (to operate on a global, regional and local level 
respectively) to address the complexity of the root causes of malaria 
transmission through four core technical strategies: 1) improved and prompt 
access to effective treatment; 2) increased use of insecticide-treated nets (ITNs) 
and other locally appropriate means of vector control; 3) early detection and 
response; 4) and improved prevention and treatment of malaria in pregnant 
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women (WHOIUNICEF 2005a: xi). It also emphasises malaria R&D and 
evidence-based action and impacts to help African countries to achieve their 
national malaria targets. 
The RBM was launched on the pretext that malaria has become a global public 
health crisis requiring a public health (not private) intervention. In this context 
it attempts to link the causes and consequences of the 'malaria problem' to the 
social, cultural, political and economic fabric of developing countries and 
mobilizes a broad-based and comprehensive effort to address the complexity of 
the root causes of disease transmission (WHOIUNICEF 2005: xi). Haven 
established such a global framework, the WHO and UNICEF alongside their 
affiliated international partners then invite malaria-endemic developing 
countries to join the initiative. Empirical evidence from across the world are 
presented as 'lessons learnt', 'best practices' or 'evidenced-based' to encourage 
countries to endorse the RBM. In the case of Africa, the WHO and UNICEF 
sponsored the famous Abuja Submit to Roll Back Malaria in Africa (WHO, 
2000a). The summit concluded that previous malaria eradication campaigns in 
Africa failed because they were fragmented and uncoordinated (not because 
they did not address the determinants of health). Subsequently, the narratives 
did not immediately shift to addressing coordination mechanisms. Instead it 
went along the lines of an economistic narrative on access to medication. 
Specifically, evidence was gathered and presented to demonstrate the potential 
effectiveness of medical intervention in malaria treatment and control (WHO, 
1993; WHOIUNICEF, 2003; Mabaso et aI., 2004; Rosenberg, 2004). For 
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example, a Cochrane review (Lengcler, 2004) shows the potential of ITNs to 
prevent children from being infected by malaria. While these were considered 
as 'success stories', studies that seriously negate this narratives, for example 
those showing that adherence to treatment and control by households and 
country/region-specific strategies were the causes of failure were hardly taken 
seriously (Najera et al., 2004). In response to human rights concerns from 
NGOs and civil society organizations who argued that patents prevent 
affordability of medicines for poor households, the WHO stated that the 
pharmaceutical industry was open for negotiated discounted drug prices 
(Nabarro, 1998), a claim rooted in economistic approaches to access to 
medication. The economistic narrative then became more important, leading 
the WHO and the UNICEF, backed by the World Bank and advanced 
countries, to demonstrate the feasibility of generating funding to ensure a 30-
fold increase in the availability and affordability of drugs between 2000-2005 
(WHOIUNICEF, 2003a). Here again we see how UN agencies continue to 
promote the narrative strategies on access to medication which they had 
initiated decades earlier. 
More than 50 African leaders endorsed the RBM under the Abuja Declaration 
(WHO 2000a) by pledging to reduce malaria deaths in Africa by 60% by 2010. 
They were convinced by UN agencies that anti-malarial such as chloroquine 
can treat malaria, lINs for malaria prevention would be available and that 
donors will fund the programme. In response, the African leaders made a 
commitment to clarify the strategy to achieve the Abuja targets at country 
levels which included addressing the human rights needs of the poor in terms 
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of decentralisation of services to reach rural arcas and integrating civil society 
participation in policy making and implementation. This is the main narrative 
on which RBM programmes emerged in Africa. Addressing the public health 
needs of African countries through health system functioning was seen as the 
responsibility of national governments with only technical and funding 
assistance from GHPs. It also implied that instead of public health 
terminologies, such as public health or health promotion, the term access to 
medication became widely used. Access to medication was defined at the 
global level in terms of affordability of drugs (drug procurement and supply 
arrangements) instead of the broader public health conceptualisation defined in 
chapter two in terms of potential and actual access to medication. 
A few years after the launching of the RBM and implementation in many 
developing countries, a human rights argument was put forward by civil 
society organizations and research institutes to challenge the economistic (and 
narrow public health) narrative. Specifically, the WHO was criticised for 
promoting drugs like chloroquine and sulfadoxine-pyrimethanine despite 
knowing for several years that they were ineffective (AUaran et al; 2004). The 
same article supported ACTs as a more effective alternative. Similarly, 
Medecins Sans Frontieres had already advocated a change from Chiloquin to 
ACTs during a malaria epidemic in Ethiopia (MSF, 2004). Both Attaran et al 
(2004) and MSF (2004) argued that providing drugs that are knovm to be 
ineffective to poor people (who have no way of knowing the quality of drugs 
they are taking) is somewhat against the right to health. The timing of these 
counter-narratives are very interesting as the WHO and the Global Fund to 
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Fight AIDS, Tuberculosis and Malaria quickly changed to ACTs in 2004 
(ACTs is today the core of malaria treatment in Africa), arguably to avoid 
further criticisms. While the Lancet article is often cited in the RBM website, 
most recent Africa Afalaria Reports discuss the WHO's reluctance to quickly 
embrace the ACT in relation to the fact that African countries did not have the 
health system to deal with the change. 
To join the RBM, there was no eligibility criterion. Countries simply had to 
attend an international or regional summit (such as that held in Abuja in the 
case of African countries) and endorse agreements or declarations reached. 
Thus, the nature and success of any RBM programme at country level does not 
depend only on the country-specific mobilization and the generosity of donors. 
It also depends on the narrative strategies used by RBM partners, counter-
narratives put forward by opponents in relation to previous narrative strategies. 
More recently, The WHO is increasingly recognising issues not made explicit 
at the launching of the RBM including determinants of health factors such as 
(emphasis added) 'dwellings that offer protection against mosquitoes (and) 
transportation to a health facility capable of treating the disease' 
(WHOIUNICEF, 2003:20). This is an example of the limited emphasis on 
potential access to medication during the launching of RBM. 
The RBM's use of terms and phrases such as 'Africans cannot afford', 'poorest 
Africans' is reflected in its policy of heavy subsidization of drugs. This 
implicitly undermines an economistic narrative (e.g. the World Bank's cost 
recovery programme) that would emphasise long-term sustainability in the 
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absence of donor funding (as is increasingly becoming the case). The market 
for ITNs and ACTs involves negotiations between selected pharmaceutical 
companies and donors (large foundations, UNICEF and the Global Fund) on 
the basis of prices rather than quality, thereby contradicting a competitive 
healthcare market model that emphasises quality of products. These issues 
clearly qualify the RBM as a new kind of global model whose origins can be 
traced to theoretical developments in public health, economics and human 
rights, but also, one that attempts to reconcile the conflicting and competing 
interests of actors in global health into the RBM model as a way of facilitating 
access to medication for malaria treatment and control. The role of such a 
model in shaping policy practices at country level is the subject of the National 
Malaria Programme in Cameroon presented in Chapter six. 
4.6 GHP Models for Access to Pharmaceuticals for 
HIV/AIDS Treatment and Control 
The narratives and counter-narratives discussed in earlier in this chapter were 
vital in the creation of two (co-existing) global models for facilitating access to 
pharmaceuticals for HIV/AIDS treatment and control. One is an industry-led 
Accelerating Access Initiative (AAI). In this system, UNAIDS and WHO help 
countries to develop HIV I AIDS plans and then playa facilitator role between 
countries and companies to negotiate discounted prices. Companies set the 
rules and offer different levels of discounts to HIV/AIDS-endemic countries 
selected on the basis of clearly established eligibility requirements. The second 
is the 'Equitable Access' model. In this system, policies are implemented to 
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ensure that the price of n drug is fair, equitable and affordable, both to 
individuals and the health systems that serve them irrespective of whether the 
medicines arc patent-protected or not. Thus, while the AAI is informed by an 
economistic narrative on access to medication, the Equitable Access is largely 
informed by a human rights narrative. However, as discussed in the following 
sections, it is the interplay of public health, human rights and economistic 
narratives that ultimately shaped the development of both models. 
4.6.1 The UNAIDS·led Accelerating Access Initiative 
The AAI was formed in May 2000 by five phannaceutical companies and five 
UN organizations 41 with a principal objective 'to make HIV/AIDS drugs more 
affordable and accessible in developing countries and to improve technical 
collaboration in the development of national programme capacities to deliver 
care, treatment and support' (UNAIDS/WHO, 2002:4). The alarming global 
statistics on HIV / AIDS and the high cost of medicines protected under TRIPS 
vis-a-vis the resource capacity of developing countries (economistic narratives) 
nrc regularly cited as the main reasons behind the creation of the AAI.42 These 
factors meant that both a global effort and a global language were needed to 
fight the disease. The AAI docs not have separate legal status; it's activities nre 
coordinated by the Secrctariat of UNA IDS in Geneva, Switzerland. 
The global activism for access to medication, defined in the context of the right 
to health (human rights narrative) also played a major role in the launching of 
41 (WIIO, UNICEF, UNPF, World Dank, UNAlDS) and (Doehringer Ingelheim; Dristol Myers 
Squibb; F. Hoffman-laRoche; GlaxoSmithKline; Merck and Co., Inc; Pfizer with Abbott and 
Gilead joining later). 
41 Sub-Saharan Africa accounted for 70% ofpeopJe with HlV/AlDS in the year when AAI was 
created (UNAlDSfWIIO, 2000:5). 
" 
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the AAI. As mentioned early, by 2000 UN agencies, international CSOs and 
developing countries r e c o g n i ~ e d d that high drug prices preventing the poor from 
access treatment for HIV/AIDS touches on human rights. Accordingly, the 
AAI was established on the pretext that reductions in drug prices arc in part a 
solution to such abuses to the right to health. This was particularly important 
for African countries. It is not surprising, therefore, that the AAI was launched 
as a globally-backed country-led PPP to achieve • Universal Access' to life-
sustaining support especially in the hardest hit regions of the world. Since its 
formation, several other organizations from the public and private sector have 
joined the partnership. By mid-2003, out of 84 countries that had expressed an 
interest in joining AAI, 50 had developed national plans and concluded drug 
procurement arrangements (Sturchio 2004). 
As set out in the Statement of Intent (UNAIDS/WHO, 2002: Annex 1, p. 19), 
three expected benefits of the initiative for developing countries, particularly 
that Sub Saharan Africa43 are to: 
• Accelerate sustained access to and increased use of 'appropriate, good 
quality interventions'; 
• Strive to reach significantly greater numbers of people in need through 
'new alliances involving committed governments, private industry, the 
UN system, development assistance agencies, non-governmental 
organizations and people living with HIV/AIDS'; and to 
43 70% ofHIV/AIDS patients lived in Sub-Saharan Africa by launch of AAI (UNAlDS/WHO, 
2000:5). 
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• Implement the programme 'in ways that respond to the specific needs 
and requests of individual countries, with rcspect for human rights, 
equity, transparency and accountability'. 
To guide the AAI in its efforts to effectively address the AIDS epidemic, 
members set out to create 'new alliances involving committed governments, 
private industry, the UN system, development assistance agencies, non-
governmental organizations and people living with HIV/AIDS' 
(UNAIDS/WHO, 2002: Annex 1, p.19). The six working principles established 
as a framework for implementing the AAI reveal the co-existence of the three 
narratives on access to medication: 
1. 'Unequivocal' and sustained political commitment of national 
governments involved in the initiative; 
2. Building a 'Strengthened national capacity' in the developing countries, 
including well-designed strategies and a strong infrastructure, both 
essential to the delivery of care and treatment; 
3. 'Engagemcnt of all sectors of national society and the global 
community' in facilitating access to treatment; 
4. Developmcnt of 'efficient, reliable and secure distribution systems' to 
ensure that medicines reach the people for whom they are intended; 
S. Acquire 'significant additional funding from national and international 
sources', at a level commensurate with the epidemic's challenges; and 
6. 'Continued investment in research and development by the 
pharmaceutical industry' to meet the challenges of the epidemic today 
and tomorrow. 
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The partners and network taxonomy of the AAI also reflected the three 
narratives on access to medication. As a global PPP, the AAI was structured in 
three working groups - country support, communication and procurement 
working groups respectively. The first is the country support working group 
comprising UNAIDS Secretariat, UNICEF, WHO and individual countries 
with each of the five phannaceutical companies. This means that each country 
is expected to participate in five independent working groups (only one 
pharmaceutical company in each group). The second is the communications 
group comprising of all partners to the AAI while the third, the procurement 
group consists of the UNAIDS Secretariat, UNFPA, UNICEF and WHO. Thus, 
while each country is allowed full autonomy in its negotiations with partner 
pharmaceutical companies, the communication and procurement groups help 
with advice and technical support to facilitate bilateral agreements on drug 
prices and supply arrangements (the economistic view). This multi-actor 
representation was meant to ensure that dialogues and negotiations arc fairly 
conducted and that the public health and human rights interest of the poor in 
accessing treatment and care are given the right considerations in the face of 
the dominant economistic narrative. 
With respect to the working principles of the AAI, the economistic narrative 
dominated. The main strategic orientation is negotiated (differential) 
discounted drug pricing. First, a national plan detailing healthcare and 
pharmaceutical needs for each country is developed with technical assistance 
from the UN system (WHO, UNAIDS, UNICEF). Dialogue processes are then 
concluded with individual pharmaceutical companies on drug procurement and 
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supply agreements (UNAIDS/WHO, 2002:5·6). Bilateral discussions on 
pricing take place between national governments and individual 
pharmaceutical companies independently of UN agencies, a measure which 
reveals the strong position of pharmaceutical companies. Funding to pay for 
medication comes primarily from the countries themselves through local 
mobilization, grants and donor support from the World Bank, Global Fund and 
occasionally from other affiliated international partners. 
Despite the apparently overemphasis on prices and supply arrangements, the 
public health narratives are also important. This is evident from development 
of national plans in relation to the specific eligibility criteria set by the AAI on 
which lilY/AIDS endemic countries could join the initiative: be a 'high 
lilY/AIDS burdcn' (WHO, 2005a:l), one of the 'hardest hit regions of the 
world,' have a relevant health infrastructure and 'adequate' health system 'to 
handle the complicated HIY/AIDS medicines' (UNAIDS/WHO, 2002). As 
international public health advocates, the WHO and UNICEF through country 
support and working groups provide technical assistance to the Ministry of 
Health in prospective participating countries to enable them to develop robust 
national plans that meet these requirements. This includes for example, 
specifying how existing weaknesses within the national health system (that 
would constraint lilY/AIDS treatment and control) are being (or have been 
addressed to facilitate local distribution of ARTs as well as treatment and care 
facilities throughout the country (especiallY in poorest communities). 
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It is important to note that the elements of the public health models that 
emphasise IIIV / AIDS prevention appear to be ignored by the AAI. For 
example, the AAI model measures the impact on access to medication in tenns 
of number of persons receiving ARV treatment directly or indirectly provided 
by AAI partners, significant reduction in drug prices (UNAIDS/WHO, 2005), 
effective functional or problem-solving strategies (negotiating lower drug 
prices), governance arrangements and accountability (Sturchio 2004; Buse and 
Hanner, 2007). As will be discussed in the case study in chapter seven, 
following agreement on drug prices and supply arrangements, transcalar 
networks then became useful as a way of ensuring that the AAl's goal of 
'Accelerating Access' through global IIIV/AIDS programmes and activities at 
national and local levels can be achieved. 
4.6.2 MSF-Ied Equitable Access Initiative 
MSF is the architect of the Equitable Access Initiative (EAI). To demonstrate 
that access to medication for HIV / AIDS is a human rights issue, MSF attacked 
the AAI for being too economistic and in turn used its own published field 
experiences as a non-profit medical organization to demonstrate the feasibility 
of a human rights approach (MSF 2002, 2002a:4, 2002b). Specifically, MSF 
(2002a:6) stated that: 
'Not only is it medically unethical to deny people living with IIIV / AIDS 
existing treatments, it is also ineffective to separate prevention and 
treatment interventions: access to treatment creates conditions that 
improve the effectiveness of prevention programmes. ' 
According to MSF, 'countries are treating more people using generic versions 
of some first-line regimens than they would use AAI discounted drugs (MSF, 
2002a:4-7). Thus while the AAI emphasises patent-protected medicines 
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produced by western pharmaceutical companies, MSF favoured generic 
medicines produced in developing countries such as India. 
There are two features of the equitable access model: justification of the need 
for price reduction (Equitable Pricing) and the means of achieving equitable 
access (Generic Competition). In terms of the former, MSF argues "that price 
reductions are needed, 'where policies are implemented to ensure that the price 
of a drug is fair, equitable and affordable, both to individuals and the health 
systems that serve them' (MSF, 2002a:l0). The main objective is to ensure that 
the poorest individuals can access medicines irrespective of their ability to pay. 
To achieve this objective, MSF lobbies with developing countries and UN 
agencies to encourage drug procurement from the lowest cost reliable supplier 
and for technical assistance from the WHO and UNICEF to emphasise pre-
qualification of medicines, bulk purchasing and assistance in overcoming 
patent barriers to access more affordable medicines. MSF (2002a: 10) argues 
that generic competition is 'the most effective means of lowering drug prices. 
During the last two years, originator companies have often responded to 
generic competition'. 
There are three measures that are used to support equitable pricing 
• The use of the WHO's prequalification system for developing countries 
that do not have strong regulatory authorities to facilitate the ability of 
poor countries to pursue the best offers on the world market. 
• Enhance existing regional and local production and procurement 
capacity through voluntary licensing with originator companies (or 
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compulsory licensing if they choose not to cooperate) and technology 
transfer. 
• Reduce prices by pooled procurement at regional level - Aggregating 
demand and organising purchases through global/regional procurement. 
After establishing the above global framework, the next step in the EAI is to 
invite developing countries to join the initiative. Just as in the case of the AAI, 
HIV/AIDS endemic countries voluntarily endorse the equitable access model. 
In April 2001, MSF organized a conference of the Ministers of Health and 
Commerce of the OAPI in Yaounde, the capital of Cameroon, on the question 
of patents and access to treatment within the framework of the Bangui Accords 
(MSF, 2002b). During the conference, MSF challenged the AAI model of 
'Accelerating Access' by lecturing the delegates on its alternative 'Equitable 
Access' which ensured that even the poorest individuals could afford ART. In 
disregard of their previous positions (as signatories to the TRIPS Agreement), 
most of the participating countries ratified the revised Bangui Accord which 
allowed countries to import generic drugs in defiance of the TRIPS Agreement 
without any accompanying sanctions from the WID. In this way, CSOs such 
as MSF claim to be global partners most concerned about the right to health for 
the poorest and most vulnerable people in developing countries. 
By endorsing the equitable access model, countries such as those within the 
OAIPI, are able show an 'Equitable Access' concept to the WID as a 
justification of the fact that although they are officially committed to respect 
intellectual property laws such as the TRIPS agreement, they will continue to 
161 
import generic drugs still under patents on grounds that the poorest people in 
the world still could not afford ARTs at the price agreed through the AAI 
model. This position could not be ignored by the WTO (as a result of the 
relaxation of certain provisions of the TRIPS agreement discussed earlier) for 
countries classified by the World Bank's Debt Relief Program as least 
developed in the world. 
The efforts of CSOs such as MSF are seen not only as an attempt to render the 
TRIPS argument irrelevant as a major barrier to access to medication for 
IIIV I AIDS, but also to promote the concept of health as human rights. Such 
contributions arc recognised at the Doha Round of international trade talks 
(WTO, 2001). In particular, it is seen as a breakthrough in the international 
debate about the impact of civil society participation and the benefits of 
emphasising the poorest people in the world (as against the economistic 
interests of phannaceutical companies) in the TRIPS Agreement on access to 
medicines. 
4.7 Discussion and Conclusion 
This chapter illustrates the role of theories in the creation of development 
models and how forms of knowledge from these models, expressed as narrative 
strategies on access to medication, became embodied in GHPs. Accordingly, 
the GHP model can be defined as the embodiment of development models 
previously promoted by UN agencies. The public health narrative is rooted in 
social theory, while the economistic narrative is rooted in liberal and neo-
liberal economic theories. The analysis illustrates that national and 
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international public health institutions (WHO and UNICEF) became associated 
with a public health narrative;· economic development, trade organizations 
(lMF, World Bank, WTO) and phannaceutieal companies with an economistic 
narrative, while CSOs pushed for a global recognition of a human rights 
narrative on access to medication. These actors and narratives nre global, 
implying that their embodiment in a GHP gives rise to 'global models' on 
access to medication. The actors and narratives are also integrated into a hybrid 
network that defines the structure of a GHP. Studies on specific GHPs arc 
needed to better understand the relationships among these actors and the ways 
in which the different narratives embodied in a GHP model shape various 
aspects of policy practices at global, national and local levels in Cameroon. 
This chapter also reveals the usefulness of the conceptual framework 
developed in chapter two in understanding the embodying of models in three 
GHPs, namely, RBM, AAI and EAI. They all have characteristics of transcalar 
networks (global-national-linkages), that is, the social spaces through which 
narratives get onto national and international policy agendas. There is a strong 
relationship between social actors and the narratives (forms of knowledge) they 
produce, as seen in the ways that the narratives became embodied within 
specific GHPs. This suggests that some GHP partners are influenced by the 
narratives put forward by other partners. For example, in the AAI model, the 
economistic interest of pharmaceutical companies dominate more, while in the 
EAI, the human rights interests of the poorest people in the world who cannot 
afford medicines tend to dominate. It is also possible that although GHPs 
represent the integration of three narratives into a global model, national 
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disease control programmes c'reated through OlIPs tend to be dominated by 
these global networks in partnership with particular traditional public, private 
and local CSOs. Thus, to understand the impact of OlIPs at country levels, it is 
important to study the role of each narrative in shaping national and local 
policy practices through specific OHP programmes and activities. 
The social constructivist approach has also been useful. What emerges is that it 
the framing of issues through narratives (not a globally backed evidenced· 
based analysis), that largely detennine why a specific OlIP model should be 
adopted for facilitating access to medication for a specific disease. For 
example, in both the AAI and the EAI, access to medication is framed in tenns 
of affordability and available of discounted patent-protected and equity pricing 
of generic medicines respectively. Accordingly, the initiators of both models 
claim victory over the global fight against HIV/AIDS. MSF states that 'the 
injection of generic competition into the global ARV market has catalysed a 
dramatic drop in drug prices. As a result, medical, academic, and political 
leaders are now beginning to tackle other barriers to treatment,44. According to 
the WHO (2002b:6), reductions in drug prices are largely due to 'the work of 
hundreds of individuals and activists in non governmental organisations 
(NOOs), governments, UN agencies and the private sector ... and we are now 
in a position to consider scaling up access in resource limited settings'. 
The practical steps to reduce prices reveal how the importance of a public 
health narrative (quality of care) is undennined by the three GHP models. In 
44 MSF Access Website (2003) <http://www.accessmed-msf.orglcampaignlfaq.shtm> 
(Accessed: 25/05107). 
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trying to reduce prices and increase access to medication, nil three GHPs focus 
on changing the nature/content of medicines. The emphasis was on drug 
resistance, identified as a major barrier to access in the early years of GIIP 
experiences. To avoid drug-resistance HIV strains, in the case of the AAI, the 
WHO relaxed its guidelines on simplified standardised regimens and 
laboratory monitoring making the ART more available (WHO, 2002b). 
Similarly, Indian drug manufacturer Cipla, a major supplier of generic 
medicines in MSF's programmes, launched a once-a-day cocktail to make 
treatment much feasible in poor countries (MSF, 2003). The same procedure 
was adopted by the RBM when it recommended the use of ACTs for malaria 
treatment (WHO, 2004b)4s. As one would expect from a public health 
narrative, the emphasis was not placed on the reasons for a lack of adherence to 
treatment or prevention strategies. In the three GHP models studied in the 
chapter, scaling up access has focused on multilateral and bilateral agencies 
providing funding to pharmaceutical companies to finance drug R&D and 
consequently enable price reductions (WHO, 2001 :56; WHO, 2002b:2) so that 
the poorest people (the human rights narrative) in the world can afford the 
drugs. 
The political story on GHPs and access to medication is that they emerged 
from the need to correct governance gaps resulting from 'failed states' 
(government and market failures) in which weakened national health systems 
are unable to facilitate access to medication for rising number of poor patients 
4' For more on the change from previous anti-malaria drugs to ACTs see: Rational 
Phannaceutical Management Plus Program. 2005. Changing Malaria Treatment Policy to 
Artemisinin-Based Combinations: An Implementation Guide. Submitted to the U.S. Agency 
for International Development bythe Rational Phannaceutical Management Plus Program. 
Arlington, V A: Management Sciences for Health 
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(Dodgson et ai., 2002; Buse and Harmer, 2007). Econometric data 
commissioned by UN agencies (and their affiliated private corporations)46 and 
international CSOS47 are used to show that the consumption of medicines is 
sensitive to price as well as suggesting price reductions as a way of increasing 
the demand for treatment with relatively modest investment in infrastructure 
(see also Borrell and Watal, 2002:5; Grace 2004:10·12). This serves to 
contradict the strong public health emphasis promoted by the WHO and 
UNICEF in the RBM, especially the need for a strengthened national health 
system. 
This chapter finds that the way pharmaceutical companies have a strict 
economistic narrative which they impose on the arrangements in the TRIPS 
agreement and the way international esos use a human rights models to 
challenge them largely determines the overemphasis on the prices, the 
medicines, drug procurement and supply arrangements as against health system 
strengthening and preventive behavioural changes (related to disease 
prevention). The WHO defines access in terms of public health: 'guidance on 
the rational selection and use of drugs ... improved affordability and 
sustainability of drug financing and by accessible, appropriate and competent 
health services' (WHO, 2002:9). The RBM recognises this and calls on 
national governments to do more to address weakness in their national health 
system. However, the AAI and the EAI models more or less assume that such a 
.6 For example in 2000 the AAI contracted McKinsey & Company to produce econometric 
data on the capacity for administering ARV therapy in Uganda that can be used to project 
scaling-up of access over time (Fine, Hazelwood, Hughes and Sulcas (2001) 
.7 Joint Statement by OxfamffAClCPT/MSFlllealth GAP: 'Patents Do Matter in Africa 
According To NGOs' (1711012001): 
<http://www.accessmedmsf.orglprodlpublications.asp?scntid-l71 0200 11428SS3&contenttype 
> (Accessed: 17/11/08) 
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health system exists. MSF (2002) argues that 'the necessary infrastructure 
exists to provide antiretroviral therapy today' while UNAIDS claims there is 
no 'single place in the world where the real reason AIDS treatment is 
unavailable is that the health infrastructure has exhausted its capacity to deliver 
it (WHO, 2002:9). 
The discussion above suggests that the human rights narrative is more 
rhetorical and less practical at the global level. First of all, human rights were 
only made implicit in the PHC model, specifically targeting community (civil 
society participation) in health policy making and implementation. However, at 
the global level, policy issues seem to be negotiated in a corporatist way. 
Developing country governments are less represented in key GHP meetings 
while the monopoly power of pharmaceutical companies undermines their 
negotiating strength (Buse, 2004a). Unlike the RBM, both AAI and EAI do not 
see infrastructure development through a strengthened primary health care 
system that emphasises both medical and non-medical determinants of health 
(as the public health and human rights narratives would suggest) as a major 
barrier to access to medication. This obviously has serious implications for 
GHPs, namely, the extent to which they can achieve their country-specific 
goals. It would be interesting to study the ways in which the global narratives 
embodied within GHP models play on the issue of weak health systems and 
community participation in specific developing countries to better understand 
their role as facilitators of access to medication. 
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FinallYt the global perspective on the emergence GHP models is characterised 
by competing and conflicting narratives and this obviously affects the ways 
actors participate at the global, national and local levels. For example, in 
developing countries where the AAI and EAI models have been implemented 
simultaneouslYt it is not clear which one plays a more practical role. Brazil, 
Thailand and Cameroon are being cited as countries that 'have taken advantage 
of several strategies simultaneouslYt including local production, importation of 
generics and forceful negotiations with proprietary companies to bring prices 
down' (MSFt 2002a: 7). UNAIDS/WHO (2002:11) also makes reference to 
Cameroon (among several African countries) for successfully allocating funds 
to subsidize access to ARVs to people who are unable to afford the drugst and 
'converting part of their debt relief proceeds into a fund for care and 
treatmenf. SimilarlYt although the RllM claims to emphasise health system 
strengthening, national RBM programmes overlap with the health structures 
under the Ministry of Health (created on the basis of the PHC model) 
(Ngoasongt 2009). The two empirical case studies in this thesis are meant to 
understand the impact of GlIP models in shaping health policies and local 
delivery practices for national GlIP programmes created to facilitate access to 
medication for malaria and HIV/AIDS respectively. 
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CHAPTER 5: THE HISTORICAL CONTEXT OF 
GHPS IN CAMEROON 
5.1 Introduction 
This chapter presents the country-specific perspective on the emergence of 
GHP programmes as a new kind of global model on access to medication. It 
aims to extrapolate the key contextual characteristics that make the 
Cameroonian efforts to deploy GHP programmes an interesting and 
challenging object of analysis. The theoretical framework developed in Chapter 
Two suggested that understanding the role of models in shaping policy 
practices involve identifying instances where developments in the creation of 
models parallel or complement instances where new policies are introduced. 
From this perspective, this chapter identifies and discusses the 'trigger events' 
and the 'windows of opportunities' (Kingdom 1984; Birkland 1998) through 
which key policy issues (such as narratives or forms of knowledge embodied in 
models) get onto national policy agendas and how they shape policy practices 
in different periods in Cameroon's colonial and post-colonial history. This 
includes the main history of state building, the most important actors and 
institutions and the context in which GHP models come to play an important 
role on access to medication. Historically, the government has acted 
autonomously - through the adoption of various western models - to create a 
national health system that was subsequently transfonned through the 
development of GHP programmes. 
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Models of health development created in Europe were exported to developing 
countries through colonial routes, multilateral organizations and more recently 
GlIPs. Analysis of these historical processes reveal how western ideologies 
embodied within development models has been portrayed as superior, leading 
colonial masters to undermine indigenous knowledge when formulating 
policies that would shape local practices. This is reflected in the complexity 
and character of the barriers to access to medication. The barriers and the 
corresponding failed attempts at resolving them give rise to 'trigger events' 
that necessitate the endorsement of GHPs from the late 1990s. GHPs in tum 
create 'windows of opportunities' enabling the government to develop 
globally-backed national GlIP programmes as a panacea to previous 
programmes that did not work. Each GHP model targets a specific disease, 
policy or health system failures and each is being deployed to Cameroon as a 
panacea to previous models that did not work. 
This chapter argues that National GHP Programmes in Cameroon represent a 
new kind of global model that attempts to blur the boundaries of North-South· 
relationships by creating transcalar networks with global-national-local 
linkages. Instead of reporting directly to the colonial authority (Germany, 
France and Britain respectively) or to the state (independent and post-
independent eras), accountability over policy practices shifted to National 
Disease Control Committee. Within each committee, public, private and civil 
society actors from global, national and local levels with competing interests sit 
around the same table to formulate and implement policy. This new kind of 
participation gives absolute political control to no single stakeholder, not even 
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the state. This is the basis on which GHPs are meant to shape national health 
policy and local practices in Cameroon (nnd most African countries) for 
diseases such as HIV I AIDS, malaria and tuberculosis. 
The remainder of this chapter is organized as follows: the next section presents 
an overview of how colonial masters (Germans, French and British 
respectively) and later the IMF/World Bank-led liberal and nco-liberal models 
shaped Cameroon's political economy and laid the foundation for an 
economistic narrative on access to medication. It then describes how colonial 
medical models became embodied in variants of the WHO/UNICEF-led 
primary health care (PHC) model that emphasized a public health (with an 
implicit human rights) narrative on access to medication. A combination of 
these models and country-specific challenges created a fragmented national 
health system that could not be sustained. This laid the foundation for the 
emergence of GHP models in Cameroon. Illustrative examples on the expected 
challenges to be faced by national GHP programmes on HIV I AIDS and 
malaria are highlighted in the conclusion. 
5.2 The History of the Political Economy of Development 
Located around the Gulf of Guinea in the South West of Africa, Cameroon is a 
deVeloping market economy with an estimated popUlation of 16.6 million on a 
surface area of 475,402 Sq. km (Ako et a1. 2006). It is often referred to as 
'Africa in miniature' or 'the Africa continent in microcosm' because of its rich 
colonial history, and physical, socio-cultural, economic and demographic 
diversity (Kofele-Kale, 1986; DeLancey and Mokeba, 1990). These 
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endowments make it one of the few countries in Africa that is self-sufficient in 
food production (EIU, 2002) and puts in a nutshell the colonial and political 
trajectory of Africa. From slave trade and migration to a German colony (1884-
1922), split into two (British and French) League of Nations mandates (1922-
1945) and United Nations trust territories (1946-1960, unification to a federal 
republic (1961-1972), a centralised system of government (1972-1990) and a 
multi-party system that is now trying to reshape itself into a decentralized state 
system. Kofele-Kale (1986) describes Cameroon as a society divided along 
ethnic regional lines (with more than 200 different African ethnic groups), 
dominated by Muslims in the north and Christianity in the south and west; and 
opposition between French and English-speaking peoples based on the 
country's colonial history. 
Despite such a rich traditional and ethnic diversity, exogenous factors (colonial 
and nco-colonial) arc largely responsible for the creation of a 'nation-state' in 
Cameroon, one that governs the public sphere and supports its socio-cultural 
diversity. Colonial rule introduced political and socio-economic changes and 
policies, the consequences of which are deeply rooted in the political struggle 
for independence (1945-1961) and developments (such as infrastructure, 
industrialization in agriculture, medical services and education) since that time. 
Colonialism also introduced new languages (French and English) and enforced 
new customs (such as Christianity). The former colonial masters (France, 
Germany and Britain) eventually acted directly (due to their colonial interests) 
and indirectly (through their influences in international and global institutions) 
as major routes through which GHP models found their way into Cameroon. 
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This historical process is divided into phases and discussed in terms of the 
impact of the colonial, post-colonial and globalization eras in Cameroon. 
5.2.1 The Creation of a Nation State In Cameroon 
Most historical accounts48 hold that Portuguese merchants and missionaries 
first explored Cameroon through the south western coast establishing 
temporary slave trade routes in the 1450s. The name Cameroon originated from 
Portuguese navigator, Fernao Do Po when in 1472 he named the River Wouri. 
'Rio dos Camaroes' (river of prawns), a name subsequently translated by 
successive European colonial expeditions in Cameroon: Camaroes 
(Portuguese), Kamerun (Gennan), Cameroon (English) and Cameroun 
(French)49. The northern part was an important Muslim slave trade network 
dominated by Islamist Jihadists. When slave trade was abolished in the mid-
19th century, the London Baptist Missionary Society (around 1845) and later 
the Basel Mission from Gennany (from 1884) established a presence and 
continues to playa role in Cameroonian Christian life. Their worship centres 
and educational programmes were later taken up by Catholic and Protestant 
Churches respectively. The Portuguese and missionary arrivals were followed 
by over seven decades of colonial rule starting with Germany and later Britain 
and France. 
The colonial models of political development were militarist, bureaucratic and 
highly centralised. Despite the apparent difference in the models deployed by 
Gennany, France and Britain, they all shared a common similarity in the sense 
41 See le Vine and Roger (1974); Delancey and Delancey (2000); Ngoh (1987) for a detailed 
history of Cameroon. 
49 For the purpose of this thesis the English version Cameroon is used throughout this chapter. 
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that they were meant to achieve multiple objectives (political, economic, health 
and socio-cultural) simultaneously. Accordingly, most of the colonial 
administrators performed several tasks simultaneously. For example, Gustav 
Nachtigal the driving force towards the establishment a German colonial model 
in Cameroon was an explorer, a medical doctor, imperial consul and 
commissioner for Germany's interests in West Africa. Thus, instead of trying 
to describe the exact nature and representation of the models, this section 
focuses on key elements of the models that contributed to the creation of a 
nation state in Cameroon. 
On 14th July 1884, Gustav Nachtigal negotiated a protectorate treaty with the 
local chiefs and Cameroon became a German colony under The General Act of 
26 February 1885 at the Berlin Conference (Schnee, 2007). Germany's colonial 
model emphasised the development of an agricultural economy with absolute 
political authority from the Reichstag in Berlin. Although the goal was to 
produce goods to be exported to Europe, the model implicitly portrayed 
agriculture as the engine of economic development. Embodied in the model 
was a system of compulsory manual labour and punitive sanctions (on those 
who defaulted). When the Germans lost World War I, Cameroon was 
partitioned between France and Britain as two League of Nations Mandates 
(1922-1945) and later became UN Trust Territories after World War 11(1945-
1961). 
France gained over 80% of the geographical space, and ruled from Yaounde 
(the present day Capital) as French Cameroons. Embodied in the French 
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colonial model in Cameroon was a strategy deploying assimilaliol1 (French 
language, legal and educational systems) and indigenous pol/lies (French 
judicial and policing system while tolerating traditional legal practice) (Mbaku, 
2005). Traditional rulers often travelled to France for conferences and 
exhibitions, and under this regime Cameroon quickly became a self-sufficient 
and thriving civilization. The newly educated Cameroonian elite began to 
express a new Cameroon identity and forge the vision of a new society. They 
served in the Christian missions as catechists, pastors/priests and for the 
colonial government as junior-level civil servants. Britain gained only 20% of 
Cameroon and deployed a model of indirect rule in which the region was split 
into two and administered as provinces of Nigeria (ruled from Lagos). 
Colonialism also divided Cameroonian society between those 'elite' groups 
trained to promote colonial interests and those who opposed them by 
emphasizing traditional community values and customs. This is evident in the 
fierce local resistance to colonial rule (Mbaku, 2005). For example, Rudolph 
Douala Manga Bell was trained in Gennan law by the Gennan colonial 
administration and made king of Duala in 1910. He went on to challenge 
Gennan ownership of land in Cameroon after realising that both international 
(The General Act of 26 February 1885) and national (in Gennany) laws on 
land ownership had prohibited the ownership of land by many Germans in 
Cameroon. His legal protest to the Gennan Reichstag was rejected, and his 
continued activism led to his execution by colonial authorities in 1913 for 
treason. Other prominent Cameroonian intellectuals directly or indirectly 
persecuted for political activism include Martin-Paul Samba of the Bulu 
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(assassinated by the German authorities) and Sultan Njoya of the Bamoun 
(exiled to die in Yaounde by France) (Mbaku, 2005). The German system of 
compulsory labour as well as successive and dreadful punitive raids following 
resistance and rebellion dislocated social life and seriously reduced population 
growth (Caldwell, 1985: 483). 
Another evidence of local resistance to colonial models can be found in the 
struggle for independence from colonial rule. In 1946, a French-backed 
Representative Assembly of Cameroun (ARCAM) was created and its leaders 
(Paul Ajoulat and A. Douala Manga Bell) were assimilated as elected deputies 
of the French National Assembly. In 1945, an anti-colonial Marxist party, the 
Union des syndicals conjederes du Cameroun (UPC), had been created to fight 
for unification and independence from France. Activism was supported by 
trade-unionists in the cities and by local settlers in rural areas, expressed 
through non-violent rallies, demonstrations and boycotts. However, the 
punitive sanctions on arrested protested led to a guerrilla war between the 
rebellion and the French Fourth Republic. The rebellion was crushed and in 
1956 the ARCAM was approved by France as an autonomous Legislative 
Assembly of Cameroun (ALCM). Similar types of protests took place in 
British Cameroons; however, the indirect rule of the British meant that there 
was limited violence. 
French Cameroon was finally granted independence (backed by the UN) on 
January 1, 1960 with Ahmadou Ahidjo as president. In a UN-led plebiscite in 
February 1961, the Muslim-majority North of British Cameroon opted for 
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union with Nigeria while Southern Cameroon reunited with French Cameroon 
to form a Federal Republic of Camcroon on 1110/1961. On 20105/1972 a 
referendum transformed the federation into the United Republic of Cameroon. 
When Paul Biya replaced Ahidjo as president in 1982, the country became the 
Republic of Cameroon although it remained a centralised and sovereign one-
party state. However, in 1990, international pressures led the government to' 
introduce multi-party politics. 
Thus, the Berlin Conference of 1884, the First World War (leading to the 
League of Nations) and the Second World War (leading to the United Nations) 
can be seen as trigger events that allowed the deployment of colonial models to 
Cameroon and led to the transfer of political authority from indigenous 
Cameroonians to colonial masters. The Second World War also created a 
window of opportunity as it enabled opponents of the colonial model to begin a 
struggle for independence. Colonial models disintegrated Cameroonian society 
between those 'elite' groups trained to impose western ideologies and those 
who opposed them by emphasizing traditional values and customs. In addition, 
to achieve their colonial interests, Germany, France and Britain used different 
models to shape the political economy of Cameroon in ways that restricted the 
political liberty of indigenous Cameroonians. 
5.2.2 Development of state institutions: a system of 
government 
The attainment of independence, backed by the United Nations, created a 
window of opportunity, for the government to start acting autonomously 
(though with some indirect influence from the former colonial masters). 
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However, the manifestations of the colonial models described above continued 
to be reflected in policy and local practices. The Presidency remains the most 
important institution. TIle President, vested by Presidential Decree with 
executive authority, appoints the Prime Minister, judges, executes and ratifies 
all laws, commands the armed forces and issues orders to hold elections. 
Decisions taken in courts and at cabinet meetings are issued in his name. The 
Cabinet of Ministers is led by the Prime Minister (appointed by the President). 
In tum, the Cabinet is responsible to the president through the prime minister in 
matters of general policy and legislation. 
The cultural and ethnic diversity of Cameroon mentioned earlier implies that 
no one ethnic group is large enough to exert a dominating influence in 
Cameroon. Thus, the totality of colonial models were largely embraced: 
English and French as official languages; different provinces (or educational 
institutions) use the British and/or French model of education; internationally, 
Cameroon is a member of both the Common Wealth of Nations (British) and 
the Francophonie (French); the legal system is built on civil law (France) 
although in the English-Speaking provinces elements of the common law 
(British) still exist. With 25% of Cameroon being Muslims (most of whom are 
French-speaking), political power is implicitly shared among the French, 
British and Muslims. The President has always come from the French region 
while the posts of Prime Minister and Chairman of the National Assembly are 
often rotated between the Muslim and the English-Speaking peoples 
respectively. This distribution of portfolios is inherent in all structures of 
government at national and local levels. 
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Models based on western ideologies also provided the basis on which policy 
and local practices are mediated and enforced. As first President, Ahidjo set out 
to established a re-enforced presidency (LeVine, 1997), one that was capable 
of crushing the Gaullist model of the rebellious UPC party and one that would 
give him greater control over British Southern Cameroons. Backed by France, 
he diverted substantial public resources to create several security institutions 
(such as Brigades Mistes Mobile and Service De Documentation - SEDOC) as 
tools to maintain political stability. As a result, 'many bureaucrats sacrificed 
professionalism and efficiency for security' (Mbaku, 2004:143), and local and 
sectional loyalties became paramount under a highly centralized government. 
Since 1990 when Paul Biya introduced multi-party politics, the nature and role 
of the state never changed. The ruling elites, instead of questioning the 
suitability of colonial systems of democracy and government in local politics, 
continued to suppress the local chiefs, neglecting developments in rural 
communities (Rowlands and Wamier 1988:120). Although multipartism 
allowed the leaders of many ethnic groups to make more open political 
commitments, their scope for influence remained ceremonial. 
The discussions above reveal how western ideologies embodied in colonial 
models became superior to traditional customs and values in the development 
and functioning of the state in Cameroon. The manifestations of this cut across 
all levels of society and can be seen in the ways in which the different sectors 
of government are organized and how they function. The next section explores 
. 
how the colonial models directly (during the colonial era) and indirectly 
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(through their influence in international organizations) shaped economic 
development in Cameroon. 
5.3 How Models Shaped Economic Development Policies 
Economic development in Cameroon is a product of colonial, planned 
liberalism and neo-liberal market models respectively. Accordingly, the nature 
of North-South relationship has shifted from direct political influence (the 
colonial era) through donor-recipient commitments (independent era) to public-
private partnerships (globalization era). The economic elements embodied in 
colonial models transformed an 'informal trade-by-barter system in pre-
colonial Cameroon into a centralized market economy that was subsequently 
transformed through various international models of economic development. 
This process is described below. 
5.3.1 The legacy of colonial models on economic 
development 
The abolition of slave trade in the 14th century had enabled indigenous 
Cameroonians to trade domestic goods (e.g. palm oil) for foreign goods (e.g. 
guns, gunpOWder, scarlet uniforms and hats) with European traders. The early 
Gennan explorers exchanged these products for land with local Cameroonian 
Chiefs. In 1874 German merchants inaugurated the first scheduled passenger 
and freight service between Hamburg and Douala (Washausen, 1968:68) and 
expanded agricultural plantation operations on the acquired land, under the 
protection of the Reich. A few years later Chancellor Otto von Bismarck began 
to use the 'chartered companies' to govern the region (Washausen, 1968:116; 
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Haupt, 1984:57) thereby replacing the pursuit of private profit with direct 
political control over economic activities. 
The first German Administration (1895-1906) created Trans-National 
Corporations (TNCs) producing crops (such as cocoa, coffee, banana, latex, 
plantain) and expanding infrastructural development (roads and rail lines). 
Through 'a harsh and unpopular system of forced labour' (DeLancey and 
DeLancey, 2000:125) the Germans depicted Cameroonians as idle people 
unable to perform any productive work beyond manual labour, thereby 
reducing them to manual labourers in TNCs (Ngoasong, 2007:96). The notion 
of partnerships is embodied in the German model, with chattered companies 
(private partner) running the plantations, Cameroonians (manual labourers) and 
German administrators (public partner). This model had mutually positive 
economic impacts in terms of infrastructural development, job creation and 
economic growth. By 1911 the total volume of trade between Germany and 
Cameroon exceeded 50 million gold marks (Haupt, 1984:64). 
The notion of partnership between public and the private sectors was also 
embodied in the colonial models of Britain and French, specifically for 
economistic reasons. Despite setting out to destroy Germany's political legacy, 
France and Britain allowed German administrators to run the agricultural 
plantations. In May 1922 the British Parliament (cited in Schnee, 2007: 15 I) 
lauded the German plantations as follows: 
'As a whole they are wonderful examples of industry based on solid 
scientific knowledge .... Apart from the regular employment afforded, 
the natives have been taught discipline and have come to realise what 
can be achieved by industry. ... Large numbers who returned to their 
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villages take up cocoa or other cultivation on their own account, thus 
increasing the general prosperity of the country' 
France also benefited from the services of the Germans to expand 
infrastructural development beyond the TNCs (such as to develop electricity 
and water supply, broaden medical services and to establish educational 
establishments/schools) (Michel, 2007). These achievements supported by a 
centrally regulated partnership laid the basis for the creation of an independent 
Cameroon capable of sustaining an expanding market economy. 
5.3.2 Planned liberalism and economic development 
practices 
At independence, TNCs were perceived as inherently malevolent due to their 
dominant influence on internal policy practices, exploitation of domestic 
resources (by colonial powers and and merchants of TNCs) and the use of 
forced (or lowly paid) labour. To consolidate his power as an autonomous 
president Ahidjo launched a policy of Balanced Development. This involved 
nationalising foreign corporations and introducing maximum state ownership 
in the public and private sectors. To gain international recognition as a 
sovereign state he endorsed the World Bank-proposed Planned Liberalism 
model, a series of Five-Year Development Plans (starting from 1961). This 
rationalist model requires policy makers to rely on evidence-based policy 
analysis to shape economic development programmes. During the Second 
Five-Year DeVelopment Plan (1966-1971), all major foreign-owned companies 
were transformed into State Owned Enterprises (SOEs). Regulation, ownership 
and management decisions were decided by the Presidency through a 
paras/alai class of senior public managers (van de Walle, 1994:157). 
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Planned liberalism enabled political stability based on a set of undemocratic 
institutions that regulated socio·political interactions and provided a semblance 
of peaceful conflict resolution. The president used dictatorial powcrs to 'bribe 
competitive elites, co·opt politically dominant ethno·regional clites, neutralize 
others, force some into exile, and imprison 'many individuals who dared to 
oppose his dictatorial policies' (Mbaku, 2004: ISS). Such an approach to state 
expansion enabled the government 'to cement a 'hegemonic alliance,' 
incorporating the country's emerging elite into the state apparatus' (van de 
Walle, 1994:155). Thus, the state used the elites of ethnic groups and senior 
managers of SOEs as instruments to maintaining political equilibrium in the 
distribution of jobs, wealth, income, power and privilege at the national level. 
These elites in turn used their positions to maintain political equilibrium at 
regional and local levels. 
With extraordinary economic growth rates, this complex undemocratic set up 
raised no concerns. By 1980, success in agriculture (mostly cocoa and coffee 
exports) and the development of oil in the 1970s had stimulated extraordinary 
economic growth rates, making Cameroon one of the twenty safest countries in 
the world for investments (Ndongko, 1986), one of the few in Africa that was 
self·sufficient in food and energy production (DeLancey and Mokeba, 1990) 
and a model of political and economic stability in the world (Mbaku, 
2004:154). 
In 1982, Ahidjo resigned and appointed his Prime Minister Paul Biya, as the 
next president. Mr Biya, who is in power to date, used the media as a tool to 
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negate the legacy of his predccessor and to consolidate his own power. The 
regime change can be seen as another trigger event. For the first time the 
national media began to expose the extent of bribery and corruption that was 
embodied in Cameroon's political economy under Ahidjo. The media also 
credited the vast development projects in the country as the work of the former 
colonial masters. This even prompted the former president to attempt a failed 
coup d'etat in 1984. The brief power struggle 'weakened the new president and 
made it difficult for him to take appropriate policies to reduce the state sector 
and prevent its continued expansion' (Mbaku, 2004:158). Apart from this, 
Diya's spending decisions were very similar to those of Ahidjo's. By mid·1986 
'public spending had reached unsustainable levels and a fiscal crisis was 
inevitable' (Ibid). The regime of Mr. Biya eventually plunged the economy 
into crisis. 
In 1987 Cameroon officially announced its worst economic crisis since its 
existence as a sovereign nation. Blaming external factors, Mr Biya announced 
that 'all our export commodities fell at the same time' (DeLancey and 
DeLancey, 2000:104). He was referring to the sudden collapse in the world 
market prices of primary exports (such as cocoa, coffee and oil) in the early 
1980s. The exact causes of the crisis remain debatable, yet reflect the 
interaction between western models and local practices: the failure of the state 
to detect and resolve the crisis at an early stage, uncontrolled expansion of 
corrupt public banks, inefficient SOEs that over-stretched the public treasury 
and increased external debts beyond manageable levels (Mbaku, 2004). 
Between 1985 and 1987, Cameroon's proposed adjustment programs stalled 
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after fonner colonial masters (mostly France and Gcnnany) and the USA 
(creators of the World Bank-led liberal model) rejected the governmentts plea 
for financial assistance (sec van de Wallet 1994: 1 58). These powerful nations 
offered to provide funds conditional on Cameroon endorsing the IMF-
sponsored Structural Adjustment Programme (SAP). 
Thus, international actors moved from one failed model to another with limited 
attention to country-specific policy contexts and practices. In a press release 
announcing the SAPs for Cameroon, the IMF confinned the narrative put 
forward by the President of Cameroon, pointing to 'declining prices for the 
country's major export commodities, weakened terms of trade and significant 
increase in overall fiscal deficit (Mabaku, 2004:160) as the causes of the 
economic crisis. The next section explores the role the SAPs in shaping the 
political economy of Cameroon. 
5.3.3 Neo-Iiberal model of development - Structural 
Adjustment Programmes 
SAP was launched by the IMF in the mid-1980s to bail out poor countries from 
the financial crisis caused by a collapse of primary export prices. In Cameroon, 
it consisted of guaranteed multilateral (lMF/World Bank) and bilateral (France 
and Germany) loans and aid along with specific conditions on spending for the 
period 1988-1995. The broad goals of the SAPs include: increase public 
revenues through privatisation and efficient management of SOEs; currency 
devaluation to reduce real exchange rate and stimulate exports; credit and fiscal 
contraction; and liberalize trade to stimulate competition (van de Walle, 1994; 
IMF, 1995). Through the SAPs, the IMF and the government of Cameroon 
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reached agreements on major and additional financial resources to achieve 
these objectivesso. Two most significant agreements includesl : 
• 19/0911988: Financial rescue package of 115.525 millions US$ to 
stimulate macroeconomic performance through privatisation of SOEs 
that dominate the industrial sector as well as liberalisation of trade in 
cocoa, coffee and timber. 
• 17/09/1995: Financial package of 1010 millions US$ to continue to 
expand the structural reforms agreed in 19988 as a means to achieving 
pre-determined targets: 3% real GDP growth, 5% reduction in inflation, 
reduce current account deficit to 1% of GOP 
In addition to the financial assistance from the IMF, the former colonial 
masters (France and Germany) immediately invited Cameroonian policy 
makers to the Paris Club and approved additional bilateral financial aid as well 
as rescheduling the country's outstanding debts (van de Walle, 1994:159-160). 
Economic calculations arc often employed to evaluate the impact of SAPs 
(such as income-related indicators: economic growth rates, terms of trade and 
debt servicing). In the case of Cameroon, instead of reducing external debts to 
manageable levels, debts increased substantially, more than 50% of people 
lived below the poverty line in 1996 (Ngufor, 1999) and government spending 
deficit increased to 464 billion FCFA (Ofeh and Njong, 2006). Yet the World 
Bank maintained that SAPs were working. Since 'more time' was needed for 
interventions to translate into positive macroeconomic performance, the IMF 
and the World Bank rejected calls for SAPs to be abandoned. Even the 1997 
50 The full text of IMF (1995), a series of country reports, is available on the web site 
beginning with Starr Country Report no. 97/101 
S. For detailed statistical illustrations and terms of the SAPs see Mbaku (2004: 1 58-159). 
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IMF-sponsored Enhanced Structural Adjustment Facility (ESAF), meant to 
address the failures of previous SAPs, did not improve the much needed 
statistical evidence on success. S2 
Opponents of SAPs claim that 'scarce resources which could have bccn used to 
increase spending on such areas as health care, primary and secondary 
education, HIV / AIDS medication, and to purchase essential inputs for 
domestic industry, are being squandered on debt service' (Mbaku, 2004: 164). 
More importantly, the SAPs neither identified corruption as a major cause of 
the crisis in Cameroon nor emphasised measures to fight it as a condition for 
financial aid. For example, more than 50% of imports into Cameroon during 
1988-1990 evaded taxes through corruption in the customs department (van de 
Walle, 1994: 159). Because the SAPs served 'primarily as instruments of global 
trade that benefits mostly the GECD countries, the main contributors to these 
agencies' (Mbaku, 2004: 163), loans and aids were continuously supplied to 
increase the dependency of countries like Cameroon on western industrial 
markets (Danaher, 1994) despite continued policy failures. 
Thus, a combination of external and internal pressures forced Cameroon to 
adopt the liberal and neo-liberal models, rather than a proper evidence-based 
search for solutions to the country's persistent problems. The models created a 
'democratic culture characterised by rent-seeking behaviour' that promoted a 
vibrant black market and reinforcement tribalism (Baye, 2003:12). All facets of 
society were hit by the crisis resulting in an increase in poverty, high rates of 
52 Statistical evidence of poor performance of the SAPs can be seen through a simple 
comparison of figures presented in successive World Bank reports on the SAPs performance in 
Cameroon (see Van de Walle 1994, Mbaku 2004, 2005). 
187 
infant mortality, low levels of literacy, a reduction in life expectancy and 
limited access to medical facilities (Baye, 1998). Development models also led 
to the creation of bad leadership and defective institutions (elite-driven, top-
down, non-participatory constitutionalism backed by fonner colonial masters) 
that were later transformed by multilateral organizations (IMF and World 
Bank) with serious implications for national policy and local practices. 
5.3.4 The consequences of neo-liberalism: globalization era 
The discussion above reveals that the neo-liberal model was substantially 
economistic in Cameroon. The manifestations of the model transformed the 
Cameroonian state from a centrally planned economy to a free market 
economy. Within a decade of launching the SAPs, the number of major 
privatized firms in Cameroon reached 44 (World Bank, 2000) and 58 new 
affiliates of multinational enterprises were established between 1992 and 2001, 
while inflows of foreign investments reached 75 million dollars (EIU, 2002). 
Since the early 1990s the literature on economic development in Cameroon is 
loaded with tenns such as 'decentralization', 'deconcentration', 'devolution', 
'privatization', 'contracting out', 'public-private partnership' used 
interchangeably to describe public and private sector programmes and 
activities. Such a fragmented system obvious represents an erosion of the 
political accountability that existed in the colonial era, but that liberal and neo-
liberal models never asked for from successive governments of Cameroon. 
In the wake of the failed SAPs and the consequences that followed, bilateral 
and multilateral organizations came out more strongly on the issue of weak 
governance in Cameroon. In a detailed country study, the World Bank reports 
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that throughout the 1990s, economic and social development in Cameroon was 
hindered by the heavy burden of the external debt, balance of payment deficits, 
structural rigidities, high production costs and weak governance (World Dank, 
2000: App B), challenges that the SAPs - imposed through the World Dank· 
were meant to solve. This gives credibility to the ncguments by critics that the 
SAPs never created the governance structure necessary to regulate the market 
economy they sought to create. 
Having acknowledged this, multilateral agencies began to face a crisis of 
confidence in the capacity of the state to function effectively. They equated 
mncket failures with state failures and began to promote community-level 
(participatory development) models (World Bank, 1996) that involved 
bypassing the state to work directly with civil society organizations (CSOs) in 
programmes of poverty alleviation and sustainable development as a means of 
correcting democratic deficits within the state. This involved limiting the role 
of the state to policy making and working directly with local CSOs in policy 
implementation. Introducing community participation has led to the 
proliferation of CSOs (e.g. INOOs and NOOs) whose work are described as 
new ways of filling governance gaps in state institutions (Tarah and Asondoh 
2000). CSOs can help multilateral agencies to achieve quick results; however, 
they also have the incentive to practice rent-seeking behaviour in Cameroon, 
acting as 'brokers' who effectively confiscate the value-added from 
development projects (Baye, 2003). 
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The role of local CSOs became for formal in 2000, when the World Bank's 
Heavily Indebted Country Initiative (HIPC) was launched, another trigger 
event that further transformed the nature and functioning of the state. It came 
into effect in mid-2000, making available $86 million per year for public 
spending in areas such as healtheare (MoH, 2000). This is because the initiative 
embodied clements of community-level models with the aim of correcting 
governance failures. The initiative required the creation of a Country 
Coordinating Mechanism (CCM) - consisting of representatives of the public 
and private sectors, CSOs and donor agencies - to formulate and 
implementing. 53 Although preliminary evidence on the impact of the debt 
initiative reveals mixed results (Baye, 2003; UNCTAD, 2002), studies on 
specific sectors of the economy are hard to find. As discussed later, this new 
kind of participatory approach to governance had a direct impact on the 
development of the health sector. Thus while the liberal model gave absolute 
political power over national policy to the government, neo-liberal model 
eroded this power by creating a fragmented free market economy. The 
conditions under which resources were meant to be spent by the CCM were 
intended to ensure that the deployment of GHP models places special emphasis 
on good governance and the fight against corruption. 
The CCM, a multi-stakeholder PPP approach, is capable of blurring the North-
South divide in the sense that it replaces the state as the central political 
apparatus for deciding policy. This means that multilateral and bilateral 
development agencies would no longer give development funding directly to 
53 CREDES (2004) 'Country Coordinating Mechanism: Case Study Documentation-
Cameroon, Report prepared for the Global Fund A TM and Financed by the French Ministry of 
Foreign Affairs, CREDES, France. 
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the government (donor-recipient 'commitments); they would provide funds 
through the CCM. This type of model has bcen adopted by GIIPs to facilitate 
access to medication as discussed in the next sections. 
5.4 The Historical Context of GHP and Access to 
Medication 
In this section, the historical context in which GHP models emerged in 
Cameroon is presented, focusing on the key actors and their role in introducing 
different forms of knowledge (economistic, public health and human rights) 
into GHP programmes in Cameroon. In many ways the colonial, liberal and 
neo-liberal models discussed earlier shaped health institutions, policies and 
local practices in Cameroon. Although the state had autonomy as policy maker 
(after independence), the structure and content of health policies were largely 
influenced by western development models (Table 6). Similarly, the 
WHO/UNICEF-Ied international health policies were affected by the neo-
liberal market models. By integrating international and national partners and 
their strategic interests, the notion of PPP embodied in GIIPs transformed 
Cameroon's health policy from government to governance. Accordingly, the 
interests of global, national and local partners became integrated in a multi-
stakeholder partnership. The conflicting and competing narratives of different 
actors during different conventional time-lines shaped the construction of 
access to medication and necessitated the endorsement of GHP models for 
specific diseases by the government of Cameroon. 
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Table 6 The historical context of access to medication in Cameroon 
Conventional 1884-1961 1961-78 1978 -1998 >1998 
time-linc 
Scopc of Colonial National vs. International Global 
I'olicy Colonial 
llcvelopment Colonialism Government Government Governance 
Policy (Dictatorship) (Plattning) (Privatisation & (Public-private 
Regulation) partnerships) 
}lolicy Germany, The State State National Disease 
Maker France, Britain (Ministry of Health) Committees 
Health Curative & Curative & Medical vs. Non- Access to 
Policy Goal Preventive Preventive medical medication 
Source: Author IS analysis of published materials 
5.4.1 The legacy of colonial.medical models 
During the colonial era, Germany and later France and Britain played the role 
of the State, complemented by religious missionaries. Traditional healers 
already had well-established practices based on the customs and tradition of 
their society. On the other hand, both the colonial masters and Christian 
missions focused on selective identification and treatment of diseases. 
Colonialism in Cameroon coincided with the 'golden age' of techno-medicine 
in Europe and North America (1910-1950) described in chapter four. The 
medical profession had become increasingly institutionalised emphasising a 
combination of evidence-based preventive and curative measures in dealing 
with health problems. As a result of this science-based approach, colonial 
medical models contradicted both an evangelical narrative put forward by 
Christian missionaries and traditional healing practices that were based on the 
customs and traditions of Cameroonian society. This was evident in the 
speciality of hospitals, such as those for tropical diseases such as malaria and 
sleeping sickness. 
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Embodied within the colonial medical models was an emphasis on selective 
identification and treatment of diseases to protect the colonial citizens and to 
preserve the labour force needed to work in the agricultural plantation. In 1911, 
Ludwig Kalz, Chief German physician in Cameroon, stressed that the 'colonial 
economy should make the Negroes' strong arms subject to its purposes, 
hygiene should preserve their strength and increase their number' (Schlich, 
2001 :59). Several hospitals including centres specializing in tropical diseases 
(such as malaria) were established, based on a combination of preventive and 
curative models. 
The eradication of sleeping sickness is a classic example (Haas, 2002). Having 
graduated as a· medical doctor and with specialized training in tropical 
medicine, Dr. Eugene Jamot led a French colonial hygiene group to Cameroon 
in 1910. In partnership with a similar German group, Jamot identified the tsetse 
fly as the cause of sleeping sickness. Using treatment models applied during 
the construction of the Panama Canal (lessons learnt from other countries), his 
team eradicated the tsetse fly, and therefore the disease, in Cameroon. He 
became director of health policy formulation and implementation in French 
West Africa. The 'golden age' of techno-medicine in Europe was consequently 
prominent in Cameroon. In the interwar years, France encouraged the training 
of indigenous medical personnel to be able to deal with public health issues 
with limited supervision. French medical and military doctors emphasised a 
unity of method and the homogeneity of teams (Patton, 1996). 
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The colonial models came into conflict with indigenous healing practices, 
which were already struggling to cope with an evangelical narrative put 
forward by Christian missionaries. Initially, Christian missions responded to 
the high mortality rate of their missionaries through direct medical measures. 
Later on, in an attempt to legitimise their activities, they began to complement 
the colonial agenda (especially in rural arc as) through miraculous healings 
based on faith, prayers and medicines. Historically, traditional healers in 
Cameroon served as 'priests, magicians, spiritual and political leaders' using 
divine powers transferable through ancestral generations (Njoh, 2006: 156). 
Traditional medicine typically views sickness as the failure of complex social 
and spiritual relationships, and based their prescriptions on both human and 
supernatural interactions. While colonial medical models attempted to restore 
physical health, traditional models re-established social and emotional 
equilibrium based on traditional community values and norms. 
Achieving a convergence of the three medical cultures above was impossible. 
It is often argued that the colonial masters never sought to decisively destroy 
traditional medical practices (Njoh, 2006). However, they clashed violently 
when it came to political authority. The militarist rule of the Germans and the 
French breached the strong link between traditional healing and public 
authority that was embodied in Cameroonian society, while the British 
intervened where traditional healing posed a direct and significant threat to 
colonial rule (Maynard, 2004). Christian missions used indigenous peoples 
they had trained (as catechists, priests and pastors) as tools to label traditional 
healing systems as antithetical. Since independence, although traditional 
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medicine is not fonnerly recognised nationally and internationally the practice 
has survived due to the failure of colonial and nco-liberal models to create n 
national health system capable of providing sustained and affordable healthcare 
(see for example, WHO, 1990). 
5.4.2 From Colonial Health to International Health: WHO & 
UNICEF 
Under the planned liberalism model in the 1960s and early 70s the government 
nationalised health services and promoted a slogan of free healthcare for all. 
Health policy fonnulation was highly centralised under the Ministry of Public 
Health. However, policy implementation (health care delivery) took the form 
of partnerships between the state and Christian missions, the fonner focusing in 
large urban centres and the latter penetrating into rural areas. The creation of 
the WHO and later UNICEF added an international dimension to health policy 
in Cameroon, as these agencies began to respond to disease outbreaks by 
. 
providing emergency technical assistance. Since the late 1970s, the measures 
taken to achieve health policy goals always involve the adoption of 
international (WHO and UNICEF) and global (GlIP) models through 
international health charters, directives and conventions. 
5.4.3 The Primary Health Care Model in Cameroon 
The most significant international health model adopted by Cameroon 
following independence is Primary Health Care (PHC), the outcome of the 
WHOIUNICEF-sponsored Alma-Ata Conference. Since being effectively 
implemented from 1982, it has undergone numerous transfonnations (see 
Ghogomu et aI., 2000; Essomba et aI., 2003; Ofeh and Njong, 2006). As 
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illustrated in Figure 4 below, the PHC was vertical and centralized around 
three levels: central (the Ministry of Health and its different departments 
formulate policies), intermediate (provincial delegations, hospitals and 
paramedical training structures operational policies), and peripheral (health 
districts/areas and pharmacies implement policies) levels. 
Figure 3 The structural features of the Primary Health Care (PIIC) 
system 
Central Level ~ ~
~ o l i c y y Formulation) ~ ~
t 
Religious Units. ~ ~ Intermediate Level 
(llcalthcare Delivery) ~ ~ operronalizatiOn) 
Peripheral Level 
(Healthcare Delivery) 
Multilateral and 
Development 
Agencies 
Source: Author's processing o/technical reports/published documents 
Within the framework of the PHC model, communities were mobilised on a 
low-payor voluntary basis to construct, donate or rent property to be used as a 
health post. Each district formed a health committee headed by a person born 
in that specific district. The intermediate level trained the committees, provided 
them with drugs and equipments with which to deliver services to their 
community. Religious missions continued to complement the system as usual. 
The PHC model operated in parallel with confectioners and traditional healers, 
enabling the government to deliver its promise of free healthcare until 1990. 
High economic growth rates in the 19705 and early 19085 supported a rapid 
expansion of the network of health structures enabled the state to sustain a 
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strengthened PHC system (Ako et aI., 2006), until the eeononiic crisis in the 
late 1980s began to expose its structural weaknesses. 
Instead of dealing with the many determinants of health (as defined at Alma 
Ata) , the PHC consisted of an assortment of vertical programmes (a 
combination of parallel medical centres supported by missionaries and former 
colonial masters). The overlapping nature of treatment programmes, the crisis· 
ridden infrastructural capacity and poverty·ridden communities meant that the 
overall system could not be sustained. Community health activities were 
completely halted in 30% of 1913 villages surveyed between 1982 and 1988 
(Essomba et al., 2003). Other constraints included the lack of in·service 
training for over 50% of community health workers by mid·1980s; one district 
supervisor per ten health villages; one community health worker per 1323 
people; rising population growth, increased disease burden and falling 
government spending on health (Ofeh and Njong, 2006). 
The evidence above serve to demonstrate ultimately, that resource constraints 
were a critical factor that led to the severe drug shortages and closures of 
pharmacies in the late 1980s and 1990s. Resource constraints also exposed the 
poor governance mechanism in place for dealing with the effects of the 
financial crisis in the health sector. These constraints meant that, instead of 
addressing these country·specific challenges the government turned once again 
to the WHOIUNICEF for a revised PHC model. The processes involved in 
adopting and implementing variants of the PHC in shaping policy practices in 
Cameroon are discussed below. 
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5.4.4 The Reorientation of Primary Healthcare 
At a WHOIUNICEF·led conference on the progress of the PHC in Africa 
(1985 Lusaka Conference), it was concluded that drug financing and the rising 
pandemic of certain diseases' (TB, Malaria, Cholera and Meningitis) caused 
the PHC to fail. An economistic narrative, specifically, the economic crisis and 
structural inefficiencies was identified as the prime cause of the PHC being 
overwhelmed (Ntangsi, 1998; Essomba et al., 1993). Drug financing and the 
rising pandemic of certain diseases such as TB, Malaria, Cholera and 
Meningitis), it was argued, was making it difficult for the PHC to function 
effectively. This broad economistic narrative is consistent with that put forward 
by both the government of Cameroon and the World Bank (Ntangsi, 1998; 
Essomba et al., 1993; World Bank, 1989). 
At a follow up WHOIUNICEF·led conference (the 1987 Bamako Initiative) the 
PHC was revised into the Reorientation of primary health care (PHC·RO) with 
an emphasis on partnerships between the state and the community to co-
finance and co·manage healthcare delivery. It was effectively implemented in 
Cameroon from 1990 (Table 7 and Figure 4 below). Dialogue structures within 
the different administrative and operational structures were created in 
Cameroon to encourage participation of both the State and the community 
(Ngufor, 1999). The PHC·RO model was therefore aimed at eroding the 
excessive centrality of policy making within the structures of the Ministry of 
Public Health to encouraging public and private partnerships with local 
communities and private sectors. 
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Table 7. The structure of the National Public Health System in Cameroon 
Level Administrativ Role Operational Levc 
e Structures Structures 
Central Minister's Conccptualise and Reference and 1'1 
Cabinet. develop policies General hospitals 
Secretariat & and strategies Central and 2nd 
Directorates University 
hospitals 
Inter - Provincial Technical support 3,d 
mediate Delegations for to programmes Provincial 
Public Health hospitals 
Peripheral Health Districts Operationalise and District hospitals 4th 
& Health Areas implement primary Sub-divisional Slh 
health care hospitals 
Integrated health 6th 
centres 
Source: Ngufor (1999) .. Essomba et al (2003) 
The delivery of phannaceutical products followed a similar vertical and 
decentralized hierarchy. The importation and distribution of drugs by the state 
monopoly (the National Phannaceutical Corporation) in the 1970s and 1980s 
became subject to competition. Each of the levels described above has a 
pharmacy section that followed the same vertical administrative and 
operational hierarchy. 
The structural pattern of the PHC·RO (Figure 4) was meant to ensure that cost-
effectiveness and equity are given crucial importance in the delivery of 
healthcare and pharmaceuticals. By exposing the national health system to civil 
society and private sector participation the PHC·RO model eroded the 
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excessive centrality of policy making within the structures of the Ministry of 
Public Health to encouraging public and private partnerships at local levels. 
Figure 4. The vertical and pluralistic Primary IIealthcare System 
4 Central Level . 
Confectioners ! '\ ~ : : : = = ~ _ ~ ~ ~__ -.... ~ M u l t i l a t e r a l l D e v e l o p m e n t t Agencies (Religious :: _ ~ P h a r m a c e u t i c a l l and related trade 
Providers) "Inter ediate International NGOs and Foundations 
! 
Source: Author IS construction based on published documents 
The fact that the implementation of the PHC-RO paralleled the implementation 
of the SAPs was very significant in attempting to achieve the objectives of 
PHC-RO. The PHC-RO required the state and the community to work in 
partnership to co:finance and co-manage pharmaceutical and healthcare 
delivery while the World Bank introduced a 'cost recovery' free market system 
that promoted fee-for-service practices in both public and private sectors 
(Litvack and Bodart, 1993). The governrilent passed a decree in 1990 
authorizing the sale of medicines and the management of drug supply at the 
peripheral level between local public hospitals and pharmacies and local 
communities (Essomba et aI., 2003). 
The centrality of decision making on health care delivery around the Ministry 
of Health began to weaken as the national health system became vertical and 
decentraliscd, with multiple sources of public, private and religious healthcare 
and funding providers (Figure 4 above). The importation and distribution of 
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drugs that was a state monopoly became subject to competition, as foreign 
pharmaceutical companies could now benefit from the market mechanism 
created by the SAPs to supply drugs through private channels. Cameroon is 
often cited as a success story of the introduction of user fees in the health 
sector in Sub-Saharan Africa. An article published in the Dulletin of the WHO 
(Ridde, 2003:533) stated as follows: 
'To date, there have been only two reports that introduction of fees-for-
services had a positive impact on service utilization. The first, in 
Cameroon, showed that with an improvement in the quality of care, 
introduction of such fees went hand-in-hand with an increase in service 
utilization, with the increase being proportionally larger for the poor 
rather than the rich. 
The market-oriented healthcare system allowed individuals to choose the level 
within the national health system to consult when they are sick (wealthy 
patients could afford to travel longer distances to seek higher quality treatment 
at the provincial and central hospitals). Defending this approach, the WHO 
(2002) argued that, compared with public health services, private units are a 
valuable resource, located close to, and often trusted by the community despite 
the huge financial burden and prescription mismatch that is often a 
characteristic of their activities. By 1996 there were about 200 completely 
private, 179 Catholic, 122 Protestant healthcare providers, competing with 
thousands of traditional healers in Cameroon (Ntangsi, 1998). 
By the mid-1990s, 2% of health care providers were private-for-profit, while 
38% were non-profit (confectioner, NOOs and traditional rulers) with the 
public sector accounting for the rest (Ngufor, 1999). In 1996 there were about 
200 completely private, 179 Catholic, 122 Protestant healthcare providers, and 
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thousands of traditional healers in Cameroon (Ntangsi, 1998). Ngufor (1999) 
describes this system as evidence of public-private cooperation. First, private 
non-profit health facilities such as NGOs are increasingly being given 
responsibility to ensure health coverage for the population in their constituent 
health districts in contractual arrangements with the government. Second, 
personnel of both public and private sectors work together in district health 
teams to ensure supervision of the health centre and other services and to train 
and retrain the local staff within the principle of continuing professional 
training. 
5.4.5 The Reproductive Health System - PHC-R 
In 1995, the PHC-RO was revised by the WHOIUNICEF to Reproductive 
Health Care System (PHC-R) in order to better incorporate the cost-recovery 
programme introduced by the IMF/World Bank to address the effects of the 
failed SAPs. The vertical and decentralized structure of the PHC-RO is 
retained, the only difference being that, PHC-R is the current health system of 
Cameroon. It further stresses the need for partnerships between the public, 
private and civil society sectors in ways that give priority over policy 
implementation to civil society groups (Ghogomu, et al 2000). The main 
objective of PHC-R was to better respond to more specific public health 
challenges such as infant maternal mortality, birth control, teenage pregnancy, 
family planning and human resources (Ako et aI., 2006). Unsurprisingly, it 
paralleled the publication of the World Bank's (1996) 'Participation 
Sourcebook' in which the local community is at the forefront of policy 
implementation. This led to the creation of more specific departments within 
the Ministry of Health (e.g. Directorate of Community Medicine and Division 
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of Mother and Mental Health) as well as specific programmes and activitics 
(e.g. Medico·Social Centres for Preventionffreatment of STDs; Mother and 
Child Care Centres; High Risk Clinics for Pregnant Women) in different 
regions of the country. 
Nevertheless, privatisation and liberalization policies that resulted from the 
neo·liberal market model meant that these new programmes paralleled rather 
than complimented the diverse private health units that were already emerging 
in the country. Thus the interaction among parallel models (variants of 
WHO/UNICEF-Ied PHC and IMFlWorld Bank-led market models) meant that 
from the 1990s, the national health system of Cameroon became fragmented 
with public, private and religious health units and pharmacies competing with 
each other. 
Particularly significant from the mid-1990s is the emergence of local 
community groups (NOOs) as key partners in health development. Local 
groups are capable of ensuring health coverage for the population in rural 
districts in contractual arrangements with the government. Personnel of both 
public and private sectors work together in district health teams to ensure 
supervision of the health centre and other services in the area and to train and 
retrain the local staff within the principle of continuing professional training. 
These processes are animated by the interaction of elements of the public 
health and economic development models discussed earlier. These interactions, 
which too place among international, national and local partners, provided the 
platform in which OHP programmes emerged in Cameroon. 
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5.5 The Emergence of GHPs in Cameroon 
The discussions above suggest that by the time GHPs began tq emerge at a 
global level Cameroon was suffering from many structural and policy 
problems, the consequences of which include unequal and insufficient access 
to medication in the face of rising incidence and burden of diseases such as 
HIV I AIDS, malaria and TB. The effectiveness of a GHP in Cameroon would 
therefore depend on the extent to which these key issues are embodied in the 
strategic functions of GHPs - financing, advocacy, R&D and technical 
assistance in meeting global and national health targets (Caines et al., 2004). 
This section summarises the barriers to access to medication that ultimately led 
Cameroon to endorse GHPs. 
5.5.1 Barriers to Access to Medication 
The institutional structures of variants of the PHC model in Cameroon appear 
rigorous and complete. However, apart from the fundamental question of lack 
of funding, several problems persistently hindered sustainable and effective 
functioning. There were frequent shortages of health professionals and medical 
supplies. An oversupply of qualified staff had to work with an undersupply of 
infrastructure, equipment and drugs, or the other way round. A very low 
doctor-patient ratio of 1 :400 was made worse by a large rural-urban 
differential, limited training and low pay for qualified health workers (WHO, 
2002:4). Low salaries and allowances for an overstretched health personnel 
increased absent rates and severely hindered commitment at work in hospitals 
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and pharmacies (Ngufor, 1999). These arc major barriers to both potential ahd 
actual access to medication. 
Potential access to medication was also hindered by regulatory and 
implementation problems. Public health authorities persistently failed to 
implement key regulations and laws meant to strengthen the health system and 
promote healthcare delivery (Ako et aI., 2006). Poor regulation in tum allowed 
public health workers to resort to unfair practices (offering under-the-counter 
consultations, prescriptions and sales of medicines) which in tum increased the 
demand for private health units and traditional medicine. Ntangsi (1998) 
illustrates how 14.8% of patients consulted traditional healers while within 
modern health units; public hospital consulted 43.8% as against 56.2% in 
private units (despite the latter charging 50% higher than the former). These 
problems are related to the outcome of the SAPs described earlier. 
In many ways the liberal and then neo-liberal models of development had a 
negative effect on access to medication due to the economic crisis. The cost of 
drug procurement and local distribution increased persistently, limiting actual 
access to medication (JSI, 1991). Neo-Iiberal market models that were meant to 
deal with the crisis exacerbated the problem, by exposing the PHe model to a 
mixed competition, one that proved difficult for authorities to regulate. A 
German-Cameroon programme created to import and distributes medicines at 
cost-recovery rate with funding from the German Development Agency 
(Ngufor, 1999) was competing with the formerly monopoly drug system in the 
MoH, while several private firms also began to operate pharmacies. The 
205 
ineffectiveness of public health services and high prices for phannaceutical and 
healthcare delivery following the crisis and increased the popularity of 
traditional mcdicine despite the fact that incorporating traditional practices into 
public health policy has never been seriously considered by Cameroonian 
authorities (MoH, 2002). 
As discussed earlier, neo-liberal market models (SAPs) either created new 
governance gaps in Cameroon or worsened existing ones. Privatization and 
liberalization opened pharmaceutical and healthcare delivery to competition 
thereby eroding the centralised drug procurement system under the MoH 
instead of correcting its weaknesses. Ntangsi (1998) relates the high cost of 
drugs in Cameroon in the 1990s to major inefficiencies in the drug 
procurement system caused by complicated administrative procedures and a 
lack of transparency. Basco (2004) reports large scale diffusion and sales of 
anti malaria medicines through private fonnal and infonnal sectors that did not 
comply with quality requirements, but which were in high demand due to 
heavy disease burden. These problems are similar to those in other sectors of 
the economy mentioned earlier in this chapter. They represent the outcome of 
rent-seeking behaviour (corruption, inequality, black markets, drug trafficking 
and under-the-counter prescriptions) that resulted from implementing the neo-
liberal free market reforms created but unregulated by the IMF and the World 
Bank under the SAPs (Baye, 2003; Mbaku, 2004). 
As already mentioned, multilateral and development agencies attributed 
Cameroon's problems (such as those in the health sector described above) to 
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government failures and began to bypass the government and work with NGDs 
and community organizations as a means of filling the above governance gaps. 
Such a defensive tactic is generally described as foreign policy diplomacy as 
both development agencies and national government remain on the defensive 
when it comes to responsibility for international policy failures (Muraskin, 
1998). In this case, for GHPs to claim success in achieving potential access to 
medication, the GHP model must also be able to achieve both the objective of 
correcting governance gaps by reconciling the in-fighting among global, 
national and local actors in global health. 
5.5.2 GHP as Facilitators of Access to Medication In 
Cameroon 
The discussions so far suggest that the role of international organizations in 
facilitating access to medication in Cameroon is not new, with some form of 
intervention being commonplace since independence. However, unlike the 
technical assistance and specific policy interventions emphasised by the 
economic and public health development models up to the early 19905, such 
organisations no longer intervene unilaterally. They now intervene through the 
agency of GHPs. The emergence of GHPs in Cameroon can be attributed to the 
unintended negative consequences (or failures) of traditional development 
models in creating a national health system capable of providing access to 
medication on a sustainable basis. The strategic objectives of GHPs, namely, 
financing, advocacy, R&D for drug development, health care delivery and 
technical assistance (Caines et at, 2004) suggest that such a country-specific 
system is needed. 
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Nevertheless, multilateral and bilateral agencies have always been on the 
defensive when it comes to the failure of policy measures resulting from the 
development models they deployed in Africa. The WHO (2002:4) points to 
human resources and infrastructural problems rather than the rubostness of 
versions of the PHC model. Similarly, the failure of the SAPs in creating an 
effective healthcare market is seen by the IMF and World Bank as government 
failures, pointing to regulatory and governance constraints (World Bank, 
2000). Instead of correcting these weaknesses, these agencies began to 
undermine the structures of the Ministry of Health by aloting more power to 
local CSOs. 
The creation of GHP programmes from the later 1990s was meant partly to 
resolve the type of blame game and overlapping interventions noted above by 
ensuring the participation of global, national and local stakeholders in shaping 
health policy practices (Ngoasong, 2009). It meant that multilateral and 
bilateral agencies as well as their associated private and international civil 
society partners would now intervene through the agency of GHPs. This 
rowing back of direct action allowed the government of Cameroon to resume 
its role as a major actor without the type of absolute power it had before the 
1990s. This change in the government's position was precipitated by the major 
event of debt relief (HIPIC), while the contiguous development of GHPs 
creatcd a window of opportunity for an alternative form of engagement and 
intervcntion for all stakeholders at global, national and local levels. 
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The Debt Relief Program in Cameroon came into place in mid-2000, making 
available $86 million per year of new government expenditure until 2015 for 
poverty alleviation. $32 million were to be allocated to the health sector in the 
first three years (MoH, 2000). These funds were for HIV/AIDS, malaria, 
immunization, TB, essentials drugs, health staff, and health sector 
strengthening. Prior to the debt relief, Cameroon was one of the most highly 
indebted and corrupt countries in the world. In a multi-country study assessing 
the design and application of the medium-tenn expenditure framework as a 
tool for poverty reduction, Carlier and Jennes (2003:5) describe the extent of 
corruption in Cameroon as follows: 'First, first, seventh, fifth: these arc the 
positions Cameroon has occupied between 1998-2001 on the list of Corruption 
Perception Indices published by Transparency International.' 
Unsurprisingly, therefore, the World Bank and the IMF made debt relief 
programme conditional on anti-corruption efforts and other good governance 
initiatives. As described in (Kabemba, 2003), the government pledged to 
strengthen budgetary execution and service delivery through anticorruption 
measures. These measures were to be implemented by special anti-corruption 
units that that had already been established in ten government ministries. The 
government also pledged to increase the number of police and customs officers 
to combat import-export malpractices. The community participation model was 
also important in the debt relief agreement in the sense that local CSOs were 
appointed to provide monitoring reports to the government of Cameroon, as 
well as to the EU, World Bank, and other international donor agencies. The 
HIPIC programme therefore created a window of opportunity to stimulate 
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political commitment in the fight against the rising disease pandemics such as 
malaria, IIIV / AIDS and tuberculosis. 
The debt relief programme in Cameroon came at a time when numerous GHPs 
were being signed to facilitate access to medication in developing countries, 
especially those in Africa. The GHP model is therefore meant to promote a 
new kind of PPP in Cameroon to replace previously failed 
individual/community models emphasised by bilateral (e.g. France and 
Germany) and multilateral (UN-based agencies) initiatives. Crucially, they are 
supposed to be led by the Ministry of Health, not external actors. They are 
meant to develop comprehensive healthcare programmes to facilitate access to 
medication and strengthen the national health system (WHO, 2005a; 
UNAIDS/WHO, 2002). 
GHPs have transformed the vertical and pluralistic PHC system into a hybrid 
network that is no longer directly controlled by the Ministry of Health. Each 
programme is under the control of a National Disease Control Committee 
structured as in figure 5. Being partners to many GHPs, development agencies 
(such Germany, France, USA, Britain and the EU) immediately realigned their 
bilateral relations with Cameroon in terms of both the Debt Relief programme 
and the strategic orientation of specific GHPs. 
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Figure 5. Structure of National Gil., l'rogrammes 
Superior Council for Health 
t 
Ministry of 
Public Health 
National L . s ~ ~
S u p p o r t i n g ~ ~ Control C o m i i t t c e ~ ~
Ministries t ~ C e n t r a l l Technical Gro' 
A. Technical Services 
B. Medical Experts 
C. Provincial Coordinators 
Source: Constructed based on NSPA (2000a/" 
Local Partners 
A. NGOs & Associations 
B. Confessionals 
C. Private Firms 
D. Contractors/Consultants 
The national structure in figure 5 was created for HIV / AIDS, malaria and 
tuberculosis, being priority diseases in terms of burden, impact and challenges 
for treatment and controlling at global, national and local levels. Each 
programme is based on guidelines provided by specific GHP models (Table 8) 
and exists in parallel with each other as well as with the PHC-R described 
above. Each programme has a National Disease Control Committee comprising 
representatives from public, private and civil sectors at global, national and 
local levels. Thus, any constraints within the PHC-R model would have limited 
impact on the effectiveness of national GHP programmes. This also facilitates 
the identification of policy constraints for each of IIIV / AIDS, malaria and TB 
independently of PHC-R, thereby making it easier to address them. In this 
context, and in relation to the framework developed in chapter two, policy 
54 NSPA (2000a) Plan StraMgique de Lutte contre Ie SIDA au Cameroun 2000·200S: Rapport 
du Groupe Technique Central du Programme National de Lutte contre Ie SIDA au Cameroun 
Resume disponible, Moll. (National Strategic Plan for the fight against IIlV/AIDS in 
Cameroon 2000·200S). 
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constraints includes the extent to which GHP models relate to country-specific 
contexts (global-national context), while implementation constraints deal with 
barriers to access to medication at community and household levels (global-
national-local contexts). 
Table 8. Key GHP Programmes in Cameroon 
Global Health Strategic Objective National 
Partnership Programme 
Accelerating Access To make HIV/AIDS drugs more affordable National 
Initiative (2000) & and accessible and to improve technical HIV/AIDS 
Equitable Access collaboration in the development of national Programme 
Initiative (2001) programme capacity to deliver care, 
treatment and support55 
Roll Back Malaria Reduce malaria mortality by 60% through National 
(1998) health system strengthening and strategic Malaria 
malaria treatment and control toolsS6 Programme 
Stop TB Partnership To diagnose 70% of all people with National TB 
(2000) infectious TB and to cure 85% of those Programme 
diagnosed 57. 
Source: Own analysis of policy documents and technical reports. 
The national committee is in charge of policy making. Political leadership is 
provided through a Superior Council for Health headed by the Prime Minister. 
The former colonial masters (such as France and Germany) have realigned 
their development projects in Cameroon as global partners to GHP 
programmes. Other global partners such as the WHO, UNICEF, UNDP 
provide technical assistance to the committee to help define strategic objectives 
of treatment and control programmes. Funding is provided by the World Bank, 
55 UNAlDS/WHO (2002a:4). 
56 Roll Dack Malaria Partnership <httpllwww.rollbackmalaria.org> (Accessed: 02/02/09). 
57 The Stop TD Partnership <http://www.stoptb.orgistop_tbJnitiative> (Accessed: 02/02/09) 
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Global Fund and bilateral development agencies. These global partners then 
link the national programme to phannaceutical companies to negotiate drug 
prices and supply arrangements. International CSOs (e.g. Medecin Sans 
Frontiers, Care International, Plan International, etc) participate in the area of 
advocacy for continued funding, political commitment and local service 
delivery. 
The agency in charge of drug procurement and local distribution is the National 
Drug Procurement Centre, an autonomous institution within the Ministry of 
Health. Supporting ministries also play an active role in specific areas. For 
example the Ministry of Finance releases funds for the purchase of drugs and 
to finance programmes and activities. The Ministry of Social Affairs is active 
in advocacy and community mobilization. The Central Technical Group 
provides the interface between policy making and policy implementation. 
Consisting of technical and medical experts as well as provincial coordinators, 
it ensures that plans agreed by the national committee are implemented by the 
local partners. The local partners consist of specialised treatment centres in 
urban and rural areas, in line with the pluralistic pharmaceutical and healthcare 
delivery system in the country. 
The National HIV / AIDS Programme and the National Malaria Programme 
have been selected as empirical case studies for this research. Global policies 
are transferred through 'policy loops' (Walt et aI., 2004) involving transcalar 
networks of local, national and international partners who support medical 
intervention in addition to their own strategic objectives. Medicines for 
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HIV / AIDS are now free of charge and the average Cameroonian is aware of 
the existence, impact and burden of IIIV/AIDS as well as the availability of 
treatment. As early as 2002, Cameroon was being credited for having achieved 
both 'Accelerating Access' (UNAIDS/WHO, 2002) and 'Equitable Access' 
(MSF, 2002). On the other hand, the RBM has significantly increased the use 
of malaria medicines (ACTs and ITNs) in Cameroon through what the 
initiators of the programmes term 'health system strengthening', even though 
all of the ambitious policy goals have yet to be achieved. 58 These outcomes 
represent evidence that treatment programmes get to 'hard-to-reach' 
communities. 
Nevertheless, the incentive to govern in favour of public interest by using 
transcalar networks in which community organizations play an active role in 
implementation (bypassing the state) appears to manifest as corruption in 
Cameroon. Senior government authorities are being linked to apparent 
mismanagement of funds allocated to the malaria and HIV/AIDS programmes 
(Bidjocka, 2008). Corruption also hinders the successful distribution of ACTs 
and ITNs through pilferage and black marketing by clinical doctors and 
pharmacies. 59 The huge flow of donor funding in the presence of high levels of 
corruption obviously increases the possibility for local policy resistance which 
in tum hinders policy implementation. 
,. Successive editions of technical reports of the national HIV/AIDS and malaria programmes 
respectively report how pre-stated targets are far from being achieved. e.g. NACC (2008) 
Cameroon: Mise en Oeuvre de la Declaration D'engagement sur Ie VIHISID, Rapport De 
Progress No. J. (National AIDS Control Committee), Cameroon; NMCP (2008) National 
Multisectoral Programme/or the Fight Against Malaria, Cameroon. 
'9 Nsom, K. (2008) 'Cameroon: Corruption Hinders Distribution of Subsidized Malaria Drugs' 
The Post Online, 22/02/08 <http://allafrica.com/storiesl200802221214.html> (Accessed: 
28/05/08); Lipset, S.M. (2000) 'Corruption, Culture, and Markets,' Culture Matters: 113-124. 
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Clearly, not all the evidence points to the success of these GlIPs. Since the 
launching of GHPs for HIV/AIDS and malaria at the global level, and the 
creation of corresponding national programmes and activities at national and 
local levels, the incidence and burden of both diseases has continuously 
increased in Cameroon. This has been associated to a combination factors -
unemployment, denial, stigma, poverty, high transmission among youth and 
lack of sex education and polygamy6o. The approach of the national HIV/AIDS 
programme has been criticised for doing little to emphasise behavioural 
changes a vital public health element in the fight against diseases61 • Thcre arc 
reports of frequent shortage of subsidised ITNs and ACTs in public and private 
health units, huge price differentials for coartcm (costing tcn times as much in 
private phannacies), failure of people to seek treatment when attackcd by 
malaria and the evidence that many rural communities still consume 
chloroquine, long declared ineffective and inappropriate by the WHO in the 
mid 1 9 9 0 s 6 ~ . . These evidence points to the need for empirical studies to better 
understand the role of GHPs on access to medication in Cameroon. 
5.6 Discussions and Conclusions 
This chapter has explored the national perspective on the emergence of GHPs 
in Cameroon. It highlights two key issues that make the study of GHPs as 
60 Mosoko, J.J. and Affana O.A.N (2004) 'PREVALENCE DU VIII ET FACTEURS 
ASSOCIES (Prevalence ofHIV/AlDS and Associated Factors)' In DIIS Final Reports: 
Cameroon, Demographic and Health Survey, USAID, Chapter 16: 293-314 
<http://www.measuredhs.comJpubs/pdflFRI63/16chapitre 16. pdt> (Accessed: 25105108) 
61 Njechu, C.J. (2008) 'Scientists Condemn NACC Communication Strategy' The Post Online, 
17/0 112008 <http://www.postnewsline.coml2008/0Ilscientists-cond.html> (Accessed: 
25105108). 
62 Tchenga, M.K. (2008) 'Queen Mosquito: Strides have been made in the fight against the 
eradication of malaria but the disease's victor, the female Anopheles mosquito, still rules parts 
of the world' The Post Online: <http://www.postnewsmagazine.comlpageslhealth06.html> 
(Accessed: 1516/08). 
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models that shape national and local policies all the more interesting. First it 
reveals that the role of GHPs in influencing national health policies and local 
delivery practices is a complex one, mainly due to the multiple global, national 
and local partners involved and the interwoven nature of the links among them. 
Secondly, it suggests that even if GHPs may be succeeding in shaping national 
policies to reflect the global activism on universal access to medication 
discussed in chapter four, the impact on access to medication (as expected by 
various GHPs) is far from being realised. Apart from these two key issues, this 
chapter also reveals specific insights on some of the issues that need to be 
considered when studying the role of GHPs in shaping access to medication in 
a country such as Cameroon. 
The first specific insight raised by the analysis in this chapter is that the 
concept of multi-stakeholder partnership embodied in GHP models is not new 
to Cameroon. What seems to have changed over history is the nature of 
stakeholder participation. In the colonial era, apart from the political arena 
where the Germans (and later the French) preferred absolute control over 
political matters, there was substantial evidence of partnerships. Even when the 
Germans served as colonial master, their medical team collaborated with those 
of France under Eugene Jamot to eradicate sleeping sickness. In the interwar 
years, both the British and the French gave the Germans greater autonomy 
(despite losing the war) over the development of an expanding agricultural 
economy and its associated railway infrastructure. Similar partnerships were 
forged with Christian missionaries to better serve rural communities, especially 
in healthcare delivery and the transformation of traditional values into 
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acceptance of western ways. These strategic forms of participation have been 
an inherent part of historical developments in Cameroon. 
However, the nature of foreign participation became indirect after 
independence. With apparent state autonomy, former colonial masters and 
Christian missions began to operate in partnership with the state and through 
their influence in international organizations. The international dimension 
placed enormous pressure on the state, prevented it from acting autonomously 
and created governance gaps in the system, now labelled in development 
studies literature as government (rather than interventionary) failures. An 
interesting feature is the emergence of civil society participation in the 1990s 
as an important part of the solution to addressing governance challenges. This 
leads to what is novel about GHP models. For the first time, all these actors, 
with competing economistic, public health and human rights narratives sit 
around the same table to formulate and implement policy. This new kind of 
participation gives absolute political control to no single stakeholder, not even 
the state. It obviously blurs the North-South divide due to its complex nature. It 
would be interesting to study specific GHP programmes in Cameroon to 
uncover the nature of this kind of hybrid network, the type of knowledge that 
each stakeholder brings and how the combination of these help shape 
difference aspects of policy and local practices. 
The second specific insight from this chapter concerns national health system 
functioning. The modern functions of the national health system in Cameroon 
are rooted in the WHOIUNICEF-led PHC model that emphasised a 
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combination of behavioural and change models at the individual, interpersonal 
and community levels. Developments in the PHC model paralleled, rather than 
complemented developments in IMF/World Bank-led neo-liberal free market 
models. Unsurprisingly, therefore, neo-liberal market models transformed the 
PHC model from a state-centred vertical and centralised system (1980-1990) to 
a fragmented vertical and decentralised system with public and private 
providers (since 1990). The nature of a national GHP programme is assumed in 
terms of specific disease areas rather than its effects on such a fragmented 
system. Since the mid·1990s 'decentralization', 'deconcentration', 
'devolution', 'privatization', 'contracting out', 'public-private partnership' are 
used interchangeably to describe both the national health system (PHC model) 
and GHP programmes. The role of each GHP model needs to be studied in 
terms of how they shape national policy and local practices both for their 
targeted disease area and the wider PHC system as a whole. The National RBM 
Programme fits this context. The RBM explicitly focuses on improving malaria 
outcomes through health system strengthening. Empirical evidence is needed 
on the extent to which this can be achieved. 
The third issue arising from the discussions in this chapter relates to the 
embodiment of development models (as narrative strategies) within GHPs. It is 
particularly interesting to note that most policy documents (even those 
published by the WHO) are dominated by the economistic narrative (which 
drugs are most suitable, prices and supply arrangements and systems issues) 
with very specific and explicit mention of the relevance of medical 
interventions. Implicitly, the emphasis has shifted from selective identification 
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and treatment/prevention of diseases (the colonial era and independent era) to a 
broad and comprehensive PHC approach that emphasises both preventive and 
curative measures (1978 to mid-1990s). More recently (the G liP era), there has 
been an increasing emphasis on the medical model (access to medicines) as 
against non-medical interventions (prevention strategies). 
Thus, the role of each GHP in shaping this narrative at the nationallevcl needs 
to be studied empirically to uncover the practical steps used to determine 'drug 
prices and supply arrangements. The extent to which GHP programmes and 
activities target barriers to access to medication also needs to be examined. A 
comparative study of the national malaria and lIlV / AIDS programmes 
respectively would be interesting from this perspective. Both programmes are 
similar in terms of types of stakeholders, institutional affiliations and 
governance arrangements. However, they differ from each other in terms of 
disease area and strategic orientations, differences that provide for a nuanced 
analysis on the country-specific impact of GlIP models on access to 
medication. The GHP models used to create the programmes explicitly aim to 
achieve 'universal access' (UNAIDS-Ied Accelerating Access Initiative) and 
'equitable access' (MSF-Ied Equitable Access Initiative) to medication through 
health systems strengthening (WHOIUNICEF-led Roll Back Malaria). 
Finally, the choice of Cameroon as country case study is also very instructive. 
Its history is dominated by the influence of the major western countries and 
international organizations that initiated the creation of GIIPs (Cameroon is 
always one of the first countries to endorse them). Cameroon is also among the 
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African countries that has been deeply politicised at international and global 
levels using contrasting and contradictory narratives. Examples of such 
narratives discussed in this chapter include 'a model of political stability in the 
developing world', 'self sufficient in food production', 'a failed state', 'among 
the twenty safest in the world for foreign investments', 'a global success story 
in the fight against HIV/AIDS', 'one of the poorest country in the world', 
'most corrupt country in the world'. These qualitative classifications and 
qualifications illustrate the importance Cameroonian authorities attach to 
internationaVglobal networks and the politicisation of Cameroon at a global 
level. A study of the nature of the networks created by GHPs in Cameroon 
would therefore contribute to our understanding of the country-specific impact 
of GHP models on access to medication in Africa countries. 
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CHAPTER 6: GHPs AND ACCESS TO 
MEDICATION FOR MALARIA TREATMENT AND 
CONTROL 
6.1 Introduction 
The objective of this chapter is to describe the structure and operations of the 
National Malaria Programme in Cameroon as an example of how GHP models 
shape national policy and local practices. It argues that it is the ways in which 
development models embodied within RBM partnership are expressed in 
Cameroon through the different programmes and activities that determine how 
national malaria policies are formulated and implemented. The National RBM 
Programme of Cameroon was launched in July 2002, about two years after the 
Cameroon government endorsed the global RBM. The fundamental goal of the 
RBM is to strengthen the national health system's capacity to deliver improved 
malaria treatment and control through PPPs at global, regional and national 
levels. Global partners affiliated with the partnership arc members of 
Cameroon's national programme. Apart from technical reports and policy 
documents, there are to date no empirical studies on the role of the RBM in 
determining national policy and local practices on access to medication in 
Cameroon. Thus in addition to being the first in-depth case study on the role of 
the RBM, this chapter also discusses the relevance of the conceptual 
framework developed in chapter two in explaining this role through an 
empirically grounded analysis. 
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OUPs such as RBM are hybrid networks in which elements of public health, 
economistic and human rights models are negotiated to produce a OHP model 
on access to medication for malaria treatment and control. Such negotiations 
represent expressions of forms of knowledge. At the global level, the narrative 
strategies of certain OHP partners are influenced by the narratives (forms of 
knowledge) of other partners and they are connected to organizational actors 
who initiated the narratives. At the national and local levels, the narratives tend 
to be dominated by particular transcalar networks of public, private and civil 
society actors. This chapter explores the practical issues about what this means 
in terms of malaria treatment and control in Cameroon through the RBM. It 
highlights instances where the economistic, public health and human rights 
elements of the RBM model are at their strongest and the contexts in which 
they are less relevant. It then relates this to global-local linkages in terms of 
what the RBM claims to do and what it actually does; and what is needed for 
the National Malaria Programme in Cameroon to achieve its objectives on a 
sustainable basis. 
The empirical analysis is informed by data from policy documents and 
technical reports complemented by qualitative interviews with representatives 
from global, national and local levels directly or indirectly involved in the 
national RBM of Cameroon. A social constructivist approach, namely, NPA 
has been used to analyse the interviews. All the interviewees recognised that 
the daunting task of RBM is to set up a coordinated initiative that reaches out 
to all the different stakeholders at the country level, taking into account 
differing partners' strategic interests and challenges relating to coordination 
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mechanisms, monitoring and evaluation. After presenting the historical and 
political context of the fight against malaria in Cameroon this chapter describes 
the strategic objectives, structure and operational orientation of the programme. 
It then explores how different elements of the global ROM model shape policy 
and local practices in Cameroon, using specific programmes and activities at 
national and local levels. The challenges facing the RDM in combating malaria 
in countries like Cameroon are then explored. The conclusion discusses the 
implications of the findings for the prospects of the RBM model in Cameroon. 
6.2 Historicity and Political Context of RBM in Cameroon 
Malaria has been a major societal problem in Cameroon's history and is 
currently endemic in most parts of Cameroonian society. Historically, malaria 
is the leading cause of mortality in the country particularly targeting pregnant 
women and children less than five years of age (WHO, 2004b).63 However, this 
does not undermine continued political commitment, as the government has 
always set a national malaria strategy to be an active player in the global fight 
against malaria. The strategy of the government has been the adoption of 
international development models and advocating health policy reforms that 
requires the mobilization of support from a wide range of international and 
national partners to deal with the country-specific challenges associated with 
malaria treatment and control. 
63 For the full history of events leading to the creation of the national programme see the 
website of the national malaria programme: <http://www.pnlpcameroon.org!> (Accessed: 
23/06/08) 
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As Sub-Saharan Africa was excluded from the first ever WHO-led Malaria 
Eradication Program (MEP) in the late 1950s, having been declared 'not ready' 
by international decision makers, the fight against the disease in Cameroon was 
conducted unilaterally by the government as a part of the national health 
system (Greenwood and Mutabingwa, 2002; REM, 2002). In the late 1960s 
and 1970s the WHO sponsored bilateral vector control projects in Cameroon, 
but these were largely ineffective at country levels (WHO, 1988). During the 
resurgence of the malaria epidemic in the late 1970s and early 1980s malaria 
programs were incorporated as an inherent part of the national health system 
based on the PHC model. The behavioural element embodied within the model 
meant that the curriculum of educational establishments included hygiene and 
sanitation (that every pupil was expected to study) - techniques of malaria 
prevention, avoiding mosquito bites, responding to symptoms relating to 
malaria in seeking treatment (WHO, 1988). 
Despite the above efforts, the incidence and burden of the disease continued to 
increase in the 1980s. The causes include a combination of issues such as the 
effectiveness of behavioural models (socioeconomic determinants of health 
along with broad-based improvements in medical care), the apparent failure of 
the medical model (insecticide resistance of mosquitoes and resistance to drugs 
by the parasites) and systems issues (administrative challenges in consolidating 
case-finding programs and generally weak health services) (WHO, 1988; MoH, 
2002). In relation to the consequences of the 1987 economic crisis discussed in 
Chapter Five, the WHOIUNICEF-led public health model (PHC-RO) and the 
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IMF/World Bank-led economistic model (e.g SAPs) were meant to solve these 
types of challenges. 
The PHC·RO model had already begun to shift the emphasis on the broad PIIC 
to a narrow focus on the medical model. For example, in the early 19905 when 
the WHO began to promote the use of anti-malarial drugs that were believed 
internationally to be more effective than previous one (WHO, 1994; 1996; 
2003a), Cameroon was one of the first developing countries to adopt them. 
Similarly to the WHO's narrative, the government identified drug resistance 
and the severe health and socio-economie consequences of malaria as the 
major policy challenges (WHO, 2004b; NMCP, 200264). The introduction of 
user fees within the national health system as part of SAPs meant that malaria 
treatment was now opened to competition from private and religious healthcare 
and phannacy providers. 
In 1992 the government endorsed the WHO-led Global Malaria Control 
Strategy (OMCS) (WHO, 1993). This requires the PHC-RO system to give 
priority to case management of malaria through early detection and prompt 
treatment. In July 1995, when the PHC-RO was transfonned to the 
reproductive healthcare system (PHC-R) a National Policy Declaration for 
Malaria was adopted in the place of existing malaria programmes. The 
declaration aligned Cameroon's malaria strategy to both the WHO·led OMCS 
of 1992 (described in chapter four) and the IMP/World Dank cost recovery 
programme (described in chapter five). It was elaborated in 1997 as the 
64 NMCP (2002) Reduire Ie Fardeau du Paludisme <http://www.pnlpcameroon.orglinfo.htm> 
(Accessed: 23/06/08) 
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National Strategic Plan for the Fight against Malaria (PNLP), emphasising 
'treatment of eases and vector control in all public and private health facilities, 
supported by training, operations research, and epidemiological surveillance,65. 
By bundling the public health and economistic models, the emphasis on 
malaria treatment was being shifted from a comprehensive PHC model to a 
narrow focus on the medical model. 
The launching of the global RBM, created a window of opportunity that 
intensified Cameroon's political commitment in the fight against malaria. In 
December 1998, a Working Group for Malaria Control was created consisting 
of a National Coordinator for Malaria (within the Ministry of Health) and 
representatives from the WHO, UNICEF, research institutes and hospitals in 
the country. The group revised the 1997 PNLP into a more robust National 
Malaria Control Programme. Citing the plan the President endorsed the global 
RBM in an official letter to the WHO's Director General on 28th April 1999. 
He also ratified the Abuja Declaration of April 2000 (RBM in Africa) and set 
up a strong follow-up process. On 25th July 2002 the National Malaria 
Programme was launched in a national conference attended by representatives 
from government ministries, global RBM partners, and local private and CSOs. 
In January 2001, import taxes on malaria medication (medicines, IINs and 
other insecticides) were exonerated. In August 2001 a Situation Analysis laid 
the basis for the National RBM Strategic Plan for Malaria published by 
Presidential Decree N° 0334IMSP/CAB of 29 July 2002. The plan is 
effectively, the National RBM Programme of Cameroon. It is through this 
6' Reduire Ie Fardeau du Paludisme <http://www.pnlpcameroon.orglinfo.htm> (Accessed: 
23/06/08) 
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process that the global RBM model eventually shaped Cameroon's malaria 
policy (Table 9 below). 
The historical events above reveal the changing nature of global and national 
linkages. There has been a shift from public and private partnerships in which 
WHOIUNICEF-led public health models were implemented in parallel to 
IMF/World Bank-led economic development models to a PPP approach in 
which global, national and civil society partners associated with both public 
health and economic development models sit around the same table to 
formulate policy. 
Table 9. Objectives of RBM at global, regional and local levels 
March 1998: The RBM is launched by WHO, UNICEF and affiliated partners 
Goal: 50% reduction in global malaria deaths by 20 I 0 through a PPP approach 
April 2000: RBM is endorsed by African leaders: Abuja Declaration (WHO, 2000a) 
29 July 2002: National Malaria Programme is launched in Cameroon (NMCP, 2002) 
Glohal RBM Policy Strategies , 
• Early diagnosis and prompt treatment CameroOl"s RBlll ilIa/aria Policy Strategies 
• ITNs and vector control • 60% a c c ~ s s s to ITNs by pregnant women & 
. children' 
• Malana treatment for pregnant women . '. . P . d 'd . • Increased mtermlttent preventive treatment 
• reventlOn an response to epl emlc • Improved general trcatment of malaria 
A/rica's RBM Policy Strategies (Tile Ahllja Dec/aratiOl') 
• 60% access to treatment within 24 hours of symptoms; 
• 60% access to ITNs or preventive measures to childrcn undcr 5 
• 60% access to antimalaria treatment and IPTs to prcJ;tnant woman at risk 
In addition to the changes in the national health system discussed in Chapter 
Five, the RBM model shaped policy practices in Cameroon in three 
fundamental ways. Firstly, the PPP clement committed the state to RBM's 
strategic objectives in the spirit of good governance and the fight against 
corruption. Secondly, national malaria policy became dominated by the 
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economistic clement of the model (modern and cost effective policy strategies). 
Thirdly, the nature of the malaria problem was finally shifted from public 
health programmes which failed in the 1970s and 80s to medical intervention 
programmes defined in tenns of access to ITNs and anti-malarials. 
Cameroon has since become an important partner to the RBM at all levels. The 
Ministry of Health is the representative of the Central African Region in the 
Global RBM Board since 2005. In addition, the first ever Global Strategic Plan 
(2005-2015) since the launching of the RBM in 1998 was signed in Yaounde, 
the capital of Cameroon. The remainder of this chapter describes the operations 
of transcalar networks of PPPs involving global, national and local partners 
created as a result of the endorsement of RBM. The analysis focuses on the 
ways in which economistic, public health and human rights narratives shaped 
the structure and operations of the national malaria programme and the 
associated implementation challenges. 
6.3 Structure and Objectives of the National RBM 
Programme 
The National Malaria Programme defines the plan of action for the fight 
against malaria. The strategic objective is the scaling up of malaria treatment 
and control through tax reduction and waivers of import duties for ITNs, 
materials and antimalarial drugs; the distribution and use of ACTs and other 
antimalria medicines; house screening and the dissemination of infonnation, 
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education and communication (lEe) through PPPs at national and local levels. 
The goal is to achieve the following ambitious targets by 2010: 
• 75% access to medication for malaria treatment 
• 50% of the population have been provided with appropriate treatment 
• 70% pregnant mothers have appropriate diagnosis and antimalerial 
medicines; 
• 60% health services are covered by the p r o g r a m m e ~ ~
• 30% of families are sensitised (awareness campaigns) on the use of 
ITNs and anti-malarials 
• 50% of vulnerable population are sleeping under ITNs in rural 
communities. 
The programme aims to create a shared national vision and a nation-wide 
network infrastructure for the effective implementation of malaria treatment 
and control programmes and activities, as well as to empower and connect 
government agencies with the private and civil society sectors. This vision, it is 
believed, would create a strengthened national health system needed to achieve 
the targets above. The strategic plan for 2000.2005 laid the basis for 
introducing reforms in the following areas: the creation of national, provincial 
and district malaria centres; decentralization of implementation to rural 
communities and the promotion of PPPs at national and local levels. Table 10 
below presents the key partners, objectives and local interfaces of the national 
programme as they relate to the five fundamental objectives embodied in GBP 
models such as RBM: technical assistance, funding, advocacy, drug 
procurement and supply arrangements, and the provision of health care. 
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Table 10. Global nUM promoters, objectives and status in Cameroon 
Global nUM Key Global Objectives Responsible 
Tasks Partners National and 
Local Partner 
Technical WHO,UNDP Advice and guide national The National 
Assistance UNICEF, strategic plan to reflect both RBM RBM Committee 
Development guidelines and local context and (NMCC) 
Agency for preparing quality grant 
proposals for funding 
Funding World Bank, Provide funding for RBM The Central 
Global Fund programmes based on quality Technical Group 
proposals, good governance and (CTG) 
the fight against corruption 
Advocacy European Monitor, supervise and ensure Cameroon 
Union, continuous political will and Coalition 
INGOs 'actions at country level including Against Malaria 
the participation of local CSOs and other local 
NGOs 
Drug Norvatis, Negotiates quantity, quality, National Drug 
Procurement GlaxoSmithe prices & supply of ACTs! ITNs, Procurement 
other anti-malaria drugs and Centre 
equipments 
Coord ination, Development Donate ITNs and ACTs to the Provincial and 
Monitoring Agencies, national programme, operate district units; 
and Private parallel initiatives with local civil local initiatives 
Evaluation industry, society organizations in line with supported by 
INGOs/CSOs RDM strategic orientations global partners 
Source: Author's processing of policy documents and technical reports of RBM 
Article 4 of Presidential Decision N° 0334IMSP/CAB of29 July 2002 creating 
the National RBM designates the National RBM Committee as the focal point 
to validate policies and grant proposals and for coordinating implementation, 
The Committee is supposed to meet twice a year to evaluate progress and agree 
230 
on future courses of actions. The nature of the committee was described by a 
senior member of the national secretariat as follows: 
The National RBM Committee is an innovation by the government in 2002. 
You have the civil society with NGDs and community associations; the 
international partners and then you have different ministries involved in the 
fight against malaria. The advantage is that it is this committee that 
validates the execution of the orientations of the year. In that way, the 
international, the public and private partners logically meet in the 
committee. All the partners give priority to the technical rather than the 
political and the ensuing plan of action is usually a consensual one.66 
It is the type of PPP approach described by the above quotation that makes the 
GHP models an institutional innovation; it is different from previous models 
because it reflects the integration of elements of public health and cconomic 
development models mentioned earlier into a single global modcl (dcfined by 
the global RBM). It also has characteristics of transcalar networks as global, 
national and local partners meet there. Most of the participants interviewed 
applaud the functional structure of the committee: 'like in all other malaria-
endemic RBM countries, the National Committee is decently organised in 
terms of who is responsible for what and what kinds of requirements, rules and 
regulations are in place' .67 
As can be observed from Figure 6 below, the committee consists of a policy 
community (full lines} and a policy implementation community (dashed lines). 
The former consists of representatives from the Global RBM (multilateral 
organizations and development agencies), Ministry of Health and other 
supporting ministries, a Central Technical Group and elected representatives 
from local public, private and CSDs in the country. The latter is represented by 
66 Interview: National RBM Secretariat 
67 Interview International Development Representative, Global RBM Board 
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local partnerships among provincial and district malaria control units with 
public, private, religious and civil society health and pharmacy units and 
parallel initiatives with individual global REM partners (development 
agencies, private industry, INGOs and foundations). Drug procurement and 
supply arrangements are the responsibility of the National Drug Procurement 
Centre (CENAME) (dotted lines). 
Figure 6. The structure of the National ROM Programme 
Superior Council for Health Policy Making 
"4 
Ministery of 
t .. -. Policy Implementation 
....... Autonomous Body 
Public Health ~ ~............................................... CENAME 
t Global ........... ~ ~
.. P ~ ~ ~ ~National Malaria ~ ~ - - . . . . . . a r t n e ~ s s ./ 
Control Comiittee ',./ / t ' .. 
Supporting \ ~ ~ /' 
Ministries .. - - .. Central Technical Group .. - - -. Local Partners 
Source: Created based on official texts and interviews 
From the official text creating the committee, the Minister of Health is the 
chairperson of the committee. The minister is therefore expected to lead and to 
some extent control the activities of all other partners as it did in the creation 
phase of the programme, thus bringing about desired outcomes. In practice, 
however, the national committee, not the Ministry of Health is the most central 
actor. This stems from the fact that global, national and local partners are 
represented in policy making. It suggests that the national RBM programme is 
particularly vulnerable to any attempt to bypass the committee. 
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Another role of the committee is to ensure that 'those partners who would 
normally go on their own because of a lack of confidence in the State can gain 
legitimacy to do so by virtue of them being represented in the national 
committee,.68 This role of the committee is related to the nco-liberal models of 
community participation that aims to correct government failure (weak states 
and corruption) by limiting the amount of control exerted by the state over 
national policy and local practices. This obviously poses a dualism. Firstly, the 
national committee is expected to supervise the direct involvement of global 
RBM partners in policy implementation. Secondly, in the event that the state's 
political interest attempts to override the national committee, measures arc 
needed to ensure that the committee does not over depend on the leadership of 
the state (through the Ministry of Health). 
The Central Technical Group is headed by the Permanent Secretary of the 
national programme appointed from within the Ministry of Health. As the 
group is the executing agency of the National Committee, the secretary 
coordinates the preparation of strategic planning data, collection and 
processing of the data on basic monitoring of performance including impact 
indicators for the various programmes and activities executed at provincial and 
district levels. In effect, therefore, the central technical group connects the 
policy making community to the policy implementation community in the 
following ways: 
The national committee gives us political orientations which we use to 
prepare a grant proposal for the activities in the fight against Malaria, and 
61 Interview: National RBM Secretariat 
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to transform technical activities into operational resources. On the other 
hand we maintain a local and international partnership to promote all 
these actions at provincial and district levels.69 
Supporting ministries participate in relevant areas of the programme and are 
therefore represented in the national committee. They also provide technical 
advice and support services to the Central Technical Group. For example, the 
Ministry of Finance releases the funds to pay for subsidised medicines (and 
other expenses associated with the national programme) and determines the 
extent of import tax exemption for ITNs and ACTs entering the country. The 
Ministry of Social Affairs is active in sensitisation programmes for the fight 
against malaria. 
The local partners represent the core of the policy implementation community. 
There are ten provincial malaria control units and hundreds of district centres, 
local community organizations (NGOsl Associations, confessionals, diverse 
civil society associations, youth groups) and the private sector all of which 
coordinate the implementation of activities in various localities in the country. 
These activities are either initiated by the national programme or by individual 
global RBM partners. Through this PPP approach, the programme is constantly 
being strengthened. 
It is interesting to note that although the national committee is the focal point 
for policy making, yet has limited control over drug procurement and supply 
arrangements that form a core function of national malaria programme. This is 
devoted to CENAME, an autonomous body within the Ministry of Health in 
69 Interview: Central Technical Group 
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charge of global procurement and local distribution of drugs in the country. As 
discussed later, this is due to the dominance of the economistie narrative on 
access to medication at the global level. The next section explores the 
interaction between the RBM models and policy practices as a way of showing 
how the embodiment of fonns of knowledge within global models plays out at 
country level. 
6.4 The Role of the RBM Model in Shaping Policy 
Practices on Malaria Treatment and Control 
The country offices of the WHO, UNICEF and the UNDP provide technical 
assistance to conduct country-specific needs assessments leading to a proposal 
for action. They then link the national programme to donor organizations 
(such as World Bank and Global Fund7o) to finance programmes and activities. 
They also help to link the national programme with phannaceutical companies 
to facilitate bilateral negotiations on drug procurement and supply 
arrangements. All these global partners then link the national programme with 
their affiliated private industry and civil society partners to provide additional 
funding, advocacy support and direct service delivery through parallel 
programmes and activities in various regions of the country. In this way, the 
RBM model is able to shape the national programme in line with the objectives 
presented earlier on Table 10. 
70 Global Fund approve funding only if national grant proposals are 'based on modern and cost 
effective methods o/malaria control designed by the Roll Back Malaria initiative': 
<http://www.theglobalfund.org/programslgrantl?compid=610&grantid""286&lang-EN&Count 
ryld=CMR> Accessed: 20/0S/08) 
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6.4.1 The policy framework for malaria treatment and control 
The main objective of the RBM as explicitly stated on its website is 'to provide 
a coordinated global approach to fighting malaria' and 'the scaling up of 
interventions at country level to ensure wide spread coverage, particularly to 
population groups most vulnerable,71. Cameroon epitomises the conditions that 
led to the founding of RBM (a resurgence of the disease after failed efforts at 
eradication, declining efficacy of drugs and pesticides, program policy and 
management failures, collapsing health systems, and the global debt burden, 
making it logical for its endorsement of the partnership). However, there were 
no specific reforms required from disease-endemic countries in exchange for 
joining the RBM other than officially endorsing the partnership. This meant 
that implementation would largely depend on how endemic countries interpret 
the provisions of the RBM which in tum depends on the narrative strategies of 
global partners that are embodied within the RBM model. 
From the interview data there is some confusion over what the strategic 
objectives of the RBM are in the case of Cameroon. This was observed in the 
question of how the RBM fits into the broader national health policy of 
Cameroon. All the interviews spoke along the lines of the neo-liberal market 
model and its emphasis on the economistic narrative on access to medication. 
From a global perspective, the main role of the RBM is 'supplying strategic 
advice to countries, trickling of money and medicines through the national 
health system and making sure that access is really there for the poor.' 72 The 
71 See RBM Website: 'Malaria Country Facts' 
;::http://www.rollbackmalaria.orglcountryactionlindex.html> (Accessed: 13/06/09). 
2 Interview: International Development Representative, Global RBM Board 
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most important role of the RBM that was shared by the majority of the national 
and local partners is 'to improve access to medicines ... to help with health 
technologies and resources ... to help us to get access to markets at negotiated 
prices, at prices that are affordable.73 This quotation suggests that although 
Cameroon endorsed the RBM, it does not see any need for direct involvement 
of global partners at local levels. 
The general framework set by GHPs such as the RBM for governing relations 
across and between partners is based on voluntary agreements (Dodgson et al., 
2002). This obviously allows the strategic interests of global partners embodied 
within different elements of the RBM model to shape the nature of 
participation in the national health system. In an attempt to achieve the 
objective of correcting government failures and fight corruption, the Global 
Fund and the World Bank, instead of trusting the State authorities put strict 
conditions on funding: 
'There are problems with funds from the Global Fund and the World 
Bank. They are put in clearly defined categories as additional resources. 
They do not permit you to function normally if the State does not 
contribute its proportion. The funding is entitled to pay for mosquito nets, 
drugs, and other 'big things'. Now in transport, payment of human 
resources, the State must pay. And when the state does not pay funding is 
blocked. ,74 
The above claim is not new. As early as 2003 huge amounts of funding for the 
malaria programme remained blocked within the Cameroonian system since 
the government had not fulfilled the World Bank's conditions for disbursement 
(RBM, 2002). This obviously represents new types of governance gaps in the 
73 Interview: Division of Healthcare Organization and Health Technology, Ministry of Public 
Health 
74 Interview: Central Technical Group 
237 
system, one that undermines the effectiveness of the RBM and these are not 
being debated during policy meetings. 
Another policy issue relates to the costs of treatment and healthcare delivery 
arrangements. The general consensus among the interviewees was that it was 
important to prevent a recurrence of the situation in the late 1980s when the 
economic crisis caused the national health system for drug supply to be 
overwhelmed, forcing the government to abandon its free healthcare policy: 
'the government could no longer pay for drugs and there was no alternative 
source of payment. It is the position of the Ministry of Health that we reduce 
prices significantly without reaching zero to maintain the habit of having 
people pay something.75 This view is shared at the global RBM, especially the 
pharmaceutical industry partners, which favour 'maximum subsidisation with 
no minimum equilibrium,76. The mechanism in place to achieve this considers 
'the willingness to pay and the high cost of the actual drugs; the costs to the 
system of provided discounted drugs; the transport costs incurred by patient to 
go get the medicine, which make it difficult to provide the drugs for free. 77 
The above platform is then used by multilateral (WHO, UNICEF) and bilateral 
(such as the French Cooperation, GIZ, DFID and USAID) agencies to help the 
Central Technical Group to develop quality proposals for funding to be able to 
put in place mechanisms for heavy subsidisation. Here again, the economistic 
narratives, not the public health narratives, play more significant roles in 
defining policy on malaria treatment and control. 
75 Interview Central Technical Group 
76 Interview: Private Industry Representative of Global RBM Board. 
77 Interview: International Development Representative Global RBM Board 
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Depending on the quality of grant proposals taking the above economistie 
issues into consideration (as well as the public health and human rights 
considerations), funding is provided by the Global Fund under various rounds 
of grant application7s and the World Bank through the HIPe agreement (debt 
cancelation initiative) agreed in 2000 (MoH, 2000) and the Booster Program 
for Malaria in Africa established in 2005 (World Bank, 2007). For example the 
Global Fund makes it explicit that mitional grant proposals must be 'based on 
modern and cost effective methods of malaria control designed by the Roll 
Back Malaria initiative' .79 The impact of donor funding was discussed by the 
interviewees along the lines of the following quotation: 
'With donor funding we are heading towards free access to ACTs and Illis 
in Cameroon. It will become necessary for two reasons. The first is that the 
poor can afford and access the drugs. Secondly, since subsidised drugs 
have a commercial value; economic trafficking has been going on. If today, 
subsidisation renders drugs free of charge, the product will lose its 
commercial value and trafficking will fall. That makes me think more and 
more in our negotiations with the global partners that the prices of ACTs be 
cancelled even if for just a while because this will spare us contra-banding 
and counterfeiting. It's a purely technical reason.' so 
The above quotation relates to the problem of corruption in the drug 
procurement and supply chain and the black markets for malaria medicines that 
has been a major feature of the Cameroonian health system since the 19805 
(see Baye, 2003; Ngufor, 1999; Basco, 2004). However, the global partners do 
not advocate providing free healthcare in Cameroon. Most of them oppose 
78 For details of Global Funding for malaria treatment in Cameroon, see 'Cameroon and the 
Global Fund' 
<http://www.theglobalfund.org!programslgrantl?compid=610&grantid=286&lang=EN&Count 
~ I d = C M R > > Accessed: 20/0S/08) 
7 See 'Cameroon and the Global Fund' (Note 78) 
80 Interview: National RBM Programme Secretariat 
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giving medicines for free, citing 'the sustainability of R&D for drug 
development and the fact that donors may not continue to subsidize for ever,Sl. 
As mentioned above drug procurement and supply arrangements, while an 
essential policy issue, is the work of CENAME. Negotiations are held on a 
bilateral basis between malaria-endemic countries and pharmaceutical 
companies independently of National RBM Programmes. They are highly 
sensitive and are kept secret; no interviewee was interested to talk about it. 
This approach is favoured mostly by pharmaceutical companies: 
'We prefer direct negotiations with endemic countries. The country is 
responsible for the malaria control programme and can really explain to us 
what the volumes are likely to be in the next year so we have a better 
understanding of their requirements. Through a direct contact we can better 
understand their phasing of the different supplies throughout a given year 
in terms of how big a given supply delivery should be. This direct contact 
cannot be replaced by the RBM.,S2 
The quotation above also illustrates the strong influence of the economistic 
model in shaping the operational orientation of the national RBM. In addition 
to the CENAME, bilateral development agencies (such as the US, France and 
the UK) use their affiliated INGOs and foundations to import and distribute 
drugs at local levels claiming to complement the national programme. These 
organizations run projects in partnership with local community groups 
approved by the national malaria committee. As discussed later different global 
partners take advantage of different elements within the RBM model to achieve 
their own strategic interests, and at the same time, promote the work of the 
national programme. 
81 Interview: Bill and Melinda Gates Foundation 
82 I . ntervlew: Novartis 
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Another policy area shaped by the RBM model is advocacy for 'continuous 
political and civil society commitment, adequate supervision and follow up at 
national and local levels to ensure that there is consensus between policy 
making and policy implementation,83. The European Union84 is very active in 
monitoring and supervising the performance of the national programme. In 
2007 a delegation from the European Parliamentary Forum made a 'Malaria 
Study Tour' to Cameroon to evaluate the realities of malaria in the country and 
discussed with officials the prevailing challenges as well as propose better 
organization by the government in terms of tax: reductions on the importation 
of ACTs and ITNs. They also appointed the Cameroon Coalition Against 
Malaria (CCAM) to act as a civil society intermediary between the European 
Union and the government of Cameroon to ensure that there is sufficient 
cooperation with all stakeholders involved in the national malaria programme. 
6.4.2 The policy implementation framework for malaria 
treatment and control 
As already mention above, the policy implementation community is 
coordinated by the Central Technical Group and consists of local public 
(provincial and district RBM units) and private RBM partners (public, private, 
religious, civil society healthcare and pharmacies). The former operate under 
the vertical structures of the Ministry of Health while the latter are mostly 
supported by parallel initiatives designed and implemented by various global 
RBM partners in line with RBM's strategic objectives. 
13 Interview: International Development Representative, Global RBM Board 
14Cameroon Tribune (06/09/07) <http://allafrica.com/stories/200709060910.html> (Accessed: 
13/05108) 
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A provincial malaria treatment and control office has been established in each 
of the ten provincial capitals in the country to supervise and coordinate the 
subsidization of costs of treatment in all public and private hospitals and 
pharmacies. Provincial centres also provide malaria related information to 
urban and rural areas through district and community health facilities to enable 
them to deal with malaria cases in rural villages. They also have teams of 
health experts from public hospitals and pharmacies to deal with 
epidemiological, diagnostic and drug prescription issues. All these activities 
receive wide coverage by the national radio and TV media channels. Locally 
trained NGOs and Associations are also active in community mobilization, 
sensitization and distributing of medicines and materials. Africa Malaria 
Days85 provide an important medium for dissemination of information on 
prevention, diagnosis and treatment of malaria throughout the country. 
The national malaria programme's activities are also paralleled by a variety of 
cross-partner initiatives under the guidance of various international agencies 
that use RBM's strategic orientations. Specifically, the goal is to support the 
national programme in meeting malaria targets, to increase the capacity to 
sustain ITN and ACT programming, thereby sustaining the PPP approach. Yet 
these parallel initiatives are not directly answerable to the national RBM 
committee; they only share a common RBM objective and participate in 
national committee meetings. 
8$ An example of the Africa Malaria Day advocacy can be found at: "Malaria: The ACT 
Alternative", The Post Online: http://www.postnewsline.coml200S/04/malaria-the-act.html 
(Accessed: 31105108) 
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The RBM claims to provide a unique approach in that its 'strength lies in its 
ability to fonn effective partnerships both globally and nationally.,86 At the 
local levels the programmes within the Ministry of Health use the structures 
created under the PHC model and operate in parallel to specialised initiatives 
set up by global partners. Such initiatives are described by their promoters as 
being partners to the national programme. They also compete with non-public 
health units that are not part of the national programme. One interviewee 
described the current situation as follows: 
'It is difficult to have an overall blueprint in tenns of organizational set 
up and this makes it difficult for the RBM to answer the very country-
specific needs related to epidemiology, organizational and institutional 
differences in tenn of malaria control. We don't know exactly how 
morbidity is, how morbidity patterns are because various international 
players bring that into picture only for the regions they are involved in. 
How do you then give an impression on how effective the different 
programmes are in tenns of malaria treatment and control?,87 
The general consensus among the global partners was that it is the 
responsibility of the national government to address overlapping initiatives. 
Before exploring the challenges involved in this, the next section discusses key 
parallel initiatives, the type of narratives that infonn them, the type of global 
partners to which they are affiliated and the implications for national policy 
and local practices relating to malaria treatment and control in Cameroon. 
6.4.3 Parallel global malaria programmes and activities 
Global RBM programmes basically aim to ensure that esos play leading roles 
in programme design and implementation in various regions of the country. 
Such processes are however, non-linear and it is also likely that a number of 
86 Interview: Bill and Melinda Gates Foundation 
87 Interview: International Development Representative, global RBM Board. 
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unexpected events can bring to a halt implementation. The cases examined here 
are not exclusive; they only serve to highlight the ways in which different 
elements of the RBM model shape national and local practices. 
Illtegratetl Mallagemellt of CltiltlllOotl IIIIIess (PCIME) Programme88 
PCIME illustrates how the economistic element of the RBM model contributed 
in reframing the malaria problem in Cameroon from public health to fast track 
medical measures.89 It was first launched by the WHO and UNICEF in 
partnership with the Pan-American Health Association in 1990 to reduce infant 
mortality in developing countries through the PHC model - behavioural 
(factors that expose children to sanitary risks related to malaria), clinical 
(capability of public health personnel), institutional (healthcare infrastructure) 
and capacity building (empower the civil society to play active role in 
healthcare ). 
Following a successful feasibility study, PCIME was authorized in Cameroon 
in 2002 by the Ministry of Health as a partner to the national malaria 
programme. Funding was providing by USAid and involved Plan International 
(France), the Helen Keller International (USA), the Cameroon National Social 
Marketing Association (local implementing NGO) and provincial and district 
malaria units (technical assistance). It created Women Associations and 
Children Forums to implement malaria control activities in three provinces. 
The office of Plan International in Cameroon coordinates monitors and 
88 A more elaborate description of the programme is available on the WHO website: 
'Integrated management of childhood illnesses', < 
http://www.who.intlcountries/ethlareas/childhoodlenlindex.html> (05109/08) 
89 F or more on PCIME Cameroon see 
http://paludisme.planfrance.orglmJdoc/projet_ cameroun. pdf (02/07/08) 
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evaluates the project. Two local NGDs, namely, EMICAM and SAIMED arc in 
charge of creating and supervising these forums. These NODs and associations 
are approved by provincial and district RBM units. Public health personnel at 
provincial malaria units arc often invited to provide training and health advice 
to the forum members. 
The Women Associations work as volunteers carrying out community 
mobilization and sensitization campaigns, distribute ITNs within their 
constituencies and provide feedbacks to the country office of Plan International 
in Cameroon. They also perform family visits to encourage residents to use 
ITNs and to join fellow women groups in their localities. The clinical and 
institutional aspects of PCIME are ignored as the programme does not even use 
public health structures. Similarly, capacity building that is meant to link the 
civil society with the public health system instead bypasses the public hospitals 
and pharmacies exclusively. The only ,engagement with the national system is 
the technical advice they receive through provincial malaria units. 
Tile National Social Marketing Programme 
This initiative illustrates how competing interests within the RBM model shape 
national and local practices in ways that undennine the capacity of transcalar 
networks to correct governance gaps in Cameroon. It is a partnership between 
. 
USAID and Population Service International (PSI) and the national RBM in 
Cameroon. The goal is to compliment the national programme by increasing 
the capacity of provincial and district malaria centres to sustain ITN 
programming (USAID objective) and to achieve health impacts through 
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maternal and child healthcare (PSI objective) in vulnerable segments of the 
population (Handyside et aI., 2004). The global partners sponsored the creation 
of the National Social Marketing Association (NSMA) to serve as local 
implementing NGO. The NSMA sells Super Moustiquaire (a bundled ITN and 
BLOC treatment kit) through private commercial and NGO networks at cost 
recovery prices in the East, Centre and South provinces. It also runs 
sensitization campaigns with households on malaria transmission and 
prevention through the use ofITNs. 
The programme emphasises the economistic narrative embodied in the RBM 
model, by focusing on the procurement (international level) and sales (local 
distribution) of ITNs and providing staff training (for successful cost-recovery 
sales). The exoneration of excise duties on ITNs gives USAid the opportunity 
to provide maximum discounts and enables the NSMA to provide affordable 
medicines. This contributes by increasing the uptake of ITNs nationally and 
locally and gives credit to the NSMA as a major local RBM partner. However, 
there are serious conflict of interest between global partners and national policy 
makers (PSI, 2004: 7): 
, . .. announcements are sometimes made by the Minister of Health 
which can create changes to agreed policy ... The Minister decreed that 
no health centre ... would receive any free nets if they were found to 
be selling nets. ACMS was instructed not to sell nets to health centres. 
This has substantially affected the NSMA program design from that 
agreed with USAid, in that the roll-out of subsidized nets to clinics has 
been blocked' 
In addition to the above challenge, the exemption of imported nets does not 
cover certain netting material procured by USAid as part of the programme. 
Furthermore 'the spectre of leakage of these free nets into the commercial trade 
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... may affect NSMA's sales (PSI, 2004: 9). From such challenges we see how 
the economistic element of the RBM model (promoted in this case by global 
partners such as USAID) is resisted at the national (ministerial decisions) and 
local (leakage of free ITNs) levels thereby creating new types of governance 
challenges that further hampers policy effectiveness. 
Bolster Program/or Malaria 
Private multinational corporations are also global partners of RBM. They 
provide direct local support as well as funding for R&D for malaria vaccines 
and medicine9o• Oil giant ExxonMobiljoined the RBM in 2001 by launching a 
Bolster Programme for Malaria, a PPP between ExxonMobil (private donor) 
and three RBM partners, namely the National RBM of Cameroon (to 
strengthen on-the-malaria programmes), Harvard Malaria Initiative and 
Medicines for Malaria Venture (development of new anti-malarial drugs and 
malarial vaccines). The CEO of ExxonMobile explains the involvement of 
private industry as follows: 
'Public health is a cornerstone of opportunity and achievement. 
Partnerships can result in improved health programs and sustained 
results for local populations, and we believe that our malaria initiative 
will demonstrate that corporate investment can make a difference in 
achieving important public health goals,91 
As a potential for improved malaria outcomes, the initiative aims to eliminate 
new malaria cases for its expatriate workers, minimise malaria cases for 
national project workers (and potentially their families) thereby reducing 
90 Interview Bill and Melinda Gates Foundation 
91 For more on the b o l s ~ e r r programme, see World Bank (2007:16-17) and ESSO (2004) on the 
Chad-Cameroon pipeline project 
<http://www.esso.comlChadEnglish/PAlNewsroomffO_NewsRelease _170401.asp> 
(Accessed: 05/06/08) 
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malaria mortality within the target communities in line with RBM's guidelines. 
However, rather than channel funding through the national malaria programme, 
much of ExxonMobil's support is provided directly to local healthcare 
providers (mostly NGOs) in areas where its pipeline project workers live and 
work. As an opportunity for achievement, the initiative aims to ensure the 
successful completion of the Chad-Cameroon Pipeline Project. In this case 
funding was exclusively meant to prevent the loss of an additional 4.3 project 
days and US$4 million in expected incremental labour expenses for completing 
the project92• Surprisingly, this region is not among those highly susceptible to 
malaria mosquitoes in Cameroon (Tchenga, 2008). This undermines the public 
health element of the RBM model as the economistic interests of global 
partners override the need to target programmes to the poorest and most 
vulnerable parts of the country. 
Mobilising for Malaria Programme - Empowering local CSOs 
This advocacy programme illustrates how the RBM model is being used to 
empower CSOs to play leading roles in policy implementation. It was launched 
in 2005 as a partnership between two UK-based global RBM partners, namely 
Malaria Consortium (civil society partner) and GlaxoSmithKline 
(pharmaceutical industry partner)93. In 2006 funding from the programme was 
used to create the Cameroon Coalition against Malaria (CCAM) that is 
currently the most important civil society partner in the National Malaria 
Committee. It serves as an intermediary (reports directly to the EU) between 
92E SSO (2002): see note 91 
93 See www.gsk.comlmalaria (Accessed: 1116/2008) 
248 
the European Union and the National Malaria Programme. Apart from this, the 
CCAM performs the following role: 
'Essentially we offer advocacy services to the RBM especially the 
regional and national network. We prepare comprehensive documents 
to serve as information sources for both medical and non-medical 
persons on malaria. We have monthly programmes with public and 
private journalists and press including questions and answers sessions. 
These discussions are broadcasted over their media at different periods 
as a way to disseminate information on malaria. ,94 
The CCAM sponsors national malaria ambassadors through which pledges are 
made relating to the fight against malaria. It is also responsible for training 
local committees in the littoral province on home-based management of 
malaria with funding from the Global Fund. Here again, the conditions on 
funding set by the Global Fund, not that set by the national programme 
committee decides on the allocation of funding to the CCAM. 
Brief summary of otller parallel global programmes ami activities 
There are many other examples of parallel initiatives scattered all over the 
country supported by various global RBM partners. For example, the French 
Development Cooperation in partnership with Care International (global civil 
society), Sonafis-Aventis (a private French company) and Provincial 
Delegations of the national malaria programme implement an Impact Alalaria 
Program95 on access and capacity building, new medicine development and 
cost recovery sales of ITN and ACTs in the Centre and Northern Provinces 
(French-speaking regions of Cameroon). Although the programme is based on 
public health structures (in partnership with private and local partners), the 
agency responsible for coordinating the programme, instead of being the 
94 Interview: Cameroon Coalition Against Malaria (Local civil society partner) 
95 See more on Sonafis-Aventis program at www.impact-malaria.com (Accessed: 11/06/08) 
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national RBM programme, is designated to the Cameroon office of Care 
International. Most RBM-informed programmes are barely presented in 
technical reports and in most cases on internet sites that are hardly updated. 
This makes it virtually impossible to compile a comprehensive list of all the 
initiatives being implemented in Cameroon as a result of the RBM. 
From the above context, instead of promoting a country-led coordinated 
programme, the deployment of the RBM model has led to certain global 
partners emphasising their own strategic directives. The outcome includes a 
fragmented transcalar structure in which partners only participate in areas of 
the country where they have their own strategic interests. This implies an 
absence of projects in provinces and districts that are not covered by partners. 
The national partners who hold the key to success and sustainability do not 
have full autonomy over the national RBM programme. The state no longer 
plays the central role allotted to it by the traditional liberal models following 
independence. This role has been eroded by the dominance of the economistic 
(neo-liberal market models) embodied in the RBM. The state has been 
entangled within the transcalar networks created by the RBM. This calls into 
question the significance of the RBM's objective as a global model for health 
system strengthening. All the persons interviewed agree that more impact 
could be achieved if partners' interests and overlapping initiatives are linked 
more consistently to each other. The challenges in achieving this are explored 
below. 
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6.5 Challenges facing the National RBM Programme in 
Cameroon 
The nonnative framework of a GHP model requires two broad conditions to be 
satisfied in the case of the RBM in Cameroon: absorption of resources to meet 
Cameroon's specific malaria treatment and control targets and integration of 
overlapping programmes to achieve health system strengthening. This involves 
'localizing' the RBM model. The interplay of competing and conflicting 
narratives of global partners implies that the extent to which this is achieved 
depends on the nature of stakeholder participation and the nature of global-
national-local linkages. These issues are explored in the following sections. 
6.5.1 Participation in the National Malaria Committee 
The transcalar character of the PPPs that make up the national malaria 
programme reveals a clear discrepancy between who should decide on policy 
and who actually decides. The role of the National Committee within such a 
PPP is to ensure that 'the government is able to exert strong regulatory control 
over all partners and programmes. ,96 Thus, the national committee is defined as 
the state, what is tenned by development studies literature as a transition from 
government to governance (Dodgson et aI, 2002). To facilitate this transition, 
the community model embodied in the RBM'has made it possible to have equal 
representation of global, national and local partners. The bureaucratic 
structures of the state have been eroded with previously marginalised groups 
(the local CSOs) playing a more active role. The state now plays more of a 
ceremonial role. Representation in the committee gives global partners the 
96 Interview: Provincial Malaria Control Unit, North West Province 
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legitimacy to participate in areas of state and market failures, bypassing the 
state. 
What became apparent during the fieldwork was the multiple and overlapping 
roles of the national committee members. Representation in the committee 
differs from actual participation in the national programme. The Pennanent 
Secretary of the committee is also the Chairman of the Central Technical 
Group and the expert negotiator between the national and global partners. The 
multiple roles of the CCAM have already been discussed under the Mobilising 
for Malaria Programme. It is possible to make a similar description in 
numerous areas of the committee. The members are all the same .and they 
change their titles during the interview depending on whether or not they are 
speaking in their capacity as representatives of the national committee or head 
of speficic programmes and activities. This makes the structure of the national 
RBM programme very complex. However, it implies that the overlapping 
initiatives are to some extent linked to each other. The possibility exists to 
integrate these initiatives as long as the partners are willing to do so. 
The community participation model embodied within the RBM has led to the 
empowerment of local CSOs, in particular those that serve the interest of 
women and children most vulnerable to malaria. This is also related to the 
human rights narrative that calls for policies to reflect the needs of the poor. By 
involving CSOs, it is expected that they can better voice the problems of the 
poor as well as participate in fonnulating and implementing measures to deal 
with them. However, although civil society now has a strong presence, their 
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participation is more evident in policy implementation (as discussed in the 
programmes above). As the quotation below suggests, their role in policy 
making is limited to sitting around the same table with the other partners: 
'The mechanism for electing representatives and the manner in which 
the rules provide for feedback information presents the biggest 
problem. There are times when some representatives stand for nothing. 
So even if we have the largest representation to share power in 
decision-making which means decisions are consensual, a 
representative of the civil society who does not render accounts to that 
sector definitely ceases to represent it. It is difficult to ensure that the 
mechanism of representation, follow up and accounting is properly 
done in each case.,97 
Despite the apparent 'sham representation' described above, when talking 
informally to some of the local NGOs and associations, it was clear that they 
are aware of the status of RBM's policy and they feel they are part of the 
process. They were able to confirm key policy details and some were even able 
to confirm their contribution in policy making at national level either through 
their representative CSO or through INGOs and development agencies 
(specific examples are evident in most of the programmes and activities). Thus, 
any attempt to integrate overlapping initiatives must not undermine this active 
role of the civil society. Cameroonian elites now emphasise this basic human 
rights needs of previously marginalised groups and are obliged to be more 
accountable for their actions when they sit around the same table with the civil 
society partners. 
6.5.2 Global-Local linkages: Is bypassing the state viable? 
In previous models (such as the PHC and the SAPs), foreign agencies created 
networks around the ministerial structures of the government. The RBM model 
97 Interview: National Malaria Committee (Secretariat) 
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now gives them the legitimacy to bypass these structures. This enables the 
programme to achieve quick results; however, it affects the feasibility of the 
RBM achieving its objective of health system strengthening. The global 
partners do not even seem to see the state as the most central actor: 
'Health system functioning does not only relate to how governmental 
services protrude into the community. The lowest echelon at the village and 
even the family level is part of the health system not only as a customer, 
client or patient but also as an active participant in collaborating or 
contributing with prevention or even preventing transmission of malaria. 
Let us focus heavily on the civil society organizations and see how far we 
can influence the malaria transmission and treatment process. ,98 
Such a description of the national health system undermines the PHC model 
and its subsequent reforms configured before the launching of the RBM. When 
asked why RBM partners bypass the state, the same interviewee above stated 
that the 'government officials are keen to maintain their status and job which 
means income before protection against malaria. They have an interest to 
maintain a power balance from a national perspective which may differ from 
the needs of society at the local levels,99. On their part, the national policy 
makers confirm the global narrative that bypassing the bureaucratic structures 
of the state 'speeds an activity ... the problem is that the State (through the 
ministry of health) is no longer able to keep the much needed leadership 
role.,lOO This interviewee also noted that the global partners put their 
economistic interests before health system strengthening: 
'The global partners are interested in the number of ITNs distributed, the 
number of people who have taken medication, etc, but in the 
conceptualisation ... in developing the infrastructure that is necessary for 
the whole mechanism to succeed donors are not willing to finance it. We 
use our resources to establish a plan of action that donors are all too happy 
98 Interview: International Development Representative, Global RBM Board 
99 Ibid (note 98) 
100 Interview: Central Technical Group 
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to finance. When it does not work, we return to the ministerial structures, 
which have the difficulty of attracting global partners' 101 • 
Nevertheless, all the interviewees acknowledge the need for a central actor to 
coordinate parallel and overlapping initiatives. However, as the attribution of 
causal factors above illustrate, there are serious differences when it comes to 
whether the structure of the Ministry of Health has the capacity to function as a 
national health system. This weakness implies that global partners can play the 
boundary of different elements of the RBM model to implement their own 
parallel initiatives with local organizations. The consequences include global 
RBM partners not respecting national policies on malaria (e.g. the case of the 
national social marketing programme) the establishment of malaria initiatives 
in areas that are not the most susceptible to malaria mosquitoes (e.g. the case of 
ExxonMobil's programme). There was a feeling that Cameroon had no choice 
but to accept the RBM, due to the influence of multilateral and bilateral 
agencies including their affiliated donor partners. 
The embodiment of different narratives within the RBM model global 
institutions to exert huge influences on national malaria practices by being able 
to constraint the elitist behaviour of national politicians. In addition, local 
CSOs in Cameroon is highly mobilised and is able to act as a suitable counter-
balance between the state and the global partners. This is the basis on which 
any attempt to integrate parallel initiatives and strengthen the health system can 
be discussed. In addition, the infrastructural capacity to achieve national targets 
is distorted and conflicting narratives of partners seem to suggest that the stand 
101 Ibid (note 100) 
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point knowledge of local partners is overlooked. The next section examines the 
implications of these findings for 'localising' the RBM model in Cameroon. 
6.5.3 Localising the National Malaria Programme 
As already mentioned, despite the efforts of the various global, national and 
local partners, the national RBM targets are far from being met. Although this 
is recognised by all the organizations and institutions involved, a 
comprehensive statistics on the extent to which targets have been met (or can 
be met in the near future) is hard to extrapolate given that the different RBM 
partners only record statistics of the specific programmes in regions of the 
country where they are involved. Surprisingly, the lack of ITNs and ACTs, the 
core of the definition of access to medication by the RBM, did not feature in 
any of the interviews as one of the main challenges in the fight against malaria 
in Cameroon. However, such a medical model represents a 'technical fix': the 
use of a particular technology (in this case ACTs and ITNs) to solve the 
malaria problem with an institutional structure that is not capable of tracking its 
own activities. If access to ITNs and ACTs is not the key challenge, one 
questions what Cameroon's needs with regards to malaria treatment and 
control are. A member of the Central Technical Group summarized it in the 
following quotation: 
'Funds necessary are still insufficient ... all actions we take are not always 
followed up. There is usually a big lapse of time between the time projects 
are initiated and when they are funded. At the societal and cultural level, 
Cameroonians still attribute the causes of malaria to other things such that 
the interventions we initiate are not always adopted by the beneficiary. A 
radical behaviour change is needed in the population for measures to be 
effective, and there must be a good orientation in the search for treatment 
for Malaria.' 102 
102 Interview: Central Technical Group (Technical Services) 
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Localizing the RBM in the Cameroonian context described by the above 
quotation requires measures to be taken along the lines of both the public 
health, economistic and human rights models on the one hand, and institutional 
models on the other. Amongst the proponents of the RBM, there was a strong 
emphasis on the 'importance of the malaria problem, the weight of the disease 
on development, and the socio-cultural organisation of the country' .103 These 
are all elements embodied in the comprehensive PHC model that was gradually 
abandoned with the coming of the neo-liberal market models from the late 
1980s. Clearly, the public health narrative has been largely neglected in favour 
of the economistic narrative. 
From an institutional perspective, there is need to address the social issues 
(infrastructural capacity) to enable the national RBM programme to supervise 
and coordinate all overlapping activities. The incentive put forward by creators 
of the RBM model to govern by bypassing the state has not solved the problem 
of bad governance and defective health system. Both public, private and civil 
society actors are being linked to apparent mismanagement of funds and illegal 
distribution of drugs allocated to the national malaria programme (Lipset, 
2000; NMCP; 2008): 'sometimes low pay encourage people to find additional 
income streams, which may come from diverting medicines out of their facility 
into the infonnal sector' 104. Here, the RBM model is a tool to aid development, 
but also to satisfy the self-interested needs of some elites at the expense of poor 
Cameroonians. 
103 Interview: Bill and Melinda Gates Foundation 
104 I . eel" A . ntervlew: ameroon oa Itlon gamst Malaria 
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Other challenges affecting national programme that emerged during the 
interviews include insufficient political will to pull the necessary resources to 
fight against malaria, shortage of adequately trained and motivated health 
professionals, lack of supervision especially given the enormous workload on 
staff and the influence of traditional medicine and self-help groups. Most of the 
public health centres in urban and rural areas that were visited during the 
fieldwork were ill equipped to adequately deal with malaria: 
'a real problem is human resources in terms of disposition 
(availability) and quality. When there is money we need people to 
implement activities and to Rut into place all the programmes that are 
proposed in the peripheries.' os 
In terms of the most suitable institution to localize the RBM in Cameroon, the 
main emphasis was on measures to empower the Central Technical Group 
(CTG) to tracking all RBM programmes and activities in the country. It is the 
only actor that interacts with the global, national and local partners: 
'The CTG is an offshoot of the Ministry of Health but in reality we are 
answerable to the national committee. If you look at the text of the 
national programme, you have the national committee, the eTG and after 
that the local partnerships on the one hand and clinical services on the 
other.' 106 
The centrality of the eTG can be represented as on Figure 7 below. In fact one 
interviewee even noted that this was the missing link in the fight against 
Malaria before the launching of the RBM-backed national malaria programme. 
There was a disconnection between the policies and their operationalisation 
which hampered action' .107 The centrality of the eTG suggests that its capacity 
needs to be strengthened to be able to track the activities initiated by global 
105 Interview: National Malaria Programme Secretariat 
106 Interview: Central Technical Group 
107 Ibid 
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partners that bypass the national committce in policy implementation. The 
CTG, by virtue of it being in charge of coordination should also play an active 
role in decision making on the procurement and supply of ACT and ITNs 
alongside data collection, monitoring and evaluating of programmes and 
activities. 
Figure 7. The centrality of the Central Technical Group 
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Source: Author's processing o/policy documents and technical reports 
The role of the CTG as the most central actor in the national programme was 
also reflected in the interviews with provincial RBM coordinators who are 
members of the CTG. Their responses point to the fact that the CTG is in the 
best position to play this central role since it is more connected with the policy 
making and policy implementing community. It satisfies the requirements of 
the global partners in the sense that it is answerable to the national RBM 
committee (not the Ministry of Health) where global, national and local 
partners are represented and should therefore be able to provide a more 
complete picture of what coordination mechanism ought to look like. 
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6.6 Conclusions 
This chapter has explored the role of the RBM model in shaping national 
health policy and local delivery practices on access to medication for malaria 
treatment and control in Cameroon. The analysis reveals that the national RBM 
programme is the embodiment of previously competing and conflicting models 
of public health, economic development and human rights in relating to malaria 
treatment and control. This finding enables us to make evaluative statements 
about the effectiveness of RBM in achieving its country-specific targets in 
Cameroon (reducing malaria mortality by 60% by 2010 through health system 
strengthening). The chapter highlights three key areas in which the challenges 
to achieving this global ambition can be assessed: the nature of stakeholder 
participation in the national RBM programme, the extent to which the RBM 
model deals with the barriers to access to medication for malaria treatment and 
control, and the effectiveness of transcalar networks created as a result of the 
RBM model in shaping different elements of malaria policy practices. 
In terms of stakeholder participation, the human rights narratives tend to 
dominate the PPP approach adopted by RBM. This is particularly evident in 
the participation of CSOs (especially local community groups) in policy 
making and implementation. The involvement of this previously marginalised 
group has benefited the programme in terms of ensuring that treatment 
programmes reach the poorest and most vulnerable segments of the population. 
Community groups have been mobilised, they are represented in national 
policy meetings, they are involved in sensitization programmes, and they even 
distribute medicines and ITNs to local households. The concept of human 
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rights as implicit in the PHC model called for this type of community 
mobilization and participation. Similarly, development policies of the World 
Bank had begun to advocate their participation as a way of correcting the 
governance gap in African countries (under the debt cancellation programme). 
The integration of these models is reflected in the PPP approach in which 
global, national and civil society partners associated with both models sit 
around the same table to formulate and implement malaria policy. The PPP 
element has also committed the state to RBM's strategic objectives; however, 
the goal of the neo-liberal model to promote good governance and to fight 
corruption produces new governance challenges that undermine the 
effectiveness of the programme. 
In terms of the relationship between GHPs and access to medication, the 
economistic narrative embodied in the RBM model dominates policy and local 
practices in Cameroon. National malaria policy is now dominated by issues 
around the modem and cost effective policy strategies, with limited emphasis 
on preventive measures that formed important elements of the PHC model. 
From the analysis in this chapter, access to medication is defined in terms of 
the availability and affordability of ITNs and anti-malarials (such as ACTs). 
From this perspective, RBM has so far been very effective. The evidence show 
how, through the technical assistance of WHO and UNICEF Cameroon is able 
to prepare robust grant proposal which has so far been very successful in 
attracting grants from the Global Fund and other donors. 
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Throughout the case study, it was clear that availability and affordability of 
malaria medicines in no longer a major barrier to access to medication in 
Cameroon. This also gives credit to negotiations between the National Drug 
Procurement Centre and individual pharmaceutical companies that participate 
in the RBM. Nevertheless, the incidence and burden of malaria has continued 
to rise and the RBM is far from meeting its country-specific targets. This is 
because, the elements from the public health model that emphasise behavioural 
and socio-economic determinants of access to medication (potential access to 
medication), has so far been neglected. Resource constraints (both financial 
and human resources) has been a maj or barrier to potential access to 
medication for several decades, yet the huge amount of funding that has been 
mobilized by the RBM is substantially devoted to medicines and ITNs (rather 
than for example strengthening human resources capacity of the national health 
system as a whole and promoting preventive measures that worked in previous 
malaria eradication campaigns in the western world discussed in Chapter 
Four). 
The RBM is also failing in the area of its core strategic orientation, namely, 
health system strengthening. At the national level, the RBM claims to provide a 
country-specific coordinated PPP. This is true in the case of the national RBM 
committee which is decently organized. The structure appears to be complete 
with specific roles allocated to specific partners and with global, national and 
local partners fully represented. However, at the 10calleve1, the outcome of the 
RBM model has been the creation oftranscalar networks involving overlapping 
malaria programmes and activities favoured by individual global partners. 
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While the initiators of these parallel initiatives arc members of the national 
malaria committee (where they gain legitimacy), these programmes arc neither 
accountable to the committee nor to the MoH. Thus, instead of 'health system 
strengthening' the RBM has further fragment the national health system 
introducing new coordination challenges; making it difficult to track trickling 
down of funding and equipment to overlapping initiatives. 
Since the RBM explicitly targets health system strengthening, the extent to 
which the structure of the national programme contributes to achieving this 
goal was explored further in the chapter. The analysis suggests that the Central 
Technical Group within the national programme is the most central actor 
capable of ensuring coordination. It provides the interface between the policy 
making community (the national RBM committee) and the policy 
implementation community (provincial and' district RBM units and parallel 
initiatives implemented by individual global partners). The capacity for 
learning across the global, national and local levels can be improved if the 
varieties of different stakeholders allow the central technical group to access 
their programmes and activities. Cross-scale linkages improve the quality of 
the governance process as it allows the national RBM programme to organize 
itself to increase its capacity for learning from the success and failure stories 
from overlapping programmes and activities. 
However, the extent to which the global partners are willing to render their 
parallel initiatives accountable to the Central Technical Group (and 
consequently the national malaria programme) seems less likely due to issues 
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around foreign policy diplomacy and the North-South divide. Thus, one could 
adequately gauge the feasibility of integration improving the effectiveness of 
the RBM. It will facilitate monitoring and evaluation and trickling down of 
money. However, integration goes somewhat against the neo-liberal market 
model, as this approach is preferred by multilateral and bilateral development 
agencies. The RBM could offer a 'technical fix' but investment into these 
programmes would have to be justified on a sustainability analysis. The 
likelihood of donors investing in programmers and activities that are of little 
interest to dominant partners (such as human resources), is limited due to 
historic and present conditions that favour large scale, resource rich partners. 
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CHAPTER 7: GHPS AND ACCESS TO 
MEDICATION FOR HIV/AIDS TREATMENT AND 
CONTROL 
7.1 Introduction 
This chapter describes the structure and operations of the National HIV/AIDS 
Programme in Cameroon as another example of how the embodiment of 
development models in a GHP model shapes national health policy practices. 
This globally-backed programme was launched after the Cameroon 
government endorsed two of the global models discussed in Chapter Four - the 
UNAIDS-Ied Accelerating Access Initiative (AAI) and MSF-Ied EAI. Both 
initiatives share a common objective, that is, to facilitate access to medication 
for HIV I AIDS treatment and control in developing countries. However, the 
nature of the public health, economistic and human rights narratives embodied 
within each suggest that they have different global strategies. While AAI 
emphasises discounted patent-protected drugs (emphasis on the economistic 
narrative), EAI emphasises the ability to pay irrespective of whether drugs are 
patent-protected or not (emphasis on the human rights narrative). In practice, 
however, proponents of both models claim that the models, apart from 
facilitating access to HIV/AIDS medicines and also contribute to health system 
strengthening. 
By bundling both AAI and EAI, Cameroon was able to position its national 
HIV/AIDS programme so that it found favour with pharmaceutical companies 
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producing patent-protected medicines as well as those producing generic 
medicines. Global partners affiliated with both models are members of 
Cameroon's national programme. From July 2002 Cameroon was being hailed 
by the main programme initiators as a success story in the global fight against 
HIV/AIDS in the developing world (UNAIDS/WHO 2002; MSF, 2002a). 
However, no empirical study has ever been conducted to test and assess these 
claims. Another objective of this chapter is therefore to present a detailed 
empirical case study to test and assess the role of the national programme in 
achieving country-specific HIV I AIDS treatment and control targets. 
The AAI and the EAI are examples of GHP models. They are hybrid networks 
in which different forms of knowledge come into play to shape the structure 
and operations of the National HIV/AIDS Programme. The economistic, public 
health and human rights narratives embodied within the two GHPs shape 
different aspects of policy making and implementation. This chapter highlights 
instances where each of the two global models are at their strongest and the 
context in which they are less relevant. Just as the case of the malaria 
programme described in chapter six, it then relates this to the global level in 
terms of what the GHPs claims to do and what they actually do; and what is 
needed for the national programme to achieve its objectives of serving the 
poorest people in the country on a sustainable basis. 
The empirical research is based on documentary analysis and analysis of 
qualitative interviews conducted with a wide range of partners involved in the 
national programme. The interviewees noted the daunting task to set up a 
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coordinated programme that takes both partners' strategic interests and 
country-specific needs relating to HIV/AIDS. This case study attempts to 
unpack the network of global, national and local partners by exploring the 
ways in which the knowledge (or narrative strategies) brought in by each 
partner contributes to policy making and implementation. The historical 
context of the fight against HIV / AIDS in Cameroon is presented followed by a 
description of the strategic objectives of the National 1IIV/AIDS Programme. 
The governance mechanisms (including a description of specific programmes 
and activities) are then discussed, including the nonnative and operational 
challenges facing the programme are then explored. Finally, conclusions are 
presented. 
7.2 The Historical and Political Contexts of AAI and EAI 
in Cameroon 
This section describes the historical and political context in which GHPs 
became involved in the fight against HIV I AIDS in Cameroon. The first AIDS 
case in Cameroon was diagnosed in 1985 (WHO, 2005a). Since that time 
hundred of thousands of cases have been reported (NACP, 2001) and 
HIV/AIDS is today considered to be a 'generalized epidemic' (WHO,2005a:l) 
with adult prevalence rates in the range of 4.8-9.8% (NACP, 2008:2). The 
political commitment of the Cameroon government in the fight against 
HIV/AIDS had international dimensions from the start (see Eboko, 2001). It 
involved the transfer of international health polices by the WHO and UNICEF 
(late 19805 and early 19905) and the translation of global health policies (the 
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emergence of GHPs in the later 1990s) to reflect country-specificities. The first 
National Programme for the Fight Against HIV/AIDS (PNLS) of 1987 
reflected guidelines of the WHO's Global Programme on Aids (GPA). In 1996 
when UNAIDS replaced the GPA, Cameroon quickly revised the PNLS into 
the National AIDS Control Programme in 1998 to reflect UNAIDS guidelines. 
In December 1999, UNAIDS Country Office was created in Cameroon headed 
by Dr Emmanuel Gnaore, a former Director of the National HIV/AIDS 
Programme in Ivory Coast and formerly UNAIDS Director for Madagascar. 
His role reflects the international dimension of policy transfer (discussed in 
Chapter Four) in which 'lessons learned' (from Ivory Coast and Madagascar) 
are shared with Cameroonian authorities to inform national HIV/AIDS policy 
practices. In June 2000, Dr. Gnaore in consultation with the Ministry of Health 
outlined the following key challenge in the fight against HIV I AIDS in 
Cameroon (translated from French): 
'This country has human resources and enormous competencies but it is 
very difficult for Cameroonians to work collectively ... It is unbelievable to 
realise that we are trying to put together competent Cameroonians in the 
domain of HIV I AIDS ... and that it is Cameroonians who have demanded 
that UNAIDS should be responsible for the fight against HIV I AIDS in 
Cameroon ... Everything happens as if each and everyone need a foreign 
partner to avoid doing it alone.' 108 
In this context, UNAIDS proposed a massive social mobilisation effort and 
became actively involved in negotiating HIV/AIDS policies with Cameroonian 
authorities. UNAIDS argued that its role was important to ensure that the 
existing instability and corrupt practices that existed in previous programmes 
108 Eboko, F. (2001) 'L'organisation de la lutte contre Ie sida au Cameroun: de la verticalite a 
la dispersion' In: Un systeme de sante en mutation: Ie cas du Cameroun (Changing a Health 
System: the case of Cameroon), Bulletin De L'APAD, No. 21, 
<http://apad.revues.org/document184.html#ftn6#ftn6> (Accessed: 30/03/08) 
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on HIV/AIDS would not give a negative political publicity to any future 
HIV/AIDS treatment and control activities. Using this argument, all projects 
related to HIV/AIDS carried the signature (or symbol) ofUNAIDS-CNLS (Le. 
both UNAIDS and a newly fonned National HIV/AIDS Committee) as well as 
mentioning the active role of specific UN agencies (UNESCO, UNICEF, 
UNDP, WHO and the World Bank) who created the MI. With the technical 
support from all these partners, Cameroon was able to define its long-tenn 
HIV/AIDS policy. The involvement of the most senior government officials in 
the politics of access to medication for HIV / AIDS in Cameroon is further 
evidence of strong political commitment. The Superior Council for Health 
decreed by the President in 1999 and headed by the Prime Minister defined the 
modalities for creating the national programme. 
Cameroon officially joined the MI in March 2001 after signing an accord with 
the five original participating phannaceutical companies. While the details of 
the accord was kept secret, a ministerial order announced in all national media 
declaring 76% reduction in the prices of ART to $IOOO/annum/person (NACP, 
2001). Joining the AAI was a very simple task as Cameroon simply had to 
present its revised national HIV/AIDS programme, which was already backed 
by UNAIDS, WHO and the World Bank as consistent with the key eligibility 
criteria: a 'high HIV/AIDS burden' (WHO, 2005a: 1), one of the 'hardest hit 
regions of the world,' a relevant health infrastructure and 'adequate' health 
system 'to handle the complicated HIV/AIDS medicines (UNAIDS/WHO, 
2002: Annex 1 :29). 
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The endorsement of the MSF-Ied Equitable Access Initiative (EAI) in April 
2001 is the third strand of the evidence of political commitment. In April 2001, 
MSF organized a conference in Yaounde, the capital of Cameroon and 
sensitised the Ministers of Health and Commerce of the OAPI109 countries on 
the question of patents and access to treatment within the framework of the 
Bangui Accords (MSF, 2002b). Challenging the economistic arguments of the 
AAI, MSF claimed that the alternative it offers, the EAI, ensures that even the 
poorest individuals could afford ARTs. The government of Cameroon (having 
previously signed the TRIPS Agreement), ratified the revised Bangui Accord 
that allowed least developed countries to import generic drugs (despite this 
being in defiance of the TRIPS Agreement). INGOs such as MSF had already 
pushed for this argument in WTO during the Doha Round of trade talks 
discussed in chapter four of this thesis. This position could not also be ignored 
by the WTO, as the World Bank's Debt Relief Program had classified 
Cameroon among the poorest countries in the world. In July 2001, under the 
EAI model, the government signed a deal with generic manufacturer Cipla for 
the acquisition of 15000 treatments at a price of $350/personlyear.110 
The above political commitment highlights the importance Cameroonian actors 
give to connections with global networks in the fight against HIV / AIDS. Here 
we see how drug pricing ( economistic narrative) tends to be at the core of 
negotiations initiated by both global AAI and EAI partners. Within five months 
the price of ART reduced from $1000/annum/person (adoption of the AAI 
109 OAPI is the African Intellectual Property Organisation for French-speaking Africa 
(http://www.hahn.co.zalpatent-services-oapLhtm) (Accessed: 23/12/2009) 
110 See Pharma-Policy (2001) 'Cipla To Provide AIDS Drug To Cameroon' 
<http://lists.essential.org/pipermaiVpharm-policy/200 I-July/OO 1 333.html> (Accessed: 
27/03/07) 
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model) to $300/annumlperson (adoption of the EAI model). It is therefore 
unsurprising that by July 2002 Cameroon was already a global success story in 
. the fight against HIV I AIDS credited in terms of such reductions in the costs of 
treatment. Global partners of AAI and EAI (and their narrative strategies) are 
members of the National HIV/AIDS Programme alongside national and local 
partners. A representative of Bristol-Myers Squibb (an AAI partner) justified a 
GHP approach as follows: 
'HIV/AIDS effects have hit hardest in countries that cannot tackle it on 
their own. It is not just about prices, infrastructure and whether medical 
professionals and nurses are paid the right salaries to ,administer the 
medicines. It is a combination of all these factors, which no one group - be 
it the pharmaceutical companies, UN, national governments - can address. 
That is why the fight r e ~ u i r e s s commitment from all these groups in a 
public-private partnership.' 11 
The national HIV/AIDS programme was officially launched in August 2001 
with a budget of $189 million over five years (NACP, 2001). This chapter 
unpacks the transcalar networks of global-national-local linkages through 
which the national programme attempts to achieve its objectives. 
7.3 Objectives and Structure of the National HIV/AIDS 
Programme 
The main objectives of the national programme are defined in the National 
Strategic Plan for HIV/AIDS for 2000-2005 (Table II). The plan laid the basis 
for introducing reforms in the following areas: creation of a national 
HIV I AIDS committee (the policy making community), specialised treatment 
centres for scaling up access to ARTs; programmes to strengthen the human 
111 Interview: Bristol-Myers Squibb, AAI pharmaceutical i'ndustry partner. 
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resource capacity; decentralization of implementation to rural communities and 
promotion of PPPs at all levels. 
Table 11. The National Strategic Plan for IIIV/AIDS for 2000-2005 
HIVIAIDS Policy Challenges HIVIAIDS Policy 
• Lack of general m o b i l i z a t ~ n n • Prevention using education & information 
• Insufficient program coordmation 
• Insufficient inter-sectoral implications 
-Scarcity of resources. 
• Medical and psycho-social support 
,. Safety of blood transfusion 
• Epidemiological surveillance 
Political Commitment 
• HIV/AIDS is the priority number one of the national health development plan 
• Reorganization of national HIV I AIDS program through a national committee 
• Increased budget allocation for the fight against HIV I AIDS 
• Multi-sectoral and decentralized approach 
• Development of a national strategic plan. 
Source: NACP (2001); WHO (2005a) 
As presented in Table 12 below, the partners, objectives and local interfaces of 
the national HIV / AIDS relates to five fundamental agendas: technical 
assistance, funding, advocacy, drug procurement and supply arrangements, and 
the provision of healthcare. 
The structure of the programme and the nature of multi-stakeholder 
participation is the same as that of the malaria programme described in Chapter 
6, that is, a policy making community, policy implementation community and 
the autonomous centre for drug procurement and distribution. The only 
difference is that not all the partners are the same. The next section explores 
the role of the different actors and the forms of knowledge that they bring into 
the national programme in shaping national policy and local practices on 
HIV / AIDS treatment and control 
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Tablc 12. Thc NationallIlV/AII)S }'rogrammc: promoters ulld objectives 
Global ROM Key Global Objectives NationallLocnl 
Tasks IJartners Partners 
Technical WHO, UNICEF, Defines national strategic National 
Assistance UNAIDS, plans; validates grant IIlV/AIDS 
Germany, France, proposals for submission to Committee 
MSF donors 
Resource World Bank, Mobilise funding and Central 
Mobilization Global Fund, human resources at global, Technical 
Germany, France national and local levels Group 
Community European Union, Monitor and supervise Treatment 
Mobilization INGOs & Private programmes; increase civil centres, local 
Foundations society participation and NGOs& 
awareness campaigns Associations 
Drug Pharmaceutical Procures drugs and National 
Procurement Companies distribute to treatment Essential Drug 
centres through provincial Procurement 
supply centres Centre 
Service Development Diagnosis and treatment, ProvinciaVdistr 
Delivery Agencies; lNGOs care and support for people ict units and 
& Foundations living with lIlY/AIDS parallel global 
initiatives 
Source: Author's analysis of policy documents and technical reports 
7.4 How GHP Models Shape HIV/AIDS Policy Practices 
The AAI and the EAI model have both played important roles in shaping 
national policy practices on access to medication for HIV / AIDS in Cameroon. 
The policy framework for HIV I AIDS in Cameroon is shaped by a combination 
of public health, human rights and economistic narratives embodied within 
AAI and EAI. This takes place during periodic meetings between global, 
national and local partners within the national committee. 
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7.4.1 Technical assistance 
Technical assistance involves the transfer of normative guidelines from the 
global to the national context through the national committee. During 
committee meetings issues such as the findings from situation analysis at local 
levels and lessons learnt from other countries are discussed in the context of 
OHP guidelines. Under the leadership of UN partners to the AAI (WHO, 
UNAIDS, UNPF, UNDP, FAO and UNICEF) technical assistance is 
complemented by two main bilateral donors (France and Germany), small scale 
support from others western government (e.g. Belgium and Canada) and 
!NOOs (the most dominant of which is MSF). 
The policy making community is dominated by global partners of the AAI. The 
focus areas of policy include developing (or revising) HIV/AIDS health plan 
within the AAI and EAI frameworks; elaborating policy and strategy 
documents and guidelines for treatment and control of HIV I AIDS and other 
sexually transmitted diseases; technical support and catalytic funds to create 
and equip specialised treatment centres within WHO's guidelines; 
strengthening human resource capacity; guidelines to undertake situation 
analysis for procuring and distributing ARTs and implementing 
recommendations; developing and implementing the Global Fund proposals 
(WHO, 200Sa). 
The EAI partners use their human rights narrative to ensure that global 
normative guidelines reflect human rights principles (by reflecting actual field 
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conditions or country-specific contexts). In this context MSF is the most 
important global civil society partner of the National HIV/AIDS Committee. 
'We share experience on practical inputs on field conditions. 
Sometimes authorities have different agendas. Their concern may not 
be that they want things to work well but that they want results to 
present to donors and have more money. MSF helps authorities to take 
decisions that are based on actual field cases.' 112 
7.4.2 Resource mobilization and funding 
Once the national frameworks have been agreed on the basis of the technical 
. 
directives and advice above, resources are then mobilised for execution. 
Resource mobilization occurs at the global, national and local levels. At the 
global level, the Global Fund and the World Bank are the most important 
donors. The Global Fund provides funding based on the presentation of a 
robust grant proposal that is expected to be consistent with the National 
Strategic Plan Against AIDS. Since the grant proposal is validated by the 
national committee it is assumed to have the backing of all global, national and 
local partners of the national programme. The Global Fund also requires grant 
proposals to demonstrate a high level political commitment (evidenced by both 
Cameroon's President and its Minister of Health getting involved in 
mobilisation and making their national contribution to the fund). The Global 
Fund also emphasises that grant proposal should demonstrate evidence that 
HIV/AIDS campaigns target the most vulnerable parts of the country. 
112 Interview with MSF 
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Since the Global Fund provides funding based on the presentation of a robust 
grant proposal, not all the amount requested is approved. 1l3 For example 
according to WHO (2005a), Global Fund Round 3 approved US$ 14.4 millions 
(out of US$ 55.7 million requested) for scaling up treatment and care for 
people living with HIV I AIDS and support for orphans and vulnerable children 
while Round 4 approved US$ 6.3 million (out of US$ 16.3 million requested) 
to strengthen the participation of CSOs in the fight against AIDS in Cameroon. 
As already mentioned, Cameroon benefited from the World Bank's Debt 
cancellation initiative. The funds released represent the largest proportion of 
funding mobilised at the national level to support prevention and case 
management activities. The Government has consistently increased funding for 
HIV since 1995 and as part of the National Multisectoral Strategic Plan for 
HIV I AIDS through various government ministries for HIV / AIDS 
interventions. For example, the government has committed to provide US$ 1.0 
million each year to support scaling up antiretroviral therapy during 2000-2004 
and US$ 16.6 million for 2004-2005 (WHO, 2005a). In addition, the World 
Bank Multi-Country AIDS Program (MAP) for Africa launched in 2005 also 
provide additional financial support of US$ 50 million to Cameroon for public, 
private and community-level planning of HIV/AIDS activities, training of 
medical personnel and communication activities related to behaviour change 
(WHO, 2005a). 
113 See for example see funding decision and distribution of funds on Global Fund website: 
<http://www,theglobalfund,orglprograms/grantl?compid=609&grantid=285&lang=EN&Count 
ryld=CMR> (Accessed: 30/03/07) 
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A substantial part of World Bank's funding is expected to be contributed by the 
Cameroon itself under the World Bank's debt relief programme. This involves 
converting part of its debt relief proceeds into a fund for the national 
programme. This means that, in terms of funding for HIV/AIDS, 'Cameroon 
has on its own budget only 5% dependent on external support,1l4. A proportion 
of the HIPIC fund is thus allocated to the national HIV/AIDS programme. This 
amount is mobilised at the national and local level through 22 supporting 
government ministries and other public structures. Funding is also provided by 
bilateral and multilateral partners such as GTZ, French Corporations, MSF and 
international foundations directly through the national programme or indirectly 
through their own initiatives with local partners in various regions of the 
country. Resources mobilization takes into account the financial costs of 
treatment (before HIV/AIDS became free of charge) and non-financial 
contributions such as volunteer activities (through NOOs and community 
associations) at national and local levels. 
7.4.3 Drug procurement and supply arrangements 
One of the key global challenges in the fight against HIV/AIDS is the high 
costs of medicines and care facilities. Most of the funding for the national 
programme is devoted to payment for subsidised drugs. The CENAME, the 
focal point for the entry of HIV I AIDS medication into Cameroon was creatcd 
in 1997 with funding from the European Union (through the GTZ and the 
French Cooperation). The conditions for this funding required the government 
to create specialised Provincial Phannaceutical Supply Centres (PPSC) and to 
ensure that drug distribution reflected the pluralistic nature of Camcroon's 
114 Interview: German Development Cooperation (GTZ) 
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health system. Following the launching of the national strategic plan for 
HIV I AIDS in 2000, the Minister passed a convention aligning drug prices 
(specialties and generics) in PPSCs to those of CENAME, as recommended by 
the WHO. The WHO (200Sa) explains that this re-centralization brought about 
substantial fall in prices within the PPSCs. With the monopoly of the 
CENAME guaranteed, it became easier for the question of HIV I AIDS 
medication to be put on the national policy agenda by the UN-led AAI. 
The GHP approach to the fight against HIV/AIDS in Cameroon was dominated 
by the economistic model from the start. The shared view among the global 
partners interviewed is that 'the original argument was that the primary barrier 
to medication was affordability and a lot was needed to make medicines more 
affordable to countries that are hardest hit by HIV/AIDS,lls. This view is 
similar to those of national and local partners. It therefore suggests that the 
global economistic narrative was fully embraced in Cameroon. Local partners 
(in this case the medical practitioners who already had encounters with 
suppliers of HIV I AIDS medicines before the launching of AAI and EAI) were 
invited to contribute to policy formulation. 
, After consulting the Minister of Health, he (Permanent Secretary of the 
National HIV/AIDS Committee) called a meeting in October 2000 with 
all the prescribers working in the country and asked them to formulate 
their needs for ARTs in order to establish a protocol of payment. He did 
not even know the addresses of suppliers. After establishing the 
protocol, CENAME wrote to the different ~ h a r m a c e u t i c a l l companies 
(in the AAI) that were manufacturing ARTs.' 16 
The global framework established by the AAI model is that negotiations on 
drug procurement and supply arrangements must only take place through 
115 Interview: Bristol-Myers Squibb 
116 Interview: National Drug Procurement Centre (CENAME) 
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bilateral negotiations between pharmaceutical companies and national 
governments. As mentioned in chapter four, critics of the AAI claim that 
bilateral negotiations open disease-endemic countries to expensive patent-
protected drugs from monopoly pharmaceutical company partners. In the case 
of Cameroon, the human rights narrative embodied within the,EAI model serve 
to gloss these dominant arguments. As already mentioned, using the MSF-Ied 
EAI model, Cameroon was able to procure from generic manufacturers (such 
as Cipla) at cheaper prices (compared to AAI companies) thereby increasing its 
choices of pharmaceutical companies. Both generic competition (the EAI 
model) and discounted drug pricing (AAI model) enabled Cameroon to 
overcome drug prices as a major barrier to actual access to medication: 'the 
cost of ART and immunotherapy that was 700.000 FRS, dropped to 200.000 
FRS then to 78.000 FRS, 24.000 FRS, 15.000 FRS; 3.000 FRS then to 700 
FRS and now it is free of charge. lt7 
It is interesting to note that the decision to procure from generic manufactures 
was not forced on to Cameroon by proponents of the EAI model. It simply 
served as a window of opportunity in the face of structural problems with drug 
procurement and supply arrangements with MI pharmaceutical companies. 
'The five (AAI partner) companies that agreed to significant reduction 
in prices could not fully meet the high demand. Several months' 
deadlines for supply were announced creating a risk of interruption in 
general supplies a few months after the announcement of price 
reductions. It was then that the idea of approaching finns making 
generics in Asia was envisaged. This immediate emergency solution, 
applied in disregard of the accords on intellectual property (TRIPS) and 
of those made with firms within the framework of the AAI became an 
additional response.' 1 18 
117 Interview: Provincial IIIV/AIDS Unit, North West Province 
118 Interview: CENAME 
The above quotation contributes to explaining the dominance of the 
cconomistic narrative in the practical steps of formulating HIV/AIDS policy. 
Even the procedure of the EAI model (that claims to promote human rights) 
uses economistic language (generic competition) to achieve its goal. Having 
agreed on drug procurement and supply arrangements, the next challenge for 
the national programme is to ensure successful implementation. This is 
coordinated at three levels, namely central, provincial and district levels 
respectively. 
Just as the National Malaria Programme (chapter six) the Central Technical 
Group is responsible for coordinating policy implementation in the national 
HIV/AIDS programme. It coordinates and supports specialised treatment 
centres, districts health centres and clinics that provide HIV / AIDS treatment, 
support and counselling. Many other international private and civil society 
(international NGDs and Foundations, research and academic institutions, 
private firms) are involved at various levels of the national programme through 
parallel initiatives at local levels. The next section describes some of these 
programmes and activities. 
7.5 National HIV/AIDS Programmes and Activities 
The AAI and the EAI models did not only shape policy practices in the area of 
developing national strategic plans for HIV / AIDS and drug procurement and 
supply arrangements as discussed above. They also shaped policy 
implementation at national and local levels. In order to illustrate this, the 
following section describes the ongoing fight against HIV / AIDS in Cameroon 
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focuses on how the treatment and control efforts are shaped through the 
creation of transcalar networks with global-national-local linkages (the 
interplay of actors and their narrative strategies in relating to access to 
medication) within the national programme. Two provinces, namely, the 
Centre Province (with capital Yaounde) and the North West Province (with 
capital Bamenda) were the focus of investigation. The fonner is the capital of 
Cameroon with the most advanced and well developed hospitals and 
phannacies in the country, and also home to pioneer projects on HIV/AIDS 
created before the deployment of GHP programmes. More than 40 per cent of 
treatment centres created by the end of 2001 were based in this province 
(Eboko, 2001). On the other hand, the North West province is one of the 
poorest regions in Cameroon and got its first treatment centre at the end of 
2001 (after the creation of the national programme). Thus the North West 
Province illustrates the decentralization of programmes to the poorest and most 
vulnerable parts of the country. 
7.5.1 Specialised treatment centres: the Day Hospital of the 
Yaounde Central Hospital 
The Day Hospital was opened in 1998 with funding assistance from the French 
Cooperation, in view of France's colonial interest in Cameroon. It is the 
pioneer project for the introduction of HIV/AIDS medicines such as ARTs in 
Cameroon through privately negotiated prices with phannaceutical companies. 
The major barrier to access to medication at that time according to a senior 
phannacist at the centre was the exorbitant prices of drugs: 
'Because the prices ranged between 400.000 and SOO.OOOFCFA, the 
question of high costs of ARTs was quickly put on the table with the 
doctors of the Day Hospital and those of the PTME Programme of the 
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Centre Pasteur in order to undertake a joint negotiations with 
pharmaceutical companies to obtain specialties directly from them. In 
April 2000 the efforts led to six therapeutic protocols costing 235-300 
thousand FCFA a month. Very quickly, increasing numbers of 'rich' 
patients from many provinces of the country including some from 
. hb' . . h ti ' 1 l ~ ~nelg ounng countnes were commg ere or treatment. 
The above quotation is consistent with the AAI argument that drug prices were 
the major barrier to access to medication. In March 2001, the National 
HIV/AIDS Programme accredited the Day Hospital (alongside 16 others in the 
country) as the first specialized treatment centres. In addition, the hospital's 
pharmacy became the national distribution site for ARTs. Specialized 
personnel were appointed in CENAME to handle drug procurement issues with 
the Central Hospital Pharmacy. A Therapeutic Committee, seconded by an 
Ethical Committee, was quickly put in place to establish and implement the 
best ART protocol for each patient. 
In December 2001, CENAME replaced the Day Hospital and all treatment 
centres in the country now had to procure drugs through CENAME. This is one 
area where the global partners were quite successful in shaping local practices. 
As mentioned earlier, agreement had already be reached with AAI (March 
2001) and EAI (July 2001) pharmaceutical companies for the supply of patent-
protected and generic medicines respectively. Thus by the time the CENAME 
gain its monopoly status in the country it was already ready to handle drug 
procurement and local distribution by virtue of it being created by the upgrade 
of a private drug procurement centres. The rate of price falls that followed 
illustrates how the human right narrative (generic competition) forced 
119 Interview: Yaounde Central Hospital, Centre Province 
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proponents of the economistic narrative (discounted drug pricing) to resort to 
drug donation programmes (with funding from World Dank and Global Fund). 
Increasingly, high drug prices (affordability) quickly became irrelevant as a 
major barrier to access to medication in Cameroon. An employee at the 
Yaounde Central Hospital noted that the GHPs are late movers in the case of 
the fight against HIV / AIDS in Cameroon: 
'While they were wondering over there (GlIP at global level) whether 
or not ARTs are feasible in countries like Cameroon, for us in the field, 
that question was irrelevant since we saw that there were already people 
on ARTs here and that people could do things by themselves in this 
country. It was necessary for us to quickly put in place structures to 
minimize the threat of HIV / AIDS ... I believe we were pioneers.120 
The above example illustrates the importance of involving local actors in 
policy formulation and implementation. In this case, the local medical 
practitioners played a crucial role both in setting the stage for the deployment 
of GHP programmes and in supporting the national and global agenda. 
However, a major requirement of both AAI and 'Equitable Access' partners is 
the involvement of the civil society (especially the 1IIV/AIDS patients) to 
participate in policy formulation and play leading roles in implementation. 
However, unlike the medical practitioners, the next sub-section illustrates that 
the civil society was barely consulted in the events leading to the launching of 
the national HIV / AIDS programme. 
7.5.2 Decentralization to the poorest and most vulnerable 
regions: the case of North West Province 
A 1996 study indicates that it was a pregnant Woman who first contracted the 
HIV/AIDS in the North West Province (Eboko, 2001). Current estimates reveal 
that the province has the highest infection rate in the country of8-10% (NACP, 
120 Ibid 
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2008). The first efforts to combat lIlV I AIDS were the creation of an NOO 
called Fight Against Aids and Sexually Transmitted Diseases (FAAS)121 in the 
late 1990s by the Provincial Delegates for Public Health and National 
Education respectively, with technical assistance from the WHO and UNICEF 
country offices. As one would expect, given the WHOIUNICEF involvement, 
the public health model was deployed focusing on sexual behavioural changes 
(HIV/AIDS prevention). By 2000, FAAS had created and coordinated 58 
'Health Clubs' in schools and local communities. A secondary/high school 
biology teacher was appointed as the head of each club. The programme 
involved on and off campus sensitisation campaigns, distribution of condoms 
and counselling, seminars to develop educational programmes on good sexual 
behaviour. Similar types of health clubs were created throughout the country 
but taken more seriously in the poorer provinces such as the North West 
Province. 
In 2000, FAAS launched a 'Vaccine Project' for HIV/AIDS polytherapies 
sponsored by Missouri State University (from USA) and authorised by the 
Ministry of Public Health122. A local epidemiologist was assigned to prescribe 
treatment using 'clinical guidelines' from Missouri State University, while a 
medical doctor from the national Teaching Hospital in Yaounde visited once a 
month for consultation. The role of the local civil society was now restricted to 
compliance (local epidemiologist complies with international organizations 
while local citizens comply with epidemiologists instructions). The emphasis 
on access to medication swiftly shifted from preventive strategies in the 
121 For more on the FAAS project see Eboko (2001) 
122 For details on the transformation from FAAS to specialised HIV/AIDS projects see Eboko 
(2001). 
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'Health Clubs' to a technical fix (identifying and treating cases) within a FAAS 
centre. During the fieldwork for this research, not a single functioning health 
club could be located in schools and the community. In addition, the project 
was not implemented using the structures of the national health system 
(provincial and district hospitals and pharmacies). It was implemented in a 
specialised centre created with funding and guidelines from the global partners 
mentioned above. When asked why global partners should bypass the 
provincial delegation for public health, a senior member in the delegation 
explained as follows: 
'They (international organizations) work with the government and the 
Ministry of Health. What we are doing is to ensure that the prices and 
the treatment costs which are the key to facilitative access to 
medication, are effectively respected and at the levels and different 
sectors of the province as well as the essential drug list of the WHO.,123 
This above quotation suggests that the provincial delegate for public health 
who is responsible for translating national policies into operational strategies 
within the province has no direct influence on the national HIV/AIDS 
programme. Talking to members within the delegation and reading through 
policy documents and technical reports in the secretariat, it was clear that the 
delegation strictly operates within the guidelines of the national health system 
(defined on the WHOIUNICEF-led PHC model). As was discussed in Chapter 
Five, this seems obvious. The deployment of GHP programmes led to the 
creation of parallel systems (for HIV / AIDS, malaria and TB). This means that 
the provincial coordinators of GHP programmes in each of these disease areas 
effectively represent Provincial Delegates for HIV/AIDS, Malaria and TB 
respectively. This distinction, as well as HIV/AIDS treatment and control 
12l I . P . . I 0 I . Ii P . ntervlew: rOVInCla e egatlOn or ublic Health, North West Province. 
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through the national HIV I AIDS programme are substantiated in the next 
section. 
7.5.3 Specialised treatment centres in the North West 
Province 
Following the launching of the national HIV/AIDS programme in November 
2001, the FAAS (and the Health Clubs) were replaced by accredited treatment 
centres under Provincial HIV I AIDS Control Units. These centres report to the 
Provincial HIV/AIDS Co-ordinators (who are also representated in the Central 
Technical Group) and therefore not answerable to the Provincial Delegate for 
Public Health. The role of the provincial units can be described as follows: 
'We build the capacity of different HIV/AIDS treatment centres, health 
units and other sectors that provide access and treatment for HIV/AIDS. 
Treatment centres provide pre-therapeutic wakeup test and other 
services to patience and the National HIV/AIDS Programme through 
our office reimburses their expenses. We recruit, train and pay 
community agents at different levels who provide home-based care. All 
our treatment centres do not only offer HIV I AIDS testing and treatment 
they also offer support programmes and activities, for example to 
prevent mother-to-child transmission.' 124 
During the process of interviewing the above respondent it became clear that at 
the provincial level the nature of the ppp. approach is dominated by the 
economistic model. PPPs promoted by GHPs are meant to be mechanisms for 
public-private cooperation where public, private and civil society partners 
share the responsibility for financing and delivering a particular public service 
(Buse and Walt, 2000a, 2000b; Buse and Harmer, 2007). This works in the 
case of the national committees. The participation of HIV I AIDS patients and 
other civil society partners is meant to ensure that the human rights narratives 
124 Interview: Provincial H1V1AIDS Control Unit, North West Province 
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are also taken into account. In the case of the provincial IIlV/AIDS 
programme, what we see is a classic PPP mechanism, known as 'contracting 
out', where the government defines a particular public service in a contract and 
pay a private (or NGO) partner that is selected in open competition to deliver 
the service. 
This distinction is clearly evident in the distribution of treatment centres to 
satisfy the multiple and pluralistic nature of Cameroon's national health system 
(consisting of public, private, religious and communitylNGO health centres 
and phannacies). To be eligible as an accredited treatment centre, public 
hospitals are fully financed by the National HIV/AIDS Programme. However, 
private, religious and civil society sectors must create a fully equipped site 
before getting approval to operate as an HIV / AIDS treatment centre. The 
following owner ofa private HIV/AIDS treatment centre explained this process 
as follows: 
'We equip our laboratory, train our staff and then invite the national 
committee to come and inspect. If they are satisfied, you arc approved 
as an HIV/AIDS treatment centre. For public centres, government 
decides that they want a particular site to be a centre and then provide 
equipment and staffing. So you can say that we the private hospitals are 
doing more of a philanthropic activity. ,12S 
The above quotation reveal why certain profit-making and civil society health 
units look to global private and INGO partners associated with the AAI and the 
EAI for funding support as well as direct support with treatment and care for 
HIV/AIDS patients and HIV positive persons. Firstly, the high costs of creating 
and equipping a treatment centre for IIIV I AIDS is well beyond the financial 
12' Interview: Bamenda Polytechnic and State Hospitals 
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limit of most private hospitals, let alone local NODs, in Cameroon. Most of the 
non-public health units visited talked about various international organisations 
from whom they get their funding through grants and proposals. 
A variety of cross-partner initiatives under the guidance of various 
international agencies that use either the 'Accelerating Access' or 'Equitable 
Access' approaches have been established with non-public hospitals. Their 
participation is often cited by the national programme as additional support in 
meeting HIV I AIDS targets; increase the capacity to sustain ART and testing 
programmes, and promoting the PPP approach. Some of these global partners 
operate their own parallel treatment centres independently of the national 
programme committee. They gain their legitimacy as members of the national 
programme because they participate in meetings organised by the national 
committee. Some of these initiatives are discussed below. 
7.5.4 Parallel HIV/AIDS programmes and activities 
As mentioned above, many global partners, in addition to their role as members 
of the National AIDS Control Committee, implement their own programmes at 
provincial and district levels. The cases examined here are in no way exclusive, 
they only serve to highlight the contribution of these parallel initiatives and to 
highlight the perceived governance challenges. 
The role of international CSOs: the case of Medecin Sans Frontiere 
As discussed earlier, MSF is one of the most important in international civil 
society partners to the National HIV I AIDS Programme in Cameroon. Its role is 
not only limited to helping the national programme to procure cheap generic 
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drugs under the EAt and sharing field experiences with the national committee. 
MSF also uses its human rights narrative as a justification for operating its own 
HIV/AIDS treatment and care centres in various parts of the country. 
According to MSF, the key is to scale up access to medication for the poorest 
people, rather than spend too much time negotiating partners' interests. 
'For HIV/AIDS many studies confirm the difference in outcome for 
people who should pay to enable cost recovery and ensure 
sustainability. If we focus on this debate no one will be treated. Multi-
partner interventions for HIV I AIDS arc a much larger scale and very 
complicated. Each partner has its own agenda, political and operational. 
These different strategic interests and constraints sometimes weaken 
coordination mechanisms. ,126 
The above quotation is very interesting. One would expect, from the GHP 
approach (supported by MSF) that the field experiences of MSF would be of 
benefit to the national programme in terms of aligning programme objectives 
and partners' interests. Surprisingly, MSF also bypasses the national 
programme to work directly with local organisations. Between 2000 and 2002, 
it initiated projects in selected treatment centres with local community groups 
in selected regions of the country (MSF, 2002b): 'The doctors of MSF in the 
field were seeing many patients dying of AIDS. It was the main cause of 
mortality in some countries. You can do a lot of prevention and support but at 
the end of the day you see people dying. This is what pushed MSF to get 
directly involved.' 127 
Clearly, CSOs such as MSF also pursue a narrow medical intervention 
strategy. Talking to employees at the MSF country office in Yaounde, they 
noted that the role of MSF is very different in different settings depending on 
what other partners are doing. However, being a medical organization, the 
126 Ibid 
127 Ibid. 
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main focus is diagnosis, treatment, follow up and to a limited extent 
'preventive and support activity for which we prefer to work in partnerships' 
(Ibid). On the country-specific relevance of the national IIIV I AIDS 
programme, the position of MSF is that the approach adopted by GHPs was not 
adapted enough to the field conditions in Cameroon: 'A local response, if done 
correctly, not like the World Bank put it in place, can create a health system 
that responds to the needs of those who use it.' 128 
MSF is a strong critic of GHPs such as the AAI; however, its strategic 
interventions are consistent with the global agenda promoted by GHPs 
especially in tenns of an assumed leadership role for programme 
implementation to local CSOs which bypasses the bureaucratic structures of 
the state. In practice, then, their criticisms of governance through a centralised 
network are not entirely consistent with their actions at the local level. 
A complex global-local linkage: the National Social Marketing Programme 
This programme was set up in 1989 by a US-based INGO, Population Services 
International (PSI) with initial funding from USAID. A local NOD, the 
National Social Marketing Association (NSMA), was created to implement the 
project. The programme set out a public health approach to fight HIV / AIDS. In 
practice, however, its initial strategy based on HIV I AIDS prevention 
increasingly became dominated by the econoministic emphasis on 'marketing 
strategies to promote cost-recovery sales of condoms rather than the public 
health issues' (GTZ 2004:3). 
128 Ibid. 
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The changing nature of the NSMP (Table 13) rcvcals the complex nature of 
stakeholder participation in the sense that the local partner (NSMA has to deal 
with multiple objectives and directives from different western donor agencies 
simultaneously. There arc mUltiple objectives attached to specific funding 
sources (e.g. USAID, GTZ and Gates Foundation). 
Table 13. Time line of the National Social Marketing Programme 
Time Local Strategic Objective Funding 
Partner Agency 
1989 PSI & Reduce transmission and unwanted pregnancy USAID 
to NSMP though cost-recovery sales of condoms and 
1995 counselling services 
1992 PSI & Fonnal recognition by Ministry of Health as USAIDS 
NSMP partner to the then national programme in 
charge of condom distribution 
1996 NSMP HIV/AIDS prevention through family planning, USAIDS 
to community mobilization and social marketing 
2003 
Since NSMP Research and address misconception about Gates 
2001 condom use to specific target groups with Foundation 
skilfully targeted messages. 
Since NSMP Promote social change and mobilization of GTZ 
2001 vulnerable groups to achieve integrated 
HIV/AIDS control 
Source: Based on PSI (2004), 012 (2004), lIandysidc ct al., (2004) 
The programme is cited in all policy documents as a major civil society 
contributor to the national fight against HIV/AIDS. The usc of local NODs to 
sell and distribute condoms is consistent with the global human rights agenda 
for civil society participation. Its support for teenage mothers appears on the 
spectrum of preventive measures while access to donor funding, mobilization 
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of households to buy and use condoms, and sensitization programmes with 
local communities are behavioural measures that serve to overcome taboos and 
stigmatization, making condom use more sustainable. These are important 
public health measures that implicitly take human rights principles into 
account. The influence of the economistic models (the neo-liberal market 
model advocating bypassing the state) has been described by GTZ (2004:3) as 
follows: 
'The understanding that ministries or the public sector should finance 
and deliver all services is disappearing in favour of a more pluralistic, 
multi-stakeholder approach. There is now increasing support for ... the 
family planning franchising model of NSMP. Along the same line 
(there is) a co-operative health insurance scheme (that) is drawing on 
the experience ofPMSC for its marketing' 
More crucially, the nature of funding (bilateral development agencies that are 
global GHP partners provide funding) is what defines the strategic objectives 
of the programme rather than the local implementing organizations deciding on 
the basis of local conditions. Apart from this indirect involvement (providing 
funding and directives) these programmes overlap with those created by the 
national programme and also bypass the ministerial structures of the state. 
The role of bilateral development agencies: German Development 
Cooperation 
As the official first colonial master of Cameroon, Gennany has a long standing 
bilateral cooperation with Cameroon including health policy (and recently 
HIV/AIDS129). As Gennany's official implementing body, the Gennan 
. 
Development Cooperation (GTZ) has been operating in Cameroon for over 30 
129 For a brief description ofGTZ's HIV/AIDS programme in Cameroon see the project 
website: <http://www.gtz.de/enlweltweitlafrikalkamerunlI6978.htm> (Accessed: 15/02/09) 
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years. It continually aligns Germany's long standing technical cooperation with 
the mutually agreed priorities of both governments. In the case access to 
medication, GTZ stresses the need to adopt measures aimed at addressing the 
very high doctor-to-patient ratio and bottlenecks in the supply of drugs and 
medical equipment in state-run clinics (GTZ, 2008)130. In relation to the fight 
against HIV/AIDS, 'if the Cameroon government asks the Gennan government 
for assistance and we think we are able to do so then GTZ is the implementing 
agency ... GTZ is not a donor. t131 Thus, although GTZ is a global partner to 
the national programme (by virtue of being represented in the national 
committee and attending meetings), it implements its own HIV/AIDS related 
programmes with community organizations in four provinces (Littoral, South 
West, North West and Centre provinces) independently of specialised centres 
created by the national programme: 
'GTZ executes activities that have been negotiated between the two 
governments. We collaborate with many referral, faith-based hospitals, 
self-help groups with HIV/AIDS patients, groups with young mothers 
to prevent mother to child transmission at the 10calleveI. The question 
as to why we are focused on those sub-sectors is historical but also due 
to the access situation .... You have a problem with HIV/AIDS, access 
to health insurance, drug supply and so on. ln 
The historical motive mentioned in the above quotation relates to the fact that 
GTZ had already begun implementing its activities before the launching of the 
globally-backed national HIV / AIDS programme. Instead of promoting a 
decentralised coordination agreed by the national 1IIV/AIDS committee (of 
which GTZ is a member), the GTZ favours it own strategic directives. 
130 GTZ (2008) 'Priority Areas for Cameroon' 
<http://www.gtz.de/enlweltweitlafrikalkamerunlI311.htm> (22/11/08) 
131 Interview: GTZ 
132 Ibid 
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'One of the most important ideas is that ownership (of HIV/AIDS 
treatment and control) should belong to the Ministry of Health. 
Ownership also means dealing, piloting and orienting. The Ministry of 
Health is not playing this role. I will not say this disrupts the donor 
treatment but there is still some work to do for the Ministry to really 
claim influence in global alliances.' 133 
Germany is a major supporter of the community model promoted by the World 
Bank to correct government and market failures by given more power to the 
private sector and CSOs. From this perspective, it was observed during the 
fieldwork that the pharmaceutical supply centre in the North West Province 
(North West Special Fund for Health) was created with direct technical and 
financial support from GTZ (a German-Cameroon Project). It is an 
autonomous parastatal structure operating under the Ministry of Health but 
whose budgetary allocations are determined by funding from the GTZ and 
mark-up profits from sales of drugs to provincial and district public and private 
hospitals. This project reveals key areas in which country-specific challenges 
were ignored during the creation of the national programme: 
'Attention was not given to the drug procurement chain (when the 
national programme was created) because the private structures were 
. set up even before the government set up its own structures (Le. the 
CENAME). And when government set up its own structures it failed to 
give a look at the private structures,134 
The above quotation illustrates how the GIZ, which claims to offer technical 
advice to the national HIV/AIDS committee, ignores the need to integrate 
overlapping programmes. In terms of who is responsible for integration, the 
position of GTZ is that 'it is the government that is responsible for the national 
health system, not the partners,13s. Yet, the national committee is unable to 
133 Interview: GTZ 
134 Interview: North West Special Fund for Health (German-Cameroon Project) 
m Interview: GTZ 
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decide let alone supervise the activities of global partners such as OTZ. This 
criticism is meant to highlight the often overlooked challenges caused by a 
failure to create a centrally connected national programme promised by OUPs; 
it does not undermine the enormous contribution of the OTZ in the fight 
against HIV / AIDS and other diseases in Cameroon. 
The same type of discussion can also be made for the French Cooperation, 
again due to France's position as a former colonial master. Similarly, there are 
many other overlapping programmes and activities on HIV/AIDS treatment by 
various bilateral agencies and private foundations that bypass. the national 
programme. By operating in parallel to the existing primary healthcare system, 
one would expect to see that the institutional instability and corrupt practices 
would be avoided in the national programme. In addition, the involvement of 
bilateral agencies and INGOs that were already present in the country in the 
creation of the national programme ought to imply an integration of their 
existing programmes and activities to promoting a decenlra/ised coordination, 
defined in the national strategic plan. However, as discussed above, policy 
implementation focuses on verticalising strategic directives of international 
organizations, concentration of bilateral development agencies in areas where 
they have their own strategic interests and the absence of projects in provinces 
that are not covered by partners. 
7.6 Challenges facing the National HIV/AIDS Programme 
The analysis from the preceding sections suggests that many of the institutional 
and healthcare problems in the national health system of Cameroon were 
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largely ignored in setting up the National HIV/AIDS Programme. The impact 
of GlIPs on access to medication for HIV/AIDS is scattered in technical 
reports or internet sites of parallel initiatives that are hardly updated. This 
makes it virtually impossible to compile a comprehensive statistical overview 
of the burden and prevalence of HIV/AIDS, the number of programmes and 
activities, the extent and sources of funding and a measurable impact of the 
programme on HIV I AIDS treatment and control. 
However, the few projects described above do illustrate that there is a 
considerable overlap in the development of the infrastructure necessary for the 
national HIV I AIDS programme. All the interviewees were aware of the fact 
that greater impact could have been achieved if programmes and activities 
were linked more consistently to each other, for instance, within the framework 
of the national programme. The national normative framework of the national 
programme as highlighted by the interviewees requires two broad conditions to 
be satisfied: 1) absorption of resources to meet HIV I AIDS treatment and 
control targets in relation to the nature of the HIV/AIDS problem and 2) 
integration of overlapping initiatives into a coherent national HIV I AIDS 
programme and subsequent integration into a strengthened national health 
system. This is crucial for 'localizing' the national HIV/AIDS programme. 
7.6.1 Participation in the National HIV/AIDS Committee 
From policy documents and technical reports, it is evident that there is a fair 
distribution of power amongst the different partners in the national programme. 
This is seen in the way global, national and local partners are spread across the 
programme with no single, dominant player. In addition, the fact that the 
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national committce is defined as the state is related to the liberal argument 
about the need for government to be replaced by governance. It reveals that the 
bureaucratic structures of the state have been eroded with more decision power 
residing with the committee (policy making) and global promoters of parallel 
initiatives (policy implementation). While these same observations were made 
in the national malaria programme (presented in Chapter Six), this case study 
on the national HIV I AIDS programme reveals how the human right principles 
of community participation embodied in GHP models are ignored as civil 
society plays more of a compliance role. 
In the area of drug distribution, treatment and diagnosis, the civil society plays 
a compliance role: 'It has to be CENAME, supported by the state as the main 
actor; these two will never be outclassed by civil society,136. In addition, the 
role of the CSOs in other areas of policy making is more normative than 
practical: 
'Each treatment centre has an ethics committee that includes religious 
persons, traditional leaders, justice department, etc to propose points for 
eventual legislation. But sitting fees, transport allowances, etc for the 
committee to meet are not in place. So this part of the structure of the 
national HIV/AIDS programme does not function. 137 
Global partners of both the AAI and the EAI models frequently stress that 
HIV/AIDS patients (including HIV positive persons) should be represented at 
all levels of policy formulation and implementation. The importance of their 
participation was acknowledged by all the interviewees; however, the extent of 
their participation was questioned. 
136 Interview: CENAME 
137 Interview: Bamenda Polytechnic Clinic 
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'People with HIV/AIDS are involved in the central, technical and 
provincial committees. Firstly, their salaries depend on the committee 
concerned. None of them could really say publicly that' things are not 
working. Secondly they were relegated to minor roles like distributing 
posters. So their opinion and contribution was not so much looked into. 
Those few who tried to speak too much are isolated not only by the 
government but also sometimes by the local groups.138 
Clearly, the notion of community participation that has long been promoted as 
part of the PHC model (WHO and UNICEF), a requirement in the HIPIC 
Initiative (IMF and World Bank) and the 'Equitable Access' model (MFS) is 
far from being realised in Cameroon. Civil society groups are not given 
sufficient opportunity, resources, skills and competence to participate. Most of 
the interviewees argued that it is the responsibility of the state to ensure that 
their participation is realised. Yet, the global partners also bypass the state. The 
influence of multilateral and bilateral institutions seems to override those of the 
state. This calls into question the broader debate around global-national-local 
linkages as explored below. 
7.6.2 Global-national-Iocallinkages: Is bypassing the state a 
viable option? 
All the participants interviewed in this study share the view that at the global 
level 'every partner has a clearly defined role so you don't really need a formal 
governance structure,139. The globally-backed scenario is completely different 
when one shifts the attention from the global to the national (global-national 
linkage). Pharmaceutical companies within the AAI no longer see drug prices 
as a major barrier to access to medication at the global level. Their views on 
the question of access relates to structural problems between the global and the 
138 Interview MSF 
139 Interview: Hoffmann-La Roche 
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national, in particular, 'the complexity of the whole registration process for 
medications, taxes, quality controls, supply chain and black markets' .140 111e 
global-national linkage is supposed to be effective if concentrated between the 
GHP (both AAI and EAI) and the National HIV/AIDS Programme (the 
national committee). 
Nevertheless, the relationship is made complex by the fact that drug 
procurement and supply arrangements are based on bilateral negotiations 
between participating phannaceutical companies and the CENAME 
independently of the national committee. Thus, although a formal governance 
mechanism may seem irrelevant at the global level (as the former quotation 
above suggests), such a mechanism may actually address structural problems at 
global levels which have implications at the national level (as the latter quote 
suggests). The implications for the national programme can be described as 
follows: 
'As we try to register some medicines, it is not uncommon for it to take 
two or m ~ r e e years even after receiving approval from a stringent health 
authority. Some of our medicines in French-speaking African countries 
get to the local level but are referred back to be approved in France 
even though they had already been qualified by the WHO. This adds to 
the time line which again denies access to medicines at the patient 
level.' 141 
The issues discussed above are also related to the liberal argument that global 
programmes are often associated with foreign policy and diplomacy at one 
level, but also aim to deeply transform the current way of working of the 
bureaucratic structures and the procedures of the government at the local 
levels. The global partners share the view that 'the decisions that arc more 
140 Interview Bristol-Myers Squibb 
141 Ibid 
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political, strategic and global are the role of the government in partnership with 
the global partners. 142 Yet their actions seem to suggest that the opportunities 
for this to be realised do not exist in the current set up of GHPs at global and 
national level. The strategy of global partners to create their own transcalar 
networks that constrain the effectiveness of the national HIV/AIDS programme 
relates to the fact that the participation of global partners at the national level is 
voluntary (Dodgson et aI., 2002; Slaughter 2004). If this be the case, it is not 
surprising that the GTZ, a major global partner, is not fully aware of the 
contributions of the AAI to the national programme in Cameroon: 'I only head 
about this global health initiative (the AAI) a few months ago. At the level of 
Cameroon I have not seen much from this initiative. In the near future we hope 
to get some more information about what the Ministry is considering to do in 
this context,143 
The discussion above suggests that the strategic interests of partners, not the 
shared goal on facilitating access to medication (through drug procurement and 
supply and developing a health system to deliver programmes) tend to 
dominate GHP processes. Thus, there is constant attribution and 'blame game' 
when it comes to responsibility for failures. However, this does not undermine 
the role of both the AAI and EAI model in facilitating access to medication in 
Cameroon. The human rights model (EAI) pursued by MSF successfully 
pushed the UN-proposed economistic model (AAI) to reduce prices of drugs as 
well as agencies such as WTO to allow the importation of generic drugs that 
are patent protected. The global legacy of the GHP model is therefore that, 
142 Interview: MSF 
143 Interview: GTZ 
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affordability is no longer a barrier to access to medication for IIIV/AIDS 
treatment and control in Cameroon. However, accessibility, acceptability and 
quality of care remain major barriers as well as structural problems with policy 
making and implementation. 
'The time has passed to ask this kind of question (drug prices) in the 
case of Cameroon. The national system with all its strengths and 
weakness relatively ensures availability of drugs all over the country. 
The question is how to reinforce the capacity of the system to an extent 
that it is able to buy its own drugs without subventions coming from 
donors. In future these costs should be covered by government's own 
budget.' 144 
The above quotation leads to the question of what is needed to localise GHPs 
in Cameroon. As explored in the next section, the main barriers to the fight 
against HIV / AIDS in Cameroon through GHPs are more than the interviewee 
above (and other systems and participation challenges in the preceding sub-
sections) seem to suggest. 
7.6.3 Localising the National HIV/AIDS Programme 
Despite HIV / AIDS medicines being offered free of charge in Cameroon, the 
impact and burden of the disease has persistently been on the rise. The main 
reasons for this relates to the fact that both the AAI and the EAI over 
emphasise the very narrow publie health objective of medical intervention 
(through specialised treatment and care centres). Behavioural changes related 
to HIV / AIDS prevention are largely neglected. A combination of 
unemployment, denial, stigma, poverty, lack of sex education and polygamous 
marriage practices were cited in chapter five as major causes of the high 
incidence and burden of HIV/AIDS in Cameroon. All the interviewees studied 
144 Interview GTZ 
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in this research acknowledge this challenge. A MSF medical doctor explains as 
follows: 
'The most recent survey shows that 96% of Cameroonians know about 
HIV/AIDS and how to prevent it. But from a practical point of view can 
a married woman ask her husband to use condoms even if she knows 
that he has a woman outside? There are economic and social issues 
related to prevention that has not been tackled. Sometimes to change 
behaviour you need to change the underlying cause of this 
behaviour.' 145 
From the above quotation, it appears that the current set up of the national 
programme offers a 'technical fix' based on medical intervention to secure 
quick results to show to global partners and get more support. Talking about an 
alternative to this technical solution, sensitization programmes meant to create 
awareness on preventive measures seem to have had limited impact as well (as 
the above quotation suggests). The lack of funding is not also a major barrier to 
HIV I AIDS treatment and control, as it is to absorb the huge amount of funding 
already available to the national programme. Most of the interviewees pointed 
to the fact that a major challenge facing the fight against HIV/AIDS through 
the national programme is the sustainability of funding for the future: 'Even the 
former Minister of Public Health complained about the capacity to absorb this 
money. It is up to the country itself to create the conditions for adapting its 
programmes ... if (the country's) proposal is technically sound then it is 
accepted (by global partners).146 
Apart from addressing the behavioural changes and sustainability of funding, 
localising the national HIV I AIDS programme also requires measures to 
address institutional challenges (Table 14): 'The first problem is the 
14S Interview MSF 
146 Interview with MSF 
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availability of actual figures about the IIlV/AIDS c p i d c m i c · ~ 1 4 7 7 'decisions 
should be decentralised' 148; 'there is no sanction and there arc people and 
programmes in places they should not be,149 Obviously, there is a role for all 
actors in resolving these challenges with the national government ensuring 
effective coordination in partnership with the global and local partners. 
Ultimately, all the partners must be willing to participate in these efforts in the 
same way as they freely acknowledge the need to resolve these challenges. 
Table 14 Institutional challenges facing the IIIV/AIDS programme 
Objectives Major barriers Uecommendation 
Delivery of Insufficient equipment in Improvements in stafTtraining and 
service decentralised structure equipping treatment centres 
Resistance to The time a patient has to Improve attitude of health stafTto 
treatment wait before receiving combat illicit payments for 
treatment, care and preferential treatment and to better 
support services combat stigma and forgetfulness 
Monitoring & Distorted data on Improve transport, documentation and 
Evaluation incidence, impact, and information systems 
requirements 
Timing of Delays in the Improve predictability that 
services reimbursement of funding/drugs will be available on 
treatment centres time 
Source: Author's processing o/interview materials 
The consequences of the above challenges as well as the structural weaknesses 
associated with overlapping initiatives seriously distort implementation efforts. 
All the initiators of overlapping initiatives claim to have created treatment 
programmes that involve dialogue processes that satisfy the human rights and 
public health elements of community participation. However, the provinces 
147 Interview GTZ 
148 Expressed: North West Provincial IIIV/AIDS Unit 
149 Interview: CENAME 
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and the districts still have the centralized administrative structures of the 
ministry of public health. This implies that ministerial decisions (such as 
recruitment of health personal) often lead to short-tenn relocation of staff as 
well as competition for skilled staff between the programmes. 
Another structural issue is related to corruption, bad leadership and defective 
institutions, tactics used by global partners to push forward community 
participation as a key element within the GHP model. While the general 
consensus was that corrupt practices is a matter of state officials, several 
studies on Cameroon had already demonstrated that CSOs also practice rent-
seeking behaviour by acting as brokers and confiscating the value-added to 
development projects (Baye, 1998; Tafa and Asondo, 2000). The evidence 
from this case study reveals that corruption is a serious societal problem in 
Cameroon. 
'The huge amount of money around HIV I AIDS did not help. Many 
local people who worked in the HIV/AIDS programme carne out just 
for the money while those who were more credible and working 
initially (before the funding carne) were never financed. But there are 
other grassroots initiatives that worked very well and I believe in 
them.'rso 
As mentioned in chapter five, senior government authorities are also being 
linked to mismanagement of funds allocated to the national HIV I AIDS 
programme. One interviewee noted that the 'global partners are disappointed 
because of embezzlement by government officials. Some of them have been 
arrested and locked up by the government; some have been forced to leave the 
country, and so on. They also wanted some authorities within the programme 
I ~ O O Interview with MSF 
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to be replaced and things like that.' 151 Global partners who bypass the state arc 
faced with corruption at local levels, yet community organizations look up to 
global partners to put pressure on the government to solve the problem of 
corruption. It also emphasizes the need for programme integration to facilitate 
trickling down of money and at the same time idcntifying specific arcas where 
corruption is rampant. It was observed that the relation bctween the state and 
the civil society is quite problematic due to unequal power relations and the 
poverty situation. 
'This is the vicious cycle when you talk about community·based 
organizations, organizations for people with HIV/AIDS and so on. 
They are too dependent on the government to get money and so most of 
the time their mouths are shut. Global partners and donors should be 
much more rigorous in asking for results. They should be much more in 
the field and understand what is going on.' 152 
The above view was shared by all the intcrviewees at the local levels. 
However, it is the view of global institutions that global partners should not, 
and do not intervene in the domestic affairs of a country. In practice, however, 
in the case of Cameroon, this is not the case. There are enormous global 
interventions in ways that create more governance challenges than it solve. 
7.7 Conclusion 
This chapter has explored the role of the AAI and the EAI, both examples of 
GHP models, in shaping HIV/AIDS policy practices in Cameroon. At the 
global level each GHP exists in parallel to each other. At the national level the 
initiators of both initiatives are global partners of the National HIV I AIDS 
Programme and it is this involvement that enables thcm to emphasise their own 
1.51 Interview North West Provincial IIIV/AIDS Unit 
152 Interview MSF 
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narrative strategies on access to medication in influencing national HIV I AIDS 
policy formulation and implementation. Just as the malaria case study 
presented in chapter six, the analysis in this chapter reveals how public health, 
economistic and human rights ideas embodied within the AAI and the EAI 
shape different elements of the national HIV I AIDS programme. The chapter 
therefore provides another case study from which to understand the nature of 
GHP models both in terms of stakeholder participation, the extent to which the 
models deal with the barriers to access to medication for HIV I AIDS and the 
effectiveness of transcalar networks created as a result of deploying the model 
to shape HIV I AIDS policy practices in Cameroon. 
The evidence from this chapter is consistent with the global activism, which 
favours the view that the key factor determining the nature of GHPs in the case 
of HIV I AIDS is the human rights needs of the poor. This is reflected in several 
areas of national policy formulation and local implementation processes in 
Cameroon. As discussed in chapter four, both AAI and EAI state explicitly t h ~ ~
human rights need of the poor in terms of ensuring that the poorest and most 
vulnerable persons can access treatment irrespective of ability to pay. On the 
basis of this global activism, negotiations take place between global, national 
and local partners through a process dominated by the economistic narrative 
(drug prices and supply arrangements). This initial agreement sets up follow-up 
processes leading to the creation of the National HIV/AIDS Programme. At 
this stage we continue to see the dominance of the economistic narrative in the 
practical steps involved in formulating and implementing policies. 
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To join both AAI and EAI. Cameroon simply had to sign two separate accords 
with the global initiators before going on to create implementation systems at 
the national and local levels. The economistie narrative is the key factor 
determining the practical nature of national GHP programmes. There is an 
overemphasis on the prices and costs of treatment. Scaling up access to 
HIV/AIDS medication (framed in terms of access to ARTs, diagnostic 
equipments and care facilities) appears to overshadow the requirements to 
strengthen the national health system. We have seen how specialised centres 
have been created through the national HIV I AIDS programme to operate 
independently of the existing public health system as both are now being 
treated as competing priorities. It was even suggested by some interviewees 
that the nature of the dialogue processes within the AAI are reflective of 
specific agreements rather than PPPs since the discussions is dominated by 
drug procurement and local distribution rather than a comprehensive public 
health package. In addition, the largest share of funding provided by the World 
Bank and Global Fund are tied to drug procurement and reimbursement of 
treatment costs incurred by specialised treatment centres. 
There is evidence of some interactive policy transfer within the national 
HIV/AIDS committee. Apart from UN agencies, global partners such as 
bilateral development agencies and international NGOs (e.g. MSF) exchange 
ideas with national and local partners on 'best practices', 'field experiences' to 
help inform situational analysis, prepare grant proposals and create treatment 
centres. A key element of the human rights narrative is also taken very 
seriously, namely, the notion of community participation. Representatives of 
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local public, private and community groups participate in the dialogue process. 
This is what gives such a GHP approach the transcalar network character, with 
the national committee consisting of global, national and local partners with an 
interest in the fight against HIV I AIDS in Cameroon. In fact, it is a requirement 
for HIV/AIDS positive persons and AIDS patients to belong to committees at 
national and local levels. In this way, the GHP model attempts to align the 
public health (WHO and UNICEF), economistic (World Bank, bilateral 
development Agencies and private partners) and human rights (CSOs) 
narratives into Cameroon's national HIV/AIDS programme in which non-state 
actors are increasingly playing key roles in the policy processes. 
The outcome of policy discussions within the national HIV I AIDS committee 
suggests that the notion of participation is more of a formality than of any 
major contribution to the policy process. As the discussions on the barriers to 
access to medication suggests, one would expect that the dominance of the 
economistic narrative on access to medication (the drugs, the prices and the 
costs of treatment) would be balanced by the need to address behavioural 
change (issues related to HIV I AIDS prevention). Despite the emphasis on 
robust grant proposal that take economistic, public health and human rights 
needs into account, this does not translate into effective policy 
implementation. All the participants interviewed even acknowledged that drug 
prices and cost of treatment is no longer a major barrier to access to medication 
as treatment is now free of charge throughout the country. 
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Yet, in the case of AAI the focus is to secure funding to procure patent-
protected drugs from designated phannaceutical companies. Similarly, in the 
case of EAI, the human rights rhetoric (the nced for equitable access to 
medication) is used to cover up an cconomistic emphasis on generic 
competition to secure drugs from preferred generic manufactures in order to 
pursue their medical intervention strategy at local levels. All the participants 
interviewed for this study acknowledged the fact that more could have been 
achieved if the focus was placed on HIV I AIDS prevention. However, while the 
national and local partners blame the global partners for this policy mismatch, 
the global partners argue that it is the responsibility of the state to address such 
issues. 
At the local level, the shift from a public health emphasis to the narrow focus 
on a global medical strategy is therefore more evident. In this context the GHP 
model in the case of HIV I AIDS appears to be succeeding. Actual access to 
medication for the poor has been made possible as diagnosis and treatment are 
now offered free of charge in Cameroon. This is seen from the fact that ARTs 
are now offered at no cost to patients while an increased number of specialised 
treatment centres have been created throughout the country including some 
rural villages. In addition, there is also strong evidence of the high level 
awareness of the causes and effects of the HIV I AIDS resulting from the mass 
campaigns and sensitisation programmes. However, the GHP approach appears 
to be failing to address potential access to medication. The incidence and 
burden of HI VIA IDS has continued to rise. The number of people dying of the 
disease is increasing, the rate of HIV/AIDS is also on the rise with a 
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consequent burden (e.g. shortage of staff and equipment to cope with high 
numbers of consultations) on specialise treatment centres. 
The complex nature of the transcalar network created as a result of the 
endorsement of both AAI and EAI also becomes evident at the local level. 
Specialised treatments centres operating within the country are supposed to be 
answerable to the Central Technical Group. In reality however, several parallel 
centres have been created with funding from specific global partners and are 
therefore answerable to such donor organizations (rather than the Central 
Technical Group). In this context the strategic interests of the different partners 
tend to overshadow the reality of treatment and care programmes being 
undertaken. For example, all the partners favour a national programme that 
reaches out to all the different stakeholders at the local level including 
coordination mechanisms, involvement of the local community (especially 
HIV/AIDS patients and HIV/AIDS positive persons). The structure of the 
national programme is suited to achieve this, with the national committee 
formulating policies and the central technical group implementing them. 
However, with global partners running their own HIV/AIDS programmes 
through their affiliated NGOs and private foundations in areas of the country 
where they have their own strategic interests, the Central Technical Group is 
unable to perform the role of coordinator at local levels. These parallel 
initiatives bypass the structures of the national programme (despite being 
members of the national committee) and the actors involved are so interwoven 
that it is difficult to clearly describe the global-national-local linkages involved 
in shaping national policy practices at local levels. 
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The evidence in this chapter also reveals crucial similarities to the national 
malaria programme presented in Chaptcr Six. A comparison of the two case 
studies further reveals the role of OIIPs on access to medication in Cameroon. 
Through GHPs, global health policies for malaria and IIIV/AIDS respectively, 
are transferred to Cameroon through a consensual dialogue process involving 
global, national and local partners. The dialogue takes place within the 
National Programme Committees for each of these disease areas. Within this 
network, global health policies nre negotiated on the basis of the strategic 
orientation of specific GHPs. Global and regional targets nrc set and then 
dialogue processes are set up within the national committee to develop the 
national systems for implementation. 
The problem of overlapping initiatives is common in both programmes. What 
is common among overlapping initiatives is that they represent pre-existing 
projects that have been re-aligned to reflect the narrow objectives of GIIPs. 
Parallel and overlapping initiatives such as this help upgrade equipment; 
improve education campaigns and family-planning programmes, including 
supply of drugs and medical equipment. However, international partners use 
the agency of GHPs to bypass the state (both the structures of the ministry of 
health and the national committees). In fact, old (the PHC system) and new 
(national GHP programmes) institutions and programmes operate parallel to 
each other, achieving actual access but failing to address potential access to 
medication (as one would expect from a comprehensive public health package 
that emphasises a strengthened national health system). There is a complex 
array oflocal partner who have to deal with multiple economistic (e.g. funding) 
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objectives and technical directives from different international agencies rather 
than the consensual policy framework agreed by the national committee. This 
was seen by some interviewees as a major cause of corruption and 
mismanagement, persistent structural problems within Cameroon that the GHP 
model is failing to address. The importance of the GHP framework is seen 
from the fact that it reinvigorated political commitment in the fight against 
malaria and HIV / AIDS by providing several opportunities for continued 
dialogue to coordinate the efforts of public, private and civil society sectors 
(especially empowering the civil society and involving supporting government 
ministries). The policy implications of the above issues are explored further in 
the conclusion. 
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CHAPTER 8: CONCLUSIONS 
8.1 Introduction 
This thesis argues that to better understand the role of OHPs as facilitators of 
access to medication in developing countries, they should be conceptualised as 
'models' that occupy the intennediate position between theory and policy 
practices. OHPs have emerged as a way of dealing with both the presenting 
problem of access to medication, and organisational and multi-stakeholder 
challenges to develop and implement such a practice. As such they offer n new 
and interesting model of mixed-stakeholder interventions. Such interventions 
take place in hybrid networks animated by global-national-local linkages, what 
can be tenned transcalar networks. The key understanding that emerges from 
this thesis is that it is the interplay of development models embodied within the 
OHP model and the strategic interests of their global promoters that ultimately 
detennine the construction of access to medication by specific OUPs and the 
nature oftranscalar networks created to achieve it. 
The empirical evidence from this thesis supports a critical evaluation. OUPs 
emphasise specific medical intervention programmes, and are more effective in 
this narrow technical sense. Even though their efforts have not reduced the 
incidence and burden of malaria and HIV/AIDS, they have legitimised the 
direct intervention of international development agencies, private corporations 
and esos at the local level. The OHPs' pursuit of 'quick results' has 
fragmented the national health system and undermined the capacity of the state. 
This thesis proposes that the key to reducing disease burden and improving 
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public health is a strengthened national health system, one that the GHP model 
does not currently offer. Developed to address the supposed failure of African 
states to ensure access to medication, GHPs have further marginalised the role 
of the Cameroon state, so reducing its capacity to protect and advance the 
health of its citizens. 
To substantiate the above findings, this thesis investigated 1) the global and 
national (country-specific) perspectives on the emergence of GHPs as 
facilitators of access to medication, 2) the role of the GHP model In 
determining national policy and local practices aimed at facilitating access to 
medication for the poor and most vulnerable population and 3) the 
conceptualization of the theoretical and empirical challenges associated with 
such a hybrid network. These are presented in the case of GHPs created to 
combat malaria and HIV/AIDS (the global perspective) and Cameroon's 
attempt to deploy the GHP model to develop the institutional capacity 
necessary to become successful in the fight against these diseases (the national 
and local perspectives). The next section of this chapter presents a synopsis of 
the key findings of this thesis and the evidence presented in support of each. 
This is followed by a discussion of the policy implications of the GHP model 
for the future fight against disease pandemics in developing countries such as 
Cameroon. Finally, the contribution of this thesis to the theory and research on 
global institutions are summarised with suggestions for further studies. 
8.2 Synopsis 
The first specific research question explored in this thesis relates to the best 
approach to conceptualise and study the role of GHPs on access to medication. 
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Existing research on global institutions such as 01 IPs has not fully explored 
how the dynamics of the deployment of OUP programmes in developing 
countries embody issues that go well beyond facilitating access to medical 
technology. More critically, this thesis stresses the need to unpack the 
relationship between OHPs and access to medication, not only in terms of their 
respective meanings and conceptualisations, but also the context in which 
OHPs emerged as facilitators of access to medication at global and country 
levels. While many existing contributions in the field of development, 
international relations and policy studies are relevant to the issues of interests 
in this research, it is argued that the characteristics of the present study arc 
suggestive of the emergence of a new fonn of intertwining of medical 
technology, global institutions and their networks, national policy practices and 
the public health needs of the poorest people in society for which an 
interdisciplinary and theoretically distinctive approach is needed. 
Chapter Two presents such an interdisciplinary theoretical framework building 
on the need to consider as equally important, both potential (the presence of an 
enabling healthcare environment) and actual (the use of pharmaceutical and 
healthcare delivery services) access to medication (Ngoasong, 2009) when 
understanding the role of GHPs. The theoretical framework draws on the 
literature on models and the notion of embodied knowledge found in STS and 
social constructionist International Relations. This interdisciplinary approach 
enables us to unpack the systematic forms of knowledge (MacKenzie, 2006) 
deployed in health technology and with their social infrastructure (Kallon, 
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1991), issues that remain normative in most previous studies on GHPs 
highlighted in chapter one. 
In terms of models (Cartwright, 1983; Morrison and Morgan, 1999), the 
theoretical framework used in this research argues that the GHP model is based 
on integrating different theoretical models from public health, economics and 
human rights to produce a global 'activism' or collective story on access to 
medication, including opportunities to introduce new elements to better reflect 
practice settings. Analytically, the social constructivist approach (Boas and 
McNeil, 2004), a version of social science for analysing global institutions is 
adopted. On the basis of this approach, the notion of transcalar networks is 
introduced to describe the 'social spaces' through which global-national-local 
interactions take place in a GHP context while narrative policy analysis (NPA) 
(N goasong, 2009) provides a useful tool. Thus, we side-step into different 
disciplines to provide an interdisciplinary framework for analysing the ways in 
which public health, economistic and human rights narratives narratives (forms 
of knowledge) put forward by GHPs partners are embodied within a GHP 
model and how the narratives shape national policies and local practices on 
access to medication. 
In the late 1990s advocates of 'global health' had already began to suggest that 
globalization is increasingly causing 'altruism' and enlightened self-interest to 
converge (Yach and Bettcher, 1998). The 'knowledge (or narrative) approach' 
developed in chapter two enables us to explore the extent and nature of this 
convergence within the rhetoric of GHPs and access to medication. We have· 
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been able to substantiate claims that GIIPs can only be seen as succcssful if 
their proposed policies are consistent with country-specific contexts (Duse and 
Walt, 2000b; Buse, 2004; Caines et ai., 2004). We also realise that although 
GHPs are of a practical nature, they are implicitly theory-informcd and this 
provides the basis on which they can be studied us the embodiment of 
development models. Accordingly, the thesis demonstrates three further 
benefits for adopting a knowledge approach. First, it enables us to present a 
distinctive conceptualisation of what the GHP model embodies as a global 
actor within the realm of government in an African country. Second, how the 
GHP model is implicated in the shifting of the boundaries of the state, its 
networking with civil society and the changing nature of North-South 
relationships (described by the characteristics of transcalar networks). Finally, 
the potential for modalities of achieving sustainable access to medication 
through a GHP approach are critically examined. 
The third chapter highlighted the need to use the social constructivist approach 
to build on the interpretive case study methodology infonned by NPA (Kaplan 
1986, Krieger 1986, Roe 1989, Feldman et at, 2004) when researching GHPs 
(e.g. Ngoasong, 2009). The qualitative case study methodology was adopted. 
The social spaces in which GHP programmes are enacted was extrapolated by 
combining the analytical and theoretical tools, targeted qualitative interviews 
and analysis of policy documents and technical reports to understand the 
phenomenon under investigation. This has bcen illustrated in two case studies 
on the role of GHP models in shaping the health sector reforms and local 
pharmaceutical and healthcare delivery practices in Cameroon. The case 
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studies reveal how the GHP model was used to create two National GHP 
Programmes (for HIV / AIDS and malaria respectively) and how the 
programmes attempted to achieve 'universal access I to medication by shaping 
national and local policy practices for their target diseases. 
As presented in Chapter two, the emergence of GHPs can be linked to access to 
medication. GHPs aim to 'foster collaboration with the private industry' and 
harness 'the resources to address global health issues and the challenges posed 
by globalization' (Ngoasong, 2009:952). This is the major global challenge to 
achieving access to medication in developing countries1S3• Chapter four 
presents the global perspective on how GHPs are modelled to achieve this goal. 
It argues that it is the corporatist way in which development models are 
negotiated through the work of UN agencies and other international private and 
esos that determine the nature of GHPs at the global level. 
Different forms of knowledge located within public health, economistic and 
human rights models of health development are expressed as narratives (such 
as plots and colourful language) in GHP settings. They are either 'evidence-
based ' (were 'best practices' and 'lessons learned' are taken from other 
settings), promises of funding or civil society activism. The chapter link the 
three narratives to specific global actors to better understand how the creation 
of a hybrid narrative is essential to hold together new hybrid structures within 
the GHP network. The economistic narrative is very explicitly expressed (in 
153 Chataway and Smith (2006) have investigated these issues in the case of the International 
AIDS Vaccine Initiative (IA VI), a Product Development Partnership that also has 
characteristics ofGHPs (Buse and Harmer, 2007). However, while they focus on product 
development, the case studies in this thesis focus on the development and implementation of 
national programmes through a GHP approach. 
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terms of drug prices, supply arrangements, patent-protection, generic 
competition), the human rights narrative is captured in the very naturc of thc 
global activism (that every human being should have access to treatment 
irrespective of ability to pay) while the public health narrative appears to be 
withering as the medical model overrides preventive measurcs. The three 
narratives are the key factors determining the nature of the GHP model and the 
involvement of various stakeholders at the global level. 
As promoters of the Primary Health Care (PHC) model, the WHO and 
UNICEF are associated with a public health narrative emphasising a 
strengthened national health system; the WTO is associated with the TRIPS 
model (patent-protected medicines) and the IMF/Worid Dank with neo-Iiberal 
market models (privatisation and liberalization) both of which are economistic; 
the human rights narratives are rooted on the Universal Declaration of Human 
Rights (UNDHR), later taken up by international CSOs. These global 
institutions then mobilise their affiliated public, private and CSO partners to 
support the GHP effort at different levels of action. This is what gives the GHP 
model the type of global public-private partnership (GPPP) characteristic 
described in Buse and Walt (2000a). In terms of the theoretical framework 
developed in chapter two, this also explains the role of theory in the 
development of the GHP model at global level. 
Thus, at the global level, we see the integration of distinctive and complex 
narratives each of which plays a role in formulating OUPs. From this context, 
the GHP model is an 'instrument' (Morgan and Morrison, 1992) whose 
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representative nature provides the tools with which the relationship between 
public health, economic and human rights theoretical models of health 
development can be better understood in the context of globalization. Evidence 
of the influence of the narratives derived from of these three models can be 
observed in the way that developmental twists and turns in the core narratives 
are paralleled and reflected in their application in the GHP settings. There is a 
strong rhetorical emphasis on human rights, defined implicitly in terms of 
resource constraints - the relationship between poverty and access to 
medication. This is expressed through statements such as the following by a 
senior director of GlaxoSmithKline: 
'There are no easy solutions to the challenge of providing access to 
sustainable healthcare in developing countries ... lack of resources can 
be no excuse for lack of action. An effective global response is needed, 
and needed now' .154 
Accordingly, the GHP model is innovative. It is not an 'answer machine' for 
global policy makers as scientific and management literature would suggest. It 
is a model that is different from previous approaches because it reflects the 
integration of elements of previous public health, economistic and human 
rights models (expressed as narratives) into a single global model and a single 
global strategy to facilitate access to medication for specific disease areas. The 
GHP model can be seen as a hybrid network of social institutions or what 
Chataway et al., (2007) call social technologies. It is on this basis that the GHP 
model is studied in this thesis as 'an engine of enquiry' (MacKenzie, 2006) in 
order to understand the links among the different actors and their narrative 
strategies in shaping policy practices on access to medication. 
154 GSK (2005) Statement by Peter Bains, Senior Vice President, International Commercial 
Development GlaxoSmithKline to the European Parliament's Committee on International 
Trade Hearing on TRIPS and Access to Medicines, Brussels, 18 January 2005 
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From a practical (or interactive) point of view, at the global level, the GIIP 
model is a 'political weapon' (King and Kraemer, 1992) used by actors to 
reconcile their conflicting interests and to establish a common ground on which 
variables are included or excluded from policies to achieve access to 
medication. The economistic models tends to dominate, as manifested by the 
strong interests of the pharmaceutical industry (who seek to protect their 
market position and secure profitability by patent protection and R&D for drug 
development) and the need to mobilize funding (through global institutions 
such as the Global Fund) to achieve affordability and accessibility of 
medicines. 
The case of the three GHPs described in Chapter four supports the argument 
above. The RBM like the WHO and UNICEF is meant to be a technical 
partnership that advices government on best public health practices; however, 
powerful pharmaceutical companies such as Norvatis with an interest in 
discounted drug pricing makes the RBM too medically focused. The strong 
influence of western pharmaceutical companies and UNAIDS implies that the 
AAI appears to be a corporatist movement to supply discounted ARV s and 
related medicines. Although CSOs such as MSF use human rights arguments to 
challenge the economistic model of discounted pricing, they seek to promote 
generic competition which ultimately represents another kind of economistic 
model (achieving price reductions by procuring from generic manufacturers). 
Accordingly, the role of the previously popular PHC model has been reduced 
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to specific medical interventions rather than good public health and health 
promotion. 
The second research question focuses on how the global perspective on the 
emergence of GHPs relates to the history of the political economy of health 
development in Cameroon. As detailed in Chapter five Cameroon's efforts to 
deploy GHP programmes is a combination of three factors: a response to the 
failures of public health and economic development models mentioned above, 
international pressure for reforms (such as securing donor support and getting 
its mounting external debts cancelled by the IMP and World Bank) and more 
critically, a strategy of the survival of the state. The international dimension of 
policy placed enormous pressure on the state, prevented it from acting 
autonomously and ultimately created governance gaps in the system, now 
labelled in development studies literature as government (rather than 
interventionary) failures. From this context, the GHP model can be seen as an 
'alternative', one that is attractive because of the 'profecies' (Danzig, 1979:6) 
that it can successfully respond to 'government and market failures to provide 
public goods to the poorest and most vulnerable people' (Ngoasong, 
2009:952). To achieve this, the functions of the state through the bureaucratic 
structures of the Ministry of Public Health have been replaced by parallel and 
overlapping National GHP Programmes for malaria, HIV/AIDS and TB 
respectively. Each programme is not directly answerable to the state (through 
the Minister of Public Health); each is answerable to a National Disease 
Committee consisting of global, national and local partners for that specific 
disease. As a result of this, a sovereign state that seeks to improve the health of 
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its citizens no longer has the autonomy to regulate pharmaceutical and 
healthcare delivery, as well as steer and coordinate the network of actors in 
global health due to the complex characteristic of North-South relationships in 
GHP programmes. 
The discussion in Chapter five reveals that National Disease Committees 
appear to blur the North-South divide. In particular, the notion of PPPs 
embodied in the GHPs model redefines the role of the state from one based on 
'state-centric bureaucracy' to one that can be termed a 'hybridization of 
governance' (Dodgson et aI., 2002). For the first time, global, national and 
local public, private and civil society partners with often competing public 
health, economistic and human rights interests sit around the same table (in the 
National GHP Committees) to fonnulate and implement policy. Most notably, 
a powerful role has been allocated to international and local CSOs as a means 
of addressing governance challenges caused by state failures. This new kind of 
participation is different from transnational networks that were characterised 
by state-centric donor-recipient commitments built around government 
ministries. The current GHP network is what is described in this thesis as a 
transcalar network, in the sense that it cuts across the global-national-local 
boundaries. It can be seen as some sort of multi-actor governance (Utting and 
Zammit, 2006) to address the democratic deficits in 'weak states' (Dodgson, et 
aI., 2002). As demonstrated in chapter five, Cameroon is an example of a weak 
state (as evident in the widespread corruption and government failures), one 
that necessitates the intervention of GHPs to bypass areas of government 
failures to better serve the poor. This suggests that national GHP programme 
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partners need to be fully accountable to the national disease committees, 
thereby correcting existing governance challenges and achieving access to 
medication. There are many transcalar networks as there are national GHPs 
programmes. The nature and effectiveness of these networks is the basis of the 
empirical case studies in this thesis. 
GHPs are transcalar networks consisting of the types of global actors 
mentioned earlier and representatives of state and non-state actors in 
Cameroon. Each national GHP programme has similar types of networks 
although and each focuses on a specific disease area (such as HIV/AIDS, 
malaria and TB). National GHP programmes are meant to introduce new 
policies, new delivery systems and products, and bring in a new ranges of 
partners into policy practices in poor countries. Bringing in a new range of 
actors to either replace or compliment the state's public health services in 
policy implementation is a different model from the former state-dominated 
one (although the non-state sector - purely private, religious missions, and civil 
society hospitals and pharmacies - were already operating parallel services 
before the creation of national GHP programmes). 
Thus, at the country level, transcalar networks enable us to discuss the 
relationship between the GHP model and policy practices. It reveals the social 
spaces through which global-national-local linkages are formed and 
interactions take place. It therefore enables us to analyse the mechanisms 
through which policy making and implementation takes place (how models 
shape policy practices). Chapters Six and Seven present two empirical case 
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studies on national GHP programmes for malaria and HIV/AIDS in Cameroon 
respectively. In particular, the chapters examine the practical steps used by 
GHPs to achieve their country-specific global targets focusing on the role of 
the embodiment of elements of development models in GHPs and the 
effectiveness of transcalar networks created to formulate and implement 
policies. 
Chapter Six presents the first case study on the National Malaria Programme 
created after the Cameroon government endorsed the Roll Back Malaria 
Partnership. As a GHP, the RBM claims to offer a global public health 
response to previously failed attempts at malaria eradication. RBM explicitly 
attempts to 'strengthen national health systems to deliver improved malaria 
treatment and control outcomes' (WHO, 2000a). Interwoven within the 
analysis of the RBM model, however, is an examination of the conflict 
between three ideal narrative strategies (economistic, public health and human 
rights), for understanding the role of GHPs on access to medication. 
The distinctive claim of the RBM is that malaria mortality can be reduced by 
60% in African countries such as Cameroon by 2010 (and again by 2015) 
through a global response (WHO, 2000a). To achieve this objective, it sets out 
to address the complexity of the root causes of malaria transmission through 
early detection and response; improved and prompt access to effective anti-
malaria medication and other locally appropriate means of vector control 
focusing on pregnant women and children (WHOIUNICEF 2005a:Xi). 
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However, the case study reveals that the RBM is far from achieving its 
objectives. 
The over-riding influence of the economistic narrative leads to an emphasis on 
access to medicines (in terms of affordability and availability of ITNs and 
ACTs). Although ITNs is presented as a medical model, it serves as a 
preventive measure in line with the RBM's objective of creating a mosquito-
free zone in Africa (UN, 2000a). However, the case study suggests that there is 
limited attention given to a public health package that would strengthen the 
national health system as a whole to address accessibility, quality of care and 
preventive measures. This is evident in the fact that the incidence and burden 
of malaria continues to rise and the disease was still considered by all the 
participants interviewed in this thesis as the number one cause of death (in 
comparison with disease such as HIV I AIDS) in Cameroon. 
The second case study presented in Chapter Seven examines the National 
HIV I AIDS Programme created after the Cameroon government endorsed two 
GHPs - the industry-led AAI and the CSO-Ied EAI. Initiated by five UN 
agencies and seven western pharmaceutical companies (under the leadership of 
UNAIDS), the AAI distinctively claims that the solution to the HIV / AIDS 
pandemic in developing countries lies in making discounted patent-protected 
drugs more affordable and accessible, and in developing a proper health system 
to deliver treatment. However, this narrative stand was firmly challenged by 
the human rights orientation of the EAI model which favours the use of generic 
competition to better serve the needs of the poor. By bundling both models, 
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Cameroon's national programme currently offers treatment for HIV/AIDS free 
of charge throughout the country and Cameroon was already being hailed by 
the initiators of the two GHPs as a global success story in the fight against 
HIV/AIDS (UNAIDS/WHO, 2002; MSF 2002). While these OHPs claim such 
credits, the incidence and burden of the disease has not declined. In practice, 
both global models tend to focus too much on medical intervention with less 
attention being paid to public health measures such as behaviour changes 
related to HIV / AIDS prevention through healthy lifestyles as well as structural 
issues related to health system strengthening. 
8.3 Comparative Analysis of the Malaria and HIV/AIDS 
Programmes 
This section presents a comparative analysis of the two case studies presented 
in chapters six and seven on malaria and HIV/AIDS respectively. The 
emphasis is placed on the key factors determining the nature of the GHP 
model, the associated transcalar networks linking global, national and local 
partners and the effects on malaria and HIV / AIDSs policy making and 
implementation. 
A major role of GHPs is to help formulate and implement national health 
policies. In both the malaria and HIV / AIDS programmes, the global activism 
described in chapter four is used to convince national and local partners that a 
focus on specific medical intervention programmes is the key to achieving 
access to medication for malaria and HIV / AIDS. The RBM sets a global and 
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regional (Abuja Declaration), targets (e.g. 60% reduction in malaria deaths) 
thereby initiating dialogue processes with national governments and local 
groups within the national malaria committee to develop the systems for 
implementation. Similarly, the government signed an accord with 
pharmaceutical companies (endorsing the AAI) and endorse the EAI in a MSF-
led international conference before finalising launching of the national 
HIV/AIDS programme to reflect the guidelines of both. From the above 
contexts, the GHP model is a 'political weapon' used to identify positive (and 
discard negative) aspects of policies and to make ·decisions likely to achieve 
sensible (or acceptable) outcomes. 
At the country level the dialogue processes in which policies are negotiated, 
adopted and/or adapted are evident in the two case studies. Each programme 
has a separate national committee and each shows ~ h a r a c t e r i s t i c s s of transcalar 
networks. Global, national and local actors are not only represented in the 
committee, but have a chance to present their own narratives on where the 
emphasis should be placed on measures to achieve access to medication. The 
competing and conflicting nature of public health, economistic and human 
rights requirements suggests that policy issues are negotiated based on big 
stories, promises and colourful language rather than rational planning. 
For example, malaria and HIV/AIDS policies no longer reflect the 'evidence-
based' or 'lessons learned' perspectives promoted by the WHO and UNICEF 
in the 1980s and 90s. Successful policy transfer is now defined in terms of the 
rapid and continuous decline in the prices of medicines and related products at 
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global and local levels, the increasing number of treatment centres and points 
of access (especially in rural areas), the high success rate of Cameroon's grant 
proposals (such as those to the Global Fund), the mobilization of funding by 
supporting ministries in line with the World Bank's Debt Initiative, the direct 
involvement of multiple international and local CSOs in policy making and 
service delivery. The evidence from the malaria and HIV/AIDS programmes 
reveal that GHPs have been quite successful in achieving these objectives. 
Clearly, sensible or acceptable outcomes are therefore the key in dermining 
policy transfer in a GHP context. Such achievements are evidence of the 
'important frameworks ... and opportunities for continued dialogue to 
coordinate the efforts of public, private and civil society sectors' (Ngoasong, 
2009:955) offered by the GHP model. 
However, the case studies further demonstrate that the GHP model as it is 
currently being implemented may not strengthen the national health system in 
Cameroon, supporting instead the conclusion that the economistic interests of 
global actors override the public health and human rights needs of the poor. 
Compared to the amount of funding and commitment channelled to specific 
medical intervention programmes (drug procurement and supply arrangements, 
construction of treatment sites and points of access, training of local NOOs to 
selUdistribute mosquito nets and sponsoring policy and evaluation meetings), 
few incentives have been put in place to address behavioural and structural 
factors relating to disease prevention (even WHO/UNICEF-initiated hygiene 
and sanitation programmes that used to exist in almost all primary and 
secondary schools in the country through health clubs and other programmes 
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have closed due to a lack of both sponsorship and advocacy). This is an area in 
which one would expect to see the human rights claims (which is also implicit 
in the PHC model) coming into play. 
In addition, the human rights narrative on community participation is 
manifested through an overemphasis on elected community members to be 
represented in national and local committee and/or selling (or distributing) 
medicines and related products to community members. There is a relatively 
limited attention to interact with local communities to ensure that communities 
are primarily responsible towards hygiene and sanitation before medical 
interventions. Most of the global partners justified this along the lines of the 
following quotation: 'you can do a lot of preventive activities ... but at the end 
of the day you see a lot of people dying of HI VIA IDS ... this makes us to focus 
on the medical side more strongly' .ISS This is an example of the type of 
'colourful language' used by global partners to convince the national and local 
level partners to embrace the medical model. However, this approach questions 
the extent to which GHP models serve as a partnership between global, 
national and local partners (as national and local partners seem to be playing 
more of a compliance role in the 'big' policy decisions). 
Furthermore, the national health system has been seriously fragmented by the 
existence of multiple transcalar networks created as a result of the deployment 
of GHP programmes. GHP programmes exist in parallel to each other and 
operate independently of the Ministry of Public Health (whose role as 
m Interview with MSF 
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coordinator has been reduced to other 'neglected' discases). As required by the 
state-centric PHC model (described in chapter five), healthcare delivery 
programmes in rural and urban areas are accountable to the Ministry of Public 
Health through the ten Provincial Delegations in the country. However, the 
GHP model bypasses this bureaucratic system. In each province, a Provincial 
Delegate for Public Health (answerable to the Ministry of Health) operates in 
parallel to Provincial Disease Control Coordinators (for each of the HIV I AIDS 
and malaria programmes). These two programmes are instead answerable to 
the National Committees (through Central Technical Group). Similarly, several 
international agencies work directly with local NGOs to serve hard-to-reach 
communities, but they overlap with programmes agreed by the national 
committees. Crucially, such initiatives are still being tied to traditional donor-
recipient commitments, instead of trusting them to the various Central 
Technical Groups (at provincial level) designated by national committees to 
coordinate activities agreed by national GHP programmes. These are examples 
of how GHPs bypass the bureaucratic structures of the state in an attempt to 
achieve 'quick results' on access to medication. 
The two case studies also reveal how the complex and interwoven nature of 
transcalar networks, in the case of national GHP programmes, weaken 
implementation, promote corruption and distort monitoring and evaluation 
mechanisms created by the GHP model. By operating in parallel to the existing 
primary healthcare system, one would expect to see that the institutional 
instability and corrupt practices of the late 1980s and 1990s would be avoided 
in the National GHP Programmes. Donor such as the Global Fund and the 
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World Bank even put good governance and anti-corruption measures as a 
requirement to the funding they provide to malaria and HIV I AIDS 
programmes. Crucially, the transcalar structure of the National Committees is 
suited to achieve good governance, with global, national and local partners 
represented (and the global partners asking for robust accountability 
mechanisms when providing funding). Yet, at the level of implementation, 
specific programmes continue to be determined on the basis of strategic North-
South transnational interests. For example, due to their long standing interests 
as former colonial masters, western development agencies such as the French 
Cooperation, the German Development Agency (GTZ) continue to run parallel 
programmes in various urban and rural areas of the country on the basis of their 
strategic interests instead of direct accountability to the national GHP 
committees (through the Central Technical Groups). Similarly, other agencies 
such as USAID and international CSOs such as MSF, who advocate a 
coordinated GHP approach, run their own treatment programmes and activities 
with local NGOs in parallel to those operated by the national GHP 
programmes. 
Another similarity between the two case studies is that they show how GHPs 
have made substantial progress in achieving their intended objectives. 
Measurable successes in results are presented in terms of increased drugs 
accessibility and affordability (e.g. HIV/AIDS treatment now free of charge in 
Cameroon), increase in the number of case of malaria and HIV I AIDS treatment 
and increase in the number of specialised treatment centres and points of access 
for drugs. However, new governance and accountability challenges have been 
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created (as a result of the overlapping nature of programmes and activities 
described earlier) that tend to undermine these achievements. As a result of this 
neglect, instead of helping to deal with existing government and market 
failures, another complex deVelopmentally inhibiting structure of rent-seeking 
and corruption has been created by GHPs. For example, both national (senior 
government officials) and local (NGOs and local groups) partners are being 
accused of misappropriating financial and material (e.g. medicines) resources 
allocated to the national HIV/AIDS and malaria programmes. In this case, the 
incentive to govern through transcalar networks that bypass the ministerial 
structures of the state and gives more autonomy to CSOs also translates as 
corruption. These findings portray the complexity of global-national-local 
linkages, which has created a very fragmented national health system and 
creates new types of dependency on global actors for funding and guidelines as 
well as new ways through which programmes and activities are captured by 
non-productive groups. 
8.4 Policy Implications 
The findings from this thesis lead us to reflect on the unique features of the 
empirical case studies vis-a-vis existing studies on the impact of GHPs in 
developing countries. First of all, there is very limited empirical study on the 
role of GHPs in determining policy practices in African countries. Previous 
studies have focused on the impact of GHPs in facilitating access to medication 
by producing measurable accounts reported in policy documents and technical 
reports by GHPs (such as AAI and RBM annual reports), bilateral developed 
agencies, national governments and other international actors with an interest 
in GHPs. These studies evaluate GHPs in terms of the extent to which pre-
333 
stated targets are met (Caines et aI, 2004; Sturchio 2004), effective functional 
or problem-solving strategies, governance arrangements and accountability 
(Buse, 2004a). Numerous independent studies have produced both normative 
and measurable claims that GHPs mayor may not strengthen national health 
systems even if they can be credited with scaling up of access to medicines in 
poor countries. This thesis provides, empirically, more evidence and 
justification for such claims .. 
Unlike earlier debates that global institutions (such as GHPs) promote a 
monolithic 'colonising process or homogenising force against which the local 
is passive and helpless' (Kickbusch, 1999:451), this thesis finds that GHPs 
pursue more than the usual model of intervention and impact by opening the 
possibility that the local and the global can co-produce and co-implement 
policies even though the global partners largely dominate policy making and 
implementation. The two case studies explored this co-existence by describing 
the deployment of GHP programmes, and their application in a local context. 
The analyses reveal a constant weaving and intertwining of old connections 
and relationships with new ones through transcalar networks. This is what 
makes measurable evaluations of GHPs so difficult and renders well 
established critics of GHPs in development studies more normative than 
practical. From this perspective, this thesis highlights two areas from which 
specific policy implications for the future country-specific role of GHPs on 
access to medication can be understood: 
• The adoption of global health policy in a country-specific context 
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• Reflexivity - GHPs as a new form of North-South governance regime 
in the context of globalization 
8.4.1 The adoption of global health policy in a country-
specific context 
The first policy conclusion that emerges from this thesis is that there is a need 
to balance the influence of the economistic narrative on access to medication 
with the public health and human rights narratives in the policy formulation 
and implementation domains if the GHP model is to achieve both potential and 
actual access to medication. The economistic, public health and human rights 
narratives are equally important for strengthened national health system. 
However, the two case studies reveal that the influence of public health and 
human rights are more rhetorical at the level of policy implementation even if 
they appear to be fully embraced during policy making (and made explicit in 
policy documents). This finding is substantiated below. 
As demonstrated in Chapter Four, 'global health' has effectively replaced 
'international health'. Through 'lessons learned', international health policies 
were transferred and adapted for application in new contexts, based on the 
experience in often similar local contexts (Walt et aI., 1999; Ogden et aI., 
2003). Chapter Five highlighted this in the case of Cameroon showing how 
'lessons learned' during the construction of the Panama Canal was used by the 
French colonial hygiene team in partnership with a similar German team to 
eradicate the sleeping sickness in the early 1900s. Similarly, 'lessons leaned' 
from other developing countries formed the basis for successive reforms of the 
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WHOIUNICEF-led PHC model adopted and implemented In Cameroon 
between 1981 and 1998. 
From the late 1990s, the GHP model was introduced as a more innovative 
approach (global health policy) in which country-specific global programmes 
are designed and implemented to deliver country-specific services. As such, 
national GHP programmes (such as the malaria and HIV/AIDS programmes) 
are meant to be dynamic learning programmes in which interactive processes 
lead to the integration of 'lessons learned' and 'best practices' to deal with 
country-specific barriers to access to medication. The constitution of 
membership within the national committee of both the HIV I AIDS and malaria 
programmes, with global, national and local partners with the right mix of 
economistic, public health and human rights models appear to be suitable for 
such dynamism. Most importantly, the human rights concept of 'listening to 
the poor' is fully embraced through the incorporation of community 
participation (with efforts made to include a representative of patient groups at 
all levels). This allows not only the specific health needs of the poor to be 
sought, but the voice of the poor to be represented in policy making. 
The notion of transcalar networks for policy transfer and implementation 
enables us to understand global-national-local policy transfer process in the 
case of GHPs, as each national committee demonstrates characteristics of a 
transcalar network. Within this network, global health policies are negotiated 
on the basis of the strategic orientation of specific GHPs. This is different from 
traditional health policy transfers promoted by WHO and UNICEF (e.g. Reich 
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1995, Walt et al. 2004) in parallel with the development policies of the World 
Bank (e.g. Baye 2003, Mbaku 2004). Global and regional (Abuja Declaration) 
RBM targets are set and then dialogue processes are set up with national 
governments and local groups to develop the national systems for 
implementation. Similarly, with the AAI, the government simply had to sign an 
accord with pharmaceutical companies before creating implementation 
systems. 
There is some evidence of interactive policy transfer within the national 
committees. Apart from UN agencies, global partners such as bilateral 
development agencies and international NGOs (e.g. MSF) exchange ideas with 
national and local partners on 'best practices', 'field experiences' to help 
inform situational analysis, prepare grant proposals and create treatment 
centres. As emphasised by both the RBM and the AAI, representatives of local 
community groups participate in the dialogue process. This is what makes the 
GHP approach a transcalar network, with each committee consisting of specific 
partners with an in,terest in specific disease areas (HIV/AIDS and malaria). 
Unlike the PHC model centralised around the Ministry of Health with limited 
civil society participation in policy making, GHPs attempt to align health 
policy (WHO and UNICEF) with development policy (World Bank and 
Development Agencies) into national disease programmes in which non-state 
actors are increasingly playing key roles in policy implementation. 
However, it is questionable whether these new social, cultural and political 
contexts are understood and recognised within the GHP policy template. This 
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thesis confirms claims by Caines et al. (2004), that the GHP approach offers a 
'technical fix', based on specific medical interventions to achieve quick results. 
What is common among overlapping initiatives in the two case studies on 
malaria and HIV I AIDS in Cameroon is that they represent pre-existing projects 
that have been re-aligned to reflect the narrow objectives of GHPs. Evidence of 
the limited attention being paid to the public health, and more importantly the 
human rights narratives, is the fact that data on the incidence and rate of 
transmission of HI VIA IDS and malaria are widely debated: 
We don't know exactly how morbidity is, how morbidity patterns are 
because various international players bring that into picture only for the 
regions they are involved in. In that case how do you give an 
impression on how effective the different programmes are in terms of 
malaria treatment and control?156 
Even in the case of the HIV/AIDS programme it was clear that 'the first 
problem (that needs to address) is the lack of availability of actual figures 
about the HIV I AIDS epidemic.' 1 57 These quotations point to more questions 
than answers concerning the role of GHPs in shaping policies: Are the voices 
of the poor actually present in policy making arenas? Are country-specific 
GHP policies consistent with field conditions such as actual disease incidences 
and epidemiological surveillance as national strategic plans and technical 
reports suggest? Such question reflect the key argument made in this thesis that 
GHP policies are simply the embodiment of elements from development 
\ 
models that serve the interests of global partners imposed on disease-endemic 
countries; they involve very limited interactive policy transfer and are not fully 
adapted to local realities. 
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Ironically, at the local level, GHP programmes are animated by specific and 
overlapping treatment programmes initiated by the very global partners based 
on the international dimension of policy (through 'lessons learned' from the 
implementation of health development models in other local settings). For 
example, Chapter Six explained how the Social Marketing Programme (best 
practices from USAID's pilot projects) and the Integrated Management of 
Childhood Illness (lessons learnt by WHO, UNICEF and their affiliated 
development agencies) are being implemented under the national RBM 
programme. Although these programmes initially emphasised behaviour 
change element of the PHC model, by joining the national RBM programme, 
their strategic orientations were redefined limiting their activities to suit the 
economisitic model such as sales and distribution of ITNs. Similarly, Chapter 
Seven explained how, despite emphasising a human rights model, the 
economistic orientation of MSF from its pilot projects (cost-effective 
HIV/AIDS testing and treatment with generic medicines) as a local partner to 
the national HIV/AIDS programmes is being recommended for implementation 
in other countries. These are examples of how the embodiment of different 
forms of knowledge with the GHP model shapes local practices. 
What emerges from the case of Cameroon is that old (previous treatment and 
care programmes in the pre-GHP era) and new (those created by the national 
GHP programme) institutions and programmes have become interwoven 
following the deployment of GHPs, achieving the narrow goal of GHPs (in 
terms of affordability and accessibility of medicines), but failing to address 
potential access to medication (as the incidence and burden of malaria and 
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HIV/AIDS .continue to rise year after year). Thus, the case of Cameroon 
reveals that while scaling-up access to medication might have been successful, 
more work is needed to understand how the GHP model can be re-designed to 
be able to address potential access to medication (by not only incorporating the 
public health and human rights narratives as the core of policy making but 
translating them into specific programmes and activities). 
8.4.2 Reflexivity - the unchanging nature of North-South 
relationships in the context of globalization. 
The second policy conclusion from this thesis is that the GHP model has 
introduced new structural challenges in the national health system without 
addressing the previous ones. As explained below, the analyses from this thesis 
provide empirical evidence for this conclusion. The PPP nature of the GHP 
model, in which the traditional central element of the political economy of 
health development is no longer the state (having replaced the Ministry of 
Public Health with National Disease Control Committees) have created 
transcalar networks whose activities have led to overlapping treatment 
programmes and activities being scattered all over the country. Traditional 
transnational networks that were being built around government ministers have 
been replaced by a mechanism in which the state has become entangled in 
transcalar networks ofPPPs created by GHPs at global and local levels. 
Before the official launching of any National GHP Programme, a series of 
preparatory meetings are held with representatives of UN agencies, the national 
government and associated global and national partners. The outcome of these 
meetings ensures that the types of support provided by UN agencies must 
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reflect the Millennium Development Goals of the UN, the Poverty Reduction 
Strategy Papers of the World Bank, the Paris Declaration on AIDS 
Effectiveness and the WHO's Essential Drug List. 
The national frameworks developed are meant to ensure that the national 
programme promotes good governance, eradicate corruption and encourage 
civil society participation as demanded by the above international conventions 
and chartters. It also ensures that National Strategic Plans for specific GHP 
programmes meet the requirements for donor funding (as demanded by the 
World Bank and Global Fund) while targeting programmes to the needs of the 
poor (as illustrated in the two case studies on malaria and HIV/AIDS). This is 
the way in which the collective 'activism' developed by GHPs at the global 
level converges at the national level. This approach dismantles long established 
transnational networks (North-South divide) and creates transcalar networks 
(global-national-local linkages) thereby blurring the North-South divide. 
Such reforms, as demonstrated in chapters two and five respectively, are based 
on the liberal argument that both the government and the market (Mathews, 
1987; Dodgson et aI., 2002) were failing to deliver. In this case, one would 
expect that the formulation and implementation of GHP programmes, while 
aiming to achieve access to medication would address these failures. GHPs 
have actually included the private and non-state sectors in governance 
arrangements for more transparent ways of receiving funds. This has also been 
done as the result of the human rights narrative on the need for civil society 
participation. For the first time, we are seeing a multi-stakeholder mechanism 
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in which government is unable to prevent funding and other support reaching 
the poor; we are also seeing new efforts to improve quality in the private 
sector, and global partners seeking to fund only proposals that use robust 
national GHP plans. Clearly, the GHP model presents a new form of hybrid 
structure, one that plays the boundary between global vs national, public vs 
private, state vs. non-state, profit vs non-profit thereby bypassing traditional 
forms of state governance. Nevertheless, the practical lessons from this thesis 
reveal the unchanging nature of donor-recipient relationships, as state-centric 
governance structures have not been replace by a fully functioning multi-level 
governance framework that is capable of governing policy implementation at 
local levels. 
Global models are meant to be flexible and reflexive at global and local levels 
(e.g. King and Kraemer, 1992). In this sense, national GHP programmes 
introduced in African countries, such as Cameroon, are supposed to have 
positive impacts on their targeted populations, but also in the explicit 
knowledge that they will satisfy the interests of global partners. Over time (as 
the programme is being implemented) the unexpected and less desired 
challenges may be overcome through innovative and adaptive country-specific 
responses in a continuous (reflexive) process. Analysis of the case studies 
suggests that reflexivity is imposed on the national GHP framework by the 
global partners, supporting instead the claim that global models are alternative 
processes (Danzig, 1979) or political weapons (King and Kraemer, 1992) used 
to convince those actors who would otherwise oppose the strategic objectives 
ofGHPs (e.g. certain CSOs and local groups). 
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For example, the rhetoric of good governance promoted by global partners 
tends to override the need for reflexivity, as specific programmes and activities 
are still being tied to donor-recipient commitments in the pre-GHP eras. If 
GHPs are meant to promote good governance and fight corruption it is rather 
surprising that the state, which urgently needs to become more transparent to 
be able to govern, and working directly with local community organizations is 
not directly responsible for the implementation of GHP programmes. From the 
case studies, policies are successfully transferred very willingly, with 
government participation all the way, but implementation remains poor due to 
weak governance. Even the national committees that ought to decide how 
funds should be allocated to different programmes and activities tend to playa 
more ceremonial role as some global partners prefer to work directly with local 
CSO in urban and rural areas. This leads us to question the nature of North-
South relationships in the context of globalization. Specifically, the issues that 
policy makers must address can be expressed along the lines of the following 
quotation: 
'One has to question the role of these global partnerships. What are their 
actual functions? Are they there to foster their own aims or are they there to 
support countries solve their health problems? If you take the example of 
the French bilateral aids project (part of the World Bank's Debt Initiative), 
most of the funds have been allocated to the private sector, especially non-
profit sectors.' 158 
From the above quotation it can be argued that global policies have simply 
been adopted because policy makers (the national committee members at 
global, national and local levels) could see how they could take advantage of 
ISS Interview, Division of Healthcare Organization and Health Technology, Ministry of Public 
Health. 
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the transcalar networks to which they belong, gIven the relatively poor 
governance mechanisms of national GHP programme (as evident in corruption, 
poor legal frameworks, weak financial assessment, overlapping initiatives). At 
the local level the community participation model, which tends to dominate the 
PPP approach of GHPs appears to be a search for legitimisation in the face of a 
democratic deficit that comes from bypassing the state. As already mentioned, 
such programmes and activities are so overlapping that it is difficult (as 
demonstrated in chapter two) to provide any robust description of the specific 
links among the different stakeholders within the varous transcalar networks. 
For example, while specialised treatment centres for HIV/AIDS within the 
public sector are created (and equipped) by the national programme, those in 
the private sector are only approved by the national programme after showing 
evidence that they are fully equipped. In such context, non-public centres tum 
to international donors for direct funding and equipment support to create 
HIV I AIDS treatment centres. This has led to the proliferation of HIV I AIDS 
treatment centres in the country that were not initially created by the national 
programme (and that are not directly answerable to the national committees). 
As the two case studies on HIV / AIDS and malaria suggests, these issues are 
not being dealt with at periodic national committee meetings, they are only 
being acknowledged. What is more crucial for Cameroon is the fact that the 
same approach (National GHP Programme approach) is currently being 
debated by national policy makers for application in other health sectors. 
Most of the (public health) institutions are gone (to GHP programmes 
such as malaria, HIV I AIDS and T8). A whole set of instruments are 
being drawn to define the role of the government as a regulator and 
increasingly, to upgrade or reinstate the non-state sectors to deliver 
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health services. So increasingly the regulatory framework is tailored 
such that NOOs will have a bigger role to play since the government 
will put stronger emphasis on their contribution .... (But) so many local 
community groups operate health structures without the appropriate 
authorisation simply because they receive donor funding. T h e ~ ~ do not 
respect basic principles of health care ... and need to be closed. S9 
The above quotation from a senior director within the Division of Healthcare 
Organization and Health Technology at the Ministry of Public Health suggests 
that what the GHP model has achieved at the national institutional level is to 
create parallel national health systems for specific diseases. It is telling that this 
division is not a partner to any of the national GHP programmes. The Director 
is at the same level as the Permanent Secretaries of the National GHP 
Programmes for HIV/AIDS, malaria and TB respectively. This obviously puts 
the heads of each of these programmes (including the Minister of Public 
Health) in a difficult dilemma. They have to ensure that the demands of global 
partners are met (to continue to receive donor support) and at the same time 
they are accountable to the regime that appointed them through the executive 
powers of the President. In addition, they are forced to tolerate unethical 
practices by local community organizations simply because they want to 
maintain the survival of regime. 
This leads us to question the strategy of the GHP model to favour an approach 
that bypasses the state. This thesis proposes therefore that the political capacity 
to achieve potential access to medication does not necessarily lie within the 
formal GHP processes. It needs to gain the leadership of the state in being able 
to coordinate overlapping and parallel programmes and activities as well as 
159 Ibid (see note 3) 
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aligning the national GHP programmes into the national health system. In this 
context, the case studies presented in this thesis suggests more general findings 
that go beyond the case of Cameroon: 
• Even if transcalar networks of PPPs created by the GHP model can help 
access to medicine for the poor by involving the civil society in 
rebuilding the capacity of the government along the lines of better and 
more co-operative governance structures, this may not be a substitute 
for effective (strong) state governance if overlapping initiatives are 
answerable to specific international donor agencies (rather than the 
state). 
• Unless serious steps are taken to reduce the country's dependence on 
global institutions (especially funding agencies), the processes of 
transformation pushed by GHPs (such as technical directives on 
community participation and good governance) might end up by 
exacerbating the persistent structural constraints in the national health 
system. 
• Developing countries willing to implement GHP programmes following 
the integration of best practices or lessons learned with country-specific 
needs in relation to access to medication should have a strong efficient 
state (and government) ex ante, as GHPs may not be conducive to a 
strengthened state capacity per se due to the powerful strategic interests 
of global partners. 
Thus we have seen that the presents of transcalar networks enable international 
agencies to use local CSOs to bypass (or operate in parallel with) formal state 
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structures, thereby halting the effective coordination necessary to sustain the 
realisation of OHPs programmes. There is need for the various national GlIP 
programmes to become really 'locally owned' via empowering the local CSOs 
not to be barely represented in specific committees and parallel programmes 
but to be able to interact with the public sector at all levels. Without this the 
transfer of technology, policies, systems and expertise by OHPs, remain a 
dubious perpetuation of the status quo. 
The case study thus reveals that the elements necessary for GHP programmes 
to be legitimate in the Cameroonian social and institutional setting need to 
balance the public health, economistic and human rights needs of national and 
local partners. It appears, at the moment, that these needs are taken more 
seriously only at the global levels. In particular it directs the attention of policy 
makers to the wider political, social and historical context in which diverse 
institutional systems operate and interact which has become transcalar as 
against transnational in character. This means that both formal policies that are 
consensually agreed during national committee meetings and the informal (and 
sometimes unofficial) activities of those public, private and civil society 
institutions whose legitimacy stems from being affiliated to key GHP partners 
need to be documented on the GHP template as a stepping stone to re-
designing the GHP model at the national and local levels. 
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8.5 Envisioning a Re.design of the GHP Model on Access 
to Medication 
This thesis demonstrates that the GHP model is a form of global activism, a 
global political narrative on how access to medication can be provided to the 
poor. The evidence presented suggests that the model provides an institutional 
solution to the problem of access to medication but fails to solve the disease 
problems. At the national level the power of the state has diminished while the 
role of government as a service provider is increasingly being transformed by 
more civil society participation. This draws our attention to the subtle 
dynamics which link together institutions and organizations across various 
global health contexts. The various state and non-state actors involved in the 
realisation of GHP programmes are difficult to coordinate in the current global 
context as their responsibility is configured within wide (and apparently 
uncontrollable) transcalar networks of institutional activity. 
The 'narrative (or knowledge) approach' used to understand the role of GHPs 
on access to medication in this thesis focuses on the global activism within 
GHPs and how this shapes policy practices. It does not address the specific 
institutional or organizational challenges posed by the GHP model at global, 
national and local levels. A specific configuration of relationships across the 
global-national-local linkage that would generate different impacts on access to 
medication seems impossible to explore within the scope of this thesis. For 
example, this thesis suggests the need to integrate overlapping programmes and 
activities into the national health system under the Ministry of Health. In other 
instances, it is agued that global partners ought to trust the Central Technical 
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Group designated to coordinate policy implementation instead of implementing 
programmes at provincial and local levels that are answerable to specific 
western donor agencies. If these suggestions are to be taken on board, what 
would be the nature of the national health system? What sorts of institutional 
and organizational challenges would GHPs face? Taken these questions into 
consideration, would GHPs succeed to solve the disease problems? These are 
issues for further research, as the evidence from this thesis does not allow us to 
answer such questions. 
However, the approach used in this thesis brings to the attention of a wider 
community of researchers studying the relationship between STS, development 
and globalization, the possibility of a research agenda that can develop new 
theoretical understandings of the phenomenon of global institutions, 
programmes and policies. The cases presented highlight interesting issues for 
theoretical and empirical enquiry. By combining the notion of embodied 
knowledge in SIS and social constructionist IR, we have been able to identify 
and better understand how certain theories have shaped the narrative strategies 
in access to medication which are then supposedly 'embodied' in specific 
'organizations' that are called GHPs and then transferred to national and local 
settings for implementation by specific 'organizations' called National GHP 
Programmes. This is certainly valuable and there are very interesting insights 
of what we could call a political story of activists involved in a specific 
struggle to frame specific claims (around access to medication). More research 
is needed to better understand this political story and how this type of 'hybrid 
network' gives new insights about how specific claims are likely to be carried 
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on across frontiers both in other GHP settings and global institutions m 
general. 
In addition, the arguments developed in this thesis focuses on 'pure' health and 
medicine-related issues, as well as health policy. The knowledge approach 
enables us to identify the relevant development models and objects of study, 
the narrative analysis method chosen to address it contributes to our 
understanding of public health, economics and human rights in the context of 
global, national and local health interventions. The approach that has been 
developed (as presented in Chapter Two and applied throughout this thesis) has 
not allowed us to discuss in greater detail the organizational aspects of GHPs at 
global and national levels. Specifically, the very idea of hybridization of 
networks, the reasons why GHPs are actually developing this type of 
orientation and how this generates different impacts on access to medication 
needs to be explored further by clearly delimiting the links and specific role of 
each global, national and local partner. This is another area for further research, 
for example, by applying variants of social network analysis. 
Furthermore, this thesis highlights the institutional and organizations dynamics, 
whereby different levels of analysis are linked, insights from different 
perspectives and/or disciplines are synthesized, and complexity (legal, societal, 
political and economic) is embraced. While the thesis does not really look 
inside the organizational complexity or the political story of GHPs in greater 
details per se, it provides a very promising empirical and theoretical track to be 
pursued around the collective nature of the 'activism' that is described in the 
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different chapters (in terms of public health, economistie and human rights 
narratives). Further research is needed which might for instance require that we 
dig into a sort of Social Movement Theory or Actor-Network Theory to see 
whether the narratives could be analyzed through a proper 'framing' 
perspective that follows the actions (not merely reviewing documents and 
interviewing a selected few as has been the case in this thesis) of specific 
actors in global health to better understand the linkages that animate transcalar 
networks in the GHP domain. 
Finally, there are certain issues concerning the research methods explained in 
chapter three that are worthy of mention. First this is a single country study 
(Cameroon) and the empirical case studies focus on two provinces to reflect 
socio-economic (rich/poor, urban/rural) cultural-colonial (e.g. English vs 
French-speaking regions) and health inequalities (e.g. areas with access to high 
quality hospital as against villages in remote areas). As this is not a 
representative sample (as elaborated in chapter three), it can be suggested that a 
comparative (cross-country) study of more than one African country would add 
more robustness to the arguments presented. In addition, on reflection more 
local public, private and civil society groups could have been included in this 
research. Although many of these local partners were contacted (especially 
representatives from patient groups) they were only interviewed informally. 
Including more of this group would have given a deeper insight to GHPs from 
their local perspective and perhaps add new levels of complexity on the role of 
GHP in Cameroon (e.g. how policy issues agreed at the global and national 
level are translated into programmes and activities in rurual villages). 
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Nevertheless key aspects of their role documented in technical reports and 
programme evaluations by specific GHP-affiliated organizations have been 
cited were necessary. 
8.6 Contributions to the Theoretical Literature 
The contribution of this thesis to the study and research on STS is threefold. 
The first is identified with the object of study itself. GHP programmes offer for 
analysis a rather different set of issues with respect to the discipline as well as 
its relationship with globalization and development. As Sheila Jasanoffputs it: 
'STS already has a long history of engagement with development, as 
well as numerous achievements to its credit. For example, the "old" 
discourse of "appropriate technology" implicitly accepted that the 
development of technological systems in "developing" locations should 
be attentive to their social and cultural contexts. Similarly, one can see 
citizen activism and protest ... as challenging the epistemic, 
teleological, and normative assumptions of development specialists. It 
is against this backdrop of ongoing critique that we should, in all 
modesty, consider what STS can offer today.' 160 
This thesis contributes by adding to this ongoing critique a theoretical 
methodology that combines STS and International Relations (lR), approaches 
that have been used primarily independent of each other to the study of GHPs. 
Previous STS-related studies have explored the ways in which development 
policies promoted by GHPs attempt to address global market failures, 
institutional and organisational uncertainties in ensuring that pharmaceutical 
products get to reach the poorest people who need them (e.g. Chataway et aI., 
2007; Chataway and Smith, 2006). IR-re1ated studies on GHPs are dominated 
160 Sheila Jasanoff gave a Panellists' Introductory Statements to start off a Roundtable: 
"Development, Globalization, and STS" during the Joint EASSTI4S Conference, Erasmus 
University Rotterdam, Netherlands, 20-23 August. For details of the roundtable see 
http://www.st-and-dev.netlsts/nodeI18 (Accessed: 14105109). 
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by liberal and neo-liberal interventionist approaches (e.g. Dodgson et at., 2002; 
Buse 2004a; Abbot, 2007) which have long been considered as being too 
normative due to their overemphasis on the role of the state or specific 
international actors (Boas and McNeill, 2004). Doth sets of studies point our 
attention to the network of interactions taking place among global, national and 
local actors in global health, issues that are explored in this thesis. Thus, the 
present study differs fundamentally from other studies in objectives, 
development and results. 
The research presented in this thesis therefore adds to existing research an 
account of what the GHP model embodies as a global actor within an African 
country and the consequent transformation of the state through its networking 
with the global and local civil society. It enables us to better understand gloqal-
national-local linkages in global health beyond specific project or programme 
evaluations published as technical reports and policy documents by specific or 
a combination of GHP partner organizations. Specifically, this thesis unpacks 
complexity of the hybrid network structures in which global institutions (e.g. 
GHPs) are modelled to deal with country-specific problems (e.g. barriers to 
access to medication). In this way we have been able to understand the various 
state and non-state actors involved at national and local levels, and their 
responsibility within the wider GHP network. 
Previous research has also not studied the effects of the meaning ascribed to 
'access to medication' in a process of globalization, mostly taken them as 
given. This study therefore contributes to move the research frontier of the 
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discipline to address also how the construction of access to medication by key 
GHP partners affects the design of policy, organizations and institutions during 
the process of creating national GHP programmes. These have remained 
implicit in policy documents and technical reports. By making them explicit, 
this thesis highlights the powerful. role of 'rhetoric', 'promises', 'colourful 
language', or 'plots' in transforming the traditional conceptualisation measures 
to achieve access to medication from a strengthened national health system to 
parallel and overlapping GHP programmes and activities. 
The second contribution that this research seeks to make relates to the 
problems within existing theories in addressing the phenomenon of the role of 
GHPs on access to medication. As discussed in chapter two, STS and social 
constructionists IR perspectives in isolation (including their multiple 
consequences and variants) do not seem to provide an appropriate framework 
for studying GHPs even if they are widely used to address different expressions 
of such phenomenon. Each focuses on different though relevant aspects to 
interpret the functional and operational mechanisms of global institutions such 
as GHPs and their implications for national policy formulation and 
implementation. However, each reveal the presence of a diversity of 
organizational, institutional and policy contexts on a global scale, implying that 
diversity of the networks (characterised in this thesis as having a transcalar 
character) on which GHPs programmes are built need to be addressed. 
The contribution to theory in this thesis is therefore based on the benefits of 
taking a 'narrative (or knowledge) approach' to the analysis of GHP, by 
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looking at the ways in which different models arc used to create transcalar 
networks and how this process shapes policy practices. The framework 
presented in chapter two contributes along this line in terms of providing 
interdisciplinary approaches to the study of GHPs as well as offering new 
insights for answering questions about globalization and development. Further 
research in this direction would have the ability to answer questions that GHP 
programme produce in different social settings, where the role attributed to 
medical technology changes in meaning in the face of different stakeholder 
ideologies in different contexts. These in turn influence several drivers of 
policy in relation to the development, transfer and implementation of health 
policies taken into account the transcalar network characteristics of GHP 
programmes. This is not (of course) simplistically determined by technical 
knowledge (public health, economics and human rights) or the socio-political 
contexts but by a continuous and dynamic process of negotiation between the 
two, connecting the global, national and local. 
Finally, as the promotion of GHP programmes is a recurrent element of 
political economy (especially health sector) reforms of many developing 
countries, what GHPs represent in terms of a new form of governance (and the 
changing North-South relationships) becomes central to understanding the 
future direction of research in this area. The intrinsic characteristics of global 
actors and their narratives require, to a certain extent, a unified vision as to the 
requirements for achieving both potential and actual access to medication. 
Apart from this, they can be catalysts for discovering the diversity of transcalar 
networks and the extent to which established relations arc (or are not) 
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perpetuated, consolidated and extended to the complicities of specific diseases. 
In this case, the framing and analysis of GHP programmes as theoretically 
linked to global 'models' should be an object of continuing enquiry and one 
that can provide institutional, organizational and policy network mechanisms 
facilitating their conceptualisations, analytical frameworks, policy directions 
and local practices. 
356 
REFERENCES 
Abbott K.W. (2007) 'Innovations in Global Health And the Global Governance 
System', Conference Proceedings: Civil Society Organizations and Global 
Health Governance Wall Summer Institute 2007. 
Abbott, K.W. and Snidal, D. (2006) 'The Governance Triangle: Regulatory 
Standards Institutions and the Shadow of the State', Proceedings: Global 
Governance Project, Oxford University (October 2006). 
Achinstein, Peter (1968) Concepts o/Science, Baltimore: Johns Hopkins Press 
ACP-UP (2000) 'Treatment for all ... Now!' Global Manifesto, Durban, South 
Africa <http://www.actupny.org!reports/durban-access.html> (Accessed: 
21109/08). 
Aghion, Philippe and Howitt, Peter (1998) Endogenous Growth Theory. 
Cambridge, MA: MIT Press. 
Ako, S., Fokoua, S., Sinou, M. & Leke, P. (2006) 'Reproductive Health in 
Cameroon' Reproductive Health/or All, Foundation for Medical Health & 
Research 
<http://www.gfmer.chlEndolReprod _healthlCameroonIN et_ Reproduction_ 
Cameroun.htm (Accessed 24/02/2007). 
Alcalay, R. and Bell, R. (2000) Promoting Nutrilion and Physical Activity 
Through Social Marketing. Dep't of Communication & CASNSM, 
University of California, Davis, <htlp:/lsocialmarketing-
nutrition.ucdavis.edulpublications.htm> (Accessed: 07/03/2009) 
Alinsky, Saul D. (1946) Reveille for Radicals, New York: Vintage Books 
(1989 Edition) 
357 
Alinsky, Saul D. (1971) 'RulesJor Radicals: A pragmatic Primer Jor Realistic 
Radicals, New York, NT: Vintage Books (1989 Edition). 
Andersen, R.M. (1995) 'Revisiting the Behavioural Model and Access to 
medical Care: Does it matter?' Journal oj Health and Social Behaviour, 
36:1-10. 
Andreasen, Alan R. (1995) Marketing Social Change: Changing Behavior to 
Promote Heallh, Social Development, and the Environment. San Francisco, 
CA: Jossey-Bass. 
Attaran, A., Barnes, K., & Curtis, C. (2004) 'WHO, the Global Fund, and 
Medical Malpractice in Malaria Treatment' LANCET 363(9404): 237-240. 
Arendell, T. (1997) 'Reflections on the Researcher-Researched Relationship: A 
Woman Interviewing Men' Qualitative Sociology 20(3):341-368. 
Armstrong, D. (1988) 'Historical Origins of Health Behaviour' In: Anderson, 
Robert; Davies, John K., Kickbusch, Ilona; McQueen, David V., & Turner, 
Jill (Eds) Health Behaviour: Research and Health Promotion, Part I: 
Chapter Two: Oxford: University Press. 
Bache I, Flinders M. (2004) Multi-level Governance: Conclusions and 
Implications, In Bache, I. and Flinders, M. (eds.) Multi-level Governance. 
Oxford: University Press. 
Bache I, Taylor, A. (2003) The Politics of Policy Resistance: reconstructing 
higher education in Kosovo, Journal oj Public Policy 23(3):279-300. 
Bailer-Jones, D.M. (1999) 'Tracing the Development of Models in the 
Philosophy of Science', In Magnani, Lorenzo., Nancy 1. Nersessian & Paul 
Thagard (Eds) Model-Based Reasoning in Scientific Discovery. New York: 
Kluwer, pp. 23-40. 
358 
Bailer-Jones, D.M. (2003) 'When Scientific Models Represent' International 
Studies in the Philosophy of Science 17:59-74. 
Basco, L.K. (2004) 'Molecular epidemiology of malaria in Cameroon - XIX 
Quality of antimalarial drugs used for self-medication' American Journal 
of Tropical Medicine and Hygiene 70:245·250. 
Baye, M.F. (1998) 'Inequality and the Degree of Poverty Among Public Sector 
Workers in Cameroon', Nigerian Journal of Economic and Social Studies, 
40(3):433-452. 
Baye, F.M. (2003) 'Globalisation, Institutional Arrangements and Poverty in 
Rural Cameroon' Africa Development, XXVIII (3&4):112-141. 
Beaglehole, Robert and Bonita, Ruth (1997) 'Public Health at the Crossroads' 
Melbourne: Cambridge, University Press. 
Becker, P.H. (1993) 'Common Pitfalls in Published Grounded Theory 
Research', Qualitative Heallh Research 3(2):254·260. 
Bellamy, Carol (1999) 'Public, Private and Civil Society' Statement of 
UNICEF Executive Director: Harvard International Development 
Conference on Sharing Responsibility: public pril'ale and civil society. 
Cambridge, MA: 16 April. 
Bhagwati, Jagdish N. (1987) International Trade: Selected Readings, 2nd 
Edition, Cambridge, MA: MIT Press. 
Black, Max (1962) Models and Metaphors. Ithaca: Cornell University Press. 
Blyth, Mark (2002) Great Transformations: Economic Ideas and Institutional 
Change in the Twentieth Century Cambridge: Cambridge University Press. 
Bidjocka P. (2008) 'One of two former Ministers arrested rushed to hospital' 
The Entrepreneur (03/04/2008) 
359 
http://www.cntrcpreneurncwson1ine.coml2008/04/one-of-two-form.htm1 
(Accessed: 11/10/2008) 
Dijker, Wiebe E. (1995) Of Bicycles, Bakelite's and Bulbs: Toward a Theory of 
Socio-technical Change, Cambridge: MIT Press. 
Birkland, T.A. (1998) 'Focusing Events, Mobilization, and Agenda Setting' 
Journal of Public Policy 18(1 ):53-74. 
Doas, Morten and McNeil, Desmond (2004) Global Institutions and 
Development: Framing the World? London: Routledge. 
Dorrell, J-R. and Watal, J. (2002) Impact of Patents on Access to HIVIAIDS 
Drugs in Developing Countries, CID Working Paper No. 92, Centre for 
International Development, Harvard University, Cambridge MA 
Bowden, G. (1995) 'Coming of Age in STS: Some Methodological Musings', 
In Jasanoff, Sheila., Gerald E. Markle., James C. Peterson., & Trevor Pinch 
(eds.), Handbook of Science and Technology Studies, pp. 64-79, London: 
Sage. 
Brenner, N. (1999) 'Beyond State-Centrism? Space, Territoriality, and 
Geographical Scale in Globalization Studies', Theory and Society 28:39-78. 
Brenner, N. (2001) 'The Limits to Scale? Methodological Reflections on Scalar 
Structuration' Progress in Human Geography 25:591-614. 
Brewer, Garry D. and Shubik, Martin (1979) The War Game: A Critic of 
Military Problem Solving, Cambridge, MA: Harvard University Press. 
Brundtland, Gro H. (2000). Towards a strategic agenda for the WHO 
secretariat: Statement by the Director General to the Executive Board at its 
105th session, WHO: EBI05/2. 
Bryman, Alan (2001) Social Research Methods Oxford: University Press. 
360 
Burgess, Robert G. (1984) In The Field: An Introduction to Field Research 
London: Allen and Unwin. 
Buse, K. (2004a) 'Governing Public-Private Infcctious Discasc Partncrships' 
Brown Journal of World Affairs 10(2): 225-242. 
Buse, K. and Harmer, A.M. (2007) 'Seven Habits of Highly Effcctive Global 
Public-Private Health Partnerships: Practice and potential' Social Science 
& Medicine, 64(2):259-271. 
Buse, K. and Walt, G. (2000a) 'Global Public-Private Partnerships: part I - a 
new development in health?' Bulletin of the World Health Organizations, 
78(4):549-561. 
Buse, K. and Walt, G. (2000b) 'Global Public-Private Partnerships: Part II -
What are the health issues for global governance?' Bulletin of the JVorld 
Health Organization, 78(5):699-709. 
Caines, K., Buse, K., Carlson, C., de Loor, R.·M., Druce, N., Grace, C., 
Pearson, M., Sancho, J., & Sadanandan, R. (2004) 'Assessing the impact of 
global health partnerships' Synthesis of Findings from the DFID Studies: 
Global Health Partnerships: Assessing the Impact. London: DFID Health 
Resource Centre. 
Caines, K. and Lush, L. (2004) 'Impact of public- private partnerships 
addressing access to phannaceuticals in selected low and middle income 
countries.' A synthesis report from studies in Botswana, Sri Lanka, Uganda 
and Zambia. Geneva: Initiative on Public-Private Partnerships for Hclp. 
Caldwell, C.J. (1985) 'The Social Repercussions of Colonial Rule: 
Demographic Aspects'. In Boahen, Adu A. (cd.) General History of Africa. 
VII Berkeley, Univesrity of Califonia Press. 
361 
Callon, M. (1991) 'Techno-economic networks and irreversibility' In Law, 
John A. Sociology of Monsters: Essays on power, technology and 
domination, pp. 132-161), London: Routledge. 
Caplan, R. (1993) 'The Importance of Social Theory for Health Promotion: 
From Description to Reflexivity' Health Promotion International, 
8(2):147-157. 
Carlier, Krit and Jennes, Geert (2003) Country Case Study 3: An Assessment of 
the Cameroon MTEF, 001: Centre for AIDS and Expenditure, London. 
<http://www.odi.org. uklPPPG/CAPE/publicationsIMTEF%20Cameroon. pd 
1> (Accessed: 24/0612008) 
Carlson, C. (2004) Mapping Global Health Partnerships: What they are, what 
they do and where they operate. London: DFID Health Resource Centre. 
Cartwright, Nancy (1983) How the Laws of Physics Lie. Oxford: Clarendon 
Press 
Castells, Manuel (1996) The Rise of The Network Society, Oxford MA: 
Blackwell 
Castells, Manuel (1997) The Power of Identity OxfordlMalden, MA: 
Blackwell. 
Castells, Manuel (1998) End of Millenium Malden, OxfordIMalden, MA: 
Blackwell. 
Castells, Manuel (2000) The Rise oj The Network Society, 2nd Edition, Oxford 
MA: Blackwell. 
Chataway, J., Brusoni, S., Cacciatori, E., Hanlin, R., & Orsenigo, 1. (2007) 
'The International AIDS Vaccine Initiative (lAVI) in a Changing 
Landscape of Vaccine Development: A PubliclPrivate Partnership as 
362 
Knowledge Broker and Integrator,' The European Journal of Development 
Research, 19( 1 ): 100-117. 
Chataway, J. and Smith, J. (2006) The International AIDS Vaccine Initiative 
(IAVI): Is It Getting New Science and Technology to the Worldts Neglected 
Majority? World Development 34(1):16-30. 
CIPR (2002) Commission on Intellectual Property Rights (2002). Integrating 
Intellectual Property Rights and Development Policy, London 
Coffey, Amanda and Atkinson, Paul (1996) Afaking Sense ofQualilalil'e Data 
Analysis: Contemporary Strategies, Thousand Oaks: Sage (Chapters 1&2). 
Coleman, James S. (1990) Foundations of Social Theory, Cambridge, MA: 
Harvard University Press 
Compagnon, D. (2008) Transnational Public Private Partnerships and 
Environmental Governance in Africa: can new forms of governance solve 
the implementation deadlock? GARNET Working Paper: No 3208. 
Cotterill, P. and Letherby, G. (1993) 'Weaving Stories: Personal 
Auto/biographies in Feminist Research', Sociology 27(1 ):67-79. 
Cox, Robert W. (1995) Critical Political Economy, in Hettne, B. (ed.), 
International Political Economy: Understanding Global Disorder. Zed 
Books, London. 
Cox, Robert W. and Sinclair, Timothy 1. (1996) Approaches to World Order, 
Cambridge: University Press. 
CREDES (2004) 'Country Coordinating Mechanism: Case Study 
Documentation - Cameroon, Report prepared for the Global Fund ATM 
and Financed by the French Ministry of Foreign Affairs, CREDES, France. 
363 
Danaher, K. (1994) 50 Years is Enough: The case against the World Bank and 
the International Monetary Fund. Boston, Mass., USA, South End Press 
Dantzig, George n. (1979) The Role of Models in Determining Policy for 
Transition to a More Resilient Technological Society, IIASA 
DISTINGUISHED LECTURE SERIES 11, International Institute for 
Applied Systems Analysis Vienna, June 12,1979 
Danziger, 1. N. & Andersen, K. V. (2002) 'The Impacts of Information 
Technology on Public Administration: An Analysis of Empirical Research 
from the "Golden Age" of Transformation' International Journal of Public 
Administration, 25(5):591-627. 
Deardorff, A. V. (2004) 'Who Makes the Rules of Globalization?' CESIFO 
Working Paper No. 1301, Category 7: Trade Policy, Venice Summer 
Institute, Available: www.CESifo.de (accessed: 6/02/2009). 
Delancey, Mark W. and Mokeba, H. Mbella (1990) Historical Dictionary of 
the Republic of Cameroon, 2nd Edition, London: The Scarecrow Press, Inc. 
Delancey, Mark W. and Mokeba, H. Mbella (2000) Historical Dictionary of 
Cameroon, 3rd Edition, London: The Scarecrow Press, Inc. 
De Zulueta, 1. (1994) 'Malaria and ecosystems: from prehistory to 
posteradication' Parasitologia, 36(1,2):7-15. 
Dodd, R. and Cassels, A. (2006) 'Health, development and the Millennium 
Development Goals', CENTENNIAL REVIEW Annals of Tropical 
Medicine & Parasitology, 100(5&6):379-387. 
Dodgson, R., Lee, K. & Drager, N. (2002) Global Health Governance: A 
Conceptual Review. London: Centre on Global Change & Health, London 
School of Hygiene & Tropical Medicine. 
364 
Dolowitz D and Marsh D (2000) Learning From Abroad: the role of policy 
transfer in contemporary policy-making Go\'ernance 13( 1 ):5-24. 
Doron, G. (1986) 'A comment: Telling the Big Stories - Policy Responses to 
Analytical Complexity,' Journal of Policy Analysis and Afanagemenl, 
5(4):798-802. 
Doyle, L. (2004) 'Gender and the 10/90 gap in health research' Bulletin of the 
World Health Organization, 82(3):162. 
Draper, Peter (1991) Health Through Public Policy: The greening of public 
health. London: Merlin (Ed.) 
Dutton, W.H. (1992) 'The Ecology of Games Shaping Telecommunications 
Policy' Communications Theory 2(4):303-328. 
Eboko, F. (2001) 'L'organisation de la lutte contre Ie sida au Cameroun: de la 
verticalite a la dispersion' In: Un sysleme de sante en mutation: Ie cas dll 
Cameroun (Changing a Health System: the case of Cameroon), Bulletin De 
L' A.P.A.D, No. 21. <http://apad.revues.orgldocument184.html#ftn6#ftn6> 
(Accessed: 3010312008) 
EI Gaddal, A.A. (1985) 'The Blue Nile Health Project: a comprehensive 
approach to the prevention and control of water-associated diseases in 
irrigated schemes of the Sudan', Journal of Tropical Afedicine and 
Hygiene, 88(2):47-56. 
EIU (2002) 'Cameroon: Country Profile 2002' The Economist Intelligence 
Unit, [Online] 6 February 2003. 
365 
Essomba, R.O., Bryant, M. and Bodart, C. (1993) 'The reorientation of primary 
health care in Cameroon: rationale, obstacles and constraints' Health Policy 
and Planning, 8(3}: 232-239 
Etya'ale, D.E. (1998) Mectizan as a stimulus for development of novel 
partnership: the international organization's perspective. Annals of Tropical 
Medicine Parasitology 92 (Supp!. I): S73-S77. 
Fagerberg, J. (2000) 'Vision and Fact: A Critical Essay on the Growth 
Literature' In: Madrick, Jeffrey (ed) Unconventional Wisdom: Alternative 
Perspectives in the New Economy, New York: The Century Foundation 
Press, (pp. 299-320). 
Farley John (2004) To Cast Out Disease: A History of the International Health 
Division of the Rockefeller Foundation, New York: Oxford University 
Press. 
Fawcett, S.B., Francisco, V.T., Schultz, J.A., Berkowitz, B., Wolff, TJ., & 
Nagy, G. (2000) 'The Community Tool Box: A Web-Based Resource for 
Building Healthier Communities' Public Health Reports, 115(2-3):274-
278. 
Feachem R, Medlin C, Daniels D, Dunlop D, Mshinda H, Petko J, et al. (2002) 
'Achieving impact: Roll Back Malaria in the next phase. Final report of the 
external evaluation of Roll Back Malaria. (29/08/2002): 
<http://mosquito. who.intlcmc _ upload/O/OOO/O 15/905/ee. pdf> 
(Accessed:03/12/06). 
Fee, E. and Parry (2008) 'Jonathan Mann, HIV/AIDS, and Human Rights' 
Journal of Public Health Policy 29:54-71 
366 
Feldman, M.S., Skoldberg, K., Brown, R.N., & Homer, D. (2004) 'Making 
Sense of Stories: A Rhetorical Approach to Narrative Analysis' Journal of 
Public Administration Research and Theory, 14(2):147-70. 
Fettennan, David M., Kaftarian, Shakeh., & Wanders man, Abraham (1996) 
Empowerment Evaluation: Knowledge and Tools for Self-assessment and 
Accountability. Thousand Oaks, CA: Sage Publications. 
Fetzer, J.H. (1999) 'Mental Models: Reasoning without Rules' Minds and 
Machines, 9: (1):119-125. 
Fine, D., Hazelwood, J., Hughes, D. Sulcas, A., (2001) AIDS: A flicker of 
hope in Africa, The McKinsey Quarterly, No 1. Nonprofit Anthology. 
Fishbein, Martin and Ajzen, Icek (1975) Belief, Attitude, Intention, and 
Behavior: An Introduction to Theory and Research, Reading, MA: 
Addison-Wesley. 
Flexner, A. (1910) 'Medical Education in the United States and Canada' 
Bulletin Number Four (The Flexner Report). New York: The Carnegie 
Foundation for the Advancement of Teaching. 
Fromm, G., Hamilton, W.L. and Hamilton, D.E. (1975) Federally Supported 
Mathematical Models: Survey and Analysis Washington, DC: U.S. 
Government Printing Office. 
Frost, L. and Reich, M. (1998) Mectizan donation program: Origins, 
experiences, and relationships with co-ordinating bodies for 
onchocerciasis control. Boston, MA, Harvard School of Public Health. 
Gallup, J. and Sachs, J (2001) 'The economic burden of malaria', American 
Journal of Medicine and Hygiene, 64(1,2) S: 85-96 
367 
Gergen, Kenneth J. (1995) Realities and Relationships: Soundings in Social 
Construction, Cambridge MA: Havard University Press. 
Ghogomu, N. A., Schmidt-Ehry, B., Tata H., a d Meloni, R. (2000) 'The 
Impact of Socio-economic Crises on the Reorganized Health System in the 
North-West Province of Cameroon', GTZ and Ministry of Public Health, 
Cameroon. 
Gibbons, M. (2000) Mode 2 society and the emergence of context sensitive 
science. Science and Public Policy, Journal of the International Science 
Policy Foundation, Special Issue on Interactive Social Science 27(3): 159-
63. 
Giere, Ronald N. (1999) Science without Laws. Chicago and London: The 
University of Chicago Press. 
Giere, R.N. (2004) 'How Models Are Used to Represent Reality', Philosophy 
of Science (Symposia) 71 :742-752. 
Gish, O. (1992) 'Malaria Eradication and the Selective Approach to Health 
Care: Some Lessons from Ethiopia' International Journal of Health 
Services, 22(1):179-92. 
GlaxoSmithKline (2002) 'Facing The Challenge One Year On: A progress 
report on our contribution to improving healthcare in the developing 
world' , http://www.gsk.comlcommunity/facing_the_challenge.pdf 
(Accessed 25/05/2008) 
Globkom (2002) 'A More Equitable World without Poverty', Report of The 
Parliamentary Committee on Sweden's Policy for Global Development, 
Stockholm: Fritzes. SOU.2001 :96. 
368 
Grace, C. (2004) 'GHP Study Paper 3: Global Health Partnership Impact on 
Commodity Pricing and Security', Part of the Series: Global Health 
Partnerships: Assessing the Impact, DFID Health Resource Centre, 
London. 
Grace, C. (2006). Developing new technologies to address neglected diseases: 
The role of Product Development Partnerships and Advanced Market 
Commitments. London: DFID Health Resource Centre. 
Grant, R. W. and Keohane, R. O. (2005) 'Accountability and Abuses of Power 
in World Politics' American Political Science Review, 99(1):29-43. 
Green, Lawrence W. and Kreuter, Marshall W. (1999) An Educational and 
Ecological Approach to Health Promotion Planning. 3rd Edition, Mountain 
View, CA: Mayfield 
Greenberger, Martin., Crenson, Matthew A., & Crissey, Brian L. (1976) 
Models in the Policy Process: Public Decision Making in the Computer 
Era, New York: Russell Sage Foundation. 
Greenwood, B. and Mutabingwa, T. (2002) 'Malaria in 2002' Nature, 415: 
670-672. 
GTZ (2004) Role of Social Marketing in HIV/AIDS Prevention in Cameroon. 
A case study contributed to the conference "Scaling Up Poverty Reduction: 
A Global Learning Process and Conference", Shanghai, May 25-27, 2004, 
by German Developement Cooperation. KfW Bankengruppe 
GTZ (2008) 'Priority Areas for Cameroon' 
<http://www.gtz.de/en/weltweitlafrika/kamerun/1311.htm> (2211112007) 
Haas, L.F. (2002) Neurological Stamp Eugene Jamot (1879-1937) Journal of 
Neurology Neurosurgery and Psychiatry 73:656 
369 
Haglund, B.J.A., Pettersson, B., Finer, D., & Tillgren, P. (1996) Creating 
Supportive Environments for Health: Stories from the Third International 
Conference on Health Promotion, Sundsvall, Sweden, WHO, Geneva, 
Switzerland. 
Hamel, Jacques., Dufour, Stephane., & Fortin, Dominic (1993) Case Study 
Methods, Newbury Park: Sage. 
Hancock, T. (1998) 'Coveat Partner: Reflections on Partnerships with the 
Private Sector,' Health Promotion International 13(3):193-196. 
Hancock, T. (1985) 'Beyond Health Care: From Public Health Policy to 
Healthy Public Policy', Canadian Journal of Public Health, 76, supp. 1 
(May-June) 
Handyside, A., Dennis, R., and Sy A (1998) Case Study of the PSI Social 
Marketing Program in Cameroon, Report No. 97-113-61 USAIDS, 
<http://pdf.usaid.gov/pdCdocsIPNACJOI7.pdf.> (Accessed: 03/0112008) 
Hargittai, E. and Centeno, M.A. (2001) 'Introduction: Defining a Global 
Geography', American Behavioural Scientist 1 0(44): 1545-1560. 
Haupt, Werner (1984). Deutschlands Schutzgebiete in Ubersee 1884-1918. 
[Germany's Overseas Protectorates 1884-1918]. Friedberg: Podzun-Pallas 
Verlag. 
Helpman, E. (1993) 'Innovation, Imitation and Intellectual Property Rights' 
Econometrica, 6(61):1247-1280. 
Helpman, Elhanan and Krugman, Paul R. (1985) Market Structure and Foreign 
Trade, Cambridge, MA: MIT Press. 
Hesse, Mary (1966) Models and Analogies in Science. Milwaukee: University 
of Notre Dame Press. 
370 
Hill, Charles W.L. (2006) International Business: Competing in the Global 
Marketplace, NY: McGraw Hill Inc., pp. 156-157 
Holm, K. (2001) 'Public-Private Partnerships for Health and Guaranteeing 
Drug Delivery Through Health Systems: Issues Needing Further Analysis'. 
Report of a Meeting Hosted by the London School of Hygiene and Tropical 
Medicine, September 27-28, London. 
Hopf, T. (1998) 'The Promise of Constructivism in International Relations 
Theory' International Security 23(1): 170-200. 
Hopf, Ted (2002) Social Construction of International Politics: Identity and 
Foreign Policy, Moscow, 1955 and 1999. Ithaca, New York and London: 
Cornell University Press. 
House, Peter W. and McLeod, John (1977) Large-Scale Models for Policy 
Evaluation. New York: John Wiley & Sons 
IMF (1995) Cameroon - Background Papers and Statistical Appendix, IMF 
Staf!Country Report No. 95/5 
Jasanoff, S. (1999) 'SIS and Public Policy: Getting Beyond Deconstruction' 
Science, Technology and Society, 4(1 ):59-70. 
Johnson-Laird, P.N. and Byrne, R.MJ. (1999) 'Models Rule, OK? A Reply to 
Fetzer,' Mines and Machines, 9(1):111-118. 
Joseph, S. (2003) 'Pharmaceutical corporations and access to drugs: the 
"fourthwave" of corporate human rights security' Human Rights 
Quarterly, 25: 425-452. 
JSI (1991) Interim evaluation, Maternal child health/child survival. USAID 
project no. 631-0056. 
371 
Kabemba, C. (2003) 'Regional Report: Central Africa' In Global Corruption 
Report, pp. 227-236, Transparency International. 
Kaplan, T.1. (1986) 'The Narrative Structure of Policy Analysis' Journal of 
Policy Analysis and Management, 5(4):761-778. 
Kaul, I. (2006) 'Exploring the Policy Space Between Markets and States: 
Global Public-Private Partnerships'. In Kaul, Inge and Pedro Conceicao 
(Eds.) The New Public Finance: Responding to Global Challenges, pp. 
219-268, New York: UNDP/Oxford University Press. 
Kanner, M.D. (2004) 'Framing and the Role of the Second Actor: An 
Application of Prospect Theory to Bargaining,' Political Psychology 
25(2):213-239. 
Kelle, Udo (1995) Computer-Aided Qualitative Data Analysis: Theory, 
Method and Practice. 1 st Edition, Thousand Oaks, CA: Sage Publications. 
Kickbusch I (1999) Global + local = glocal public health Journal of 
Epidemiology and Community Health 53(8):451-452. 
Kickbusch, I. and Quick, J. (1998) 'Partnerships for health in the 21st century', 
World Health Statistics Quarterly, 51 :68-74. 
King, J.L. and Kraemer, K.L. (1992) Models, Facts, and the Policy Process: 
The Political Ecology of Estimated Truth, Center for Research on 
Information Systems and Organizations, (CRITO) Working Paper #URB-
006 
Kingdon, John W. (1984) Agendas, Alternatives and Public Policies Boston: 
Little, Brown & Co. 
Kofele-Kale, N. (1986) 'Ethnicity, regionalism and political power: a post-
mortem of Ahidjo's Cameroon,' In Michael G. Schatzberg and I. William 
372 
Zartman (Eds) The Political Economy of Cameroon. pp. 53·82, New York: 
Peager Publishers. 
Krieger, M.H. (1986) 'Big Decisions and a Culture of Decisionmaking' 
Journal of Policy Analysis and Management. 5(4):779.797 
Kreuter, M. (1992) 'PATCH: its origin, basic concepts, and links to 
contemporary public health policy' Journal of Health Education, 
23(3):135-139. 
Kreuter, M.W. and Skinner, C.S. (2000) 'Tailoring: what's in a name?' Health 
Education Research 15(1):1-4. 
Kvale, Steinar (1996) InterViews: An Introduction to Qualitative Research 
Interviewing. London: Sage Publications. 
Latour, Bruno (1999) Pandora's Hope: Essays on the Reality of Science 
Studies Cambridge, MA: Harvard University Press. 
Latour, Bruno and Woolgar, Steve (1986) Laboratory Life: The Construction 
of Scientific Facts. Princeton: University Press. 
LeVine, V. T. (1997) 'The Fall and Rise of Constitutionalism in West Africa,' 
Journal of Modern African Studies, 35(2): 181-206. 
LeVine, Victor T. and Nye, Roger P. (1974) Historical dictionary of Cameroon 
Rowman & Littlefield Publishers 
LeCompte, M.D. and Goetz, J.P. (1982) 'Problems of Reliability and Validity 
in Ethnographic Research', Review of Educational Research 52:31·60. 
Lengeler, C. (2004) 'Insecticide-treated Bed Nets and Curtains for Preventing 
Malaria' Cochrane Database o/Systematic Review (2), CD000363. 
Lewis, Jenny M. (2005) Health Policy and Politics: Networks. ideas and 
power, Melbourne: IP Communications. 
373 
Lind, Per (1991) Computerization in Developing Countries: Model and 
Reality, Routledge, London. 
Lipset, S.M. (2000) 'Corruption, Culture, and Markets,' Culture Matters: 113-
124. 
Litvack, 1.1. and Bodart, C. (1993) User fees plus quality equals improved 
access to health care: results of a field experiment in Cameroon. Social 
Science and Medicine, 37(3):369-83. 
Loue, S. (2006) 'Community Health Advocacy' Journal of Epidemiology & 
Community Health, 60(6):458-463. 
Lucas, R (1988) 'On the Mechanics of Economic Development' Journal of 
Monetary Economics 22 (1):3-42. 
Mabaso, M.L.H., Sharp, B., & Lengeler, C. (2004) 'Historical review of 
malarial control in Southern African with emphasis on the use of indoor 
residual house-spraying', Tropical 'Medicine and International Health, 
9(8): 846-856. 
MacDougall, H. (2007) 'Reinventing public health: A New Perspective on the 
Health of Canadians and its International Impact', Journal of Epidemiology 
and Community Health 61 :955-959 
MacKenzie, Donald (2006) An Engine, Not a Camera: How Financial Models 
Shape Markets. Cambridge (MA): MIT Press. 
MacKenzie, Donald and Wajcman, Judy (1987) The Social Shaping of 
Technology. Open University Press, Buckingham. 
MacKenzie, D. and Wajcman, 1. 1999 (1995). "Introductory Essay" in The 
Social Shaping of Technology: How the refrigerator got its hum, UK: Open 
University Press, pp. 2-25. 
374 
MacRae, DJr. (1980) 'Concepts and Methods of Policy Analysis', Policy 
Studies Annual Review, 4:74·80. 
Mann, J.M. (1999) 'Medicine and public health, ethics and human rights' In: 
Mann JM, Gruskin S, Grodin MA, Annas GJ, (eds). Health and Human 
Rights: A Reader. New York: Routledge, PartVI:439·445. 
Mann, Jonathan M., Sofia Gruskin., Michael A Grodin., & George A. Annas 
(1999) Health and Human Rights -A Reader, New York: Routledge. 
Marks G. (1993) Structural Policy and Multi·Level Governance in the EC, In 
Cafruny A W, Rosenthal G. (Eds.) The State of the European Community: 
The Maastricht Debates and Beyond. Boulder, Colorado: Lynne Reiner. 
Marsh D. (1998) Comparing Policy Networks Open University Press. 
Martens, J. (2007) 'Multistakeholder Partnerships: Future Models of 
Multilateralism?' Dialogue on Globalization: Occasional Papers, No. 29. 
Berlin: Friedrich·Ebert·Stiftung. 
Mathews, J.T. (1997) 'Power Shift: The Rise of Global Civil Society.' Foreign 
Affairs, 76(1):50·66. 
Maskus, Keith E. (2000) Intellectual Property Rights in the Global Economy, 
Institute for International Economics, Washington, D.C. 
Maynard, Kent (2004) Making Kedjom Medicine: a History of Public Health 
and Well·Being in Cameroon Westport: Praeger. 
Mbaku, John M. (2004) Institutions and development in Africa, Africa World 
Press 
Mbaku, John M. (2005) Cultures and Customs of Cameroon, Greenwood 
Publishing. 
375 
McBeth, M.K., Shanahan, E.A., Arnell, RJ., & Hathaway, P.L. (2007) 'The 
Intersection of Narrative Policy Analysis and Policy Change Theory' The 
Policy Studies Journal, 35(1):87-108 
McKeown, Thomas (1979) The Role of Medicine: Dream, Mirage or Nemesis? 
Oxford: Basil Blackwell. 
McKinlay, J.B. and McKinlay, S.M. (1977) 'The Questionable Contribution of 
Medical Measures to the Decline of Mortality in the United States in the 
Twentieth Century' Millbank Memorial Fund Quarterly, Health and 
Society 55(3):405-428. 
McConnick J. (2001) Environmental Policy in the European Union. New 
York: Palgrave. 
Michel, M. (2007) 'La Guerre Oubliee du Cameroun' L 'Histoire, 318:50-53. 
Midgley, James., Hall, Anthony., Margaret Hardiman, Margaret., & Methuen, 
Dhanpaul N. (1986) Community Participation, Social Development and the 
State, London: Methuen. 
MoH (2000). HIPIC Budget: Health and HIV/AIDS. Ministry of Health, 
. 
MIN SANTE Cameroon. 
MoH (2002). Strategie Sectorielle de Sante: Analyse Situationnelle du Secteur 
Sante au Cameroun, Ministry of Public Health, Yaounde - Cameroon (pp. 
32-49). 
Moravcsik, A. (1997) 'Taking Preferences Seriously: A Liberal Theory of 
International Politics,' International Organization 51(4):513-553. 
Morgan, Mary S. and Morrison, Margaret. (1999) Models as Mediators: 
Perspectives on Natural and Social Sciences, Cambridge: University Press. 
376 
Morton, A. and Suarez, M. (2001) 'Kinds of Modcls' In Anderson, Malcolm G. 
and Paul D. Bates (Eds) Model Validation: Perspectives in Hydrological 
Science, pp. 11·21, New York: John Wiley and Sons, Ltd. 
Mosoko, J.J. and Affana G.A.N (2004) 'PREVALENCE DU VIII ET 
FACTEURS ASSOCIES (Prevalence of HIV I AIDS and Associated 
Factors), In DHS Final Reports: Cameroon, Demographic and Health 
Survey, US AID, Chapter 16: 293·314 
<http://www.measuredhs.comlpubs/pdflFRI63/16chapitreI6.pdf.> 
(Accessed: 25105/2008) 
MSF (2002) Untangling the Web of Price Reductions: A Pricing Guide for the 
Purchase of ARVs for Developing Countries, 2nd Edition, 22 June 2002 
<http://www.accessmedmsf.org/prod/publications> (Accessed: 
15/10/2007). 
MSF (2002a) Campaign for Access to Essential Medicines - From Durban to 
Barcelona: Overcoming the Treatment Deficit, MSF, Geneva (July 2002). 
MSF (2002b) 'Le Journal Qui Vous Informe Des Actions Que Vous Rendez 
Possibles', Medecin Sans Frontieres, Geneva, Switzerland. 
<http://www.msf.chlfileadminluser_upload/uploads/ligne _ directe/LD60 _ fro 
pdf.> (6/1/2007). 
MSF (2003) Untangling the Web of Price Reductions: A Pricing Guide for the 
Purchase of ARVsfor Developing Countries, 4th Edition, Geneva. 
MSF. (2004). Ethiopia: advancing treatment for deadly diseases. MSF online 
06.12.04. <http://www.msf.org/msfinternationall> . Accessed 21/02/07. 
377 
Muraskin, W. (1998) The politics of international health. The children's 
vaccine initiative and the struggle to develop vaccines for the third world. 
New York: State University of New York Press. 
Murphy, Elizabeth and Dingwall, Robert (2003) Qualitative Methods and 
Health Policy Research. New York: Aldine de Gruyter. 
Nabarro, D. (1998) 'Roll Back Malaria (RBM): WHO Malaria Briefing' UK 
Department for International Development. 
<www.malaria.org/pptlrbm.htm>. (Accessed 04/04/07). 
Nabarro, D.N. and Tayler, E.M. (1998) 'The "Roll Back Malaria" Campaign', 
Science 280:2067-2068. 
NACC (2001) Programme Multisectoriel de lutte contre Ie sida (Multi sectoral 
Programme for the Fight Against HIV 1 AIDS), Cameroon, April 2001. 
NACC (2008) Cameroon: Mise en Oeuvre de la Declaration D'engagement sur 
Ie VIHlSID, Rapport De Progress No.3. (National AIDS Control 
Committee); Cameroon. 
Nagel, Ernest (1961) The Structure of Science. New York: Harcourt, Brace & 
World. 
Najera, J.A. (2001) 'Malaria control: achievements, problems and strategies', 
Parassitologia, 43:1-89. 
Najera, J.A., Kouznetsov, R.L. and Delacollette, C. (1998) Malaria Epidemics 
Detection and Control Forecasting and Prevention, WHO/MAL/98.1 084. 
Ndongko, W. A. (1986) "The Political Economy of Development in 
Cameroon: relations between the state, indigenous business, and foreign 
investors". In: Michael, G. S. and Zartman, I. W. The Political Economy of 
Cameroon. P. 33-110, New York, Praeger Publishers. 
378 
Nelson, J. (2002) Building Partnerships: Cooperalion belween Ihe United 
Nations Syslem and the Private Sector. New York: United Nations 
Department of Public Information 
Newell, A. and Simon, H.A. (1963) 'GPS, a program that simulates human 
thought' In Feigenbaum, Edward A. and Julian Feldman (Eds) Computers 
and Thought, pp. 279-293, New York: McGraw-Hill (Originally published 
in 1961). 
Newell, Allen and Simon, Herbert A. (1972) Human Problem Solving, 
Englewood Cliffs, NJ: Prentice-Hall. 
Ngoasong, M.Z. (2007). Does Innovation Matter for Economic Development? 
An empirical study of small and medium-sized enterprises in the city of 
Kumba- Cameroon, NEGOTIA, 52(1): 91-110. 
Ngoasong, M.Z. (2009) 'The Emergence of Global Health Partnerships as 
Facilitators of Access to Medication in Africa: a narrative policy analysis' 
Social Science & Medicine 68(5): 949-956. 
Ngoh, V. J. (1987) Cameroon 1884-1985: A Hundred Years of Hislory, Navi-
Group Publications, Limbe. 
Ngufor, G.F. (1999) 'Public service reforms and their impact on health sector 
personnel in Cameroon' In ILO/WHO Public service reforms and their 
impact on health sector personnel: pp. 1-42. 
Nielsen, Henrik K. (2001) The World Heallh Organisalion: Implementing the 
Right to Health, 2nd Edition, Copenhagen: Norsker & Co. 
Nishtar, S. (2004) 'Public-Private Partnerships in Health: A Global Call to 
Action.' Health Policy Research and Systems 2(5):1-7. 
379 
Njechu, C.J. (2008) 'Scientists Condemn NACC Communication Strategy' The 
Post Online, 17/0112008 
<http://www.postnewsline.coml2008/0 1 Iscientists-cond.html> (Accessed: 
25/05/2008). 
Njoh, Ambe J. ( 2006) Tradition, Culture and Development in Africa: 
Historical Lessons for Modern Development Planning Ashgate 
Publishing, pp.156-157. 
NMCP (2002) National Malaria Control Programme (Decision N° 0334IMSP/CAB), 
Yaounde, Cameroon, Document available online: 
<http://www.pnlpcameroon.org!> (Accessed: 2011212006) 
Nsom, K. (2008) 'Cameroon: Corruption Hinders Distribution of Subsidized 
Malaria Drugs' The Post Online, 22/02/2008 
<http://allafrica.com/stories/200802221214.html> 
28/05/2008). 
(Accessed: 
Nordstrom, Hakan (2000) 'The Trade and Development Debate - An 
Introductory Note with Emphasis on WTO Issues' 
Ntangsi, J. (1998) An Analysis of Health Sector Expenditures in Cameroon 
Using a National Health Accounts Framework, Takemi Program in 
International Health, Harvard School of Public Health, USA. 
Odell, 1. and Sell, S. (2003) 'Reframing the Issue: The WTO Coalition on 
Intellectual Property and Public Health, 2001' Paper Presented at 
Developing Countries and the Trade Negotiation Process, UNCTAD, 
Geneva, 6-7 November 
Ofeh, M.A. and Njong, M.A. (2006) 'Exploring Co-operation in a health 
programme based on community participation: The case of NWPSFH in 
Cameroon,' Journal for Sustainable Development in Africa, 8(2):68-80. 
380 
Ogden, J., Walt, O. and Lush, L. (2003) The Politics of 'Branding' in Policy 
Transfer: the case of DOTS for tuberculosis control. Social Science and 
Medicine 57(1):179-188. 
Oliver, A.L. and Ebers, M. (1998) 'Networking Network Studies: An Analysis 
of Conceptual . Configurations in the Study of Inter-Organizational 
Relationships' Organizational Studies 19(4):549-583. 
Patton, A. (1996) Physicians, Colonial Racism and Diaspora in TVest Africa. 
Miami: University Press of Florida. 
Pearson, L.B. (1969) Partners in development: Report of the Commission on 
International Development. London: Commission on International 
Development. 
Peters, D.H. and Philips, T. (2004) Mectizan Donation Program: Evaluation of 
a Public-Private Partnership' Tropical Medicine and International Health, 
9(4):A4-AI5. 
Piachaud, B. S. (2005) 'Challenges to improving access to essential drugs: 
perspectives from across the divide', International Journal of Technology 
and Globalisation, 1 (2): 
Pianta, R.C. and Rimm-Kaufman, S. (2006) 'The Social Ecology of the 
Transition to School: Classrooms, Families and Children; In Debora Philips 
and Kathleen McCartney (Eds.) The Blackwell Handbook of Early 
Childhood Development Blackwell Publishing, Part VI, Chapter 24:490-
507. 
Porter, Michael (1990) The Competitive Advantage of Nations New York: The 
Free Press. 
381 
Powell, Walter W. and Dimaggio, Paul (1991) The New Institutionalism in 
Organizational Analysis, Chicago: University Press. 
Prior, L. (2001) 'Rationing Through Risk Assessment in Clinical Genetics: All 
Categories Have Wheel', Sociology of Health & Illness 23(59):570-593. 
Prochaska, J . ~ . . and DiClemente, C.C. (1983) 'Stages and processes of self-
change of smoking: Toward an integrative model of change' Journal of 
Consulting and Clinical Psychology 51(3):390-395. 
PSI (2004) 'ITN National Social Marketing Project in Cameroon Midtenn 
Evaluation Report' Population Service International (PSI), 
<http://pdf.dec.org/pdCdocsIPDACD279.pdf.> Accessed: 25/09/2008. 
Quade, E.S. (1975) Analysis for Public Decisions New York: Elsevier. 
Radnor, M., Rubenstein, A.H. and Tansik, D. (1970) 'Implementation in 
Operative Research and R&D in Government and Business Organizations' 
Operations Research, 18:967-981. 
Rawson, D. (1992) 'The Growth of Health Promotion Theory and its Rational 
Reconstruction: Lessons from the Philosophy of Science' In Bunton, Robin 
and Macdonald, Gordon (Eds) Health Promotion: Disciplines and 
Diversities. Page? London: Routledge. 
RBM (2002) 'Achieving Impact: Back Malaria in the Next Phase' Final Report 
of the External Evaluation of Roll Back Malaria, Malaria Consortium, 
November 2002: <http://pdf. usaid.gov/pdC docsIPCAAB3 82. pdf.> 
Accessed: 29/09/2007. 
Redfield, P. (2008) 'Doctors, Borders, and Life III Crisis', Cultural 
Anthropology, 20(3):328-361. 
382 
Reich, M.R. (1995) 'The Politics of Agenda Setting in International Health: 
child health versus adult health in developing countries' Journal oj 
International Development 7(3):489·502. 
Reinicke, Wolfgang H. and Deng, Francis, M. (2000) Critical Choices: The 
United Nations, Networks, and the Future oj Global Governance (Eds), 
International Development Research Center. 
Richards, T. and Richards, L. (1998) 'Using Computers in Qualitative 
Research' Denzin, Norman and Lincoln, Yvonna (Eds) Collecting and 
Interpreting Qualitative Materials. Thousand Oaks: Sage. Page? 
Richter, J. (2004a) 'Public·Private Partnerships for Health: A Trend With no 
Alternatives?' Development 47:43-48. 
Richter, J. (2004b) Public-Private Partnerships and HealthJor All: How can 
WHO Safeguard Public Interests? Helsinki: Ministry of Foreign Affairs, 
Finland. 
Ridde, V. (2003) Fees-far-services, cost recovery, and equity in a district of 
Burkina Faso operating the Bamako Initiative, Bulletin oJthe World Health 
Organization 81 (7):542-538. 
Roberts, K. and Wilson, R. (2002) 'ICT and Research Process: Issues Around 
the Compatibility of Technology with Qualitative Data Analysis', Forum 
Qualitative SozialJorschung (FQS), 3(2) May, 
Roe, E. M. (1989) 'Narrative Analysis for the Policy Analyst: A Case Study of 
the 1980-1982 Medfly Controversy in California' Journal of Policy 
Analysis and Management 8 (2): 251-273. 
Romer, P.M (1986) 'Increasing Returns and Long-Run Growth' Journal oj 
Political Economy 94(5):1002-37. 
383 
Romer, P.M. (1990) 'Endogenous Growth and Technical Change' Journal of 
Political Economy, 99(4):807-827. 
Rosenberg, Tina (2004) 'What the World needs now is DDT' The New York 
Times Available Online: 11 April 2004) 
<http://www.nytimes.coml2004/04111 /magazine/ll DDT.html?pagewanted 
=all> (Accessed: 13/02/2007). 
Rosenstock, I. M (1974) 'Historical Origins of the Health Belief Model' Health 
Education Monographs, 2(4):328-335. 
Rothman, Jan (1968) Three Models of Community Organization Practice in 
Social Work Practice, New York: Columbia University Press. 
Rothman, Jack (2001) 'Approaches to Community Intervention' In: Rothman, 
Jack., Erlich, John L., & Tropman, John E. (Eds.) Strategies of Community 
Intervention, Itasca, Ill.: Peacock Publishers, Inc. (pp. 27-64). 
Rowlands, M. and Wamier, J.-P., (1988) 'Sorcery, Power and the Modem State 
In Cameroon' Man. 23(1):118-32. 
Sachs, 1. and Malaney, P. (2002) 'The economic and social burden of malaria', 
Nature, 415(6872): 680-686. 
Sahay, S. and Walsham, G. (1997) 'Social Structure and Managerial Agency in 
India' Organization Studies, 19(3):415-444. 
Sakakibara, M. and Branstetter, L. (2001) 'Do Stronger Patents Induce More 
Innovation? Evidence from the 1988 Japanese Patent Law Refonns' Rand 
Journal of Economics. 32(1):77-100. 
Schnee, H. (2007) German Colonization Past and Future - The Truth about the 
German Colonies, Read Books, (Reprint of 1926 edition). 
384 
Schlich, T. (2001) 'Book Review: Wolfgang U. Eckart (1997) Medizin und 
Kolonialimperialismus: Deutschland 1884-1945 Paderborn, Germany: 
Ferdinand Schaningh' Bulletin of the History of Medicine, 75(1):154-155, 
Schultz, Randall L. and Sleven, Dennis P. (1975) Implementing Operations 
Research/Management Science, New York: American Elsevier. 
Schulz, C.-E. (2001). Pen gene og livet, in Nrerstad, A. (ed.), Globaliser 
kampen, globaliser hapet, Utviklingsfondet Oslo. In: PIUSS (Norwegian 
Association against AIDS) <http://www.pluss-lma.no!english!> Accessed: 
13/1 012007. 
Sell, S.K. (2004) 'The Quest for Global Governance in Intellectual Property 
and Public Health: Structural, Discursive, and Institutional Dimensions' 
Temple Law Review 77(2):363-399. 
Sell, S.K. and Prakash, A. (2004) 'Using Ideas Strategically: The Contest 
Between Business and NGO Networks in Intellectual Property Rights,' 
International Studies Quarterly 48:143-175. 
Shetty, P. (2004) 'Funding doubts for Roll Baek Malaria initiative', The Lancet 
-Infec-tious Diseases, 4(6):319. 
Sikkink K. (2005) Patterns of Dynamic Multilevel Governance and the Insider-
Outsider Coalition, In Porta DP, Tarrow S. (Eds.) Transnational Protest 
and Global Activism: people, passions and power. Lanham: Rowman and 
Littlefield: 151-174. 
Silverman, David (2001) Interpreting Qualitative Data: Methodsfor Analysing 
Talk, Text and Interaction, 2nd Edition, London: Sage Publications 
385 
Silverman, D. (2003) 'Analyzing Talk and Text' In Denzin, Norman and 
Yvonna Lincoln, (Eds) Collecting and Interpreting Qualitative Materials. 
Thousand Oaks: Sage. pp. 340-362. 
Simon, Herbert A. (1960) The New Science of Management Decision, New 
York: Harper. 
Simon, Herbert A. (1991) Models of My Life, New York: Basic Books. 
Slaughter, Anne-Marie (2004) A New World Order, Princeton: University 
Press 
Solow, R.M. (1956) 'A Contribution to the Theory of Economic Growth' 
Quarterly Journal of Economics 70(1 ):65-94. 
Swan, T.W. (1956) 'Economic Growth and Capital Accumulation' Economic 
Record,32(2):334-61. 
Stake, Robert E. (1994) The Art of Case Study Research, Thousand Oaks: 
Sage. 
Stone D. (2003) Policy Knowledge in the Global Agora, In Krizsan A, Zentai 
V. (Eds.) Reshaping Globalisation: multilateral dialogues and new policy 
initiatives. Budapest: Central European University Press: 41-62. 
Sturchio, J.L. (2004) 'Partnership for Action: The Experience of the 
Accelerating Access Initiative, 2000-04, and Lessons Learned', 
EssMedicine, Ch. 6:115-151. 
Suppe, Frederick (1977) The Structure of Scientific Theories, 2nd Edition, 
Urbana: University of Illinois Press. 
Tafah, E.E.O and Asondoh, R.T. (2000) 'Partnership Mix in Assisting Local 
Communities to reach Sustainable Development in Cameroon' 
International Journal of Public-Private Partnerships, 2(3):463-475. 
386 
Tchenga, M.K. (2008) 'Queen Mosquito: Strides have been made in the fight 
against the eradication of malaria but the disease's victor, the female 
Anopheles mosquito, still rules parts of the world' The Post Online: Date 
published online 
<http://www.postnewsmagazine.com/pages/health06.html> (15/612008). 
Tejada de Rivero, D.A (2003) Alma-Ata Revisited, Perspectives in Health 
Magazine The Magazine of the Pan American Health Organization 8(2):. 
<http://www.paho.orglEnglishlddlpinlNumberI7article}4.htm> 
(Accessed: 25101108). 
Tesh, Sylvia N. (1988) Hidden Arguments: Political Ideology and Disease 
Prevention Policy. New Brunswick, NJ: Rutgers State University. 
Toebes, B.C.A. (1999) 'The Rights to Health as a Human Right in International 
Law' Human Rights Research Series, 1:8-13; 
AntwerpenlGroningenlOxford. 
Tones, Keith and Tilford, Sylvia (2001) Health Promotion: Effectiveness, 
Efficiency and Equity, 3rd Edition, Cheltenham: Nelson Thomes. 
Trullen, J. and Stevenson, W.B. (2006) 'Strategy and Legitimacy: 
Pharmaceutical Companies' Reachtion to the HIV Crisis' Business & 
Society 45(2): 178-21 O. 
Turner, Bryan S. (1995) Medical Power and Social Knowledge, 2nd Edition, 
London: Sage. 
UN (2000a) 'Malaria: roll back campaign launched', Africa Recovery, UN 
Online, 14(2): July 
<http://www.un.org/ecosocdev/geninfo/afrec/voI14n02/watch2.htm> 
(Accessed: 11103/09) 
387 
UNAIDS (2000a). New public/private sector effort initiated to accelerate 
access to HIV / AIDS care and treatment in developing countries, UNAIDS, 
Geneva, 11 May. 
UNAIDS (2002) Keeping the Promise: Summary of the Declaration of 
Commitment on HIV/AIDS, UNGASS, 25-27 June 2001, New York, 
UNAIDS/02.31E (Geneva: UNAIDS). 
UNAIDS (2004) Report on the Global AIDS Epidemic: 4th Global Report, 
UNAIDS/04.16E (Geneva: UNAIDS). 
UNAIDS/WHO (2000) AIDS Epidemic Update: December 2000, 
UNAIDS/00.44E (Geneva: UNAIDS/WHO). 
UNAIDSIWHO (2002) 'Accelerating Access Initiative: Widening access to 
care and support for people living with HIV / AIDS' Progress Report, June 
2002, 
UNAIDS/WHO (2002a) AIDS Epidemic Update, UNAIDS/02.46E. Geneva, 
Switzerland (December). 
UNCTAD (1996) The TRIPS Agreement and the Developing Countries, 
UNCTAD Geneva. 
Utting, P. and A. Zammit, A. (2006) 'Beyond Pragmatism: Appraising UN-
Business Partnerships,' Markets, Business and Regulation Programme 
Paper Number 1, Geneva: United Nations Research Institute for Social 
Development (UNRISD). 
van de Walle, N (1994) Neopatrimonialism and Democracy in Africa, with an 
Illustration from Cameroon. In J. A. Widner, J.A. (Eds.) Economic Change 
and Political Liberalization in Sub-Saharan Africa, Baltimore: Johns 
Hopkins. 
388 
van Fraassen, Bas (1980) The Scientific Image, Oxford: Oxford University 
Press 
Walt, G. (2001) 'Global Cooperation in Global Public Health' In M. Merson, 
R. Black, and A. Mills (eds) International Public Health:67-99. 
Gaithersburg: Aspen Publishers. 
Walt, G., Pavignani E., Gilson L., & Buse, K. (1999) 'Managing External 
Resources in the Health Sector: Are there lessons for SWAps? Health 
Policy and Planning (14(3):273-284. 
Walt, G., Lush, L., & Ogden, J. (2004) 'International Organizations in Transfer 
of Infectious Diseases: Iterative Loops of Adoption, Adaptation, and 
Marketing' , 
Governance 17(2). 
W a s ~ a u s e n , , Helmut (1968). Hamburg und die Kolonialpolitik des Deutschen 
Reiches. [Hamburg and Colonial Politics of the German Empire]. 
Hamburg: Hans Christians Verlag. 
WEF (2005) Development-Driven Public-Private Partnerships in Health: 
Emerging Priorities for Roundtable Discussions. Geneva: World Economic 
Forum <http://www.weforum.org!pdflppp_health_summary.pdf.> 
Accessed: 30/07/2008). 
Weinstein, N.D. (1988) 'The precaution adoption process' Health Psychology, 
7(4):355-386 
Wendt, A. (1992) 'Anarchy is what states make of it' International 
Organization 46: 391-425. 
Wendt, Alexander (1999) Social Theory of International Politics. New York: 
Cambridge University Press. 
389 
Whitelaw, S., McKeown, K. & Williams, J. (1997) 'Global Health Promotion 
Models: Enlightenment or Entrapment', Health Education Research: 
Theory and Practice, 12(4):479-490. 
WHO (1978) Primary Health Care: Report on the International Conference on 
Primary Health Care, Alma Ata, 6-12 September. Geneva: WHOIUNICEF. 
WHO (1986) The Ottawa Charter for Health Promotion, Health Promotion, 
1(4): i-v. 
WHO (1988) 'Antimalarial Activities: The,Last 40 Years: Antimalarial Action 
Program' World Health Statistic Quarterly, 41: 64--73. 
WHO (1990) Report of the Consultation on AIDS and Traditional Medicine: 
Prospects for Involving Traditional Health Practitioners, paper presented at 
1990 Traditional Medicine Programme and Global Programme on AIDS, 
Francistown, Botswana, 23-27 July. 
WHO (1993) Report of a WHO Study Group on the Implementation of the 
Global Plan of Action for Malaria Control 1993-2000, Technical Report 
Series, No 839, Geneva: WHO. 
WHO (1994) Antimalarial drug policies: data requirements, treatment of 
uncomplicated malaria and management of malaria in pregnancy Geneva, 
WHOIMAL/94.1070. 
WHO (1996). Assessment of therapeutic efficacy of antimalarial drugs for 
uncomplicated falciparum malaria in areas with intense transmission. 
Geneva, WHOIMAL/96.1077. 
WHO (1999) Guidelines on Collaboration and Partnerships with Commercial 
Enterprises (Unpublished Document). Geneva: WHO. 
390 
WHO (2000). WHO expert committee on malaria 20th Report. WHO 
Technical Report Series 892. WHO, Geneva. 71 pp. 
WHO (2000a) The African Summit on Roll Back Malaria, Abuja, April 2000, 
World Health Organization, Geneva, WHO/CDs/RBMl2000.17. 
WHO (2001) Macroeconomics and Health: Investing in Health for Economic 
Development Geneva: Commission on Macroeconomics and Health, WHO. 
<http://whqlibdoc. who.intlpublications/200 1/924154550x. pdt> Accessed: 
25101108). 
WHO (2002) 'Scaling up the response to infectious diseases: A way out of 
poverty' Chapter 3: 42-60, Geneva, Switzerland. 
<http://www . who.intlinfectious-disease-
reportl2002/pdfversionlCh2HealthServices.pdt> (Accessed: 30/08/07). 
WHO (2002a) A Commitment to Action for Expanded Access to HIVIAIDS 
Treatment, International HIV Treatment Access Coalition, 
WHOIHIV 12002.24. 
WHO (2002b). Scaling up Antiretroviral Therapy in Resource-Limited 
Settings: guidelines for a public health approach, WHO: NLM 
classification: QV 268.5. 
WHO (2003) Essential Medicines. WHO Model List, 13th Edition 
WHO (2003). Assessment and monitoring of antimalarial drug efficacy for the 
treatment of uncomplicated falciparum malaria. Geneva, 
WHOIHTMlRBMl2003.50. 
WHO (2004) World Medicine Situation WHOIEDMlPARl2004.5 
WHO (2004a) Essential Drugs and Medicines Policy, Available Online: 
<http://www.who.intlmedicines> (Accessed: 13/06/2008). 
391 
WHO (2004b) 'Position Paper of WHO Roll Back Malaria Department on 
Malaria Treatment Policy'. Geneva: WHO 
WHO (2005) Price, availability and affordability, An international comparison 
of chronic disease medicines, WHO Background Report, WHO, Geneva. 
WHO (2005a) Cameroon: Summary Country Profile for HIV/AIDS Treatment 
Scale-up 
13/2/2007) 
<http://www.who.intlhivIHIVCP_CMR.pdf.> (Accessed: 
WHO (2006) The Global Plan to Stop TB, 2006-2015. Geneva. 
(WHOIHTMISTB/2006.35). 
WHOIUNICEF (2003) Africa Malaria Report 2003 
WHO/CDSIMAL/2003.1093 
WHOIUNICEF (2005) Africa Malaria Report 2005 WHO/incomplete? 
WHOIUNICEF (2005a) World Malaria Report 2005. Geneva: World Health 
Organization <http://rbm.who intlwmr2005/> (Accessed: 15/0112007). 
Widdus, R. (2003) 'Public-Private Partnerships for Health Require Thoughtful 
Evaluation', Bulletin of the World Health Organization, 81(4):235. 
World Bank (1989) World Development Report: Cameroon, Oxford: 
University Press. 
World Bank (1996) Participation Sourcebook Washington, D.C.:The World 
Bank 
World Bank (1998) Partnership for development: Proposed actions for the 
World Bank. Washington, DC: World Bank. 
World Bank, (2000) World Development Report, Washington D.C. The World 
Bank 
392 
World Bank (2007) The World Bank Booster Program for Malaria Control in 
Africa: Scaling-Up for Impact (SUFI) - A Two-Year Progress Report, 
Malaria Implementation Resource Team for Africa, World Bank 
Woods, N. (2007) War by Other Means - Part 1: The Secretive World of Trade 
Negotiations, British Broadcasting Corporation (BBC), Online 
(08/0112007): 
<http://news.bbc.co.ukI2Ihi/programmes/documentary_archive/6242451.st 
m> (Accessed: 15/12/2008) 
WTO (2001) 'Declaration on the TRIPS Agreement and Public Health' Doha 
WTO Ministerial Declaration: TRIPS, WTIMIN(01)IDEC/2 (20 November 
2001). 
Yach, D and Bettcher, D .. (1998) 'The Globalization of Public Health: Threats 
and Opportunities' Americanjournal of public health, 88(5):735-738. 
Yin, Rober K. (1989) Case Study Research: Design and Methods, 1 st Edition, 
London: Sage. 
Yin, Rober K. (1994) Case Study Research: Design and Methods, 2nd Edition, 
London: Sage. 
Yin, Robert K. (2003) Case Study Research: Design and Methods 3rd Edition, 
London: Sage. 
Zacher M. (1999) 'Uniting Nations: Global Regimes and the United Nations 
System' In. Vayrynen, Raimo V (ed) Globalization and Global 
Governance, Lanham: Rowman and Littlefield. 
Zilber, B.T. (2007) 'Stories and the discursive dynamics of institutional 
entrepreneurship: the case of Israeli high-tech after the bubble' 
Organization Studies, 28(7): 1 035-1 054. 
393 
APPENDIX: INTERVIEW SCHEDULE 
A. The National Context of Access to Medication 
This Interview schedule was prepared for those respondents at national, 
provincial and district levels of the National health System who are not directly 
responsible for GIIP programmes. This includes the Division of Health 
Technology and lIealthcare Organization (}.[inistry of Health), Provincial and 
District Delegations for Public Health in the Centre and North West Provinces 
including a selection a/hospitals and pharmacies. 
Tell me about Cameroon's national health system. How can you describe the 
structures in place that hospitals and pharmacies can follow? 
There are public, private and NGO sources of financing and health care 
providers in Cameroon today. In what ways do national health policies relate to 
the role of health care providers in these different sectors? What are the 
systems and policies in place to ensure acceptable standards of health care 
delivery? 
How can you assess the structure of the national health system in terms of the 
need to serve all segments of the population (rural vs. urban, rich vs. poor, 
publie vs. private, profit vs. non-profit)? 
394 
My research focuses on malaria and IIlV/AIDS. \Vhat do you see as the major 
barriers to access to medication for malaria and IIlV/AIDS and what is the rotc 
of the government in dealing with those barriers? 
As you may know Cameroon has endorsed several OUPs. \Vhy do you think 
the government decided to join these initiatives (R&D nnd marketing vs. 
philanthropy and drug donation programmes)? 
How would you classify the national health system within the institutional set 
up of a GHP? How compatible nrc national OUP programmes \\;thin the 
national health system in Cameroon? 
What types of assistance do you receive from OllPs in designing and 
implementing health interventions? In what ways does the government 
allocate such assistance to satisfy the pluralistic health care system? 
How would you judge overall country and local level awareness and 
satisfaction with the role of OHPs in providing, monitoring and evaluating 
national and local level programmes? 
How well do you understand the direction of the Govcrnment (nt national nnd 
local levels) in regards to National GIIP Programmes nnd nctivitics and the 
benefits that have been realized? 
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B. GHPs and Access to Medication for Malaria and 
HIV/AIDS 
This interview schedule was prepared for global. national and local GHP 
partners. The questions were modified depending on which of these levels a 
respondent is located. the type of GHP (RBAI. AAI. EAI) and the disease area 
(malaria. HI VIA IDS). 
What do you see as the main problems that a country like Cameroon is facing 
in the fight against malaria (or HIV/AIDS)? How is it that everyone has 
suddenly realised that such problems need to be addressed through GHPs ? 
Why did your organization become involved in GHPs? What does your 
organization benefit out of this? How can you describe your role in OHPs at 
global, national and local levels? 
How does institutional diversity affect the allocation of initiative among 
partners within OHPs for defining goals and assessing results (governance 
issues and organizational arrangements in scaling up access to medication)? 
Can you tell me how bilateral negotiations take place between pharmaceutical 
companies and individual developing country governments? What is the role of 
OHPs in the effectiveness of such negotiations? 
What are the conditions that a developing country like Cameroon had to put in 
place before being accepted to join a GHP? 
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What steps are being taken within the AAI to ensure compatibility with country 
context. .. to ensure that the AAI does not end up as one of those previously 
failed policies? 
What are some of the problems of access to medication in Cameroon that you 
can attribute to the a) government (national health system) and b) global 
pharmaceutical and healthcare market? 
GHP policies are implemented in Cameroon through National Malaria (or 
HIV I AIDS) Programmes. In what ways does this take place? What is the role 
of your organization in the policy making and implementation process? 
A fundamental principle of GHPs is civil society participation (especially the 
representation of patient groups) in designing and implementing programmes 
and activities. How does this happen in practice? What arc the benefits of this 
approach? Do you know of any associated challenges? 
What measures are being taken to ensure that the selection of health units for 
malaria (or HIV/AIDS) patients satisfies the pluralistic nature of Cameroon's 
national health system (government, private, religious, NGDs, etc)? 
Most people undergoing treatment pay a certain amount of money per year and 
the government covers the remaining costs (through funding mobilized with 
the help of GHPs). To what extent is the government able to cover thcse costs? 
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To what extent do treatment costs impede effective delivery and utilization of 
medicines and care facilities? 
What (national and global) guidelines do specific GHP partners use in 
delivering treatment to patients and local levels? How do you perceive the type 
of activities that you implement in terms of the overall contribution to access to 
medication (potential vs. actual)? 
What do you see as the knowledge, perception and acceptability of treatment 
offered to patients in Cameroon by your organization as a partner to the 
National GHP Programmes? To what extent does this determine whether 
patients will seck treatment through your health centres as against specialised 
centres designated by national GHP programmes? 
What are some of the criticisms that have been directed at GHPs and what 
prospects do you see for the future? 
398 
